1	The	DT	O	the	det	3	SENT_1	[p1l459t88r503b110],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_1	[p1l512t88r741b117],
3	journal	NN	O	journal	nsubj	5	SENT_1	[p1l749t88r833b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l844t88r920b116],
5	2005	CD	DATE	2005	_	0	SENT_1	[p1l844t88r920b116],
6	)	NN	O	)	nsubj	17	SENT_1	[p1l844t88r920b116],
7	5	CD	NUMBER	5	num	6	SENT_1	[p1l930t89r949b114],
8	,	,	O	,	_	0	SENT_1	[p1l930t89r949b114],
9	292-297	CD	NUMBER	292-297	num	16	SENT_1	[p1l960t88r1053b110],
10	©	CD	NUMBER	©	number	11	SENT_1	[p1l349t120r365b139],
11	2005	CD	DATE	2005	num	16	SENT_1	[p1l373t120r419b139],
12	Nature	NNP	O	Nature	nn	16	SENT_1	[p1l429t120r491b139],
13	Publishing	NNP	O	Publishing	nn	16	SENT_1	[p1l501t119r594b145],
14	Group	NNP	O	Group	nn	16	SENT_1	[p1l603t120r661b145],
15	All	NNP	O	All	nn	16	SENT_1	[p1l669t119r691b139],
16	rights	NNS	O	rights	appos	6	SENT_1	[p1l700t119r751b145],
17	reserved	VBD	O	reserve	rcmod	5	SENT_1	[p1l760t119r835b139],
18	1470-269X	NN	O	1470-269x	dobj	17	SENT_1	[p1l845t119r979b141],
19	/	:	O	/	punct	23	SENT_1	[p1l845t119r979b141],
20	05	CD	NUMBER	05	dep	23	SENT_1	[p1l845t119r979b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l989t119r1053b140],
22	30.00	CD	MONEY	30.00	num	21	SENT_1	[p1l989t119r1053b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	5	SENT_1	[p1l857t165r1053b190],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t229r1919b268],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1938t229r2148b268],

1	B	NN	O	b	_	0	SENT_3	[p1l17t362r486b457],
2	.	.	O	.	_	0	SENT_3	[p1l17t362r486b457],

1	—	NN	O	—	_	0	SENT_4	[p1l17t362r486b457],
2	.	.	O	.	_	0	SENT_4	[p1l17t362r486b457],

1	B	NN	O	b	nn	3	SENT_5	[p1l17t362r486b457],
2	|	NN	O	|	nn	3	SENT_5	[p1l17t362r486b457],
3	ockade	NN	O	ockade	_	0	SENT_5	[p1l17t362r486b457],
4	and	CC	O	and	_	0	SENT_5	[p1l527t362r683b437],
5	increased	VBD	O	increase	amod	6	SENT_5	[p1l729t362r1129b437],
6	dyslipidemia	NN	O	dyslipidemia	conj_and	3	SENT_5	[p1l1173t362r1714b461],
7	in	IN	O	in	_	0	SENT_5	[p1l1759t364r1828b436],
8	patients	NNS	O	patient	prep_in	3	SENT_5	[p1l15t489r354b586],
9	bearing	VBG	O	bear	partmod	8	SENT_5	[p1l397t487r718b586],
10	Glu27	NN	O	glu27	nn	11	SENT_5	[p1l763t487r1022b562],
11	variant	NN	O	variant	dobj	9	SENT_5	[p1l1060t489r1359b562],
12	of	IN	O	of	_	0	SENT_5	[p1l1396t487r1479b562],
13	[	CD	NUMBER	[	number	14	SENT_5	[p1l1520t489r1605b582],
14	32	CD	NUMBER	32	prep_of	11	SENT_5	[p1l1520t489r1605b582],
15	adrenergic	JJ	O	adrenergic	amod	17	SENT_5	[p1l1646t487r2108b586],
16	receptor	NN	O	receptor	nn	17	SENT_5	[p1l15t620r378b710],
17	gene	NN	O	gene	dep	14	SENT_5	[p1l413t634r625b710],

1	G	NN	O	g	nn	3	SENT_6	[p1l10t797r40b832],
2	laccarinol	NN	O	laccarinol	nn	3	SENT_6	[p1l63t792r261b832],
3	V	NN	O	v	dep	16	SENT_6	[p1l8t856r37b890],
4	Trimarco	NNP	PERSON	Trimarco	dep	3	SENT_6	[p1l53t850r289b890],
5	"	``	O	"	punct	4	SENT_6	[p1l53t850r289b890],
6	2	CD	NUMBER	2	num	8	SENT_6	[p1l53t850r289b890],
7	F	NN	O	f	nn	8	SENT_6	[p1l12t914r29b948],
8	Lanni	NNP	PERSON	Lanni	dep	4	SENT_6	[p1l51t908r173b949],
9	‘	CD	NUMBER	‘	num	10	SENT_6	[p1l51t908r173b949],
10	E	NN	O	e	dep	16	SENT_6	[p1l12t972r31b1006],
11	Cipollettal	JJ	O	cipollettal	amod	16	SENT_6	[p1l50t966r265b1018],
12	R	NN	O	r	nn	16	SENT_6	[p1l12t1030r34b1065],
13	lzzol	NN	O	lzzol	nn	16	SENT_6	[p1l54t1024r146b1065],
14	O	NN	O	o	nn	16	SENT_6	[p1l10t1088r44b1123],
15	Arcucci3	NN	O	arcucci3	nn	16	SENT_6	[p1l62t1082r233b1123],
16	N	NN	O	n	dep	20	SENT_6	[p1l12t1147r42b1180],
17	De	NNP	PERSON	De	nn	18	SENT_6	[p1l65t1147r119b1181],
18	Luca	NNP	PERSON	Luca	dep	16	SENT_6	[p1l141t1140r247b1181],
19	‘	CD	NUMBER	‘	num	20	SENT_6	[p1l141t1140r247b1181],
20	G	NN	O	g	dep	22	SENT_6	[p1l10t1204r40b1239],
21	Di	NNP	O	Di	nn	22	SENT_6	[p1l63t1204r103b1239],
22	Renzoz	NNP	O	Renzoz	_	0	SENT_6	[p1l126t1199r268b1239],

1	‘	NNP	O	‘	nn	2	SENT_7	[p1l10t1294r17b1308],
2	Department	NNP	O	Department	_	0	SENT_7	[p1l25t1298r192b1330],
3	of	IN	O	of	_	0	SENT_7	[p1l201t1297r230b1322],
4	Clinical	JJ	O	clinical	amod	5	SENT_7	[p1l237t1297r337b1322],
5	Medicine	NN	O	medicine	prep_of	2	SENT_7	[p1l346t1297r475b1327],
6	,	,	O	,	_	0	SENT_7	[p1l346t1297r475b1327],
7	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	conj_and	5	SENT_7	[p1l490t1297r696b1322],
8	and	CC	ORGANIZATION	and	_	0	SENT_7	[p1l10t1334r64b1359],
9	Immunological	NNP	ORGANIZATION	Immunological	nn	10	SENT_7	[p1l76t1334r282b1367],
10	Sciences	NNPS	ORGANIZATION	Sciences	conj_and	5	SENT_7	[p1l294t1335r412b1364],
11	,	,	O	,	_	0	SENT_7	[p1l294t1335r412b1364],
12	School	NNP	ORGANIZATION	School	appos	5	SENT_7	[p1l428t1334r519b1359],
13	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l530t1334r558b1359],
14	Medicine	NNP	ORGANIZATION	Medicine	nn	17	SENT_7	[p1l568t1334r692b1359],
15	Federico	NNP	ORGANIZATION	Federico	nn	17	SENT_7	[p1l11t1371r121b1397],
16	II	NNP	ORGANIZATION	II	nn	17	SENT_7	[p1l134t1373r151b1396],
17	University	NNP	ORGANIZATION	University	prep_of	12	SENT_7	[p1l164t1372r299b1404],
18	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l310t1371r339b1397],
19	Naples	NNP	ORGANIZATION	Naples	prep_of	17	SENT_7	[p1l347t1371r448b1405],
20	,	,	O	,	_	0	SENT_7	[p1l347t1371r448b1405],
21	Naples	NNP	LOCATION	Naples	appos	5	SENT_7	[p1l464t1371r564b1405],
22	,	,	O	,	_	0	SENT_7	[p1l464t1371r564b1405],
23	Italy	NNP	LOCATION	Italy	appos	21	SENT_7	[p1l580t1371r648b1404],
24	;	:	O	;	_	0	SENT_7	[p1l580t1371r648b1404],
25	2Department	NN	O	2department	dep	5	SENT_7	[p1l9t1406r192b1442],
26	of	IN	O	of	_	0	SENT_7	[p1l204t1409r232b1434],
27	Neuroscience	NNP	O	Neuroscience	prep_of	25	SENT_7	[p1l241t1410r429b1439],
28	,	,	O	,	_	0	SENT_7	[p1l241t1410r429b1439],
29	Division	NNP	O	Division	appos	5	SENT_7	[p1l445t1409r552b1434],
30	of	IN	O	of	_	0	SENT_7	[p1l565t1409r594b1434],
31	Pharmacology	NNP	O	Pharmacology	prep_of	29	SENT_7	[p1l11t1446r214b1479],
32	,	,	O	,	_	0	SENT_7	[p1l11t1446r214b1479],
33	School	NNP	ORGANIZATION	School	appos	5	SENT_7	[p1l230t1446r321b1471],
34	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l332t1446r361b1471],
35	Medicine	NNP	ORGANIZATION	Medicine	nn	38	SENT_7	[p1l370t1446r494b1471],
36	Federico	NNP	ORGANIZATION	Federico	nn	38	SENT_7	[p1l506t1446r616b1471],
37	II	NNP	ORGANIZATION	II	nn	38	SENT_7	[p1l629t1447r645b1471],
38	University	NNP	ORGANIZATION	University	prep_of	33	SENT_7	[p1l12t1484r147b1516],
39	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l157t1483r186b1509],
40	Naples	NNP	ORGANIZATION	Naples	prep_of	38	SENT_7	[p1l195t1483r295b1517],
41	,	,	O	,	_	0	SENT_7	[p1l195t1483r295b1517],
42	Naples	NNP	LOCATION	Naples	nn	44	SENT_7	[p1l311t1483r412b1517],
43	,	,	O	,	_	0	SENT_7	[p1l311t1483r412b1517],
44	Italy	NNP	LOCATION	Italy	appos	5	SENT_7	[p1l428t1483r495b1516],
45	;	:	O	;	_	0	SENT_7	[p1l428t1483r495b1516],
46	3IRCCS	NNP	O	3IRCCS	nn	47	SENT_7	[p1l509t1480r606b1509],
47	NEUROMED	NNP	ORGANIZATION	NEUROMED	dep	5	SENT_7	[p1l10t1522r186b1551],
48	,	,	O	,	_	0	SENT_7	[p1l10t1522r186b1551],
49	Pozzilli	NNP	LOCATION	Pozzilli	nn	51	SENT_7	[p1l203t1521r303b1551],
50	,	,	O	,	_	0	SENT_7	[p1l203t1521r303b1551],
51	Italy	NNP	LOCATION	Italy	appos	5	SENT_7	[p1l319t1521r380b1554],

1	Correspondence	NN	O	correspondence	_	0	SENT_8	[p1l10t1603r271b1637],
2	:	:	O	:	_	0	SENT_8	[p1l10t1603r271b1637],
3	Professor	NNP	O	Professor	nn	6	SENT_8	[p1l11t1641r153b1666],
4	G	NNP	PERSON	G	nn	6	SENT_8	[p1l165t1642r186b1666],
5	Di	NNP	PERSON	Di	nn	6	SENT_8	[p1l202t1641r232b1666],
6	Renzo	NNP	PERSON	Renzo	dep	1	SENT_8	[p1l247t1642r348b1671],
7	,	,	O	,	_	0	SENT_8	[p1l247t1642r348b1671],
8	Department	NNP	ORGANIZATION	Department	appos	1	SENT_8	[p1l364t1642r551b1674],
9	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l563t1641r594b1666],
10	Neuroscience	NNP	ORGANIZATION	Neuroscience	prep_of	8	SENT_8	[p1l11t1679r224b1708],
11	,	,	ORGANIZATION	,	_	0	SENT_8	[p1l11t1679r224b1708],
12	Unit	NNP	ORGANIZATION	Unit	appos	1	SENT_8	[p1l237t1678r301b1703],
13	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l310t1678r342b1703],
14	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	12	SENT_8	[p1l352t1678r579b1711],
15	,	,	ORGANIZATION	,	_	0	SENT_8	[p1l352t1678r579b1711],
16	School	NNP	ORGANIZATION	School	appos	1	SENT_8	[p1l591t1678r691b1703],
17	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l9t1716r41b1741],
18	Medicine	NNP	ORGANIZATION	Medicine	nn	21	SENT_8	[p1l52t1715r191b1741],
19	Federico	NNP	ORGANIZATION	Federico	nn	21	SENT_8	[p1l204t1715r333b1741],
20	II	NNP	ORGANIZATION	II	nn	21	SENT_8	[p1l346t1717r361b1740],
21	University	NNP	ORGANIZATION	University	prep_of	16	SENT_8	[p1l375t1716r527b1749],
22	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l538t1715r569b1741],
23	Naples	NNP	ORGANIZATION	Naples	prep_of	21	SENT_8	[p1l580t1715r691b1749],
24	,	,	O	,	_	0	SENT_8	[p1l580t1715r691b1749],
25	via	IN	O	via	_	0	SENT_8	[p1l8t1753r51b1779],
26	5	CD	NUMBER	5	prep_via	1	SENT_8	[p1l65t1754r89b1779],
27	.	.	O	.	_	0	SENT_8	[p1l65t1754r89b1779],

1	Pansini	NNP	PERSON	Pansini	_	0	SENT_9	[p1l105t1753r211b1779],
2	5	CD	NUMBER	5	num	1	SENT_9	[p1l225t1754r242b1779],
3	80131	CD	NUMBER	80131	dep	1	SENT_9	[p1l255t1754r356b1784],
4	,	,	O	,	_	0	SENT_9	[p1l255t1754r356b1784],
5	Naples	NNP	LOCATION	Naples	nn	7	SENT_9	[p1l372t1753r483b1787],
6	,	,	O	,	_	0	SENT_9	[p1l372t1753r483b1787],
7	Italy	NNP	LOCATION	Italy	appos	3	SENT_9	[p1l499t1753r570b1787],
8	.	.	O	.	_	0	SENT_9	[p1l499t1753r570b1787],

1	Tel	NNP	O	Tel	_	0	SENT_10	[p1l8t1795r63b1820],
2	:	:	O	:	_	0	SENT_10	[p1l8t1795r63b1820],
3	+	CC	O	+	dep	5	SENT_10	[p1l83t1800r105b1822],
4	39 081 746 3317	CD	NUMBER	39 081 746 3317	num	5	SENT_10	[p1l299t1796r373b1820],[p1l114t1796r150b1820],
5	Fax	NN	O	fax	dep	1	SENT_10	[p1l11t1837r68b1861],
6	:	:	O	:	_	0	SENT_10	[p1l11t1837r68b1861],
7	+39 081 7463323	CD	NUMBER	+39 081 7463323	dep	8	SENT_10	[p1l237t1837r366b1861],[p1l89t1837r155b1864],
8	E-mail	NN	O	e-mail	parataxis	5	SENT_10	[p1l11t1873r111b1899],
9	:	:	O	:	_	0	SENT_10	[p1l11t1873r111b1899],
10	gdirenzo@unina.it	NN	O	gdirenzo@unina.it	dep	8	SENT_10	[p1l125t1873r409b1907],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l11t2598r154b2623],
2	:	:	O	:	_	0	SENT_11	[p1l11t2598r154b2623],
3	23	CD	DATE	23	num	4	SENT_11	[p1l168t2599r203b2623],
4	February	NNP	DATE	February	dobj	1	SENT_11	[p1l219t2598r353b2631],
5	2005	CD	DATE	2005	num	4	SENT_11	[p1l365t2599r439b2623],
6	Revised	VBN	O	revise	partmod	4	SENT_11	[p1l11t2635r134b2661],
7	:	:	O	:	_	0	SENT_11	[p1l11t2635r134b2661],
8	17	CD	DATE	17	num	9	SENT_11	[p1l150t2636r184b2660],
9	May	NNP	DATE	May	dep	4	SENT_11	[p1l198t2637r263b2668],
10	2005	CD	DATE	2005	num	9	SENT_11	[p1l275t2636r348b2661],
11	Accepted	JJ	O	accepted	dep	9	SENT_11	[p1l8t2673r161b2706],
12	:	:	O	:	_	0	SENT_11	[p1l8t2673r161b2706],
13	8	CD	DATE	8	num	14	SENT_11	[p1l174t2673r192b2698],
14	June	NNP	DATE	June	dep	4	SENT_11	[p1l204t2674r271b2704],
15	2005	CD	DATE	2005	num	14	SENT_11	[p1l284t2673r357b2698],
16	Published	VBN	O	publish	partmod	14	SENT_11	[p1l11t2710r158b2735],
17	online	NN	O	online	prep	16	SENT_11	[p1l172t2710r267b2735],
18	19	CD	NUMBER	19	num	19	SENT_11	[p1l282t2711r316b2735],
19	]	NN	O	]	dep	17	SENT_11	[p1l328t2710r384b2743],
20	uly	RB	O	uly	amod	14	SENT_11	[p1l328t2710r384b2743],
21	2005	CD	DATE	2005	tmod	20	SENT_11	[p1l396t2711r469b2735],

1	ABSTRACT	NN	O	abstract	npadvmod	40	SENT_12	[p1l748t791r945b818],
2	In	IN	O	in	_	0	SENT_12	[p1l750t835r779b864],
3	this	DT	O	this	det	4	SENT_12	[p1l804t833r867b865],
4	study	NN	O	study	prep_in	40	SENT_12	[p1l890t833r997b875],
5	,	,	O	,	_	0	SENT_12	[p1l890t833r997b875],
6	the	DT	O	the	det	7	SENT_12	[p1l1023t833r1080b865],
7	effects	NNS	O	effect	prep_in	40	SENT_12	[p1l1104t833r1219b865],
8	of	IN	O	of	_	0	SENT_12	[p1l1242t834r1277b865],
9	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_12	[p1l1301t833r1580b875],
10	of	IN	O	of	_	0	SENT_12	[p1l1604t834r1639b865],
11	the	DT	O	the	det	12	SENT_12	[p1l1660t833r1718b865],
12	[	NN	O	[	prep_of	9	SENT_12	[p1l1744t834r1779b873],
13	32	CD	NUMBER	32	num	12	SENT_12	[p1l1744t834r1779b873],
14	and	CC	O	and	_	0	SENT_12	[p1l1803t833r1869b865],
15	[	CD	NUMBER	[	number	16	SENT_12	[p1l1896t834r1932b873],
16	33	CD	NUMBER	33	num	19	SENT_12	[p1l1896t834r1932b873],
17	adrenergic	JJ	O	adrenergic	amod	19	SENT_12	[p1l1956t833r2149b875],
18	receptor	NN	O	receptor	nn	19	SENT_12	[p1l750t884r901b921],
19	genes	NNS	O	gene	conj_and	4	SENT_12	[p1l919t889r1024b921],
20	on	IN	O	on	_	0	SENT_12	[p1l1043t889r1087b911],
21	the	DT	O	the	det	22	SENT_12	[p1l1107t880r1164b911],
22	occurrence	NN	O	occurrence	prep_on	19	SENT_12	[p1l1184t889r1384b911],
23	of	IN	O	of	_	0	SENT_12	[p1l1403t880r1438b911],
24	dyslipidemia	NN	O	dyslipidemia	nn	27	SENT_12	[p1l1456t880r1682b921],
25	and	CC	O	and	_	0	SENT_12	[p1l1703t880r1768b911],
26	diabetes	NN	O	diabetes	nn	27	SENT_12	[p1l1789t880r1939b911],
27	mellitus	NN	O	mellitus	prep_of	22	SENT_12	[p1l1960t880r2098b911],
28	in	IN	O	in	_	0	SENT_12	[p1l2118t881r2147b911],
29	hypertensive	JJ	O	hypertensive	amod	30	SENT_12	[p1l750t927r978b968],
30	patients	NNS	O	patient	prep_in	19	SENT_12	[p1l997t928r1139b968],
31	treated	VBN	O	treat	partmod	30	SENT_12	[p1l1156t927r1283b958],
32	with	IN	O	with	_	0	SENT_12	[p1l1301t927r1378b958],
33	B-blockers	NNS	O	b-blocker	prep_with	31	SENT_12	[p1l1400t927r1582b966],
34	(	CD	NUMBER	(	num	35	SENT_12	[p1l1600t927r1757b966],
35	atenolol	NN	O	atenolol	nsubjpass	40	SENT_12	[p1l1600t927r1757b966],
36	or	CC	O	or	_	0	SENT_12	[p1l1777t936r1814b958],
37	metoprolol	NN	O	metoprolol	nn	38	SENT_12	[p1l1831t927r2044b968],
38	)	NN	O	)	conj_or	35	SENT_12	[p1l1831t927r2044b968],
39	were	VBD	O	be	auxpass	40	SENT_12	[p1l2061t936r2149b958],
40	evaluated	VBN	O	evaluate	_	0	SENT_12	[p1l749t973r933b1005],
41	.	.	O	.	_	0	SENT_12	[p1l749t973r933b1005],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_13	[p1l952t974r1090b1005],
2	who	WP	O	who	nsubj	3	SENT_13	[p1l1104t973r1182b1005],
3	gave	VBD	O	give	rcmod	1	SENT_13	[p1l1197t983r1281b1015],
4	written	VBN	O	write	amod	6	SENT_13	[p1l1295t974r1422b1005],
5	informed	VBN	O	inform	amod	6	SENT_13	[p1l1440t973r1602b1005],
6	consent	NN	O	consent	dobj	3	SENT_13	[p1l1618t977r1761b1005],
7	were	VBD	O	be	auxpass	8	SENT_13	[p1l1773t983r1860b1005],
8	asked	VBN	O	ask	_	0	SENT_13	[p1l1875t973r1974b1005],
9	to	TO	O	to	aux	10	SENT_13	[p1l1989t977r2025b1005],
10	return	VB	O	return	xcomp	8	SENT_13	[p1l2041t977r2147b1005],
11	for	IN	O	for	_	0	SENT_13	[p1l747t1020r798b1051],
12	blood	NN	O	blood	nn	13	SENT_13	[p1l815t1020r916b1051],
13	sampling	NN	O	sampling	prep_for	10	SENT_13	[p1l935t1020r1099b1061],
14	for	IN	O	for	_	0	SENT_13	[p1l1117t1020r1168b1051],
15	estimation	NN	O	estimation	prep_for	13	SENT_13	[p1l1184t1021r1371b1051],
16	of	IN	O	of	_	0	SENT_13	[p1l1390t1020r1425b1051],
17	serum	NN	O	serum	nn	18	SENT_13	[p1l1441t1029r1549b1051],
18	glucose	NN	O	glucose	prep_of	15	SENT_13	[p1l1569t1020r1715b1061],
19	,	,	O	,	_	0	SENT_13	[p1l1569t1020r1715b1061],
20	total	JJ	O	total	amod	21	SENT_13	[p1l1735t1020r1814b1051],
21	cholesterol	NN	O	cholesterol	appos	18	SENT_13	[p1l1833t1020r2039b1058],
22	,	,	O	,	_	0	SENT_13	[p1l1833t1020r2039b1058],
23	HDL	NN	O	hdl	appos	18	SENT_13	[p1l2061t1021r2146b1058],
24	,	,	O	,	_	0	SENT_13	[p1l2061t1021r2146b1058],
25	triglycerides	NNS	O	triglyceride	appos	18	SENT_13	[p1l748t1067r967b1108],
26	and	CC	O	and	_	0	SENT_13	[p1l997t1067r1062b1098],
27	for	IN	O	for	_	0	SENT_13	[p1l1092t1067r1142b1098],
28	genotype	NN	O	genotype	nn	29	SENT_13	[p1l1170t1071r1342b1108],
29	determination	NN	O	determination	conj_and	13	SENT_13	[p1l1372t1067r1640b1098],
30	.	.	O	.	_	0	SENT_13	[p1l1372t1067r1640b1098],

1	Genotyping	NN	O	genotyping	nn	2	SENT_14	[p1l1672t1068r1886b1108],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_14	[p1l1917t1067r2053b1108],
3	was	VBD	O	be	auxpass	4	SENT_14	[p1l2081t1076r2149b1098],
4	performed	VBN	O	perform	_	0	SENT_14	[p1l750t1114r938b1155],
5	by	IN	O	by	_	0	SENT_14	[p1l960t1114r1002b1155],
6	PCR-RFLP	NN	O	pcr-rflp	nn	7	SENT_14	[p1l1021t1115r1190b1145],
7	assay	NN	O	assay	agent	4	SENT_14	[p1l1209t1123r1310b1155],
8	.	.	O	.	_	0	SENT_14	[p1l1209t1123r1310b1155],

1	In	IN	O	in	_	0	SENT_15	[p1l1333t1115r1362b1145],
2	patients	NNS	O	patient	nsubj	3	SENT_15	[p1l1383t1114r1525b1155],
3	bearing	VBG	O	bear	prepc_in	12	SENT_15	[p1l1545t1114r1679b1155],
4	BZAR	NN	O	bzar	nn	5	SENT_15	[p1l1701t1114r1787b1153],
5	Glu27	NN	O	glu27	dobj	3	SENT_15	[p1l1805t1114r1913b1145],
6	or	CC	O	or	_	0	SENT_15	[p1l1933t1123r1970b1145],
7	the	DT	O	the	det	10	SENT_15	[p1l1986t1114r2043b1145],
8	B3AR	NN	O	b3ar	nn	10	SENT_15	[p1l2064t1114r2150b1153],
9	Arg64	NN	O	arg64	nn	10	SENT_15	[p1l747t1161r857b1201],
10	variant	NN	O	variant	conj_or	5	SENT_15	[p1l870t1161r995b1192],
11	there	EX	O	there	expl	12	SENT_15	[p1l1006t1160r1099b1192],
12	was	VBD	O	be	_	0	SENT_15	[p1l1112t1169r1180b1192],
13	a	DT	O	a	det	15	SENT_15	[p1l1193t1169r1211b1192],
14	larger	JJR	O	larger	amod	15	SENT_15	[p1l1226t1160r1329b1201],
15	occurrence	NN	O	occurrence	nsubj	12	SENT_15	[p1l1341t1169r1541b1192],
16	of	IN	O	of	_	0	SENT_15	[p1l1554t1160r1589b1192],
17	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	15	SENT_15	[p1l1603t1160r1987b1201],
18	,	,	O	,	_	0	SENT_15	[p1l1603t1160r1987b1201],
19	alone	RB	O	alone	dep	17	SENT_15	[p1l2003t1160r2100b1192],
20	or	CC	O	or	_	0	SENT_15	[p1l2114t1169r2151b1192],
21	in	IN	O	in	dep	17	SENT_15	[p1l750t1208r779b1238],
22	combination	NN	O	combination	pobj	21	SENT_15	[p1l793t1207r1022b1238],
23	with	IN	O	with	_	0	SENT_15	[p1l1034t1207r1112b1238],
24	elevated	JJ	O	elevated	amod	26	SENT_15	[p1l1127t1207r1276b1238],
25	cholesterol	NN	O	cholesterol	nn	26	SENT_15	[p1l1290t1207r1485b1238],
26	levels	NNS	O	level	prep_with	17	SENT_15	[p1l1500t1207r1605b1238],
27	.	.	O	.	_	0	SENT_15	[p1l1500t1207r1605b1238],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_16	[p1l1622t1207r1855b1245],
2	,	,	O	,	_	0	SENT_16	[p1l1622t1207r1855b1245],
3	the	DT	O	the	det	5	SENT_16	[p1l1870t1207r1928b1238],
4	BZAR	NN	O	bzar	nn	5	SENT_16	[p1l1942t1208r2028b1246],
5	Glu27	NN	O	glu27	nsubj	8	SENT_16	[p1l2040t1207r2148b1238],
6	variant	JJ	O	variant	amod	5	SENT_16	[p1l747t1254r872b1285],
7	significantly	RB	O	significantly	advmod	6	SENT_16	[p1l899t1254r1114b1295],
8	associates	VBZ	O	associate	_	0	SENT_16	[p1l1142t1254r1318b1285],
9	with	IN	O	with	_	0	SENT_16	[p1l1345t1254r1423b1285],
10	hypetriglyceridemia	NN	O	hypetriglyceridemia	prep_with	8	SENT_16	[p1l1455t1254r1814b1295],
11	in	IN	O	in	_	0	SENT_16	[p1l1845t1254r1873b1285],
12	a	DT	O	a	det	14	SENT_16	[p1l1904t1263r1921b1285],
13	cumulative	JJ	O	cumulative	amod	14	SENT_16	[p1l1950t1254r2148b1285],
14	fashion	NN	O	fashion	prep_in	10	SENT_16	[p1l747t1300r887b1332],
15	.	.	O	.	_	0	SENT_16	[p1l747t1300r887b1332],

1	The	DT	O	the	det	2	SENT_17	[p1l909t1300r975b1332],
2	risk	NN	O	risk	nsubj	12	SENT_17	[p1l998t1300r1055b1332],
3	to	TO	O	to	aux	4	SENT_17	[p1l1074t1304r1110b1332],
4	develop	VB	O	develop	infmod	2	SENT_17	[p1l1130t1300r1274b1342],
5	this	DT	O	this	det	7	SENT_17	[p1l1294t1300r1356b1332],
6	side	JJ	O	side	amod	7	SENT_17	[p1l1376t1300r1446b1332],
7	effect	NN	O	effect	dobj	4	SENT_17	[p1l1467t1300r1566b1332],
8	after	IN	O	after	_	0	SENT_17	[p1l1585t1301r1667b1332],
9	B-blockade	NN	MISC	b-blockade	prep_after	4	SENT_17	[p1l1688t1300r1885b1340],
10	was	VBD	O	be	cop	12	SENT_17	[p1l1905t1310r1972b1332],
11	four-fold	RB	O	four-fold	advmod	12	SENT_17	[p1l1991t1300r2147b1332],
12	higher	JJR	O	higher	_	0	SENT_17	[p1l750t1347r866b1388],
13	in	IN	O	in	_	0	SENT_17	[p1l884t1348r913b1378],
14	patients	NNS	O	patient	prep_in	12	SENT_17	[p1l934t1348r1075b1388],
15	homozygous	JJ	O	homozygous	amod	14	SENT_17	[p1l1095t1347r1327b1388],
16	for	IN	O	for	_	0	SENT_17	[p1l1344t1347r1395b1378],
17	the	DT	O	the	det	20	SENT_17	[p1l1411t1347r1468b1378],
18	BZAR	NN	O	bzar	nn	20	SENT_17	[p1l1489t1348r1574b1387],
19	Glu27	NN	O	glu27	nn	20	SENT_17	[p1l1592t1347r1700b1378],
20	variant	NN	O	variant	prep_for	15	SENT_17	[p1l1718t1348r1842b1378],
21	as	IN	O	as	prep	12	SENT_17	[p1l1859t1356r1893b1378],
22	compared	VBN	O	compare	_	0	SENT_17	[p1l1911t1347r2094b1388],
23	to	TO	O	to	prepc_compared_to	12	SENT_17	[p1l2113t1351r2149b1378],
24	B2AR27G	NN	O	b2ar27g	nn	27	SENT_17	[p1l751t1394r946b1433],
25	|	NN	O	|	nn	27	SENT_17	[p1l751t1394r946b1433],
26	n	NN	O	n	nn	27	SENT_17	[p1l751t1394r946b1433],
27	allele	NN	O	allele	pobj	12	SENT_17	[p1l964t1394r1065b1425],
28	.	.	O	.	_	0	SENT_17	[p1l964t1394r1065b1425],

1	This	DT	O	this	det	2	SENT_18	[p1l1082t1394r1154b1425],
2	result	NN	O	result	nsubj	3	SENT_18	[p1l1171t1394r1268b1425],
3	allows	VBZ	O	allow	_	0	SENT_18	[p1l1283t1394r1394b1425],
4	the	DT	O	the	det	5	SENT_18	[p1l1409t1394r1467b1425],
5	identification	NN	O	identification	nsubj	12	SENT_18	[p1l1485t1394r1719b1425],
6	of	IN	O	of	_	0	SENT_18	[p1l1737t1394r1772b1425],
7	patients	NNS	O	patient	prep_of	5	SENT_18	[p1l1788t1395r1930b1435],
8	at	IN	O	at	_	0	SENT_18	[p1l1946t1397r1979b1425],
9	high	JJ	O	high	amod	10	SENT_18	[p1l1996t1394r2074b1435],
10	risk	NN	O	risk	prep_at	7	SENT_18	[p1l2093t1394r2150b1425],
11	to	TO	O	to	aux	12	SENT_18	[p1l748t1444r784b1472],
12	develop	VB	O	develop	xcomp	3	SENT_18	[p1l801t1441r943b1482],
13	metabolic	JJ	O	metabolic	amod	14	SENT_18	[p1l962t1441r1140b1472],
14	complications	NNS	O	complication	dobj	12	SENT_18	[p1l1156t1441r1408b1482],
15	to	TO	O	to	_	0	SENT_18	[p1l1424t1444r1460b1472],
16	chronic	JJ	O	chronic	amod	22	SENT_18	[p1l1477t1441r1611b1472],
17	B	NN	O	b	nn	22	SENT_18	[p1l1629t1441r1826b1480],
18	—	NN	O	—	nn	22	SENT_18	[p1l1629t1441r1826b1480],
19	b	NN	O	b	nn	22	SENT_18	[p1l1629t1441r1826b1480],
20	|	NN	O	|	nn	22	SENT_18	[p1l1629t1441r1826b1480],
21	ockade	NN	O	ockade	nn	22	SENT_18	[p1l1629t1441r1826b1480],
22	treatment	NN	O	treatment	prep_to	12	SENT_18	[p1l1842t1444r2032b1472],
23	.	.	O	.	_	0	SENT_18	[p1l1842t1444r2032b1472],

1	The	DT	O	the	det	3	SENT_19	[p1l753t1487r811b1518],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_19	[p1l824t1487r1150b1528],
3	journal	NN	O	journal	_	0	SENT_19	[p1l1160t1487r1283b1526],
4	(	CD	NUMBER	(	dep	3	SENT_19	[p1l1294t1487r1411b1526],
5	2005	CD	DATE	2005	num	6	SENT_19	[p1l1294t1487r1411b1526],
6	)	NN	O	)	dep	4	SENT_19	[p1l1294t1487r1411b1526],
7	5	CD	NUMBER	5	dep	3	SENT_19	[p1l1425t1488r1456b1525],
8	,	,	O	,	_	0	SENT_19	[p1l1425t1488r1456b1525],
9	292-297	CD	NUMBER	292-297	appos	7	SENT_19	[p1l1472t1488r1637b1518],
10	.	.	O	.	_	0	SENT_19	[p1l1472t1488r1637b1518],

1	doi	FW	O	doi	_	0	SENT_20	[p1l1654t1487r2147b1528],
2	:10.1038	CD	NUMBER	:10.1038	dep	1	SENT_20	[p1l1654t1487r2147b1528],
3	/	:	O	/	punct	4	SENT_20	[p1l1654t1487r2147b1528],
4	sj	NN	O	sj	dep	2	SENT_20	[p1l1654t1487r2147b1528],
5	.	.	O	.	_	0	SENT_20	[p1l1654t1487r2147b1528],

1	tpj	NN	O	tpj	_	0	SENT_21	[p1l1654t1487r2147b1528],
2	.6500324	CD	NUMBER	.6500324	num	1	SENT_21	[p1l1654t1487r2147b1528],
3	;	:	O	;	_	0	SENT_21	[p1l1654t1487r2147b1528],
4	published	VBN	O	publish	dep	1	SENT_21	[p1l750t1534r917b1575],
5	online	NN	O	online	prep	4	SENT_21	[p1l935t1534r1041b1565],
6	19	CD	DATE	19	dep	5	SENT_21	[p1l1059t1535r1100b1565],
7	July	NNP	DATE	July	tmod	4	SENT_21	[p1l1116t1534r1178b1575],
8	2005	CD	DATE	2005	num	7	SENT_21	[p1l1193t1535r1281b1565],

1	Keywords	NNPS	O	Keywords	_	0	SENT_22	[p1l749t1630r920b1663],
2	:	:	O	:	_	0	SENT_22	[p1l749t1630r920b1663],
3	hypertriglyceridemia	NN	O	hypertriglyceridemia	dep	1	SENT_22	[p1l940t1630r1301b1663],
4	;	:	O	;	_	0	SENT_22	[p1l940t1630r1301b1663],
5	diabetes	NN	O	diabetes	nn	6	SENT_22	[p1l1319t1630r1460b1655],
6	mellitus	NN	O	mellitus	dep	3	SENT_22	[p1l1477t1630r1620b1660],
7	;	:	O	;	_	0	SENT_22	[p1l1477t1630r1620b1660],
8	B2	NN	O	b2	dep	3	SENT_22	[p1l1638t1632r1668b1662],
9	and	CC	O	and	_	0	SENT_22	[p1l1685t1630r1746b1655],
10	[	NN	O	[	dep	3	SENT_22	[p1l1764t1632r1793b1662],
11	53	CD	NUMBER	53	num	14	SENT_22	[p1l1764t1632r1793b1662],
12	adrenergic	JJ	O	adrenergic	amod	14	SENT_22	[p1l1810t1630r1991b1663],
13	receptor	NN	O	receptor	nn	14	SENT_22	[p1l2008t1633r2151b1663],
14	variants	NNS	O	variant	dep	8	SENT_22	[p1l747t1667r882b1693],

1	INTRODUCTION	NN	O	introduction	nsubj	73	SENT_23	[p1l749t1883r1036b1910],
2	The	DT	O	the	det	4	SENT_23	[p1l747t1929r812b1957],
3	antihypertensive	JJ	O	antihypertensive	amod	4	SENT_23	[p1l833t1929r1124b1966],
4	treatment	NN	O	treatment	nsubjpass	15	SENT_23	[p1l1145t1932r1316b1957],
5	with	IN	O	with	_	0	SENT_23	[p1l1335t1929r1414b1957],
6	B	NN	O	b	prep_with	4	SENT_23	[p1l1437t1930r1453b1964],
7	adrenergic	JJ	O	adrenergic	amod	12	SENT_23	[p1l1474t1929r1654b1966],
8	receptor	NN	O	receptor	nn	12	SENT_23	[p1l1675t1932r1817b1966],
9	(	NN	O	(	nn	12	SENT_23	[p1l1838t1929r1909b1964],
10	AR	NN	O	ar	nn	12	SENT_23	[p1l1838t1929r1909b1964],
11	)	NN	O	)	nn	12	SENT_23	[p1l1838t1929r1909b1964],
12	blockers	NNS	O	blocker	dep	6	SENT_23	[p1l1930t1929r2071b1957],
13	has	VBZ	O	have	aux	15	SENT_23	[p1l2092t1929r2149b1957],
14	been	VBN	O	be	auxpass	15	SENT_23	[p1l747t1976r830b2004],
15	associated	VBN	O	associate	dep	1	SENT_23	[p1l847t1976r1020b2004],
16	with	IN	O	with	_	0	SENT_23	[p1l1036t1976r1115b2004],
17	a	DT	O	a	det	19	SENT_23	[p1l1132t1984r1149b2004],
18	higher	JJR	O	higher	amod	19	SENT_23	[p1l1165t1976r1278b2013],
19	incidence	NN	O	incidence	prep_with	15	SENT_23	[p1l1294t1976r1460b2004],
20	of	IN	O	of	_	0	SENT_23	[p1l1477t1976r1512b2004],
21	diabetes	NN	O	diabetes	prep_of	19	SENT_23	[p1l1527t1976r1675b2010],
22	,	,	O	,	_	0	SENT_23	[p1l1527t1976r1675b2010],
23	hypercholesterolemia	NN	O	hypercholesterolemia	prep_of	19	SENT_23	[p1l1694t1976r2068b2013],
24	and	CC	O	and	_	0	SENT_23	[p1l2085t1976r2149b2004],
25	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	19	SENT_23	[p1l748t2028r1135b2069],
26	.1	CD	NUMBER	.1	dep	36	SENT_23	[p1l748t2028r1135b2069],
27	Although	IN	O	although	dep	36	SENT_23	[p1l785t2088r949b2125],
28	the	DT	O	the	det	29	SENT_23	[p1l964t2088r1019b2116],
29	mechanism	NN	O	mechanism	nsubj	36	SENT_23	[p1l1035t2088r1236b2116],
30	underlying	VBG	O	underlie	partmod	29	SENT_23	[p1l1250t2088r1442b2125],
31	these	DT	O	these	det	33	SENT_23	[p1l1456t2088r1545b2116],
32	adverse	JJ	O	adverse	amod	33	SENT_23	[p1l1561t2088r1688b2116],
33	events	NNS	O	event	dobj	30	SENT_23	[p1l1703t2091r1813b2116],
34	might	MD	O	might	aux	36	SENT_23	[p1l1828t2088r1932b2125],
35	be	VB	O	be	cop	36	SENT_23	[p1l1946t2088r1986b2116],
36	intuitive	JJ	O	intuitive	dep	15	SENT_23	[p1l2001t2089r2149b2116],
37	given	VBN	O	give	prep	36	SENT_23	[p1l748t2145r842b2181],
38	the	DT	O	the	det	39	SENT_23	[p1l853t2144r908b2172],
39	presence	NN	O	presence	dep	37	SENT_23	[p1l919t2152r1068b2181],
40	of	IN	O	of	_	0	SENT_23	[p1l1079t2144r1114b2172],
41	B	NN	O	b	nn	42	SENT_23	[p1l1126t2145r1142b2180],
42	ARs	NNS	O	ar	prep_of	39	SENT_23	[p1l1152t2145r1215b2172],
43	on	IN	O	on	_	0	SENT_23	[p1l1227t2152r1271b2172],
44	the	DT	O	the	det	45	SENT_23	[p1l1282t2144r1337b2172],
45	liver	NN	O	liver	prep_on	42	SENT_23	[p1l1348t2144r1424b2172],
46	and	CC	O	and	_	0	SENT_23	[p1l1435t2144r1499b2172],
47	their	PRP$	O	they	poss	48	SENT_23	[p1l1510t2144r1592b2172],
48	role	NN	O	role	conj_and	42	SENT_23	[p1l1602t2144r1667b2172],
49	in	IN	O	in	_	0	SENT_23	[p1l1678t2145r1712b2172],
50	the	DT	O	the	det	51	SENT_23	[p1l1723t2144r1778b2172],
51	regulation	NN	O	regulation	prep_in	48	SENT_23	[p1l1789t2144r1967b2181],
52	of	IN	O	of	_	0	SENT_23	[p1l1978t2144r2013b2172],
53	glucose	NN	O	glucose	nn	56	SENT_23	[p1l2022t2144r2149b2181],
54	and	CC	O	and	_	0	SENT_23	[p1l749t2191r813b2219],
55	lipid	NN	O	lipid	nn	56	SENT_23	[p1l826t2191r905b2228],
56	homeostasis	NN	O	homeostasis	prep_of	51	SENT_23	[p1l919t2191r1139b2226],
57	,	,	O	,	_	0	SENT_23	[p1l919t2191r1139b2226],
58	the	DT	O	the	det	59	SENT_23	[p1l1155t2191r1210b2219],
59	reason	NN	O	reason	appos	39	SENT_23	[p1l1225t2199r1337b2219],
60	why	WRB	O	why	advmod	65	SENT_23	[p1l1350t2191r1425b2228],
61	some	DT	O	some	det	62	SENT_23	[p1l1438t2199r1527b2219],
62	subjects	NNS	O	subject	nsubj	65	SENT_23	[p1l1542t2191r1677b2228],
63	are	VBP	O	be	cop	65	SENT_23	[p1l1692t2199r1741b2219],
64	more	RBR	O	more	advmod	65	SENT_23	[p1l1756t2199r1844b2219],
65	likely	JJ	O	likely	rcmod	59	SENT_23	[p1l1859t2191r1953b2228],
66	to	TO	O	to	aux	67	SENT_23	[p1l1966t2194r2000b2219],
67	develop	VB	O	develop	xcomp	65	SENT_23	[p1l2015t2191r2149b2228],
68	adverse	JJ	O	adverse	amod	69	SENT_23	[p1l748t2238r875b2266],
69	events	NNS	O	event	dobj	67	SENT_23	[p1l892t2242r1001b2266],
70	is	VBZ	O	be	cop	73	SENT_23	[p1l1017t2239r1042b2266],
71	not	RB	O	not	neg	73	SENT_23	[p1l1058t2242r1117b2266],
72	completely	RB	O	completely	advmod	73	SENT_23	[p1l1133t2238r1326b2275],
73	clear	JJ	O	clear	_	0	SENT_23	[p1l1341t2238r1427b2266],
74	.	.	O	.	_	0	SENT_23	[p1l1341t2238r1427b2266],

1	It	PRP	O	it	nsubj	3	SENT_24	[p1l1446t2239r1471b2266],
2	is	VBZ	O	be	cop	3	SENT_24	[p1l1486t2240r1511b2266],
3	possible	JJ	O	possible	_	0	SENT_24	[p1l1527t2238r1664b2275],
4	to	TO	O	to	aux	5	SENT_24	[p1l1681t2242r1715b2266],
5	speculate	VB	O	speculate	xcomp	3	SENT_24	[p1l1732t2238r1890b2275],
6	that	IN	O	that	complm	11	SENT_24	[p1l1906t2238r1976b2266],
7	a	DT	O	a	det	9	SENT_24	[p1l1992t2246r2009b2266],
8	genetic	JJ	O	genetic	amod	9	SENT_24	[p1l2025t2239r2149b2275],
9	background	NN	O	background	nsubj	11	SENT_24	[p1l747t2285r953b2322],
10	might	MD	O	might	aux	11	SENT_24	[p1l967t2285r1071b2322],
11	affect	VB	O	affect	ccomp	5	SENT_24	[p1l1086t2285r1179b2313],
12	the	DT	O	the	det	14	SENT_24	[p1l1193t2285r1249b2313],
13	individual	JJ	O	individual	amod	14	SENT_24	[p1l1263t2285r1440b2313],
14	tolerability	NN	O	tolerability	dobj	11	SENT_24	[p1l1455t2285r1645b2322],
15	to	TO	O	to	_	0	SENT_24	[p1l1658t2288r1692b2313],
16	the	DT	O	the	det	17	SENT_24	[p1l1707t2285r1762b2313],
17	treatment	NN	O	treatment	prep_to	11	SENT_24	[p1l1777t2288r1957b2313],
18	.	.	O	.	_	0	SENT_24	[p1l1777t2288r1957b2313],

1	The	DT	O	the	det	5	SENT_25	[p1l785t2332r849b2360],
2	[	CD	NUMBER	[	number	3	SENT_25	[p1l865t2333r898b2368],
3	32	CD	NUMBER	32	num	5	SENT_25	[p1l865t2333r898b2368],
4	AR	NN	O	ar	nn	5	SENT_25	[p1l910t2333r959b2360],
5	gene	NN	O	gene	nsubj	6	SENT_25	[p1l971t2340r1051b2369],
6	displays	VBZ	O	display	_	0	SENT_25	[p1l1065t2332r1201b2369],
7	high	JJ	O	high	amod	9	SENT_25	[p1l1214t2332r1293b2369],
8	genetic	JJ	O	genetic	amod	9	SENT_25	[p1l1306t2334r1431b2369],
9	variability	NN	O	variability	dobj	6	SENT_25	[p1l1442t2332r1619b2369],
10	and	CC	O	and	_	0	SENT_25	[p1l1632t2332r1696b2360],
11	common	JJ	O	common	amod	12	SENT_25	[p1l1709t2340r1864b2360],
12	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_25	[p1l1877t2332r2149b2369],
13	at	IN	O	at	_	0	SENT_25	[p1l748t2382r780b2407],
14	codons	NNS	O	codon	prep_at	6	SENT_25	[p1l796t2379r919b2407],
15	such	JJ	O	such	_	0	SENT_25	[p1l937t2379r1015b2407],
16	as	IN	O	as	_	0	SENT_25	[p1l1032t2387r1064b2407],
17	Arg16Gly	NN	O	arg16gly	prep_such_as	14	SENT_25	[p1l1081t2379r1246b2416],
18	or	CC	O	or	_	0	SENT_25	[p1l1262t2387r1297b2407],
19	Glu27Gln	NN	O	glu27gln	prep_such_as	14	SENT_25	[p1l1314t2379r1484b2407],
20	and	CC	O	and	_	0	SENT_25	[p1l1501t2379r1565b2407],
21	Thr164Ile	NN	O	thr164ile	prep_such_as	14	SENT_25	[p1l1581t2379r1749b2407],
22	which	WDT	O	which	nsubj	24	SENT_25	[p1l1766t2379r1874b2407],
23	could	MD	O	could	aux	24	SENT_25	[p1l1891t2379r1986b2407],
24	result	VB	O	result	rcmod	14	SENT_25	[p1l2003t2379r2098b2407],
25	in	IN	O	in	_	0	SENT_25	[p1l2115t2380r2149b2406],
26	altered	JJ	O	altered	amod	28	SENT_25	[p1l749t2426r866b2454],
27	receptor	NN	O	receptor	nn	28	SENT_25	[p1l889t2429r1031b2463],
28	function	NN	O	function	prep_in	24	SENT_25	[p1l1055t2422r1231b2454],
29	?	.	O	?	_	0	SENT_25	[p1l1055t2422r1231b2454],

1	The	DT	O	the	det	3	SENT_26	[p1l1254t2425r1318b2454],
2	Glu27	NN	O	glu27	nn	3	SENT_26	[p1l1344t2425r1447b2454],
3	variant	NN	O	variant	nsubjpass	6	SENT_26	[p1l1471t2427r1594b2454],
4	has	VBZ	O	have	aux	6	SENT_26	[p1l1618t2426r1674b2454],
5	been	VBN	O	be	auxpass	6	SENT_26	[p1l1698t2426r1780b2454],
6	reported	VBN	O	report	_	0	SENT_26	[p1l1805t2426r1950b2463],
7	to	TO	O	to	aux	8	SENT_26	[p1l1974t2429r2008b2454],
8	induce	VB	O	induce	ccomp	6	SENT_26	[p1l2032t2426r2149b2454],
9	resistance	NN	O	resistance	dobj	8	SENT_26	[p1l748t2474r915b2501],
10	to	TO	O	to	_	0	SENT_26	[p1l948t2476r982b2501],
11	agonist	NN	O	agonist	nn	12	SENT_26	[p1l1014t2473r1323b2510],
12	—	NN	O	—	prep_to	8	SENT_26	[p1l1014t2473r1323b2510],
13	promoted	VBD	O	promote	partmod	12	SENT_26	[p1l1014t2473r1323b2510],
14	downregulation3	NN	O	downregulation3	dobj	13	SENT_26	[p1l1355t2469r1647b2510],
15	and	CC	O	and	_	0	SENT_26	[p1l1679t2473r1743b2501],
16	to	TO	O	to	aux	17	SENT_26	[p1l1775t2476r1809b2501],
17	increase	VB	O	increase	ccomp	6	SENT_26	[p1l1841t2474r1980b2501],
18	agonist	NN	O	agonist	nn	19	SENT_26	[p1l2012t2474r2149b2510],
19	—	NN	O	—	nsubj	20	SENT_26	[p1l2012t2474r2149b2510],
20	mediated	VBD	O	mediate	ccomp	17	SENT_26	[p1l748t2520r909b2548],
21	responsiveness	NN	O	responsiveness	nn	22	SENT_26	[p1l928t2516r1210b2557],
22	}	NN	O	}	dobj	20	SENT_26	[p1l928t2516r1210b2557],
23	while	IN	O	while	mark	28	SENT_26	[p1l1228t2520r1323b2548],
24	the	DT	O	the	det	26	SENT_26	[p1l1343t2520r1398b2548],
25	Arg16	NN	O	arg16	nn	26	SENT_26	[p1l1417t2521r1518b2557],
26	allele	NN	O	allele	nsubjpass	28	SENT_26	[p1l1538t2520r1626b2548],
27	is	VBZ	O	be	auxpass	28	SENT_26	[p1l1646t2521r1671b2548],
28	associated	VBN	O	associate	advcl	20	SENT_26	[p1l1691t2520r1864b2548],
29	with	IN	O	with	_	0	SENT_26	[p1l1882t2520r1961b2548],
30	enhanced	VBN	O	enhance	amod	32	SENT_26	[p1l1981t2520r2149b2548],
31	agonist	NN	O	agonist	nn	32	SENT_26	[p1l749t2567r1048b2604],
32	—	NN	O	—	nsubj	33	SENT_26	[p1l749t2567r1048b2604],
33	mediated	VBD	O	mediate	prepc_with	28	SENT_26	[p1l749t2567r1048b2604],
34	desensitizationf	JJ	O	desensitizationf	amod	35	SENT_26	[p1l1063t2564r1348b2595],
35	‘	CD	NUMBER	‘	dobj	33	SENT_26	[p1l1063t2564r1348b2595],
36	The	DT	O	the	det	37	SENT_26	[p1l785t2614r849b2642],
37	[	NN	O	[	nsubj	53	SENT_26	[p1l868t2614r900b2649],
38	33	CD	NUMBER	33	num	39	SENT_26	[p1l868t2614r900b2649],
39	AR	NNS	O	ar	dep	37	SENT_26	[p1l917t2614r966b2642],
40	recognizes	VBZ	O	recognize	rcmod	35	SENT_26	[p1l982t2615r1161b2651],
41	most	JJS	O	most	dobj	40	SENT_26	[p1l1178t2617r1263b2642],
42	of	IN	O	of	_	0	SENT_26	[p1l1280t2614r1315b2642],
43	the	DT	O	the	det	44	SENT_26	[p1l1329t2614r1384b2642],
44	B1	NN	O	b1	prep_of	41	SENT_26	[p1l1403t2614r1434b2649],
45	and	CC	O	and	_	0	SENT_26	[p1l1453t2614r1517b2642],
46	[	NN	O	[	dobj	40	SENT_26	[p1l1535t2614r1568b2649],
47	32	CD	NUMBER	32	num	49	SENT_26	[p1l1535t2614r1568b2649],
48	AR	NNS	O	ar	nn	49	SENT_26	[p1l1584t2614r1633b2642],
49	antagonists	NNS	O	antagonist	dep	46	SENT_26	[p1l1649t2615r1846b2651],
50	as	IN	O	as	_	0	SENT_26	[p1l1864t2622r1895b2642],
51	agonists5	NN	O	agonists5	prep_as	40	SENT_26	[p1l1913t2610r2067b2651],
52	and	CC	O	and	_	0	SENT_26	[p1l2085t2614r2150b2642],
53	reveals	VBZ	O	reveal	rcmod	35	SENT_26	[p1l748t2660r864b2688],
54	a	DT	O	a	det	56	SENT_26	[p1l881t2668r898b2688],
55	lower	JJR	O	lower	amod	56	SENT_26	[p1l913t2660r1008b2688],
56	affinity	NN	O	affinity	dobj	53	SENT_26	[p1l1023t2660r1150b2697],
57	for	IN	O	for	_	0	SENT_26	[p1l1164t2660r1212b2688],
58	catecholaminesf	NN	O	catecholaminesf	nn	59	SENT_26	[p1l1227t2657r1523b2688],
59	‘	NN	O	‘	prep_for	56	SENT_26	[p1l1227t2657r1523b2688],
60	Thus	RB	O	thus	advmod	53	SENT_26	[p1l1538t2660r1631b2694],
61	,	,	O	,	_	0	SENT_26	[p1l1538t2660r1631b2694],
62	the	DT	O	the	det	64	SENT_26	[p1l1649t2660r1704b2688],
63	primary	JJ	O	primary	amod	64	SENT_26	[p1l1720t2662r1858b2697],
64	function	NN	O	function	nsubj	69	SENT_26	[p1l1872t2660r2021b2688],
65	of	IN	O	of	_	0	SENT_26	[p1l2037t2660r2072b2688],
66	this	DT	O	this	det	67	SENT_26	[p1l2086t2660r2149b2688],
67	receptor	NN	O	receptor	prep_of	64	SENT_26	[p1l748t2711r890b2744],
68	may	MD	O	may	aux	69	SENT_26	[p1l904t2715r979b2744],
69	be	VB	O	be	conj_and	33	SENT_26	[p1l992t2707r1031b2735],
70	to	TO	O	to	aux	71	SENT_26	[p1l1047t2711r1081b2735],
71	maintain	VB	O	maintain	xcomp	69	SENT_26	[p1l1096t2708r1254b2735],
72	signaling	NN	O	signaling	dobj	71	SENT_26	[p1l1270t2707r1427b2744],
73	during	IN	O	during	_	0	SENT_26	[p1l1442t2707r1556b2744],
74	periods	NNS	O	period	prep_during	71	SENT_26	[p1l1571t2707r1696b2744],
75	of	IN	O	of	_	0	SENT_26	[p1l1712t2707r1747b2735],
76	sustained	JJ	O	sustained	amod	78	SENT_26	[p1l1761t2707r1922b2735],
77	sympathetic	JJ	O	sympathetic	amod	78	SENT_26	[p1l1938t2707r2149b2744],
78	stimulation7	NN	O	stimulation7	prep_of	74	SENT_26	[p1l10t2898r451b2962],
79	and	CC	O	and	_	0	SENT_26	[p1l484t2904r616b2962],
80	it	PRP	O	it	nsubjpass	82	SENT_26	[p1l647t2907r696b2962],
81	is	VBZ	O	be	auxpass	82	SENT_26	[p1l727t2907r778b2962],
82	considered	VBN	O	consider	conj_and	33	SENT_26	[p1l810t2904r1193b2962],
83	a	DT	O	a	det	85	SENT_26	[p1l1225t2921r1260b2962],
84	prime	JJ	O	prime	amod	85	SENT_26	[p1l1291t2907r1497b2980],
85	candidate	NN	O	candidate	dobj	82	SENT_26	[p1l1530t2904r1874b2962],
86	for	IN	O	for	_	0	SENT_26	[p1l1907t2904r2005b2962],
87	the	DT	O	the	det	88	SENT_26	[p1l2035t2904r2148b2962],
88	regulation	NN	O	regulation	prep_for	85	SENT_26	[p1l9t2999r372b3075],
89	of	IN	O	of	_	0	SENT_26	[p1l414t2999r485b3057],
90	lypolysis	NN	O	lypolysis	nn	93	SENT_26	[p1l521t2999r827b3075],
91	and	CC	O	and	_	0	SENT_26	[p1l869t2999r1000b3057],
92	insulin	NN	O	insulin	conj_and	90	SENT_26	[p1l1041t2999r1287b3057],
93	sensitivity	NN	O	sensitivity	prep_of	88	SENT_26	[p1l1330t3002r1691b3075],
94	in	IN	O	in	_	0	SENT_26	[p1l1729t3002r1799b3056],
95	humans	NNS	O	human	prep_in	82	SENT_26	[p1l1840t2999r2144b3057],
96	.	.	O	.	_	0	SENT_26	[p1l1840t2999r2144b3057],

1	The	DT	O	the	det	2	SENT_27	[p1l7t3093r139b3151],
2	polymorphism	NN	O	polymorphism	nsubjpass	24	SENT_27	[p1l179t3093r705b3169],
3	in	IN	O	in	_	0	SENT_27	[p1l744t3096r814b3150],
4	the	DT	O	the	det	7	SENT_27	[p1l853t3094r966b3151],
5	B3	NN	O	b3	nn	7	SENT_27	[p1l1010t3095r1075b3166],
6	AR	NN	O	ar	nn	7	SENT_27	[p1l1115t3095r1216b3150],
7	gene	NN	O	gene	prep_in	2	SENT_27	[p1l1253t3110r1435b3169],
8	,	,	O	,	_	0	SENT_27	[p1l1253t3110r1435b3169],
9	that	WDT	O	that	nsubj	10	SENT_27	[p1l1479t3093r1622b3151],
10	results	VBZ	O	result	rcmod	2	SENT_27	[p1l1661t3093r1886b3151],
11	in	IN	O	in	_	0	SENT_27	[p1l1926t3096r1996b3150],
12	the	DT	O	the	det	13	SENT_27	[p1l2035t3093r2148b3151],
13	replacement	NN	O	replacement	prep_in	10	SENT_27	[p1l9t3188r448b3264],
14	of	IN	O	of	_	0	SENT_27	[p1l510t3188r582b3246],
15	Trp	NN	O	trp	prep_of	13	SENT_27	[p1l638t3191r755b3264],
16	by	IN	O	by	_	0	SENT_27	[p1l816t3188r904b3264],
17	Arg	NN	O	arg	prep_by	10	SENT_27	[p1l963t3190r1085b3264],
18	at	IN	O	at	_	0	SENT_27	[p1l1147t3196r1211b3246],
19	position	NN	O	position	prep_at	17	SENT_27	[p1l1272t3191r1564b3264],
20	64	CD	NUMBER	64	num	19	SENT_27	[p1l1629t3190r1728b3259],
21	,	,	O	,	_	0	SENT_27	[p1l1629t3190r1728b3259],
22	is	VBZ	O	be	auxpass	24	SENT_27	[p1l1796t3191r1847b3246],
23	closely	RB	O	closely	advmod	24	SENT_27	[p1l1911t3188r2151b3264],
24	associated	VBN	O	associate	_	0	SENT_27	[p1l9t3282r365b3340],
25	with	IN	O	with	_	0	SENT_27	[p1l391t3282r552b3340],
26	abdominal	JJ	O	abdominal	amod	27	SENT_27	[p1l581t3282r961b3340],
27	obesity	NN	O	obesity	prep_with	24	SENT_27	[p1l989t3282r1242b3358],
28	and	CC	O	and	_	0	SENT_27	[p1l1268t3282r1399b3340],
29	insulin	NN	O	insulin	nn	30	SENT_27	[p1l1426t3282r1673b3340],
30	resistance	NN	O	resistance	conj_and	27	SENT_27	[p1l1700t3275r2147b3340],
31	.	.	O	.	_	0	SENT_27	[p1l1700t3275r2147b3340],

1	”	NN	O	”	nn	2	SENT_28	[p1l1700t3275r2147b3340],
2	B2	NN	O	b2	nsubjpass	11	SENT_28	[p1l90t3379r156b3450],
3	and	CC	O	and	_	0	SENT_28	[p1l220t3378r350b3435],
4	B3AR	NN	O	b3ar	nsubjpass	11	SENT_28	[p1l416t3379r586b3450],
5	but	CC	O	but	_	0	SENT_28	[p1l643t3378r763b3435],
6	not	RB	O	not	_	0	SENT_28	[p1l825t3385r945b3435],
7	B1	NN	O	b1	nn	8	SENT_28	[p1l1011t3379r1074b3450],
8	polymorphisms	NNS	O	polymorphism	conj_negcc	2	SENT_28	[p1l1139t3378r1691b3453],
9	have	VBP	O	have	aux	11	SENT_28	[p1l1755t3378r1919b3435],
10	been	VBN	O	be	auxpass	11	SENT_28	[p1l1980t3378r2148b3435],
11	demonstrated	VBN	O	demonstrate	_	0	SENT_28	[p1l9t3473r495b3531],
12	to	TO	O	to	aux	13	SENT_28	[p1l564t3480r633b3531],
13	exert	VB	O	exert	xcomp	11	SENT_28	[p1l704t3480r877b3531],
14	an	DT	O	a	det	15	SENT_28	[p1l946t3490r1031b3531],
15	impact	NN	O	impact	dobj	13	SENT_28	[p1l1099t3476r1343b3549],
16	on	IN	O	on	_	0	SENT_28	[p1l1411t3490r1503b3531],
17	metabolism	NN	O	metabolism	prep_on	13	SENT_28	[p1l1572t3473r2002b3531],
18	.	.	O	.	_	0	SENT_28	[p1l1572t3473r2002b3531],

1	In	IN	O	in	_	0	SENT_29	[p1l2076t3476r2149b3530],
2	particular	JJ	O	particular	prep_in	13	SENT_29	[p1l8t3568r360b3644],
3	,	,	O	,	_	0	SENT_29	[p1l8t3568r360b3644],
4	the	DT	O	the	det	6	SENT_29	[p1l392t3568r503b3626],
5	Glu27Gln	NN	O	glu27gln	nn	6	SENT_29	[p1l534t3568r879b3626],
6	genotype	NN	O	genotype	nsubjpass	13	SENT_29	[p1l908t3575r1231b3644],
7	of	IN	O	of	_	0	SENT_29	[p1l1260t3568r1331b3626],
8	the	DT	O	the	det	11	SENT_29	[p1l1354t3568r1465b3626],
9	[	NN	O	[	nn	11	SENT_29	[p1l1499t3570r1566b3641],
10	32	CD	NUMBER	32	num	11	SENT_29	[p1l1499t3570r1566b3641],
11	AR	NN	O	ar	prep_of	6	SENT_29	[p1l1591t3570r1692b3625],
12	is	VBZ	O	be	auxpass	13	SENT_29	[p1l1717t3571r1768b3626],
13	associated	VBN	O	associate	_	0	SENT_29	[p1l1796t3568r2149b3626],
14	with	IN	O	with	_	0	SENT_29	[p1l7t3663r167b3720],
15	elevated	JJ	O	elevated	amod	18	SENT_29	[p1l235t3663r524b3720],
16	triglyceride	NN	O	triglyceride	nn	18	SENT_29	[p1l590t3663r985b3738],
17	plasma	NN	O	plasma	nn	18	SENT_29	[p1l1052t3663r1300b3738],
18	levels	NNS	O	level	prep_with	13	SENT_29	[p1l1367t3663r1559b3720],
19	in	IN	O	in	_	0	SENT_29	[p1l1626t3666r1696b3720],
20	a	DT	O	a	det	22	SENT_29	[p1l1764t3679r1799b3720],
21	Swedish	JJ	MISC	swedish	amod	22	SENT_29	[p1l1867t3663r2148b3720],
22	population	NN	O	population	prep_in	13	SENT_29	[p1l8t3749r485b3832],
23	,	,	O	,	_	0	SENT_29	[p1l8t3749r485b3832],
24	”	NN	O	”	appos	22	SENT_29	[p1l8t3749r485b3832],
25	while	IN	O	while	mark	35	SENT_29	[p1l507t3756r700b3814],
26	this	DT	O	this	det	27	SENT_29	[p1l724t3756r853b3814],
27	genotype	NN	O	genotype	nsubj	35	SENT_29	[p1l878t3763r1202b3832],
28	and	CC	O	and	_	0	SENT_29	[p1l1228t3756r1359b3814],
29	the	DT	O	the	det	30	SENT_29	[p1l1382t3756r1494b3814],
30	[	NN	O	[	nsubj	35	SENT_29	[p1l1524t3758r1589b3829],
31	33	CD	NUMBER	33	num	34	SENT_29	[p1l1524t3758r1589b3829],
32	AR	NNS	O	ar	nn	34	SENT_29	[p1l1614t3758r1714b3813],
33	Arg64	NN	O	arg64	nn	34	SENT_29	[p1l1736t3758r1942b3832],
34	allele	NN	O	allele	dep	30	SENT_29	[p1l1968t3756r2148b3814],
35	show	VBP	O	show	advcl	13	SENT_29	[p2l10t25r193b83],
36	a	DT	O	a	det	38	SENT_29	[p2l218t42r253b83],
37	protective	JJ	O	protective	amod	38	SENT_29	[p2l278t28r629b101],
38	effect	NN	O	effect	dobj	35	SENT_29	[p2l657t25r847b83],
39	against	IN	O	against	_	0	SENT_29	[p2l873t28r1121b101],
40	metabolic	JJ	O	metabolic	amod	41	SENT_29	[p2l1146t25r1494b83],
41	disorders	NNS	O	disorder	prep_against	38	SENT_29	[p2l1520t25r1834b83],
42	in	IN	O	in	_	0	SENT_29	[p2l1860t28r1931b82],
43	obese	JJ	O	obese	amod	44	SENT_29	[p2l1957t25r2148b83],
44	families	NNS	O	family	prep_in	41	SENT_29	[p2l9t119r281b177],
45	from	IN	O	from	_	0	SENT_29	[p2l324t119r493b177],
46	southern	JJ	O	southern	amod	47	SENT_29	[p2l539t119r852b177],
47	Poland	NNP	LOCATION	Poland	prep_from	35	SENT_29	[p2l895t112r1221b177],
48	.	.	O	.	_	0	SENT_29	[p2l895t112r1221b177],

1	“	NN	O	“	npadvmod	16	SENT_30	[p2l895t112r1221b177],
2	On	IN	O	on	_	0	SENT_30	[p2l1269t120r1376b177],
3	the	DT	O	the	det	4	SENT_30	[p2l1419t119r1531b177],
4	contrary	NN	O	contrary	prep_on	16	SENT_30	[p2l1576t126r1884b195],
5	,	,	O	,	_	0	SENT_30	[p2l1576t126r1884b195],
6	recent	JJ	O	recent	amod	7	SENT_30	[p2l1932t126r2150b177],
7	evidence	NN	O	evidence	nsubj	16	SENT_30	[p2l9t215r317b272],
8	in	IN	O	in	_	0	SENT_30	[p2l370t217r440b271],
9	a	DT	O	a	det	12	SENT_30	[p2l494t231r528b272],
10	north	JJ	O	north	amod	11	SENT_30	[p2l581t214r780b272],
11	European	JJ	MISC	european	amod	12	SENT_30	[p2l834t217r1166b290],
12	cohort	NN	O	cohort	prep_in	7	SENT_30	[p2l1220t215r1451b272],
13	of	IN	O	of	_	0	SENT_30	[p2l1504t214r1575b272],
14	obese	JJ	O	obese	amod	15	SENT_30	[p2l1624t214r1815b272],
15	patients	NNS	O	patient	prep_of	12	SENT_30	[p2l1868t217r2148b290],
16	negates	VBZ	O	negate	_	0	SENT_30	[p2l9t317r269b385],
17	the	DT	O	the	det	18	SENT_30	[p2l294t309r406b367],
18	association	NN	O	association	dobj	16	SENT_30	[p2l432t312r820b367],
19	between	IN	O	between	_	0	SENT_30	[p2l842t309r1138b367],
20	common	JJ	O	common	amod	21	SENT_30	[p2l1162t326r1480b367],
21	polymorphisms	NNS	O	polymorphism	prep_between	18	SENT_30	[p2l1503t309r2056b385],
22	of	IN	O	of	_	0	SENT_30	[p2l2082t309r2153b367],
23	the	DT	O	the	det	24	SENT_30	[p2l8t403r120b461],
24	B1AR	NN	O	b1ar	prep_of	21	SENT_30	[p2l154t405r324b476],
25	and	CC	O	and	_	0	SENT_30	[p2l351t403r483b461],
26	obesity	NN	O	obesity	prep_of	21	SENT_30	[p2l511t403r761b479],
27	or	CC	O	or	_	0	SENT_30	[p2l788t420r860b461],
28	lypolisis	NN	O	lypolisis	prep_of	21	SENT_30	[p2l887t403r1172b479],
29	in	IN	O	in	_	0	SENT_30	[p2l1202t406r1272b460],
30	isolated	VBN	O	isolate	amod	32	SENT_30	[p2l1300t403r1571b461],
31	fat	JJ	O	fat	amod	32	SENT_30	[p2l1599t403r1689b461],
32	cells	NNS	O	cell	prep_in	18	SENT_30	[p2l1719t396r1955b461],
33	.	.	O	.	_	0	SENT_30	[p2l1719t396r1955b461],

1	”	NN	O	”	_	0	SENT_31	[p2l1719t396r1955b461],

1	Altogether	RB	O	altogether	advmod	5	SENT_32	[p2l84t499r459b574],
2	the	DT	O	the	det	4	SENT_32	[p2l499t499r611b556],
3	above-mentioned	JJ	O	above-mentioned	amod	4	SENT_32	[p2l653t499r1278b556],
4	observations	NNS	O	observation	nsubj	5	SENT_32	[p2l1319t499r1764b556],
5	allow	VBP	O	allow	_	0	SENT_32	[p2l1807t499r1997b556],
6	the	DT	O	the	det	7	SENT_32	[p2l2035t499r2148b556],
7	speculation	NN	O	speculation	dobj	5	SENT_32	[p2l10t594r416b670],
8	that	IN	O	that	complm	17	SENT_32	[p2l468t594r612b652],
9	the	DT	O	the	det	10	SENT_32	[p2l664t594r777b652],
10	polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_32	[p2l830t594r1386b670],
11	of	IN	O	of	_	0	SENT_32	[p2l1441t594r1512b652],
12	the	DT	O	the	det	13	SENT_32	[p2l1560t594r1673b652],
13	[	NN	O	[	prep_of	10	SENT_32	[p2l1731t596r1765b667],
14	3	CD	NUMBER	3	num	15	SENT_32	[p2l1731t596r1765b667],
15	ARs	NNS	O	ar	dep	13	SENT_32	[p2l1816t596r1945b652],
16	may	MD	O	may	aux	17	SENT_32	[p2l1998t611r2151b670],
17	contribute	VB	O	contribute	ccomp	5	SENT_32	[p2l9t689r377b747],
18	to	TO	O	to	aux	19	SENT_32	[p2l415t696r484b747],
19	modify	VB	O	modify	xcomp	17	SENT_32	[p2l522t689r777b765],
20	the	DT	O	the	det	22	SENT_32	[p2l810t689r923b747],
21	metabolic	JJ	O	metabolic	amod	22	SENT_32	[p2l961t689r1311b747],
22	response	NN	O	response	dobj	19	SENT_32	[p2l1347t706r1653b765],
23	to	TO	O	to	_	0	SENT_32	[p2l1690t696r1760b747],
24	long-term	JJ	O	long-term	amod	26	SENT_32	[p2l1797t689r2148b765],
25	antihypertensive	JJ	O	antihypertensive	amod	26	SENT_32	[p2l9t784r605b860],
26	treatment	NN	O	treatment	prep_to	19	SENT_32	[p2l659t791r1009b842],
27	with	IN	O	with	_	0	SENT_32	[p2l1060t784r1221b842],
28	B-blockers	NNS	O	b-blocker	prep_with	26	SENT_32	[p2l1279t784r1648b857],
29	.	.	O	.	_	0	SENT_32	[p2l1279t784r1648b857],

1	The	DT	O	the	det	3	SENT_33	[p2l1704t784r1836b842],
2	present	JJ	DATE	present	amod	3	SENT_33	[p2l1889t791r2149b860],
3	study	NN	O	study	nsubjpass	5	SENT_33	[p2l10t879r203b955],
4	was	VBD	O	be	auxpass	5	SENT_33	[p2l262t896r390b937],
5	undertaken	VBN	O	undertake	_	0	SENT_33	[p2l454t879r861b937],
6	to	TO	O	to	aux	7	SENT_33	[p2l925t886r995b937],
7	test	VB	O	test	xcomp	5	SENT_33	[p2l1059t886r1183b937],
8	the	DT	O	the	det	9	SENT_33	[p2l1246t879r1358b937],
9	hypothesis	NN	O	hypothesis	dobj	7	SENT_33	[p2l1424t879r1807b955],
10	that	IN	O	that	complm	24	SENT_33	[p2l1871t879r2014b937],
11	in	IN	O	in	_	0	SENT_33	[p2l2078t882r2149b936],
12	hypertensive	JJ	O	hypertensive	amod	13	SENT_33	[p2l9t974r463b1049],
13	patients	NNS	O	patient	prep_in	24	SENT_33	[p2l502t976r785b1049],
14	a	DT	O	a	det	16	SENT_33	[p2l825t990r860b1031],
15	given	VBN	O	give	amod	16	SENT_33	[p2l899t976r1091b1049],
16	polymorphism	NN	O	polymorphism	nsubj	24	SENT_33	[p2l1130t973r1656b1049],
17	of	IN	O	of	_	0	SENT_33	[p2l1696t973r1767b1031],
18	B2	NN	O	b2	nn	22	SENT_33	[p2l1806t975r1874b1046],
19	and/or	NN	O	and/or	nn	22	SENT_33	[p2l1913t973r2149b1039],
20	[	CD	NUMBER	[	number	21	SENT_33	[p2l13t1070r78b1141],
21	33	CD	NUMBER	33	num	22	SENT_33	[p2l13t1070r78b1141],
22	ARs	NNS	O	ar	prep_of	16	SENT_33	[p2l116t1070r245b1127],
23	might	MD	O	might	aux	24	SENT_33	[p2l284t1069r497b1145],
24	predict	VB	O	predict	ccomp	7	SENT_33	[p2l534t1069r781b1145],
25	the	DT	O	the	det	26	SENT_33	[p2l819t1069r931b1127],
26	occurrence	NN	O	occurrence	dobj	24	SENT_33	[p2l970t1086r1355b1127],
27	of	IN	O	of	_	0	SENT_33	[p2l1395t1069r1466b1127],
28	metabolic	JJ	O	metabolic	amod	30	SENT_33	[p2l1500t1069r1850b1127],
29	adverse	JJ	O	adverse	amod	30	SENT_33	[p2l1888t1069r2148b1127],
30	events	NNS	O	event	prep_of	26	SENT_33	[p2l9t1171r233b1221],
31	during	IN	O	during	_	0	SENT_33	[p2l276t1164r512b1239],
32	[	NN	O	[	nn	34	SENT_33	[p2l557t1165r590b1236],
33	3	CD	NUMBER	3	num	34	SENT_33	[p2l557t1165r590b1236],
34	AR	NN	O	ar	prep_during	24	SENT_33	[p2l632t1165r732b1220],
35	blocking	VBG	O	block	partmod	34	SENT_33	[p2l771t1163r1080b1239],
36	treatment	NN	O	treatment	dobj	35	SENT_33	[p2l1121t1171r1489b1221],
37	.	.	O	.	_	0	SENT_33	[p2l1121t1171r1489b1221],

1	In	IN	O	in	_	0	SENT_34	[p2l1537t1166r1609b1220],
2	particular	JJ	O	particular	prep_in	5	SENT_34	[p2l1651t1164r2007b1239],
3	,	,	O	,	_	0	SENT_34	[p2l1651t1164r2007b1239],
4	we	PRP	O	we	nsubj	5	SENT_34	[p2l2052t1180r2148b1221],
5	evaluated	VBD	O	evaluate	_	0	SENT_34	[p2l9t1258r348b1316],
6	the	DT	O	the	det	7	SENT_34	[p2l371t1258r483b1316],
7	effects	NNS	O	effect	dobj	5	SENT_34	[p2l508t1258r730b1316],
8	of	IN	O	of	_	0	SENT_34	[p2l755t1258r826b1316],
9	known	JJ	O	known	amod	10	SENT_34	[p2l845t1258r1090b1316],
10	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_34	[p2l1113t1258r1669b1334],
11	of	IN	O	of	_	0	SENT_34	[p2l1695t1258r1766b1316],
12	the	DT	O	the	det	13	SENT_34	[p2l1785t1258r1898b1316],
13	B2	NN	O	b2	prep_of	10	SENT_34	[p2l1926t1260r1994b1331],
14	and	CC	O	and	_	0	SENT_34	[p2l2018t1258r2149b1316],
15	[	NN	O	[	nn	18	SENT_34	[p2l13t1356r78b1427],
16	33	CD	NUMBER	33	num	18	SENT_34	[p2l13t1356r78b1427],
17	AR	NN	O	ar	nn	18	SENT_34	[p2l134t1356r235b1411],
18	genes	NNS	O	gene	conj_and	13	SENT_34	[p2l289t1371r501b1430],
19	,	,	O	,	_	0	SENT_34	[p2l289t1371r501b1430],
20	which	WDT	O	which	nsubjpass	22	SENT_34	[p2l560t1354r780b1412],
21	are	VBP	O	be	auxpass	22	SENT_34	[p2l837t1371r938b1412],
22	involved	VBN	O	involve	rcmod	10	SENT_34	[p2l995t1354r1303b1412],
23	in	IN	O	in	_	0	SENT_34	[p2l1359t1357r1429b1411],
24	glucose	NN	O	glucose	nn	27	SENT_34	[p2l1484t1354r1744b1430],
25	and	CC	O	and	_	0	SENT_34	[p2l1802t1354r1933b1412],
26	lipid	NN	O	lipid	nn	27	SENT_34	[p2l1988t1354r2149b1430],
27	metabolism	NN	O	metabolism	prep_in	22	SENT_34	[p2l9t1449r442b1519],
28	,	,	O	,	_	0	SENT_34	[p2l9t1449r442b1519],
29	on	IN	O	on	_	0	SENT_34	[p2l472t1465r563b1506],
30	the	DT	O	the	det	31	SENT_34	[p2l587t1449r700b1506],
31	occurrence	NN	O	occurrence	prep_on	5	SENT_34	[p2l726t1465r1111b1506],
32	of	IN	O	of	_	0	SENT_34	[p2l1137t1448r1208b1506],
33	diabetes	NN	O	diabetes	prep_of	31	SENT_34	[p2l1229t1449r1514b1506],
34	and	CC	O	and	_	0	SENT_34	[p2l1540t1449r1671b1506],
35	dyslipidemia	NN	O	dyslipidemia	prep_of	31	SENT_34	[p2l1696t1449r2149b1524],
36	observed	VBN	O	observe	partmod	31	SENT_34	[p2l9t1544r322b1601],
37	after	IN	O	after	_	0	SENT_34	[p2l386t1543r544b1601],
38	long-term	JJ	O	long-term	amod	39	SENT_34	[p2l606t1544r957b1619],
39	treatment	NN	O	treatment	prep_after	36	SENT_34	[p2l1021t1551r1372b1601],
40	with	IN	O	with	_	0	SENT_34	[p2l1433t1544r1595b1601],
41	B-blockers	NNS	O	b-blocker	prep_with	36	SENT_34	[p2l1662t1544r2014b1616],
42	in	IN	O	in	_	0	SENT_34	[p2l2079t1547r2149b1601],
43	hypertensive	JJ	O	hypertensive	amod	44	SENT_34	[p2l9t1640r463b1716],
44	patients	NNS	O	patient	prep_in	41	SENT_34	[p2l487t1643r770b1716],
45	in	IN	O	in	mark	48	SENT_34	[p2l794t1643r864b1697],
46	order	NN	O	order	dep	48	SENT_34	[p2l889t1640r1074b1698],
47	to	TO	O	to	aux	48	SENT_34	[p2l1097t1647r1167b1698],
48	identify	VB	O	identify	purpcl	36	SENT_34	[p2l1191t1640r1470b1716],
49	possible	JJ	O	possible	amod	50	SENT_34	[p2l1491t1640r1771b1716],
50	predictors	NNS	O	predictor	dobj	48	SENT_34	[p2l1795t1640r2148b1716],
51	of	IN	O	of	_	0	SENT_34	[p2l9t1735r81b1793],
52	individual	JJ	O	individual	amod	53	SENT_34	[p2l122t1735r485b1793],
53	risk	NN	O	risk	prep_of	50	SENT_34	[p2l532t1735r657b1793],
54	to	TO	O	to	aux	55	SENT_34	[p2l701t1742r771b1793],
55	develop	VB	O	develop	xcomp	48	SENT_34	[p2l818t1735r1094b1811],
56	metabolic	JJ	O	metabolic	amod	57	SENT_34	[p2l1140t1735r1491b1793],
57	disorders	NNS	O	disorder	dobj	55	SENT_34	[p2l1537t1735r1853b1793],
58	as	IN	O	as	_	0	SENT_34	[p2l1901t1752r1966b1793],
59	side	JJ	O	side	amod	60	SENT_34	[p2l2015t1735r2148b1793],
60	effects	NNS	O	effect	prep_as	55	SENT_34	[p2l9t1830r230b1888],
61	of	IN	O	of	_	0	SENT_34	[p2l261t1830r332b1888],
62	antihypertensive	JJ	O	antihypertensive	amod	63	SENT_34	[p2l358t1830r954b1906],
63	therapy	NN	O	therapy	prep_of	60	SENT_34	[p2l985t1830r1268b1906],
64	.	.	O	.	_	0	SENT_34	[p2l985t1830r1268b1906],

1	METHODS	NNS	O	method	_	0	SENT_35	[p2l11t2060r388b2115],

1	Patients	NNS	O	patient	_	0	SENT_36	[p2l13t2152r292b2208],

1	A	DT	O	a	det	2	SENT_37	[p2l7t2249r58b2304],
2	cohort	NN	O	cohort	nsubjpass	9	SENT_37	[p2l100t2247r332b2305],
3	of	IN	O	of	_	0	SENT_37	[p2l375t2247r447b2305],
4	1050	CD	DATE	1050	num	7	SENT_37	[p2l490t2249r656b2305],
5	white	JJ	O	white	amod	7	SENT_37	[p2l696t2247r895b2305],
6	Caucasian	JJ	MISC	caucasian	amod	7	SENT_37	[p2l940t2249r1298b2305],
7	patients	NNS	O	patient	prep_of	2	SENT_37	[p2l1339t2250r1622b2323],
8	was	VBD	O	be	auxpass	9	SENT_37	[p2l1663t2264r1790b2305],
9	recruited	VBN	O	recruit	_	0	SENT_37	[p2l1833t2247r2149b2305],
10	from	IN	O	from	_	0	SENT_37	[p2l9t2341r178b2399],
11	those	DT	O	those	prep_from	9	SENT_37	[p2l211t2342r400b2399],
12	followed	VBN	O	follow	partmod	11	SENT_37	[p2l434t2341r741b2399],
13	at	IN	O	at	_	0	SENT_37	[p2l774t2349r837b2399],
14	the	DT	O	the	det	17	SENT_37	[p2l870t2342r982b2399],
15	outpatient	NN	O	outpatient	nn	17	SENT_37	[p2l1017t2345r1389b2417],
16	Hypertension	NN	O	hypertension	nn	17	SENT_37	[p2l1422t2344r1903b2417],
17	Clinic	NNP	O	Clinic	prep_at	12	SENT_37	[p2l1938t2342r2149b2399],
18	of	IN	O	of	_	0	SENT_37	[p2l9t2436r81b2494],
19	the	DT	O	the	det	20	SENT_37	[p2l105t2437r218b2494],
20	Department	NNP	ORGANIZATION	Department	prep_of	17	SENT_37	[p2l248t2439r675b2512],
21	of	IN	ORGANIZATION	of	_	0	SENT_37	[p2l705t2436r776b2494],
22	Clinical	JJ	ORGANIZATION	clinical	amod	23	SENT_37	[p2l802t2437r1075b2494],
23	Medicine	NN	ORGANIZATION	medicine	prep_of	20	SENT_37	[p2l1104t2437r1432b2494],
24	and	CC	O	and	_	0	SENT_37	[p2l1462t2437r1594b2494],
25	Cardiovascular	NNP	O	Cardiovascular	nn	28	SENT_37	[p2l1624t2437r2150b2494],
26	and	CC	O	and	_	0	SENT_37	[p2l9t2532r141b2590],
27	Immunological	NNP	O	Immunological	nn	28	SENT_37	[p2l167t2532r712b2608],
28	Sciences	NNPS	O	Sciences	prep_of	17	SENT_37	[p2l740t2534r1030b2590],
29	of	IN	O	of	_	0	SENT_37	[p2l1057t2532r1128b2590],
30	the	DT	O	the	det	33	SENT_37	[p2l1151t2532r1263b2590],
31	Federico	NNP	ORGANIZATION	Federico	nn	33	SENT_37	[p2l1291t2532r1584b2590],
32	II	NNP	ORGANIZATION	II	nn	33	SENT_37	[p2l1612t2535r1661b2589],
33	University	NNP	ORGANIZATION	University	prep_of	28	SENT_37	[p2l1688t2535r2057b2608],
34	of	IN	ORGANIZATION	of	_	0	SENT_37	[p2l2081t2532r2153b2590],
35	Naples	NNP	ORGANIZATION	Naples	prep_of	33	SENT_37	[p2l7t2627r243b2703],
36	and	CC	O	and	_	0	SENT_37	[p2l270t2627r401b2685],
37	included	VBD	O	include	conj_and	9	SENT_37	[p2l426t2627r736b2685],
38	all	PDT	O	all	predet	40	SENT_37	[p2l762t2627r844b2685],
39	the	DT	O	the	det	40	SENT_37	[p2l869t2627r982b2685],
40	patients	NNS	O	patient	dobj	37	SENT_37	[p2l1007t2630r1290b2703],
41	who	WP	O	who	nsubj	42	SENT_37	[p2l1314t2627r1467b2685],
42	were	VBD	O	be	rcmod	40	SENT_37	[p2l1491t2644r1655b2685],
43	on	IN	O	on	_	0	SENT_37	[p2l1682t2644r1773b2685],
44	treatment	NN	O	treatment	prep_on	42	SENT_37	[p2l1798t2634r2149b2685],
45	with	IN	O	with	_	0	SENT_37	[p2l7t2722r168b2780],
46	the	DT	O	the	det	48	SENT_37	[p2l197t2722r309b2780],
47	same	JJ	O	same	amod	48	SENT_37	[p2l341t2739r515b2780],
48	drug	NN	O	drug	prep_with	44	SENT_37	[p2l546t2722r707b2798],
49	from	IN	O	from	_	0	SENT_37	[p2l735t2722r905b2780],
50	at	IN	DURATION	at	quantmod	52	SENT_37	[p2l934t2729r998b2780],
51	least	JJS	DURATION	least	mwe	50	SENT_37	[p2l1026t2722r1184b2780],
52	6	CD	DURATION	6	num	53	SENT_37	[p2l1215t2724r1252b2780],
53	months	NNS	NUMBER	month	prep_from	48	SENT_37	[p2l1282t2722r1555b2780],
54	and	CC	O	and	_	0	SENT_37	[p2l1586t2722r1717b2780],
55	returned	VBD	O	return	conj_and	42	SENT_37	[p2l1745t2722r2050b2780],
56	to	TO	O	to	_	0	SENT_37	[p2l2078t2729r2148b2780],
57	the	DT	O	the	det	59	SENT_37	[p2l8t2816r121b2874],
58	Outpatient	NNP	O	Outpatient	nn	59	SENT_37	[p2l172t2818r560b2892],
59	Clinic	NNP	O	Clinic	prep_to	55	SENT_37	[p2l610t2816r821b2874],
60	for	IN	O	for	_	0	SENT_37	[p2l869t2816r967b2874],
61	a	DT	O	a	det	64	SENT_37	[p2l1016t2833r1051b2874],
62	scheduled	VBN	O	schedule	amod	64	SENT_37	[p2l1101t2816r1454b2874],
63	follow-up	NN	O	follow-up	nn	64	SENT_37	[p2l1503t2816r1843b2892],
64	control	NN	O	control	prep_for	55	SENT_37	[p2l1892t2816r2148b2874],
65	from	IN	O	from	_	0	SENT_37	[p2l9t2912r178b2970],
66	February	NNP	DATE	February	prep_from	64	SENT_37	[p2l204t2912r512b2988],
67	1	CD	DATE	1	num	66	SENT_37	[p2l540t2914r569b2969],
68	to	TO	O	to	_	0	SENT_37	[p2l598t2919r668b2970],
69	31	CD	DATE	31	prep_to	37	SENT_37	[p2l694t2913r771b2970],
70	March	NNP	DATE	March	tmod	37	SENT_37	[p2l800t2912r1027b2970],
71	2003	CD	DATE	2003	num	70	SENT_37	[p2l1051t2913r1239b2970],
72	.	.	O	.	_	0	SENT_37	[p2l1051t2913r1239b2970],

1	At	IN	O	at	_	0	SENT_38	[p2l1267t2913r1346b2970],
2	the	DT	O	the	det	3	SENT_38	[p2l1370t2912r1482b2970],
3	end	NN	O	end	prep_at	17	SENT_38	[p2l1508t2912r1639b2970],
4	of	IN	O	of	_	0	SENT_38	[p2l1664t2912r1735b2970],
5	the	DT	O	the	det	7	SENT_38	[p2l1755t2912r1867b2970],
6	clinical	JJ	O	clinical	amod	7	SENT_38	[p2l1893t2912r2148b2970],
7	control	NN	O	control	prep_of	3	SENT_38	[p2l9t3006r265b3064],
8	the	DT	O	the	det	9	SENT_38	[p2l324t3006r436b3064],
9	protocol	NN	O	protocol	nsubjpass	17	SENT_38	[p2l496t3006r794b3082],
10	and	CC	O	and	_	0	SENT_38	[p2l854t3007r985b3064],
11	the	DT	O	the	det	12	SENT_38	[p2l1043t3006r1156b3064],
12	aims	NNS	O	aim	conj_and	9	SENT_38	[p2l1216t3009r1377b3064],
13	of	IN	O	of	_	0	SENT_38	[p2l1438t3006r1509b3064],
14	the	DT	O	the	det	15	SENT_38	[p2l1564t3006r1676b3064],
15	study	NN	O	study	prep_of	12	SENT_38	[p2l1737t3006r1930b3082],
16	were	VBD	O	be	auxpass	17	SENT_38	[p2l1984t3023r2148b3064],
17	illustrated	VBN	O	illustrate	_	0	SENT_38	[p2l9t3101r365b3159],
18	to	TO	O	to	_	0	SENT_38	[p2l423t3109r492b3159],
19	the	DT	O	the	det	20	SENT_38	[p2l552t3101r664b3159],
20	patients	NNS	O	patient	prep_to	17	SENT_38	[p2l722t3104r1005b3177],
21	and	CC	O	and	_	0	SENT_38	[p2l1064t3101r1196b3159],
22	those	DT	O	those	nsubj	27	SENT_38	[p2l1253t3101r1442b3159],
23	who	WP	O	who	nsubj	24	SENT_38	[p2l1500t3101r1653b3159],
24	accepted	VBD	O	accept	rcmod	22	SENT_38	[p2l1713t3101r2021b3177],
25	to	TO	O	to	aux	26	SENT_38	[p2l2078t3109r2148b3159],
26	participate	VB	O	participate	xcomp	24	SENT_38	[p2l8t3200r385b3273],
27	gave	VBD	O	give	conj_and	17	SENT_38	[p2l422t3214r578b3273],
28	written	VBN	O	write	amod	30	SENT_38	[p2l615t3200r872b3255],
29	informed	VBN	O	inform	amod	30	SENT_38	[p2l909t3197r1237b3255],
30	consent	NN	O	consent	dobj	27	SENT_38	[p2l1275t3204r1552b3255],
31	and	CC	O	and	_	0	SENT_38	[p2l1589t3197r1720b3255],
32	were	VBD	O	be	auxpass	33	SENT_38	[p2l1755t3214r1918b3255],
33	asked	VBN	O	ask	conj_and	27	SENT_38	[p2l1956t3197r2149b3255],
34	to	TO	O	to	aux	35	SENT_38	[p2l8t3299r78b3349],
35	return	VB	O	return	xcomp	33	SENT_38	[p2l112t3299r331b3349],
36	in	IN	O	in	_	0	SENT_38	[p2l365t3295r435b3349],
37	the	DT	O	the	det	40	SENT_38	[p2l467t3292r580b3349],
38	overnight	JJ	TIME	overnight	amod	40	SENT_38	[p2l615t3292r961b3367],
39	fasting	JJ	O	fasting	amod	40	SENT_38	[p2l994t3291r1232b3367],
40	state	NN	O	state	prep_in	35	SENT_38	[p2l1265t3299r1424b3349],
41	for	IN	O	for	_	0	SENT_38	[p2l1459t3291r1557b3349],
42	blood	NN	O	blood	nn	43	SENT_38	[p2l1587t3292r1791b3349],
43	sampling	NN	O	sampling	prep_for	40	SENT_38	[p2l1825t3292r2150b3367],
44	for	IN	O	for	_	0	SENT_38	[p2l9t3386r107b3444],
45	estimation	NN	O	estimation	prep_for	35	SENT_38	[p2l161t3390r538b3444],
46	of	IN	O	of	_	0	SENT_38	[p2l594t3386r665b3444],
47	blood	NN	O	blood	nn	48	SENT_38	[p2l713t3387r917b3444],
48	concentration	NN	O	concentration	prep_of	45	SENT_38	[p2l972t3390r1472b3444],
49	of	IN	O	of	_	0	SENT_38	[p2l1527t3386r1599b3444],
50	glucose	NN	O	glucose	prep_of	48	SENT_38	[p2l1649t3387r1927b3462],
51	,	,	O	,	_	0	SENT_38	[p2l1649t3387r1927b3462],
52	total	JJ	O	total	amod	53	SENT_38	[p2l1986t3387r2148b3444],
53	cholesterol	NN	O	cholesterol	conj_and	50	SENT_38	[p2l9t3482r397b3540],
54	and	CC	O	and	_	0	SENT_38	[p2l438t3482r570b3540],
55	triglycerides	NNS	O	triglyceride	conj_and	50	SENT_38	[p2l610t3482r1040b3558],
56	and	CC	O	and	_	0	SENT_38	[p2l1082t3482r1213b3540],
57	for	IN	O	for	_	0	SENT_38	[p2l1254t3482r1353b3540],
58	genotype	NN	O	genotype	nn	59	SENT_38	[p2l1392t3489r1718b3558],
59	determination	NN	O	determination	conj_and	45	SENT_38	[p2l1761t3482r2148b3540, p2l8t3580r171b3635],
60	.	.	O	.	_	0	SENT_38	[p2l1761t3482r2148b3540, p2l8t3580r171b3635],

1	During	IN	O	during	_	0	SENT_39	[p2l200t3579r448b3653],
2	the	DT	O	the	det	3	SENT_39	[p2l470t3577r582b3635],
3	visit	NN	O	visit	pobj	1	SENT_39	[p2l605t3580r771b3647],
4	,	,	O	,	_	0	SENT_39	[p2l605t3580r771b3647],
5	the	DT	O	the	det	6	SENT_39	[p2l799t3577r911b3635],
6	patients	NNS	O	patient	nsubjpass	8	SENT_39	[p2l935t3580r1218b3653],
7	were	VBD	O	be	auxpass	8	SENT_39	[p2l1240t3594r1403b3635],
8	examined	VBN	O	examine	dep	3	SENT_39	[p2l1428t3577r1776b3635],
9	and	CC	O	and	_	0	SENT_39	[p2l1800t3577r1931b3635],
10	office	NN	O	office	nn	12	SENT_39	[p2l1956t3577r2148b3635],
11	blood	NN	O	blood	nn	12	SENT_39	[p2l7t3672r211b3730],
12	pressure	NN	O	pressure	nsubjpass	14	SENT_39	[p2l240t3689r527b3748],
13	was	VBD	O	be	auxpass	14	SENT_39	[p2l556t3689r684b3730],
14	measured	VBN	O	measure	dep	3	SENT_39	[p2l715t3672r1054b3730],
15	three	CD	NUMBER	three	num	16	SENT_39	[p2l1084t3672r1264b3730],
16	times	NNS	O	time	tmod	14	SENT_39	[p2l1295t3675r1485b3730],
17	at	IN	O	at	_	0	SENT_39	[p2l1517t3679r1581b3730],
18	2-min	JJ	DURATION	2-min	amod	19	SENT_39	[p2l1612t3674r1823b3729],
19	interval	NN	O	interval	prep_at	14	SENT_39	[p2l1853t3672r2144b3742],
20	,	,	O	,	_	0	SENT_39	[p2l1853t3672r2144b3742],

1	with	IN	O	with	_	0	SENT_40	[p3l7t16r168b74],
2	a	DT	O	a	det	3	SENT_40	[p3l206t33r240b74],
3	mercury	NN	O	mercury	prep_with	10	SENT_40	[p3l277t33r572b92],
4	sphygmomanometer	NN	O	sphygmomanometer	nsubjpass	10	SENT_40	[p3l608t17r1348b92],
5	after	IN	O	after	_	0	SENT_40	[p3l1384t16r1542b74],
6	the	DT	O	the	det	7	SENT_40	[p3l1579t16r1691b74],
7	patient	NN	O	patient	prep_after	4	SENT_40	[p3l1728t19r1981b92],
8	had	VBD	O	have	aux	10	SENT_40	[p3l2017t16r2149b74],
9	been	VBN	O	be	auxpass	10	SENT_40	[p3l6t112r176b170],
10	seated	VBN	O	seat	_	0	SENT_40	[p3l216t112r432b170],
11	for	IN	O	for	_	0	SENT_40	[p3l469t112r568b170],
12	10	CD	DURATION	10	num	13	SENT_40	[p3l610t113r688b170],
13	min	NN	DURATION	min	prep_for	10	SENT_40	[p3l705t115r848b169],
14	in	IN	O	in	_	0	SENT_40	[p3l885t115r956b169],
15	a	DT	O	a	det	17	SENT_40	[p3l994t129r1029b170],
16	quiet	JJ	O	quiet	amod	17	SENT_40	[p3l1067t115r1247b188],
17	room	NN	O	room	prep_in	13	SENT_40	[p3l1284t129r1490b182],
18	,	,	O	,	_	0	SENT_40	[p3l1284t129r1490b182],
19	according	VBG	O	accord	_	0	SENT_40	[p3l1534t112r1881b188],
20	to	TO	O	to	prepc_according_to	10	SENT_40	[p3l1917t119r1987b170],
21	ISH	NN	O	ish	nn	22	SENT_40	[p3l2027t113r2147b170],
22	guidelines	NNS	O	guideline	pobj	10	SENT_40	[p3l9t197r455b280],
23	.	.	O	.	_	0	SENT_40	[p3l9t197r455b280],

1	”	NN	O	”	nn	3	SENT_41	[p3l9t197r455b280],
2	A	NN	O	a	nn	3	SENT_41	[p3l487t206r538b261],
3	minimum	NN	O	minimum	nsubjpass	8	SENT_41	[p3l569t207r927b262],
4	of	IN	O	of	_	0	SENT_41	[p3l960t204r1032b262],
5	three	CD	NUMBER	three	num	6	SENT_41	[p3l1058t205r1239b262],
6	readings	NNS	O	reading	prep_of	3	SENT_41	[p3l1272t204r1567b280],
7	was	VBD	O	be	auxpass	8	SENT_41	[p3l1597t221r1725b262],
8	performed	VBN	O	perform	_	0	SENT_41	[p3l1757t204r2144b280],
9	,	,	O	,	_	0	SENT_41	[p3l1757t204r2144b280],
10	and	CC	O	and	_	0	SENT_41	[p3l9t301r141b358],
11	the	DT	O	the	det	12	SENT_41	[p3l167t301r280b358],
12	average	NN	O	average	nsubjpass	19	SENT_41	[p3l309t317r571b376],
13	of	IN	O	of	_	0	SENT_41	[p3l599t300r671b358],
14	the	DT	O	the	det	17	SENT_41	[p3l694t301r806b358],
15	last	JJ	O	last	amod	17	SENT_41	[p3l834t301r953b358],
16	two	CD	NUMBER	two	num	17	SENT_41	[p3l980t308r1110b358],
17	readings	NNS	O	reading	prep_of	12	SENT_41	[p3l1138t301r1433b376],
18	was	VBD	O	be	auxpass	19	SENT_41	[p3l1459t317r1587b358],
19	recorded	VBN	O	record	conj_and	8	SENT_41	[p3l1615t301r1940b358],
20	.	.	O	.	_	0	SENT_41	[p3l1615t301r1940b358],

1	Body	NN	O	body	nn	3	SENT_42	[p3l1972t301r2151b376],
2	mass	NN	O	mass	nn	3	SENT_42	[p3l9t412r178b453],
3	index	NN	O	index	_	0	SENT_42	[p3l220t395r419b453],
4	(	CD	NUMBER	(	num	6	SENT_42	[p3l463t395r654b467],
5	BMI	NN	O	bmus	nn	6	SENT_42	[p3l463t395r654b467],
6	)	NN	O	)	nsubjpass	8	SENT_42	[p3l463t395r654b467],
7	was	VBD	O	be	auxpass	8	SENT_42	[p3l697t412r825b453],
8	calculated	VBN	O	calculate	rcmod	3	SENT_42	[p3l867t395r1224b453],
9	with	IN	O	with	_	0	SENT_42	[p3l1263t395r1425b453],
10	the	DT	O	the	det	12	SENT_42	[p3l1466t395r1578b453],
11	usual	JJ	O	usual	amod	12	SENT_42	[p3l1619t395r1805b453],
12	formula	NN	O	formulum	prep_with	8	SENT_42	[p3l1846t395r2144b453],
13	:	:	O	:	_	0	SENT_42	[p3l1846t395r2144b453],
14	weight	NN	O	weight	nn	17	SENT_42	[p3l7t489r248b564],
15	(	CD	NUMBER	(	num	17	SENT_42	[p3l294t481r720b564],
16	kg	NN	O	kg	nn	17	SENT_42	[p3l294t481r720b564],
17	)	NN	O	)	dep	3	SENT_42	[p3l294t481r720b564],
18	/	:	O	/	punct	19	SENT_42	[p3l294t481r720b564],
19	heightz	NN	O	heightz	dep	17	SENT_42	[p3l294t481r720b564],
20	(	CD	NUMBER	(	num	19	SENT_42	[p3l766t481r936b561],
21	m2	NN	O	m2	nn	22	SENT_42	[p3l766t481r936b561],
22	)	NN	O	)	dep	17	SENT_42	[p3l766t481r936b561],
23	.	.	O	.	_	0	SENT_42	[p3l766t481r936b561],

1	Blood	NN	O	blood	nn	2	SENT_43	[p3l983t489r1187b546],
2	glucose	NN	O	glucose	nsubjpass	9	SENT_43	[p3l1230t489r1508b564],
3	,	,	O	,	_	0	SENT_43	[p3l1230t489r1508b564],
4	total	JJ	O	total	amod	5	SENT_43	[p3l1555t489r1717b546],
5	cholesterol	NN	O	cholesterol	nsubjpass	9	SENT_43	[p3l1761t489r2148b546],
6	and	CC	O	and	_	0	SENT_43	[p3l9t585r141b642],
7	triglycerides	NNS	O	triglyceride	nsubjpass	9	SENT_43	[p3l193t585r623b660],
8	were	VBD	O	be	auxpass	9	SENT_43	[p3l676t601r839b642],
9	measured	VBN	O	measure	_	0	SENT_43	[p3l894t585r1232b642],
10	by	IN	O	by	_	0	SENT_43	[p3l1283t585r1371b660],
11	enzymatic	JJ	O	enzymatic	amod	12	SENT_43	[p3l1422t588r1786b660],
12	methods	NNS	O	method	agent	9	SENT_43	[p3l1840t585r2148b642],
13	using	VBG	O	use	xcomp	9	SENT_43	[p3l7t683r200b756],
14	commercial	JJ	O	commercial	amod	15	SENT_43	[p3l228t680r643b738],
15	kits	NNS	O	kit	dobj	13	SENT_43	[p3l673t680r813b738],
16	.	.	O	.	_	0	SENT_43	[p3l673t680r813b738],

1	[	NN	O	[	nn	2	SENT_44	[p3l9t921r265b978],
2	5-blockade	NN	O	5-blockade	_	0	SENT_44	[p3l9t921r265b978],
3	and	CC	O	and	_	0	SENT_44	[p3l284t921r372b966],
4	dyslipidemia	NN	O	dyslipidemia	nn	5	SENT_44	[p3l391t921r696b980],
5	mg	NN	O	mg	conj_and	2	SENT_44	[p3l2025t909r2151b1033],
6	C	NN	O	c	nn	7	SENT_44	[p3l8t994r38b1034],
7	Iaccarino	NN	PERSON	iaccarino	dep	2	SENT_44	[p3l60t993r241b1034],
8	et	FW	O	et	nn	9	SENT_44	[p3l261t997r297b1034],
9	al	FW	O	al	dep	2	SENT_44	[p3l314t992r350b1034],

1	Determination	NN	O	determination	nsubjpass	8	SENT_45	[p3l12t1281r526b1338],
2	of	IN	O	of	_	0	SENT_45	[p3l559t1280r631b1338],
3	Genotypes	NNP	O	Genotypes	prep_of	1	SENT_45	[p3l659t1282r1039b1356],
4	The	DT	O	the	det	6	SENT_45	[p3l6t1376r139b1434],
5	study	NN	O	study	nn	6	SENT_45	[p3l184t1376r376b1452],
6	population	NN	O	population	dep	3	SENT_45	[p3l416t1376r808b1452],
7	was	VBD	O	be	auxpass	8	SENT_45	[p3l849t1393r977b1434],
8	genotyped	VBN	O	genotype	_	0	SENT_45	[p3l1020t1376r1393b1452],
9	for	IN	O	for	_	0	SENT_45	[p3l1435t1376r1533b1434],
10	the	DT	O	the	det	12	SENT_45	[p3l1575t1376r1687b1434],
11	following	VBG	O	follow	amod	12	SENT_45	[p3l1731t1376r2069b1452],
12	[	NN	O	[	prep_for	8	SENT_45	[p3l2115t1378r2148b1449],
13	3	CD	NUMBER	3	num	17	SENT_45	[p3l2115t1378r2148b1449],
14	adrenergic	JJ	O	adrenergic	amod	17	SENT_45	[p3l9t1471r378b1547],
15	receptor	NN	O	receptor	nn	17	SENT_45	[p3l441t1478r732b1547],
16	gene	NN	O	gene	nn	17	SENT_45	[p3l794t1488r957b1547],
17	polymorphisms	NNS	O	polymorphism	dep	12	SENT_45	[p3l1020t1471r1596b1547],
18	.	.	O	.	_	0	SENT_45	[p3l1020t1471r1596b1547],

1	[	NN	O	[	_	0	SENT_46	[p3l1668t1473r1735b1544],
2	32	CD	NUMBER	32	num	1	SENT_46	[p3l1668t1473r1735b1544],
3	Arg16Gly	NN	O	arg16gly	dep	1	SENT_46	[p3l1796t1471r2144b1547],
4	,	,	O	,	_	0	SENT_46	[p3l1796t1471r2144b1547],
5	Glu27G1n	NN	O	glu27g1n	dep	1	SENT_46	[p3l10t1566r358b1623],
6	and	CC	O	and	_	0	SENT_46	[p3l404t1566r535b1623],
7	Thr164Ile	NN	O	thr164ile	conj_and	3	SENT_46	[p3l578t1566r942b1635],
8	;	:	O	;	_	0	SENT_46	[p3l578t1566r942b1635],
9	B3	NN	O	b3	nn	10	SENT_46	[p3l995t1567r1060b1638],
10	Trp64Arg	NN	O	trp64arg	dep	1	SENT_46	[p3l1104t1567r1450b1641],
11	.	.	O	.	_	0	SENT_46	[p3l1104t1567r1450b1641],

1	We	PRP	O	we	nsubj	2	SENT_47	[p3l1499t1568r1608b1623],
2	consider	VBP	O	consider	_	0	SENT_47	[p3l1655t1566r1953b1623],
3	wild	JJ	O	wild	amod	4	SENT_47	[p3l1996t1566r2149b1623],
4	type	NN	O	type	iobj	2	SENT_47	[p3l8t1668r159b1737],
5	the	DT	O	the	det	6	SENT_47	[p3l217t1661r330b1719],
6	sequences	NNS	O	sequence	dobj	2	SENT_47	[p3l390t1678r742b1737],
7	originally	RB	O	originally	advmod	8	SENT_47	[p3l801t1661r1143b1737],
8	described	VBN	O	describe	partmod	6	SENT_47	[p3l1199t1661r1530b1719],
9	for	IN	O	for	_	0	SENT_47	[p3l1587t1661r1686b1719],
10	each	DT	O	each	det	11	SENT_47	[p3l1743t1661r1904b1719],
11	gene	NN	O	gene	prep_for	8	SENT_47	[p3l1962t1678r2144b1737],
12	.	.	O	.	_	0	SENT_47	[p3l1962t1678r2144b1737],

1	Accordingly	RB	O	accordingly	advmod	42	SENT_48	[p3l7t1756r447b1832],
2	,	,	O	,	_	0	SENT_48	[p3l7t1756r447b1832],
3	the	DT	O	the	det	4	SENT_48	[p3l481t1756r594b1814],
4	Arg16	NN	O	arg16	nsubjpass	42	SENT_48	[p3l623t1758r831b1832],
5	of	IN	O	of	_	0	SENT_48	[p3l862t1756r934b1814],
6	the	DT	O	the	det	7	SENT_48	[p3l959t1756r1071b1814],
7	BZAR	NN	ORGANIZATION	bzar	prep_of	4	SENT_48	[p3l1107t1758r1276b1829],
8	it	PRP	O	it	nsubjpass	10	SENT_48	[p3l1304t1759r1354b1814],
9	is	VBZ	O	be	auxpass	10	SENT_48	[p3l1383t1759r1433b1814],
10	defined	VBN	O	define	rcmod	7	SENT_48	[p3l1464t1756r1729b1814],
11	as	IN	O	as	_	0	SENT_48	[p3l1759t1773r1824b1814],
12	the	DT	O	the	det	14	SENT_48	[p3l1854t1756r1967b1814],
13	wild	JJ	O	wild	amod	14	SENT_48	[p3l1996t1756r2149b1814],
14	type	NN	O	type	prep_as	10	SENT_48	[p3l8t1858r177b1927],
15	,	,	O	,	_	0	SENT_48	[p3l8t1858r177b1927],
16	although	IN	O	although	mark	22	SENT_48	[p3l206t1851r528b1927],
17	it	PRP	O	it	nsubj	22	SENT_48	[p3l551t1854r600b1909],
18	is	VBZ	O	be	cop	22	SENT_48	[p3l623t1854r673b1909],
19	the	DT	O	the	det	22	SENT_48	[p3l697t1851r810b1909],
20	less	JJR	O	less	amod	22	SENT_48	[p3l834t1851r953b1909],
21	frequent	JJ	O	frequent	amod	22	SENT_48	[p3l977t1851r1278b1927],
22	allele	NN	O	allele	dep	7	SENT_48	[p3l1302t1851r1503b1920],
23	;	:	O	;	_	0	SENT_48	[p3l1302t1851r1503b1920],
24	for	IN	O	for	_	0	SENT_48	[p3l1531t1851r1629b1909],
25	the	DT	O	the	det	27	SENT_48	[p3l1651t1851r1763b1909],
26	other	JJ	O	other	amod	27	SENT_48	[p3l1788t1851r1977b1909],
27	loci	NNS	O	locus	prep_for	7	SENT_48	[p3l1999t1851r2143b1921],
28	,	,	O	,	_	0	SENT_48	[p3l1999t1851r2143b1921],
29	Gln27	NN	O	gln27	prep_for	7	SENT_48	[p3l10t1946r225b2004],
30	and	CC	O	and	_	0	SENT_48	[p3l257t1946r389b2004],
31	Thr164	NN	O	thr164	prep_for	7	SENT_48	[p3l416t1946r671b2004],
32	of	IN	O	of	_	0	SENT_48	[p3l703t1946r775b2004],
33	the	DT	O	the	det	34	SENT_48	[p3l800t1946r913b2004],
34	BZAR	NN	ORGANIZATION	bzar	prep_of	7	SENT_48	[p3l948t1948r1118b2019],
35	and	CC	O	and	_	0	SENT_48	[p3l1147t1946r1279b2004],
36	Trp64	NN	O	trp64	conj_and	34	SENT_48	[p3l1306t1948r1509b2022],
37	of	IN	O	of	_	0	SENT_48	[p3l1541t1946r1613b2004],
38	the	DT	O	the	det	40	SENT_48	[p3l1638t1946r1751b2004],
39	B3AR	NN	O	b3ar	nn	40	SENT_48	[p3l1786t1948r1956b2019],
40	gene	NN	O	gene	prep_of	34	SENT_48	[p3l1984t1963r2148b2022],
41	are	VBP	O	be	auxpass	42	SENT_48	[p3l9t2058r110b2099],
42	considered	VBN	O	consider	_	0	SENT_48	[p3l141t2041r524b2099],
43	wild-type	JJ	O	wild-type	acomp	42	SENT_48	[p3l551t2041r903b2117],
44	.	.	O	.	_	0	SENT_48	[p3l551t2041r903b2117],

1	Genomic	JJ	MISC	genomic	amod	3	SENT_49	[p3l86t2137r410b2194],
2	deoxyribonucleic	JJ	O	deoxyribonucleic	amod	3	SENT_49	[p3l432t2136r1046b2212],
3	acid	NN	O	acid	nsubjpass	8	SENT_49	[p3l1070t2136r1211b2194],
4	(	NN	O	(	nn	6	SENT_49	[p3l1238t2136r1454b2208],
5	DNA	NN	MISC	dna	nn	6	SENT_49	[p3l1238t2136r1454b2208],
6	)	NN	O	)	dep	3	SENT_49	[p3l1238t2136r1454b2208],
7	was	VBD	O	be	auxpass	8	SENT_49	[p3l1478t2153r1606b2194],
8	extracted	VBN	O	extract	_	0	SENT_49	[p3l1630t2136r1956b2194],
9	from	IN	O	from	_	0	SENT_49	[p3l1978t2136r2148b2194],
10	peripheral	JJ	O	peripheral	amod	11	SENT_49	[p3l8t2230r369b2306],
11	lymphocytes	NNS	O	lymphocyte	prep_from	8	SENT_49	[p3l411t2230r864b2306],
12	with	IN	O	with	_	0	SENT_49	[p3l904t2230r1066b2288],
13	phenol	NN	O	phenol	nn	15	SENT_49	[p3l1106t2230r1800b2306],
14	—	CD	NUMBER	—	num	15	SENT_49	[p3l1106t2230r1800b2306],
15	chloroform	NN	O	chloroform	prep_with	8	SENT_49	[p3l1106t2230r1800b2306],
16	followed	VBN	O	follow	partmod	15	SENT_49	[p3l1842t2230r2149b2288],
17	by	IN	O	by	_	0	SENT_49	[p3l6t2324r94b2400],
18	ethanol	NN	O	ethanol	nn	19	SENT_49	[p3l135t2324r406b2382],
19	precipitation	NN	O	precipitation	agent	16	SENT_49	[p3l448t2317r994b2400],
20	.	.	O	.	_	0	SENT_49	[p3l448t2317r994b2400],

1	”	NN	O	”	nn	3	SENT_50	[p3l448t2317r994b2400],
2	Genotyping	NN	O	genotyping	nn	3	SENT_50	[p3l1039t2326r1462b2400],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_50	[p3l1505t2324r1780b2400],
4	was	VBD	O	be	auxpass	5	SENT_50	[p3l1822t2341r1950b2382],
5	conducted	VBN	O	conduct	_	0	SENT_50	[p3l1995t2341r2148b2382, p3l9t2420r249b2478],
6	by	IN	O	by	_	0	SENT_50	[p3l290t2420r378b2496],
7	the	DT	O	the	det	17	SENT_50	[p3l420t2420r532b2478],
8	polymerase	NN	O	polymerase	nn	17	SENT_50	[p3l577t2420r979b2496],
9	chain	NN	O	chain	nn	17	SENT_50	[p3l1025t2420r1221b2478],
10	reaction-restriction	NN	O	reaction-restriction	nn	17	SENT_50	[p3l1265t2423r1946b2478],
11	fragment	NN	O	fragment	nn	17	SENT_50	[p3l1990t2420r2147b2496, p3l8t2522r195b2572],
12	length	NN	O	length	nn	17	SENT_50	[p3l223t2515r452b2590],
13	polymorphism	NN	O	polymorphism	nn	17	SENT_50	[p3l479t2515r1005b2590],
14	(	NN	O	(	nn	17	SENT_50	[p3l1038t2515r1432b2587],
15	PCR-RFLP	NN	O	pcr-rflp	nn	17	SENT_50	[p3l1038t2515r1432b2587],
16	)	NN	O	)	nn	17	SENT_50	[p3l1038t2515r1432b2587],
17	assay	NN	O	assay	agent	5	SENT_50	[p3l1464t2531r1655b2590],
18	.	.	O	.	_	0	SENT_50	[p3l1464t2531r1655b2590],

1	The	DT	O	the	det	2	SENT_51	[p3l1686t2515r1818b2572],
2	PCR	NN	O	pcr	nsubjpass	4	SENT_51	[p3l1848t2516r1994b2572],
3	was	VBD	O	be	auxpass	4	SENT_51	[p3l2020t2531r2147b2572],
4	performed	VBN	O	perform	_	0	SENT_51	[p3l8t2610r377b2686],
5	as	IN	O	as	mark	6	SENT_51	[p3l426t2627r491b2668],
6	described	VBN	O	describe	advcl	4	SENT_51	[p3l542t2610r873b2668],
7	previously	RB	DATE	previously	advmod	6	SENT_51	[p3l921t2610r1290b2686],
8	with	IN	O	with	_	0	SENT_51	[p3l1335t2610r1496b2668],
9	minor	JJ	O	minor	amod	10	SENT_51	[p3l1545t2613r1764b2668],
10	modification	NN	O	modification	prep_with	6	SENT_51	[p3l1812t2610r2147b2668, p3l8t2696r240b2761],
11	.	.	O	.	_	0	SENT_51	[p3l1812t2610r2147b2668, p3l8t2696r240b2761],

1	”	NN	O	”	nsubj	9	SENT_52	[p3l1812t2610r2147b2668, p3l8t2696r240b2761],
2	The	DT	O	the	det	5	SENT_52	[p3l268t2703r401b2761],
3	final	JJ	O	final	amod	5	SENT_52	[p3l431t2703r590b2761],
4	25	CD	NUMBER	25	num	5	SENT_52	[p3l621t2705r700b2761],
5	ul	NN	O	ul	dep	1	SENT_52	[p3l722t2703r782b2776],
6	of	IN	O	of	_	0	SENT_52	[p3l813t2703r884b2761],
7	PCR	NN	O	pcr	nn	8	SENT_52	[p3l910t2705r1056b2761],
8	mixture	NN	O	mixture	prep_of	1	SENT_52	[p3l1084t2706r1363b2761],
9	contained	VBD	O	contain	_	0	SENT_52	[p3l1394t2703r1749b2761],
10	14.25	CD	NUMBER	14.25	num	11	SENT_52	[p3l1784t2705r1968b2761],
11	ul	NN	O	ul	dep	36	SENT_52	[p3l1991t2703r2051b2776],
12	of	IN	O	of	_	0	SENT_52	[p3l2081t2703r2152b2761],
13	PCR	NN	O	pcr	nn	15	SENT_52	[p3l9t2798r155b2855],
14	grade	NN	O	grade	nn	15	SENT_52	[p3l188t2797r378b2873],
15	water	NN	O	water	prep_of	11	SENT_52	[p3l412t2804r620b2867],
16	,	,	O	,	_	0	SENT_52	[p3l412t2804r620b2867],
17	2.5	CD	NUMBER	2.5	num	18	SENT_52	[p3l661t2798r762b2855],
18	ul	NN	O	ul	appos	15	SENT_52	[p3l785t2797r845b2869],
19	of	IN	O	of	_	0	SENT_52	[p3l881t2797r952b2855],
20	10	CD	NUMBER	10	prep_of	18	SENT_52	[p3l988t2798r1066b2855],
21	x	CC	O	x	_	0	SENT_52	[p3l1092t2815r1129b2853],
22	PCR	NN	O	pcr	nn	23	SENT_52	[p3l1186t2798r1332b2855],
23	buffer	NN	O	buffer	conj_x	18	SENT_52	[p3l1363t2797r1575b2855],
24	(	CD	NUMBER	(	num	25	SENT_52	[p3l1612t2790r1832b2873],
25	Mg2	NN	O	mg2	dep	23	SENT_52	[p3l1612t2790r1832b2873],
26	+	CC	O	+	_	0	SENT_52	[p3l1612t2790r1832b2873],
27	)	NN	O	)	conj_x	18	SENT_52	[p3l1846t2797r1887b2869],
28	,	,	O	,	_	0	SENT_52	[p3l1846t2797r1887b2869],
29	1	CD	NUMBER	1	num	30	SENT_52	[p3l1933t2799r1962b2854],
30	ul	NN	O	ul	appos	27	SENT_52	[p3l1986t2797r2046b2869],
31	of	IN	O	of	_	0	SENT_52	[p3l2081t2797r2152b2855],
32	deoxiribonuclease	NN	O	deoxiribonuclease	prep_of	30	SENT_52	[p3l9t2893r650b2951],
33	triphosphatase	NN	O	triphosphatase	dep	36	SENT_52	[p3l689t2893r1212b2969],
34	(	CD	NUMBER	(	num	33	SENT_52	[p3l1255t2894r1381b2965],
35	2.5	CD	NUMBER	2.5	num	36	SENT_52	[p3l1255t2894r1381b2965],
36	umol/l	NN	O	umol/l	dep	9	SENT_52	[p3l1404t2893r1636b2966],
37	each	DT	O	each	det	38	SENT_52	[p3l1675t2893r1880b2965],
38	)	NN	O	)	dep	36	SENT_52	[p3l1675t2893r1880b2965],
39	,	,	O	,	_	0	SENT_52	[p3l1675t2893r1880b2965],
40	2ul	NN	O	2ul	appos	38	SENT_52	[p3l1924t2893r2042b2966],
41	of	IN	O	of	_	0	SENT_52	[p3l2081t2893r2152b2951],
42	primer	NN	O	primer	prep_of	40	SENT_52	[p3l8t2991r245b3064],
43	(	CD	NUMBER	(	number	44	SENT_52	[p3l271t2988r378b3060],
44	10	CD	NUMBER	10	num	45	SENT_52	[p3l271t2988r378b3060],
45	umol/l	NN	O	umol/l	dobj	9	SENT_52	[p3l397t2988r628b3060],
46	each	DT	O	each	det	47	SENT_52	[p3l652t2988r857b3060],
47	)	NN	O	)	dep	45	SENT_52	[p3l652t2988r857b3060],
48	,	,	O	,	_	0	SENT_52	[p3l652t2988r857b3060],
49	0.25	CD	NUMBER	0.25	num	50	SENT_52	[p3l886t2989r1032b3046],
50	ul	NN	O	ul	dobj	9	SENT_52	[p3l1054t2988r1114b3060],
51	of	IN	O	of	prep	50	SENT_52	[p3l1138t2988r1210b3046],
52	T	NN	O	t	nn	55	SENT_52	[p3l1232t2990r1282b3045],
53	aq	NN	O	aq	nn	55	SENT_52	[p3l1274t3005r1352b3064],
54	DNA	NN	O	dna	nn	55	SENT_52	[p3l1375t2989r1544b3045],
55	polymerase	NN	O	polymerase	dep	51	SENT_52	[p3l1566t2988r1968b3064],
56	(	CD	NUMBER	(	num	57	SENT_52	[p3l1995t2988r2148b3060],
57	5U	NN	O	5u	dep	55	SENT_52	[p3l1995t2988r2148b3060],
58	/	:	O	/	punct	55	SENT_52	[p3l1995t2988r2148b3060],
59	ul	NN	O	ul	dep	55	SENT_52	[p3l10t3083r89b3155],
60	;	:	O	;	_	0	SENT_52	[p3l10t3083r89b3155],
61	Quiagen	NNP	O	Quiagen	nn	62	SENT_52	[p3l124t3083r444b3159],
62	)	NN	O	)	dep	59	SENT_52	[p3l124t3083r444b3159],
63	and	CC	O	and	_	0	SENT_52	[p3l478t3083r609b3141],
64	5	CD	NUMBER	5	num	65	SENT_52	[p3l640t3085r674b3141],
65	ul	NN	O	ul	conj_and	45	SENT_52	[p3l697t3083r757b3155],
66	of	IN	O	of	_	0	SENT_52	[p3l788t3083r859b3141],
67	genomic	JJ	O	genomic	amod	69	SENT_52	[p3l884t3086r1190b3159],
68	DNA	NN	O	dna	nn	69	SENT_52	[p3l1219t3084r1389b3140],
69	sample	NN	O	sample	prep_of	65	SENT_52	[p3l1419t3083r1683b3159],
70	.	.	O	.	_	0	SENT_52	[p3l1419t3083r1683b3159],

1	For	IN	O	for	_	0	SENT_53	[p3l86t3180r197b3235],
2	the	DT	O	the	det	4	SENT_53	[p3l225t3177r337b3235],
3	direct	JJ	O	direct	amod	4	SENT_53	[p3l367t3178r567b3235],
4	identification	NN	O	identification	prep_for	11	SENT_53	[p3l596t3177r1078b3235],
5	of	IN	O	of	_	0	SENT_53	[p3l1107t3177r1179b3235],
6	the	DT	O	the	det	8	SENT_53	[p3l1204t3177r1316b3235],
7	B2	NN	O	b2	nn	8	SENT_53	[p3l1350t3179r1417b3250],
8	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_53	[p3l1445t3177r2020b3253],
9	,	,	O	,	_	0	SENT_53	[p3l1445t3177r2020b3253],
10	we	PRP	O	we	nsubj	11	SENT_53	[p3l2051t3194r2147b3235],
11	used	VBD	O	use	_	0	SENT_53	[p3l7t3272r167b3330],
12	the	DT	O	the	det	14	SENT_53	[p3l222t3272r334b3330],
13	following	VBG	O	follow	amod	14	SENT_53	[p3l390t3272r728b3348],
14	sense	NN	O	sense	nsubj	18	SENT_53	[p3l784t3289r966b3330],
15	and	CC	O	and	_	0	SENT_53	[p3l1023t3272r1154b3330],
16	antisense	JJ	O	antisense	amod	17	SENT_53	[p3l1209t3275r1534b3330],
17	primers	NNS	O	primer	conj_and	14	SENT_53	[p3l1589t3275r1856b3348],
18	(	VBP	O	(	ccomp	11	SENT_53	[p3l1916t3270r2144b3344],
19	5	CD	NUMBER	5	number	20	SENT_53	[p3l1916t3270r2144b3344],
20	’	CD	NUMBER	’	dobj	18	SENT_53	[p3l1916t3270r2144b3344],
21	.	.	O	.	_	0	SENT_53	[p3l1916t3270r2144b3344],

1	—	NN	O	—	_	0	SENT_54	[p3l1916t3270r2144b3344],
2	.	.	O	.	_	0	SENT_54	[p3l1916t3270r2144b3344],

1	3	CD	NUMBER	3	num	2	SENT_55	[p3l1916t3270r2144b3344],
2	’	NN	O	’	_	0	SENT_55	[p3l1916t3270r2144b3344],
3	)	CD	NUMBER	)	dep	2	SENT_55	[p3l1916t3270r2144b3344],
4	:	:	O	:	_	0	SENT_55	[p3l1916t3270r2144b3344],
5	codon	NN	O	codon	nn	8	SENT_55	[p3l9t3366r229b3424],
6	16	CD	NUMBER	16	num	8	SENT_55	[p3l282t3368r360b3424],
7	(	NN	O	(	nn	8	SENT_55	[p3l411t3366r809b3438],
8	nucleotide	NN	O	nucleotide	dep	2	SENT_55	[p3l411t3366r809b3438],
9	46	CD	NUMBER	46	number	10	SENT_55	[p3l858t3366r964b3438],
10	)	CD	NUMBER	)	dep	8	SENT_55	[p3l858t3366r964b3438],
11	ATGGGGCAACCCGGGAACGG	NN	ORGANIZATION	atggggcaacccgggaacgg	dep	10	SENT_55	[p3l1014t3368r2148b3424],
12	and	CC	O	and	_	0	SENT_55	[p3l9t3461r140b3518],
13	ACGATGAGAGACATGACGATG	NN	O	acgatgagagacatgacgatg	dep	10	SENT_55	[p3l172t3462r1337b3530],
14	;	:	O	;	_	0	SENT_55	[p3l172t3462r1337b3530],
15	codon	NN	O	codon	nn	18	SENT_55	[p3l1375t3461r1595b3518],
16	27	CD	NUMBER	27	num	18	SENT_55	[p3l1629t3462r1710b3518],
17	(	NN	O	(	nn	18	SENT_55	[p3l1749t3461r2147b3533],
18	nucleotide	NN	O	nucleotide	dep	2	SENT_55	[p3l1749t3461r2147b3533],
19	79	CD	NUMBER	79	number	20	SENT_55	[p3l14t3556r116b3628],
20	)	CD	NUMBER	)	dep	18	SENT_55	[p3l14t3556r116b3628],
21	CCGGGAACGGCAGCGC	NN	O	ccgggaacggcagcgc	dep	20	SENT_55	[p3l145t3558r1061b3614],
22	and	CC	O	and	_	0	SENT_55	[p3l1086t3556r1217b3614],
23	ATGGCCAGGACGATGAGAGAC	NN	O	atggccaggacgatgagagac	conj_and	21	SENT_55	[p3l1240t3558r2148b3614, p3l10t3653r306b3721],
24	;	:	O	;	_	0	SENT_55	[p3l1240t3558r2148b3614, p3l10t3653r306b3721],
25	codon	NN	O	codon	nn	28	SENT_55	[p3l362t3651r582b3709],
26	164	CD	NUMBER	164	num	28	SENT_55	[p3l640t3653r761b3709],
27	(	NN	O	(	nn	28	SENT_55	[p3l817t3651r1215b3723],
28	nucleotide	NN	O	nucleotide	dep	2	SENT_55	[p3l817t3651r1215b3723],
29	491	CD	NUMBER	491	number	30	SENT_55	[p3l1269t3652r1419b3723],
30	)	CD	NUMBER	)	dep	28	SENT_55	[p3l1269t3652r1419b3723],
31	TTACTTCACCTTTCAAGTACCAGAGC	NN	O	ttacttcacctttcaagtaccagagc	dep	30	SENT_55	[p3l1472t3653r2148b3709, p3l10t3747r718b3803],
32	and	CC	O	and	_	0	SENT_55	[p3l771t3746r902b3803],
33	CATAGCAGTTGATGGCTTCCTG	NN	O	catagcagttgatggcttcctg	dep	30	SENT_55	[p3l953t3747r2144b3803],
34	.	.	O	.	_	0	SENT_55	[p3l953t3747r2144b3803],

1	Temperature	NN	O	temperature	dep	145	SENT_56	[p4l7t32r453b105],
2	cycling	NN	O	cycling	dep	145	SENT_56	[p4l486t29r740b105],
3	proceeded	VBD	O	proceed	dep	145	SENT_56	[p4l769t29r1132b105],
4	as	IN	O	as	dep	145	SENT_56	[p4l1164t46r1229b87],
5	follows	VBZ	O	follow	dep	145	SENT_56	[p4l1261t29r1531b87],
6	:	:	O	:	_	0	SENT_56	[p4l1261t29r1531b87],
7	initial	JJ	O	initial	dep	145	SENT_56	[p4l1567t29r1777b87],
8	denaturation	NN	O	denaturation	dep	145	SENT_56	[p4l1809t29r2147b87, p4l8t126r153b181],
9	for	IN	O	for	dep	145	SENT_56	[p4l179t123r277b181],
10	4	CD	DURATION	4	dep	145	SENT_56	[p4l303t126r341b180],
11	min	NN	DURATION	min	dep	145	SENT_56	[p4l358t126r501b180],
12	at	IN	O	at	dep	145	SENT_56	[p4l528t131r591b181],
13	94	CD	NUMBER	94	dep	145	SENT_56	[p4l618t125r805b194],
14	°	CD	NUMBER	°	dep	145	SENT_56	[p4l618t125r805b194],
15	C	NN	O	c	dep	145	SENT_56	[p4l618t125r805b194],
16	,	,	O	,	_	0	SENT_56	[p4l618t125r805b194],
17	followed	VBN	O	follow	dep	145	SENT_56	[p4l835t123r1142b181],
18	by	IN	O	by	dep	145	SENT_56	[p4l1166t123r1253b199],
19	35	CD	NUMBER	35	dep	145	SENT_56	[p4l1278t125r1357b181],
20	cycles	NNS	O	cycle	dep	145	SENT_56	[p4l1387t123r1592b199],
21	of	IN	O	of	dep	145	SENT_56	[p4l1620t123r1691b181],
22	30	CD	NUMBER	30	dep	145	SENT_56	[p4l1714t125r1796b181],
23	s	NNS	O	s	dep	145	SENT_56	[p4l1815t140r1840b181],
24	at	IN	O	at	dep	145	SENT_56	[p4l1867t131r1931b181],
25	94	CD	NUMBER	94	dep	145	SENT_56	[p4l1957t125r2144b194],
26	°	CD	NUMBER	°	dep	145	SENT_56	[p4l1957t125r2144b194],
27	C	NN	O	c	dep	145	SENT_56	[p4l1957t125r2144b194],
28	,	,	O	,	_	0	SENT_56	[p4l1957t125r2144b194],
29	30s	CD	NUMBER	30s	dep	145	SENT_56	[p4l10t219r135b276],
30	at	IN	O	at	dep	145	SENT_56	[p4l167t225r230b276],
31	55	CD	NUMBER	55	dep	145	SENT_56	[p4l261t219r429b276],
32	°	CD	NUMBER	°	dep	145	SENT_56	[p4l261t219r429b276],
33	C	NN	O	c	dep	145	SENT_56	[p4l261t219r429b276],
34	for	IN	O	for	dep	145	SENT_56	[p4l460t218r558b276],
35	T	NN	O	t	dep	145	SENT_56	[p4l584t220r631b275],
36	hr164Ile	NN	O	hr164ile	dep	145	SENT_56	[p4l633t218r947b288],
37	,	,	O	,	_	0	SENT_56	[p4l633t218r947b288],
38	63	CD	NUMBER	63	dep	145	SENT_56	[p4l985t219r1152b276],
39	°	NN	O	°	dep	145	SENT_56	[p4l985t219r1152b276],
40	C	NN	O	c	dep	145	SENT_56	[p4l985t219r1152b276],
41	for	IN	O	for	dep	145	SENT_56	[p4l1182t218r1281b276],
42	G1u27G1n	NN	O	g1u27g1n	dep	145	SENT_56	[p4l1311t218r1660b276],
43	and	CC	O	and	dep	145	SENT_56	[p4l1691t218r1822b276],
44	56	CD	NUMBER	56	dep	145	SENT_56	[p4l1853t219r2021b276],
45	°	NN	O	°	dep	145	SENT_56	[p4l1853t219r2021b276],
46	C	NN	O	c	dep	145	SENT_56	[p4l1853t219r2021b276],
47	for	IN	O	for	dep	145	SENT_56	[p4l2051t218r2149b276],
48	Arg16Gly	NN	O	arg16gly	dep	145	SENT_56	[p4l7t313r355b389],
49	,	,	O	,	_	0	SENT_56	[p4l7t313r355b389],
50	1min	NN	O	1min	dep	145	SENT_56	[p4l418t315r611b370],
51	at	IN	O	at	dep	145	SENT_56	[p4l665t321r728b371],
52	72	CD	NUMBER	72	dep	145	SENT_56	[p4l786t315r968b384],
53	°	CD	NUMBER	°	dep	145	SENT_56	[p4l786t315r968b384],
54	C	NN	O	c	dep	145	SENT_56	[p4l786t315r968b384],
55	,	,	O	,	_	0	SENT_56	[p4l786t315r968b384],
56	and	CC	O	and	dep	145	SENT_56	[p4l1026t313r1157b371],
57	a	DT	O	a	dep	145	SENT_56	[p4l1210t330r1245b371],
58	terminal	JJ	O	terminal	dep	145	SENT_56	[p4l1297t313r1599b371],
59	extension	NN	O	extension	dep	145	SENT_56	[p4l1653t316r1998b371],
60	for	IN	O	for	dep	145	SENT_56	[p4l2051t313r2149b371],
61	10min	NN	O	10min	dep	145	SENT_56	[p4l14t411r251b467],
62	at	IN	O	at	dep	145	SENT_56	[p4l297t416r360b467],
63	72	CD	NUMBER	72	dep	145	SENT_56	[p4l409t411r592b467],
64	°	CD	NUMBER	°	dep	145	SENT_56	[p4l409t411r592b467],
65	C.	NN	O	c.	dep	145	SENT_56	[p4l409t411r592b467],
66	The	DT	O	the	dep	145	SENT_56	[p4l638t409r771b467],
67	amplified	VBN	O	amplify	dep	145	SENT_56	[p4l817t409r1153b485],
68	DNA	NN	O	dna	dep	145	SENT_56	[p4l1198t411r1367b466],
69	fragments	NNS	O	fragment	dep	145	SENT_56	[p4l1410t409r1763b485],
70	including	VBG	O	include	dep	145	SENT_56	[p4l1808t409r2150b485],
71	Arg16Gly	JJ	O	arg16gly	dep	145	SENT_56	[p4l7t504r345b580],
72	polymorphic	JJ	O	polymorphic	dep	145	SENT_56	[p4l386t504r846b580],
73	site	NN	O	site	dep	145	SENT_56	[p4l891t507r1006b562],
74	were	VBD	O	be	dep	145	SENT_56	[p4l1050t521r1213b562],
75	separately	RB	O	separately	dep	145	SENT_56	[p4l1260t504r1613b580],
76	digested	VBN	O	digest	dep	145	SENT_56	[p4l1655t504r1945b580],
77	with	IN	O	with	dep	145	SENT_56	[p4l1987t504r2149b562],
78	Ncol	NN	O	ncol	dep	145	SENT_56	[p4l6t601r159b656],
79	(	CD	NUMBER	(	dep	145	SENT_56	[p4l199t599r514b674],
80	England	NNP	LOCATION	England	dep	145	SENT_56	[p4l199t599r514b674],
81	Bio	NNP	O	Bio	dep	145	SENT_56	[p4l549t601r660b656],
82	labs	NNS	O	lab	dep	145	SENT_56	[p4l696t599r849b669],
83	,	,	O	,	_	0	SENT_56	[p4l696t599r849b669],
84	Beverly	NNP	PERSON	Beverly	dep	145	SENT_56	[p4l889t599r1158b674],
85	,	,	O	,	_	0	SENT_56	[p4l889t599r1158b674],
86	MA	NNP	O	MA	dep	145	SENT_56	[p4l1197t600r1337b669],
87	,	,	O	,	_	0	SENT_56	[p4l1197t600r1337b669],
88	USA	NNP	LOCATION	USA	dep	145	SENT_56	[p4l1377t599r1548b671],
89	)	CD	NUMBER	)	dep	145	SENT_56	[p4l1377t599r1548b671],
90	at	IN	O	at	dep	145	SENT_56	[p4l1587t606r1651b656],
91	37	CD	NUMBER	37	dep	145	SENT_56	[p4l1687t600r1855b656],
92	°	CD	NUMBER	°	dep	145	SENT_56	[p4l1687t600r1855b656],
93	C	NN	O	c	dep	145	SENT_56	[p4l1687t600r1855b656],
94	for	IN	O	for	dep	145	SENT_56	[p4l1891t598r1989b656],
95	2h	NN	O	2h	dep	145	SENT_56	[p4l2024t599r2144b668],
96	;	:	O	;	_	0	SENT_56	[p4l2024t599r2144b668],
97	those	DT	O	those	dep	145	SENT_56	[p4l8t694r197b752],
98	including	VBG	O	include	dep	145	SENT_56	[p4l236t694r578b770],
99	G1u27G1n	NN	O	g1u27g1n	dep	145	SENT_56	[p4l616t694r965b752],
100	polymorphic	JJ	O	polymorphic	dep	145	SENT_56	[p4l1003t694r1463b770],
101	site	NN	O	site	dep	145	SENT_56	[p4l1503t697r1618b752],
102	were	VBD	O	be	dep	145	SENT_56	[p4l1656t711r1819b752],
103	digested	VBN	O	digest	dep	145	SENT_56	[p4l1859t694r2149b770],
104	with	IN	O	with	dep	145	SENT_56	[p4l7t789r168b847],
105	Bbvl	NN	O	bbvl	dep	145	SENT_56	[p4l196t789r347b847],
106	(	CD	NUMBER	(	dep	145	SENT_56	[p4l384t789r699b865],
107	England	NNP	LOCATION	England	dep	145	SENT_56	[p4l384t789r699b865],
108	Bio	NNP	O	Bio	dep	145	SENT_56	[p4l731t792r842b847],
109	labs	NNS	O	lab	dep	145	SENT_56	[p4l875t789r1027b859],
110	,	,	O	,	_	0	SENT_56	[p4l875t789r1027b859],
111	Beverly	NNP	PERSON	Beverly	dep	145	SENT_56	[p4l1065t789r1334b865],
112	,	,	O	,	_	0	SENT_56	[p4l1065t789r1334b865],
113	MA	NNP	O	MA	dep	145	SENT_56	[p4l1370t791r1510b860],
114	,	,	O	,	_	0	SENT_56	[p4l1370t791r1510b860],
115	USA	NNP	LOCATION	USA	dep	145	SENT_56	[p4l1547t789r1718b861],
116	)	CD	NUMBER	)	dep	145	SENT_56	[p4l1547t789r1718b861],
117	at	IN	O	at	dep	145	SENT_56	[p4l1754t796r1817b847],
118	37	CD	NUMBER	37	dep	145	SENT_56	[p4l1850t791r2019b847],
119	°	CD	NUMBER	°	dep	145	SENT_56	[p4l1850t791r2019b847],
120	C	NN	O	c	dep	145	SENT_56	[p4l1850t791r2019b847],
121	for	IN	O	for	dep	145	SENT_56	[p4l2051t789r2149b847],
122	2h	NN	O	2h	dep	145	SENT_56	[p4l9t884r112b941],
123	and	CC	O	and	dep	145	SENT_56	[p4l142t884r273b942],
124	Thr164Ile	NN	O	thr164ile	dep	145	SENT_56	[p4l300t884r645b942],
125	polymorphic	JJ	O	polymorphic	dep	145	SENT_56	[p4l675t884r1135b960],
126	site	NN	O	site	dep	145	SENT_56	[p4l1166t887r1282b942],
127	with	IN	O	with	dep	145	SENT_56	[p4l1310t884r1472b942],
128	Mnll	NN	O	mnll	dep	145	SENT_56	[p4l1498t884r1657b941],
129	(	CD	NUMBER	(	dep	145	SENT_56	[p4l1691t884r2006b960],
130	England	NNP	LOCATION	England	dep	145	SENT_56	[p4l1691t884r2006b960],
131	Bio	NNP	LOCATION	Bio	dep	145	SENT_56	[p4l2037t886r2148b942],
132	Labs	NNPS	LOCATION	Labs	dep	145	SENT_56	[p4l9t979r180b1049],
133	,	,	O	,	_	0	SENT_56	[p4l9t979r180b1049],
134	Beverly	NNP	PERSON	Beverly	dep	145	SENT_56	[p4l239t979r508b1055],
135	,	,	O	,	_	0	SENT_56	[p4l239t979r508b1055],
136	MA	NNP	LOCATION	MA	dep	145	SENT_56	[p4l565t981r705b1050],
137	,	,	O	,	_	0	SENT_56	[p4l565t981r705b1050],
138	USA	NNP	LOCATION	USA	dep	145	SENT_56	[p4l763t979r934b1051],
139	)	CD	NUMBER	)	dep	145	SENT_56	[p4l763t979r934b1051],
140	at	IN	O	at	dep	145	SENT_56	[p4l991t986r1055b1037],
141	65	CD	NUMBER	65	dep	145	SENT_56	[p4l1110t981r1278b1037],
142	°	CD	NUMBER	°	dep	145	SENT_56	[p4l1110t981r1278b1037],
143	C	NN	O	c	dep	145	SENT_56	[p4l1110t981r1278b1037],
144	for	IN	O	for	dep	145	SENT_56	[p4l1331t979r1429b1037],
145	1h	NN	O	1h	_	0	SENT_56	[p4l1487t979r1602b1037],
146	.	.	O	.	_	0	SENT_56	[p4l1487t979r1602b1037],

1	The	DT	O	the	det	3	SENT_57	[p4l1658t979r1790b1037],
2	different	JJ	O	different	amod	3	SENT_57	[p4l1845t979r2149b1037],
3	patterns	NNS	O	pattern	nsubjpass	9	SENT_57	[p4l8t1081r295b1149],
4	of	IN	O	of	_	0	SENT_57	[p4l357t1073r429b1131],
5	the	DT	O	the	det	7	SENT_57	[p4l485t1073r598b1131],
6	digested	VBN	O	digest	amod	7	SENT_57	[p4l660t1073r950b1149],
7	fragments	NNS	O	fragment	prep_of	3	SENT_57	[p4l1010t1073r1363b1149],
8	were	VBD	O	be	auxpass	9	SENT_57	[p4l1422t1090r1586b1131],
9	visualized	VBN	O	visualize	_	0	SENT_57	[p4l1646t1073r1996b1131],
10	on	IN	O	on	_	0	SENT_57	[p4l2057t1090r2148b1131],
11	ethidium	NN	O	ethidium	nn	12	SENT_57	[p4l9t1169r335b1227],
12	bromide	NN	O	bromide	prep_on	9	SENT_57	[p4l381t1169r962b1227],
13	—	CD	NUMBER	—	nsubj	14	SENT_57	[p4l381t1169r962b1227],
14	stained	VBD	O	stain	rcmod	12	SENT_57	[p4l381t1169r962b1227],
15	3	CD	PERCENT	3	number	16	SENT_57	[p4l1011t1170r1119b1227],
16	%	NN	PERCENT	%	amod	18	SENT_57	[p4l1011t1170r1119b1227],
17	agarose	NN	O	agarose	nn	18	SENT_57	[p4l1167t1186r1425b1245],
18	gel	NN	O	gel	dobj	14	SENT_57	[p4l1474t1169r1592b1245],
19	.	.	O	.	_	0	SENT_57	[p4l1474t1169r1592b1245],

1	The	DT	O	the	det	2	SENT_58	[p4l1641t1169r1774b1227],
2	Trp64Arg	NN	O	trp64arg	_	0	SENT_58	[p4l1820t1170r2149b1245],
3	B3	NN	O	b3	dep	2	SENT_58	[p4l13t1265r208b1336],
4	.	.	O	.	_	0	SENT_58	[p4l13t1265r208b1336],

1	—	NN	O	—	_	0	SENT_59	[p4l13t1265r208b1336],
2	.	.	O	.	_	0	SENT_59	[p4l13t1265r208b1336],

1	AR	NN	O	ar	nn	3	SENT_60	[p4l13t1265r208b1336],
2	gene	NN	O	gene	nn	3	SENT_60	[p4l233t1280r396b1339],
3	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_60	[p4l424t1263r949b1339],
4	was	VBD	O	be	auxpass	5	SENT_60	[p4l974t1280r1102b1321],
5	identified	VBN	O	identify	_	0	SENT_60	[p4l1129t1263r1472b1321],
6	by	IN	O	by	_	0	SENT_60	[p4l1496t1263r1584b1339],
7	PCR	NN	O	pcr	agent	5	SENT_60	[p4l1609t1265r1755b1321],
8	performed	VBN	O	perform	partmod	7	SENT_60	[p4l1779t1263r2149b1339],
9	with	IN	O	with	_	0	SENT_60	[p4l7t1359r168b1417],
10	20	CD	NUMBER	20	num	11	SENT_60	[p4l244t1361r327b1417],
11	ng	NN	O	ng	prep_with	8	SENT_60	[p4l344t1376r433b1435],
12	of	IN	O	of	_	0	SENT_60	[p4l507t1359r579b1417],
13	genomic	JJ	O	genomic	amod	14	SENT_60	[p4l650t1362r955b1435],
14	DNA	NN	O	dna	prep_of	11	SENT_60	[p4l1032t1361r1201b1416],
15	with	IN	O	with	_	0	SENT_60	[p4l1272t1359r1433b1417],
16	upstream	JJ	O	upstream	amod	17	SENT_60	[p4l1507t1366r1837b1435],
17	primer	NN	O	primer	prep_with	14	SENT_60	[p4l1911t1362r2149b1435],
18	5	CD	NUMBER	5	num	17	SENT_60	[p4l10t1452r1210b1511],
19	’	SYM	O	’	dep	17	SENT_60	[p4l10t1452r1210b1511],
20	-	:	O	-	_	0	SENT_60	[p4l10t1452r1210b1511],
21	CCAGTGGCGTGGCGAGGG-3	NN	O	ccagtggcgtggcgaggg-3	nn	22	SENT_60	[p4l10t1452r1210b1511],
22	’	NN	O	’	dep	14	SENT_60	[p4l10t1452r1210b1511],
23	and	CC	O	and	_	0	SENT_60	[p4l1257t1453r1388b1511],
24	downstream	JJ	O	downstream	amod	25	SENT_60	[p4l1431t1453r1868b1511],
25	primer	NN	O	primer	dep	14	SENT_60	[p4l1912t1456r2150b1529],
26	5	CD	NUMBER	5	num	25	SENT_60	[p4l10t1545r897b1622],
27	’	SYM	O	’	dep	11	SENT_60	[p4l10t1545r897b1622],
28	-	:	O	-	_	0	SENT_60	[p4l10t1545r897b1622],
29	gccagtggcgcccaacgg	NN	O	gccagtggcgcccaacgg	dep	11	SENT_60	[p4l10t1545r897b1622],
30	—	CD	NUMBER	—	number	31	SENT_60	[p4l10t1545r897b1622],
31	3	CD	NUMBER	3	num	32	SENT_60	[p4l10t1545r897b1622],
32	’	NN	O	’	dep	29	SENT_60	[p4l10t1545r897b1622],
33	.	.	O	.	_	0	SENT_60	[p4l10t1545r897b1622],

1	The	DT	O	the	det	3	SENT_61	[p4l933t1547r1066b1604],
2	resulting	VBG	O	result	amod	3	SENT_61	[p4l1101t1547r1412b1622],
3	248	CD	NUMBER	248	nsubjpass	7	SENT_61	[p4l1447t1548r1571b1604],
4	bp	NN	O	bp	nn	5	SENT_61	[p4l1587t1547r1676b1622],
5	product	NN	O	product	nsubjpass	7	SENT_61	[p4l1710t1547r1988b1622],
6	was	VBD	O	be	auxpass	7	SENT_61	[p4l2020t1563r2148b1604],
7	digested	VBN	O	digest	_	0	SENT_61	[p4l9t1642r299b1718],
8	with	IN	O	with	_	0	SENT_61	[p4l334t1642r495b1700],
9	Mval	JJ	O	mval	amod	10	SENT_61	[p4l528t1645r700b1700],
10	(	NN	O	(	nn	14	SENT_61	[p4l741t1642r1147b1714],
11	Amersham	NNP	ORGANIZATION	Amersham	nn	14	SENT_61	[p4l741t1642r1147b1714],
12	Pharmacia	NNP	ORGANIZATION	Pharmacia	nn	14	SENT_61	[p4l1184t1642r1555b1700],
13	Biotech	NNP	ORGANIZATION	Biotech	nn	14	SENT_61	[p4l1592t1642r1904b1714],
14	)	NN	O	)	prep_with	7	SENT_61	[p4l1592t1642r1904b1714],
15	.	.	O	.	_	0	SENT_61	[p4l1592t1642r1904b1714],

1	RFLPS	NNS	O	rflp	nsubjpass	3	SENT_62	[p4l1946t1645r2147b1700],
2	were	VBD	O	be	auxpass	3	SENT_62	[p4l7t1754r170b1795],
3	interpreted	VBN	O	interpret	_	0	SENT_62	[p4l196t1737r590b1813],
4	by	IN	O	by	_	0	SENT_62	[p4l612t1737r700b1813],
5	three	CD	NUMBER	three	num	7	SENT_62	[p4l722t1737r903b1795],
6	independent	JJ	O	independent	amod	7	SENT_62	[p4l928t1737r1382b1813],
7	investigators	NNS	O	investigator	agent	3	SENT_62	[p4l1406t1740r1855b1813],
8	(	VBP	O	(	rcmod	7	SENT_62	[p4l1884t1737r2017b1809],
9	VT	NN	O	vt	dobj	8	SENT_62	[p4l1884t1737r2017b1809],
10	,	,	O	,	_	0	SENT_62	[p4l1884t1737r2017b1809],
11	FL	NN	LOCATION	fl	appos	9	SENT_62	[p4l2047t1740r2143b1807],
12	,	,	O	,	_	0	SENT_62	[p4l2047t1740r2143b1807],
13	EC	NNP	ORGANIZATION	EC	nn	14	SENT_62	[p4l9t1832r150b1904],
14	)	NNP	O	)	appos	11	SENT_62	[p4l9t1832r150b1904],
15	,	,	O	,	_	0	SENT_62	[p4l9t1832r150b1904],
16	and	CC	O	and	_	0	SENT_62	[p4l216t1832r347b1890],
17	in	IN	O	in	_	0	SENT_62	[p4l409t1835r479b1889],
18	case	NN	O	case	_	0	SENT_62	[p4l541t1849r682b1890],
19	of	IN	O	of	_	0	SENT_62	[p4l745t1832r817b1890],
20	disagreement	NN	O	disagreement	prep_in_case_of	25	SENT_62	[p4l874t1832r1365b1908],
21	,	,	O	,	_	0	SENT_62	[p4l874t1832r1365b1908],
22	the	DT	O	the	det	23	SENT_62	[p4l1431t1832r1543b1890],
23	procedure	NN	O	procedure	nsubjpass	25	SENT_62	[p4l1606t1832r1959b1908],
24	was	VBD	O	be	auxpass	25	SENT_62	[p4l2020t1849r2147b1890],
25	performed	VBN	O	perform	conj_and	3	SENT_62	[p4l8t1926r377b2002],
26	again	RB	O	again	advmod	25	SENT_62	[p4l431t1929r638b2002],
27	.	.	O	.	_	0	SENT_62	[p4l431t1929r638b2002],

1	Molecular	JJ	MISC	molecular	amod	2	SENT_63	[p4l695t1926r1051b1984],
2	diagnosis	NN	O	diagnosis	nsubjpass	13	SENT_63	[p4l1105t1927r1432b2002],
3	of	IN	O	of	_	0	SENT_63	[p4l1487t1926r1559b1984],
4	those	DT	O	those	det	5	SENT_63	[p4l1608t1926r1797b1984],
5	cases	NNS	O	case	prep_of	2	SENT_63	[p4l1852t1943r2024b1984],
6	in	IN	O	in	_	0	SENT_63	[p4l2078t1929r2148b1983],
7	which	WDT	O	which	rel	11	SENT_63	[p4l7t2021r227b2079],
8	no	DT	O	no	det	9	SENT_63	[p4l267t2038r358b2079],
9	agreement	NN	O	agreement	nsubjpass	11	SENT_63	[p4l401t2029r773b2097],
10	was	VBD	O	be	auxpass	11	SENT_63	[p4l811t2038r939b2079],
11	obtained	VBN	O	obtain	rcmod	5	SENT_63	[p4l981t2021r1293b2079],
12	was	VBD	O	be	auxpass	13	SENT_63	[p4l1332t2038r1460b2079],
13	discerned	VBN	O	discern	_	0	SENT_63	[p4l1502t2021r1839b2079],
14	by	IN	O	by	_	0	SENT_63	[p4l1877t2021r1965b2097],
15	PCR	NN	O	pcr	nn	17	SENT_63	[p4l2004t2023r2150b2079],
16	product	NN	O	product	nn	17	SENT_63	[p4l8t2117r285b2193],
17	sequencing	NN	O	sequencing	agent	13	SENT_63	[p4l316t2120r716b2193],
18	(	CD	NUMBER	(	number	19	SENT_63	[p4l748t2117r943b2189],
19	3100	CD	NUMBER	3100	dep	17	SENT_63	[p4l748t2117r943b2189],
20	Avant	NNP	O	Avant	dep	19	SENT_63	[p4l971t2119r1180b2175],
21	genetic	JJ	O	genetic	amod	19	SENT_63	[p4l1209t2120r1464b2193],
22	Analyzer	NNP	O	Analyzer	dep	19	SENT_63	[p4l1492t2117r1846b2193],
23	)	CD	NUMBER	)	num	22	SENT_63	[p4l1492t2117r1846b2193],
24	.	.	O	.	_	0	SENT_63	[p4l1492t2117r1846b2193],

1	Protocol	NNP	O	Protocol	nn	2	SENT_64	[p4l12t2347r302b2404],
2	The	NNP	O	The	_	0	SENT_64	[p4l6t2442r139b2499],
3	study	NN	O	study	nn	4	SENT_64	[p4l184t2442r377b2517],
4	population	NN	O	population	nsubjpass	6	SENT_64	[p4l416t2442r809b2517],
5	was	VBD	O	be	auxpass	6	SENT_64	[p4l850t2458r978b2499],
6	divided	VBN	O	divide	rcmod	2	SENT_64	[p4l1021t2442r1284b2499],
7	according	VBG	O	accord	_	0	SENT_64	[p4l1328t2442r1675b2517],
8	to	TO	O	to	prepc_according_to	6	SENT_64	[p4l1716t2449r1786b2499],
9	the	DT	O	the	det	11	SENT_64	[p4l1829t2442r1942b2499],
10	antihypertensive	JJ	O	antihypertensive	amod	11	SENT_64	[p4l1986t2445r2147b2499, p4l8t2537r454b2613],
11	treatment	NN	O	treatment	pobj	6	SENT_64	[p4l482t2544r827b2595],
12	performed	VBN	O	perform	partmod	11	SENT_64	[p4l852t2537r1233b2613],
13	:	:	O	:	_	0	SENT_64	[p4l852t2537r1233b2613],
14	Group	NNP	O	Group	dobj	12	SENT_64	[p4l1265t2539r1485b2613],
15	1	CD	NUMBER	1	number	16	SENT_64	[p4l1518t2537r1575b2609],
16	)	CD	NUMBER	)	num	18	SENT_64	[p4l1518t2537r1575b2609],
17	[	NN	O	[	nn	18	SENT_64	[p4l1610t2537r1954b2610],
18	3-blockers	NNS	O	3-blocker	nsubj	19	SENT_64	[p4l1610t2537r1954b2610],
19	(	VBP	O	(	rcmod	14	SENT_64	[p4l1985t2537r2149b2609],
20	that	DT	O	that	nsubj	23	SENT_64	[p4l1985t2537r2149b2609],
21	is	VBZ	O	be	cop	23	SENT_64	[p4l8t2635r59b2689],
22	atenolol	NN	O	atenolol	nn	23	SENT_64	[p4l85t2632r370b2689],
23	(	NN	O	(	ccomp	19	SENT_64	[p4l399t2632r672b2704],
24	50	CD	NUMBER	50	number	25	SENT_64	[p4l399t2632r672b2704],
25	—	CD	NUMBER	—	num	27	SENT_64	[p4l399t2632r672b2704],
26	10O	NN	O	10o	nn	27	SENT_64	[p4l399t2632r672b2704],
27	mg/die	NN	O	mg/die	dep	23	SENT_64	[p4l688t2631r955b2707],
28	)	CD	NUMBER	)	dep	23	SENT_64	[p4l688t2631r955b2707],
29	or	CC	O	or	_	0	SENT_64	[p4l985t2648r1057b2689],
30	metoprolol	NN	O	metoprolol	nn	31	SENT_64	[p4l1080t2632r1469b2707],
31	(	NN	O	(	conj_or	23	SENT_64	[p4l1498t2632r1814b2704],
32	100	CD	NUMBER	100	number	33	SENT_64	[p4l1498t2632r1814b2704],
33	—	CD	NUMBER	—	dep	31	SENT_64	[p4l1498t2632r1814b2704],
34	200	CD	NUMBER	200	num	35	SENT_64	[p4l1498t2632r1814b2704],
35	mg/die	NN	O	mg/die	dep	33	SENT_64	[p4l1830t2631r2144b2707],
36	)	CD	NUMBER	)	num	37	SENT_64	[p4l1830t2631r2144b2707],
37	)	NN	O	)	dep	2	SENT_64	[p4l1830t2631r2144b2707],
38	,	,	O	,	_	0	SENT_64	[p4l1830t2631r2144b2707],
39	alone	RB	O	alone	dep	37	SENT_64	[p4l9t2727r200b2784],
40	or	CC	O	or	_	0	SENT_64	[p4l229t2743r300b2784],
41	in	IN	O	in	dep	37	SENT_64	[p4l327t2730r397b2784],
42	combination	NN	O	combination	pobj	41	SENT_64	[p4l424t2727r881b2784],
43	with	IN	O	with	_	0	SENT_64	[p4l907t2727r1068b2784],
44	other	JJ	O	other	amod	46	SENT_64	[p4l1095t2727r1284b2784],
45	antihypertensive	JJ	O	antihypertensive	amod	46	SENT_64	[p4l1311t2727r1906b2802],
46	drugs	NNS	O	drug	prep_with	42	SENT_64	[p4l1936t2727r2145b2802],
47	;	:	O	;	_	0	SENT_64	[p4l1936t2727r2145b2802],
48	Group	NNP	O	Group	dep	2	SENT_64	[p4l10t2824r233b2898],
49	2	CD	NUMBER	2	number	50	SENT_64	[p4l263t2822r326b2894],
50	)	CD	NUMBER	)	num	53	SENT_64	[p4l263t2822r326b2894],
51	other	JJ	O	other	amod	53	SENT_64	[p4l360t2822r549b2880],
52	antihypertensive	JJ	O	antihypertensive	amod	53	SENT_64	[p4l578t2822r1173b2898],
53	drugs	NNS	O	drug	dep	48	SENT_64	[p4l1204t2822r1413b2898],
54	.	.	O	.	_	0	SENT_64	[p4l1204t2822r1413b2898],

1	www.nature.com/tpj	NN	O	www.nature.com/tpj	_	0	SENT_65	[p4l1596t3090r2147b3149],

1	@	SYM	O	@	dep	2	SENT_66	[p4l8t3253r135b3377],
2	[	CD	NUMBER	[	dep	7	SENT_66	[p4l1461t3265r1718b3322],
3	3-blockade	NN	O	3-blockade	nn	7	SENT_66	[p4l1461t3265r1718b3322],
4	and	CC	O	and	_	0	SENT_66	[p4l1737t3265r1824b3310],
5	dyslipidemia	NN	O	dyslipidemia	nn	7	SENT_66	[p4l1844t3265r2148b3324],
6	G	NN	O	g	nn	7	SENT_66	[p4l1812t3338r1842b3378],
7	Iaccarino	NN	O	iaccarino	_	0	SENT_66	[p4l1864t3337r2045b3378],
8	et	FW	O	et	nn	9	SENT_66	[p4l2065t3341r2101b3378],
9	al	FW	O	al	dep	7	SENT_66	[p4l2117t3336r2153b3378],

1	The	DT	O	the	det	2	SENT_67	[p5l83t84r216b142],
2	incidence	NN	O	incidence	nsubjpass	91	SENT_67	[p5l256t84r596b142],
3	of	IN	O	of	_	0	SENT_67	[p5l637t84r708b142],
4	diabetes	NN	O	diabetes	nn	5	SENT_67	[p5l743t84r1028b142],
5	mellitus	NN	O	mellitus	prep_of	2	SENT_67	[p5l1068t84r1353b142],
6	(	CD	NUMBER	(	num	9	SENT_67	[p5l1395t84r1840b156],
7	antidiabetic	JJ	O	antidiabetic	amod	9	SENT_67	[p5l1395t84r1840b156],
8	therapy	NN	O	therapy	nn	9	SENT_67	[p5l1878t84r2151b160],
9	and/or	NN	O	and/or	nsubj	51	SENT_67	[p5l9t179r246b244],
10	fasting	VBG	O	fast	partmod	9	SENT_67	[p5l269t179r507b255],
11	blood	NN	O	blood	nn	13	SENT_67	[p5l527t179r732b237],
12	glucose	NN	O	glucose	nn	13	SENT_67	[p5l755t179r1015b255],
13	concentration	NN	O	concentration	dobj	10	SENT_67	[p5l1041t182r1540b237],
14	above	IN	O	above	_	0	SENT_67	[p5l1566t179r1769b237],
15	126	CD	NUMBER	126	num	16	SENT_67	[p5l1800t180r1922b237],
16	mg/dl	NN	O	mg/dl	prep_above	13	SENT_67	[p5l1939t179r2148b255],
17	at	IN	O	at	advmod	16	SENT_67	[p5l9t279r73b329],
18	least	JJS	O	least	pobj	17	SENT_67	[p5l99t272r257b329],
19	three	CD	NUMBER	three	num	20	SENT_67	[p5l283t272r463b329],
20	times	NNS	O	time	tmod	16	SENT_67	[p5l491t264r745b329],
21	”	RB	O	”	advmod	10	SENT_67	[p5l491t264r745b329],
22	by	IN	O	by	_	0	SENT_67	[p5l772t271r860b347],
23	colorimetric	JJ	O	colorimetric	amod	25	SENT_67	[p5l885t272r1316b329],
24	assay	NN	O	assay	nn	25	SENT_67	[p5l1344t272r1567b347],
25	)	NN	O	)	nsubj	32	SENT_67	[p5l1344t272r1567b347],
26	,	,	O	,	_	0	SENT_67	[p5l1344t272r1567b347],
27	hypercholesterolemia	NN	O	hypercholesterolemia	appos	25	SENT_67	[p5l1598t271r2148b347, p5l9t367r248b425],
28	(	CD	NUMBER	(	num	31	SENT_67	[p5l292t367r1043b443],
29	cholesterol-lowering	JJ	O	cholesterol-lowering	amod	31	SENT_67	[p5l292t367r1043b443],
30	therapy	NN	O	therapy	nn	31	SENT_67	[p5l1082t367r1356b443],
31	and/or	NN	O	and/or	dep	27	SENT_67	[p5l1394t367r1630b433],
32	fasting	VBG	O	fast	agent	10	SENT_67	[p5l1670t367r1908b443],
33	blood	NN	O	blood	nn	35	SENT_67	[p5l1945t367r2149b425],
34	cholesterol	NN	O	cholesterol	nn	35	SENT_67	[p5l9t461r397b519],
35	concentration	NN	O	concentration	nsubj	36	SENT_67	[p5l425t464r925b519],
36	>	JJR	O	>	xcomp	32	SENT_67	[p5l964t463r1156b519],
37	200	CD	NUMBER	200	num	38	SENT_67	[p5l964t463r1156b519],
38	mg/dl	NN	O	mg/dl	dep	36	SENT_67	[p5l1172t461r1382b537],
39	at	IN	O	at	advmod	42	SENT_67	[p5l1410t468r1474b519],
40	least	JJS	O	least	pobj	39	SENT_67	[p5l1500t461r1658b519],
41	three	CD	NUMBER	three	num	42	SENT_67	[p5l1684t461r1864b519],
42	times	NNS	O	time	tmod	32	SENT_67	[p5l1893t454r2148b519],
43	“	RB	O	“	advmod	10	SENT_67	[p5l1893t454r2148b519],
44	by	IN	O	by	_	0	SENT_67	[p5l7t557r94b632],
45	colorimetric	JJ	O	colorimetric	amod	47	SENT_67	[p5l129t557r561b614],
46	assay	NN	O	assay	nn	47	SENT_67	[p5l599t557r800b632],
47	)	NN	O	)	agent	10	SENT_67	[p5l599t557r800b632],
48	,	,	O	,	_	0	SENT_67	[p5l841t603r854b627],
49	hypertriglyceridemia	NN	O	hypertriglyceridemia	nn	50	SENT_67	[p5l896t557r1638b632],
50	(	NN	O	(	appos	47	SENT_67	[p5l1678t557r2149b629],
51	documented	VBD	O	document	rcmod	5	SENT_67	[p5l1678t557r2149b629],
52	history	NN	O	history	dobj	51	SENT_67	[p5l9t652r259b728],
53	of	IN	O	of	_	0	SENT_67	[p5l308t652r379b710],
54	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	52	SENT_67	[p5l425t652r1167b728],
55	plus	CC	O	plus	prep	54	SENT_67	[p5l1217t652r1362b728],
56	lipid-lowering	JJ	O	lipid-lowering	amod	58	SENT_67	[p5l1413t652r1913b728],
57	treatment	NN	O	treatment	nn	58	SENT_67	[p5l1962t659r2148b710, p5l9t754r195b805],
58	and/or	NN	O	and/or	dep	55	SENT_67	[p5l271t747r507b812],
59	fasting	VBG	O	fast	xcomp	51	SENT_67	[p5l582t747r820b823],
60	blood	NN	O	blood	nn	62	SENT_67	[p5l892t747r1097b805],
61	triglyceride	NN	O	triglyceride	nn	62	SENT_67	[p5l1172t747r1571b823],
62	concentration	NN	O	concentration	nsubj	63	SENT_67	[p5l1648t750r2148b805],
63	>	JJR	O	>	xcomp	59	SENT_67	[p5l21t839r439b915],
64	150mg/dl	CD	NUMBER	150mg/dl	number	67	SENT_67	[p5l21t839r439b915],
65	at	IN	O	at	quantmod	67	SENT_67	[p5l487t847r551b897],
66	least	JJS	O	least	quantmod	67	SENT_67	[p5l597t840r755b897],
67	three	CD	NUMBER	three	num	68	SENT_67	[p5l802t840r982b897],
68	times	NNS	O	time	tmod	59	SENT_67	[p5l1030t833r1286b897],
69	“	RB	O	“	advmod	51	SENT_67	[p5l1030t833r1286b897],
70	by	IN	O	by	_	0	SENT_67	[p5l1331t840r1419b915],
71	colorimetric	JJ	O	colorimetric	amod	73	SENT_67	[p5l1464t840r1896b897],
72	assay	NN	O	assay	nn	73	SENT_67	[p5l1944t840r2145b915],
73	)	NN	O	)	prep_by	51	SENT_67	[p5l1944t840r2145b915],
74	and	CC	O	and	_	0	SENT_67	[p5l9t934r141b992],
75	low	JJ	O	low	amod	77	SENT_67	[p5l163t934r291b992],
76	HDL	NN	O	hdl	nn	77	SENT_67	[p5l312t937r474b991],
77	(	NN	O	(	conj_and	73	SENT_67	[p5l499t934r582b1006],
78	<	JJR	O	<	amod	73	SENT_67	[p5l499t934r582b1006],
79	40	CD	NUMBER	40	num	80	SENT_67	[p5l597t936r681b992],
80	mg/dl	NN	O	mg/dl	dobj	51	SENT_67	[p5l698t934r907b1010],
81	at	IN	O	at	quantmod	83	SENT_67	[p5l931t942r994b992],
82	least	JJS	O	least	mwe	81	SENT_67	[p5l1016t934r1174b992],
83	three	CD	NUMBER	three	num	84	SENT_67	[p5l1196t934r1376b992],
84	times	NNS	O	time	dep	85	SENT_67	[p5l1400t927r1656b992],
85	“	RB	O	“	amod	80	SENT_67	[p5l1400t927r1656b992],
86	by	IN	O	by	_	0	SENT_67	[p5l1676t934r1764b1010],
87	enzymatic	JJ	O	enzymatic	amod	89	SENT_67	[p5l1785t937r2149b1010],
88	assay	NN	O	assay	nn	89	SENT_67	[p5l9t1030r211b1105],
89	)	NN	O	)	prep_by	51	SENT_67	[p5l9t1030r211b1105],
90	were	VBD	O	be	auxpass	91	SENT_67	[p5l242t1046r406b1087],
91	assessed	VBN	O	assess	_	0	SENT_67	[p5l437t1029r719b1087],
92	in	IN	O	in	_	0	SENT_67	[p5l748t1032r818b1086],
93	the	DT	O	the	det	95	SENT_67	[p5l848t1029r960b1087],
94	two	CD	NUMBER	two	num	95	SENT_67	[p5l991t1037r1121b1087],
95	groups	NNS	O	group	prep_in	91	SENT_67	[p5l1151t1046r1406b1105],
96	.	.	O	.	_	0	SENT_67	[p5l1151t1046r1406b1105],

1	Then	RB	O	then	advmod	5	SENT_68	[p5l1438t1029r1640b1100],
2	,	,	O	,	_	0	SENT_68	[p5l1438t1029r1640b1100],
3	patients	NNS	O	patient	nsubjpass	5	SENT_68	[p5l1673t1032r1955b1105],
4	were	VBD	O	be	auxpass	5	SENT_68	[p5l1984t1046r2147b1087],
5	subdivided	VBN	O	subdivide	_	0	SENT_68	[p5l10t1125r395b1183],
6	according	VBG	O	accord	_	0	SENT_68	[p5l439t1125r786b1201],
7	to	TO	O	to	prepc_according_to	5	SENT_68	[p5l829t1132r898b1183],
8	the	DT	O	the	det	9	SENT_68	[p5l943t1125r1055b1183],
9	presence	NN	O	presence	pobj	5	SENT_68	[p5l1099t1142r1404b1201],
10	of	IN	O	of	_	0	SENT_68	[p5l1450t1125r1522b1183],
11	each	DT	O	each	prep_of	9	SENT_68	[p5l1561t1125r1722b1183],
12	considered	VBN	O	consider	partmod	11	SENT_68	[p5l1766t1125r2149b1183],
13	polymorphism	NN	O	polymorphism	dobj	12	SENT_68	[p5l8t1219r534b1295],
14	in	IN	O	in	_	0	SENT_68	[p5l563t1222r634b1276],
15	the	DT	O	the	det	16	SENT_68	[p5l663t1219r776b1277],
16	genotype	NN	O	genotype	prep_in	13	SENT_68	[p5l806t1227r1151b1295],
17	.	.	O	.	_	0	SENT_68	[p5l806t1227r1151b1295],

1	Statistical	JJ	MISC	statistical	amod	3	SENT_69	[p5l11t1394r347b1452],
2	Analysis	NN	MISC	analysis	nn	3	SENT_69	[p5l378t1394r661b1470],
3	Agreement	NN	MISC	agreement	nsubj	6	SENT_69	[p5l7t1491r394b1565],
4	between	IN	O	between	_	0	SENT_69	[p5l415t1489r711b1547],
5	genotypes	NNS	O	genotype	prep_between	3	SENT_69	[p5l735t1496r1091b1565],
6	observed	VBN	O	observe	_	0	SENT_69	[p5l1116t1489r1428b1547],
7	and	CC	O	and	_	0	SENT_69	[p5l1452t1489r1583b1547],
8	those	DT	O	those	nsubj	9	SENT_69	[p5l1606t1489r1795b1547],
9	predicted	VBN	O	predict	conj_and	6	SENT_69	[p5l1818t1489r2149b1565],
10	by	IN	O	by	_	0	SENT_69	[p5l7t1582r94b1657],
11	the	DT	O	the	det	12	SENT_69	[p5l116t1582r229b1639],
12	Hardy	NNP	PERSON	Hardy	prep_by	9	SENT_69	[p5l255t1582r847b1657],
13	.	.	O	.	_	0	SENT_69	[p5l255t1582r847b1657],

1	—	NN	O	—	_	0	SENT_70	[p5l255t1582r847b1657],
2	.	.	O	.	_	0	SENT_70	[p5l255t1582r847b1657],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_71	[p5l255t1582r847b1657],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_71	[p5l871t1582r1286b1657],
3	was	VBD	O	be	auxpass	4	SENT_71	[p5l1309t1599r1437b1639],
4	assessed	VBN	O	assess	_	0	SENT_71	[p5l1462t1582r1743b1639],
5	by	IN	O	by	_	0	SENT_71	[p5l1765t1582r1853b1657],
6	a	DT	O	a	det	8	SENT_71	[p5l1876t1599r1910b1639],
7	X2	NN	O	x2	nn	8	SENT_71	[p5l1935t1575r2002b1654],
8	test	NN	O	test	agent	4	SENT_71	[p5l2026t1589r2149b1639],
9	with	IN	O	with	_	0	SENT_71	[p5l7t1678r168b1736],
10	one	CD	NUMBER	one	num	11	SENT_71	[p5l220t1695r349b1736],
11	degree	NN	O	degree	prep_with	4	SENT_71	[p5l402t1678r628b1754],
12	of	IN	O	of	_	0	SENT_71	[p5l682t1678r753b1736],
13	freedom	NN	O	freedom	prep_of	11	SENT_71	[p5l801t1678r1111b1736],
14	.	.	O	.	_	0	SENT_71	[p5l801t1678r1111b1736],

1	The	DT	O	the	det	2	SENT_72	[p5l1165t1678r1297b1736],
2	results	NNS	O	result	nsubjpass	7	SENT_72	[p5l1350t1678r1575b1736],
3	of	IN	O	of	_	0	SENT_72	[p5l1628t1678r1699b1736],
4	continuous	JJ	O	continuous	amod	5	SENT_72	[p5l1748t1681r2148b1736],
5	variables	NNS	O	variable	prep_of	2	SENT_72	[p5l6t1773r315b1831],
6	are	VBP	O	be	auxpass	7	SENT_72	[p5l378t1790r479b1831],
7	expressed	VBN	O	express	_	0	SENT_72	[p5l542t1773r880b1849],
8	as	IN	O	as	_	0	SENT_72	[p5l942t1790r1006b1831],
9	meansiSE	NN	O	meansise	prep_as	7	SENT_72	[p5l1069t1775r1470b1840],
10	.	.	O	.	_	0	SENT_72	[p5l1069t1775r1470b1840],

1	Before	IN	O	before	_	0	SENT_73	[p5l1537t1773r1756b1831],
2	statistical	JJ	O	statistical	amod	3	SENT_73	[p5l1820t1773r2149b1831],
3	analysis	NN	O	analysis	prep_before	12	SENT_73	[p5l9t1868r302b1944],
4	,	,	O	,	_	0	SENT_73	[p5l9t1868r302b1944],
5	normal	JJ	O	normal	amod	6	SENT_73	[p5l338t1868r594b1926],
6	distribution	NN	O	distribution	nsubjpass	12	SENT_73	[p5l627t1868r1044b1926],
7	and	CC	O	and	_	0	SENT_73	[p5l1077t1868r1208b1926],
8	homogeneity	NN	O	homogeneity	nsubjpass	12	SENT_73	[p5l1239t1868r1713b1944],
9	of	IN	O	of	_	0	SENT_73	[p5l1743t1868r1815b1926],
10	variables	NNS	O	variable	prep_of	6	SENT_73	[p5l1840t1868r2148b1926],
11	were	VBD	O	be	auxpass	12	SENT_73	[p5l7t1978r170b2019],
12	tested	VBN	O	test	_	0	SENT_73	[p5l237t1961r462b2019],
13	.	.	O	.	_	0	SENT_73	[p5l237t1961r462b2019],

1	We	PRP	O	we	nsubj	2	SENT_74	[p5l532t1964r641b2019],
2	used	VBD	O	use	_	0	SENT_74	[p5l707t1961r867b2019],
3	the	DT	O	the	det	5	SENT_74	[p5l933t1961r1046b2019],
4	X2	NN	O	x2	nn	5	SENT_74	[p5l1113t1954r1181b2034],
5	test	NN	O	test	dobj	2	SENT_74	[p5l1247t1969r1370b2019],
6	for	IN	O	for	_	0	SENT_74	[p5l1435t1961r1534b2019],
7	comparison	NN	O	comparison	prep_for	2	SENT_74	[p5l1599t1964r2015b2037],
8	of	IN	O	of	_	0	SENT_74	[p5l2082t1961r2153b2019],
9	proportions	NNS	O	proportion	prep_of	7	SENT_74	[p5l8t2060r424b2133],
10	and	CC	O	and	_	0	SENT_74	[p5l484t2057r616b2115],
11	the	DT	O	the	det	13	SENT_74	[p5l673t2057r786b2115],
12	unpaired	JJ	O	unpaired	amod	13	SENT_74	[p5l844t2057r1162b2133],
13	t	NN	O	t	prep_for	2	SENT_74	[p5l1222t2063r1394b2115],
14	—	CD	NUMBER	—	num	15	SENT_74	[p5l1222t2063r1394b2115],
15	test	NN	O	test	dep	13	SENT_74	[p5l1222t2063r1394b2115],
16	for	IN	O	for	_	0	SENT_74	[p5l1452t2057r1550b2115],
17	comparison	NN	O	comparison	prep_for	2	SENT_74	[p5l1607t2060r2023b2133],
18	of	IN	O	of	_	0	SENT_74	[p5l2082t2057r2153b2115],
19	quantitative	JJ	O	quantitative	amod	20	SENT_74	[p5l9t2155r439b2228],
20	variables	NNS	O	variable	prep_of	17	SENT_74	[p5l492t2152r819b2210],
21	.	.	O	.	_	0	SENT_74	[p5l492t2152r819b2210],

1	Binary	JJ	O	binary	amod	4	SENT_75	[p5l878t2154r1107b2228],
2	logistic	JJ	O	logistic	amod	4	SENT_75	[p5l1160t2152r1411b2228],
3	regression	NN	O	regression	nn	4	SENT_75	[p5l1465t2155r1819b2228],
4	analysis	NN	O	analysis	nsubjpass	14	SENT_75	[p5l1873t2152r2149b2228],
5	using	VBG	O	use	partmod	4	SENT_75	[p5l7t2249r200b2322],
6	the	DT	O	the	det	7	SENT_75	[p5l245t2246r357b2304],
7	presence	NN	O	presence	dobj	5	SENT_75	[p5l404t2263r709b2322],
8	of	IN	O	of	_	0	SENT_75	[p5l757t2246r829b2304],
9	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	7	SENT_75	[p5l872t2246r1611b2322],
10	as	IN	O	as	_	0	SENT_75	[p5l1659t2263r1723b2304],
11	dependent	JJ	O	dependent	amod	12	SENT_75	[p5l1772t2246r2149b2322],
12	variable	NN	O	variable	prep_as	5	SENT_75	[p5l6t2342r283b2400],
13	was	VBD	O	be	auxpass	14	SENT_75	[p5l308t2359r436b2400],
14	performed	VBN	O	perform	_	0	SENT_75	[p5l462t2342r830b2418],
15	with	IN	O	with	_	0	SENT_75	[p5l854t2342r1015b2400],
16	a	DT	O	a	det	19	SENT_75	[p5l1041t2359r1075b2400],
17	forward	JJ	O	forward	amod	19	SENT_75	[p5l1101t2342r1374b2400],
18	step	NN	O	step	nn	19	SENT_75	[p5l1401t2349r1539b2418],
19	model	NN	O	model	prep_with	14	SENT_75	[p5l1565t2342r1805b2412],
20	,	,	O	,	_	0	SENT_75	[p5l1565t2342r1805b2412],
21	in	IN	O	in	_	0	SENT_75	[p5l1835t2345r1905b2399],
22	which	WDT	O	which	rel	26	SENT_75	[p5l1929t2342r2149b2400],
23	each	DT	O	each	det	24	SENT_75	[p5l9t2437r170b2495],
24	variable	NN	O	variable	nsubjpass	26	SENT_75	[p5l228t2437r506b2495],
25	was	VBD	O	be	auxpass	26	SENT_75	[p5l565t2454r694b2495],
26	inserted	VBN	O	insert	rcmod	19	SENT_75	[p5l755t2437r1038b2495],
27	in	IN	O	in	_	0	SENT_75	[p5l1098t2440r1168b2494],
28	the	DT	O	the	det	29	SENT_75	[p5l1230t2437r1342b2495],
29	equation	NN	O	equation	prep_in	26	SENT_75	[p5l1405t2440r1718b2513],
30	when	WRB	O	when	advmod	33	SENT_75	[p5l1778t2437r1975b2495],
31	the	DT	O	the	det	32	SENT_75	[p5l2035t2437r2148b2495],
32	tolerance	NN	O	tolerance	nsubj	33	SENT_75	[p5l8t2532r334b2589],
33	met	VBD	O	meet	dep	29	SENT_75	[p5l356t2539r492b2589],
34	a	DT	O	a	det	36	SENT_75	[p5l514t2548r548b2589],
35	0.0001	CD	NUMBER	0.0001	num	36	SENT_75	[p5l570t2533r802b2589],
36	level	NN	O	level	dobj	33	SENT_75	[p5l829t2532r1008b2602],
37	,	,	O	,	_	0	SENT_75	[p5l829t2532r1008b2602],
38	without	IN	O	without	_	0	SENT_75	[p5l1033t2532r1316b2589],
39	changing	VBG	O	change	prepc_without	33	SENT_75	[p5l1338t2532r1667b2607],
40	the	DT	O	the	det	41	SENT_75	[p5l1688t2532r1801b2589],
41	tolerance	NN	O	tolerance	dobj	39	SENT_75	[p5l1823t2532r2148b2589],
42	of	IN	O	of	_	0	SENT_75	[p5l9t2627r81b2685],
43	another	DT	O	another	det	44	SENT_75	[p5l107t2627r384b2685],
44	variable	JJ	O	variable	prep_of	41	SENT_75	[p5l411t2627r688b2685],
45	already	RB	O	already	advmod	39	SENT_75	[p5l719t2627r976b2703],
46	in	IN	O	in	_	0	SENT_75	[p5l1002t2630r1072b2684],
47	the	DT	O	the	det	48	SENT_75	[p5l1102t2627r1214b2685],
48	equation	NN	O	equation	prep_in	39	SENT_75	[p5l1245t2630r1577b2703],
49	.	.	O	.	_	0	SENT_75	[p5l1245t2630r1577b2703],

1	In	IN	O	in	_	0	SENT_76	[p5l1611t2630r1684b2684],
2	this	DT	O	this	det	3	SENT_76	[p5l1713t2627r1843b2685],
3	analysis	NN	O	analysis	prep_in	5	SENT_76	[p5l1873t2627r2149b2703],
4	we	PRP	O	we	nsubj	5	SENT_76	[p5l7t2739r103b2780],
5	included	VBD	O	include	_	0	SENT_76	[p5l153t2722r463b2780],
6	BMI	NNP	MISC	BMI	dobj	5	SENT_76	[p5l511t2725r672b2793],
7	,	,	O	,	_	0	SENT_76	[p5l511t2725r672b2793],
8	smoke	NN	O	smoke	dobj	5	SENT_76	[p5l728t2722r968b2793],
9	,	,	O	,	_	0	SENT_76	[p5l728t2722r968b2793],
10	age	NN	O	age	dobj	5	SENT_76	[p5l1024t2739r1155b2798],
11	,	,	O	,	_	0	SENT_76	[p5l1024t2739r1155b2798],
12	sex	NN	O	sex	dobj	5	SENT_76	[p5l1211t2739r1336b2793],
13	,	,	O	,	_	0	SENT_76	[p5l1211t2739r1336b2793],
14	and	CC	O	and	_	0	SENT_76	[p5l1391t2722r1522b2780],
15	BZAR	NNP	O	BZAR	nn	17	SENT_76	[p5l1576t2724r1745b2795],
16	Glu	NNP	O	Glu	nn	17	SENT_76	[p5l1794t2722r1920b2780],
17	polymorphism	NN	O	polymorphism	conj_and	6	SENT_76	[p5l1969t2722r2148b2798, p5l9t2817r393b2893],
18	.	.	O	.	_	0	SENT_76	[p5l1969t2722r2148b2798, p5l9t2817r393b2893],

1	Multinomial	JJ	O	multinomial	amod	3	SENT_77	[p5l422t2817r870b2875],
2	logistic	JJ	O	logistic	amod	3	SENT_77	[p5l895t2817r1147b2893],
3	regression	NN	O	regression	nsubjpass	5	SENT_77	[p5l1171t2820r1525b2893],
4	was	VBD	O	be	auxpass	5	SENT_77	[p5l1549t2834r1677b2875],
5	used	VBN	O	use	_	0	SENT_77	[p5l1702t2817r1862b2875],
6	to	TO	O	to	aux	7	SENT_77	[p5l1886t2824r1956b2875],
7	asses	VB	O	ass	xcomp	5	SENT_77	[p5l1984t2834r2148b2875],
8	the	DT	O	the	det	9	SENT_77	[p5l8t2912r121b2970],
9	impact	NN	O	impact	dobj	7	SENT_77	[p5l152t2915r396b2988],
10	of	IN	O	of	_	0	SENT_77	[p5l427t2912r498b2970],
11	the	DT	O	the	det	12	SENT_77	[p5l525t2912r637b2970],
12	interaction	NN	O	interaction	prep_of	9	SENT_77	[p5l669t2915r1060b2970],
13	of	IN	O	of	_	0	SENT_77	[p5l1091t2912r1162b2970],
14	the	DT	O	the	det	19	SENT_77	[p5l1189t2912r1301b2970],
15	BZAR	NN	ORGANIZATION	bzar	nn	19	SENT_77	[p5l1337t2914r1507b2985],
16	genotype	NN	O	genotype	nn	19	SENT_77	[p5l1536t2919r1862b2988],
17	(	NN	O	(	nn	19	SENT_77	[p5l1897t2912r2145b2984],
18	factor	NN	O	factor	nn	19	SENT_77	[p5l1897t2912r2145b2984],
19	)	NN	O	)	prep_of	12	SENT_77	[p5l1897t2912r2145b2984],
20	and	CC	O	and	_	0	SENT_77	[p5l9t3007r140b3065],
21	[	NN	O	[	nn	24	SENT_77	[p5l182t3007r557b3079],
22	3	CD	NUMBER	3	num	24	SENT_77	[p5l182t3007r557b3079],
23	—	NN	O	—	nn	24	SENT_77	[p5l182t3007r557b3079],
24	blocl	NN	O	blocl	dep	25	SENT_77	[p5l182t3007r557b3079],
25	<	JJR	O	<	prep_of	9	SENT_77	[p5l182t3007r557b3079],
26	ade	CD	NUMBER	ade	num	29	SENT_77	[p5l182t3007r557b3079],
27	(	NN	O	(	nn	29	SENT_77	[p5l598t3007r964b3079],
28	covariate	NN	O	covariate	nn	29	SENT_77	[p5l598t3007r964b3079],
29	)	NN	O	)	dep	25	SENT_77	[p5l598t3007r964b3079],
30	on	IN	O	on	_	0	SENT_77	[p5l1006t3024r1097b3065],
31	the	DT	O	the	det	32	SENT_77	[p5l1134t3007r1247b3065],
32	presence	NN	O	presence	prep_on	7	SENT_77	[p5l1284t3024r1588b3083],
33	of	IN	O	of	_	0	SENT_77	[p5l1628t3007r1699b3065],
34	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_of	32	SENT_77	[p5l1732t3007r2148b3083, p5l9t3102r353b3160],
35	(	CD	NUMBER	(	num	36	SENT_77	[p5l386t3102r665b3178],
36	no/yes	NNS	O	no/yes	amod	34	SENT_77	[p5l386t3102r665b3178],
37	)	CD	NUMBER	)	dep	36	SENT_77	[p5l386t3102r665b3178],
38	using	VBG	O	use	dep	37	SENT_77	[p5l698t3105r891b3178],
39	a	DT	O	a	det	42	SENT_77	[p5l920t3119r955b3160],
40	forward	RB	O	forward	advmod	42	SENT_77	[p5l985t3102r1258b3160],
41	stepwise	JJ	O	stepwise	amod	42	SENT_77	[p5l1289t3105r1580b3178],
42	model	NN	O	model	dobj	38	SENT_77	[p5l1611t3102r1833b3160],
43	in	IN	O	in	mark	46	SENT_77	[p5l1864t3105r1934b3159],
44	order	NN	O	order	dep	46	SENT_77	[p5l1965t3102r2150b3160],
45	to	TO	O	to	aux	46	SENT_77	[p5l8t3203r78b3252],
46	exclude	VB	O	exclude	purpcl	38	SENT_77	[p5l140t3195r408b3252],
47	from	IN	O	from	_	0	SENT_77	[p5l470t3195r640b3252],
48	the	DT	O	the	det	49	SENT_77	[p5l700t3195r812b3252],
49	model	NN	O	model	prep_from	46	SENT_77	[p5l874t3195r1096b3252],
50	those	DT	O	those	det	51	SENT_77	[p5l1156t3195r1345b3252],
51	terms	NNS	O	term	dobj	46	SENT_77	[p5l1406t3203r1602b3252],
52	that	WDT	O	that	nsubj	55	SENT_77	[p5l1662t3195r1805b3252],
53	are	VBP	O	be	cop	55	SENT_77	[p5l1866t3212r1968b3252],
54	not	RB	O	not	neg	55	SENT_77	[p5l2029t3203r2149b3252],
55	significant	JJ	O	significant	rcmod	51	SENT_77	[p5l10t3291r398b3367],
56	.	.	O	.	_	0	SENT_77	[p5l10t3291r398b3367],

1	From	IN	O	from	_	0	SENT_78	[p5l450t3294r632b3349],
2	these	DT	O	these	det	3	SENT_78	[p5l679t3291r861b3349],
3	analyses	NNS	O	analysis	prep_from	6	SENT_78	[p5l910t3291r1216b3367],
4	,	,	O	,	_	0	SENT_78	[p5l910t3291r1216b3367],
5	we	PRP	O	we	nsubj	6	SENT_78	[p5l1266t3308r1363b3349],
6	derived	VBD	O	derive	_	0	SENT_78	[p5l1412t3291r1672b3349],
7	information	NN	O	information	nsubj	25	SENT_78	[p5l1718t3291r2149b3349],
8	regarding	VBG	O	regard	_	0	SENT_78	[p5l8t3386r344b3462],
9	the	DT	O	the	det	11	SENT_78	[p5l378t3386r490b3444],
10	relative	JJ	O	relative	amod	11	SENT_78	[p5l526t3386r784b3444],
11	significance	NN	O	significance	prep_regarding	7	SENT_78	[p5l822t3386r1237b3462],
12	of	IN	O	of	_	0	SENT_78	[p5l1274t3386r1345b3444],
13	the	DT	O	the	det	17	SENT_78	[p5l1375t3386r1488b3444],
14	parameter	NN	O	parameter	nn	17	SENT_78	[p5l1523t3393r1881b3462],
15	(	CD	NUMBER	(	num	17	SENT_78	[p5l1918t3386r2145b3458],
16	Wald	NNP	PERSON	Wald	nn	17	SENT_78	[p5l1918t3386r2145b3458],
17	)	NN	O	)	prep_of	11	SENT_78	[p5l1918t3386r2145b3458],
18	and	CC	O	and	_	0	SENT_78	[p5l9t3479r140b3537],
19	the	DT	O	the	det	24	SENT_78	[p5l173t3479r285b3537],
20	relative	JJ	O	relative	amod	24	SENT_78	[p5l320t3479r578b3537],
21	risk	NN	O	risk	nn	24	SENT_78	[p5l612t3479r737b3537],
22	(	CD	NUMBER	(	num	24	SENT_78	[p5l771t3479r912b3552],
23	RR	NN	O	rr	nn	24	SENT_78	[p5l771t3479r912b3552],
24	)	NN	O	)	conj_and	17	SENT_78	[p5l771t3479r912b3552],
25	added	VBD	O	add	ccomp	6	SENT_78	[p5l949t3479r1161b3537],
26	with	IN	O	with	_	0	SENT_78	[p5l1192t3479r1353b3537],
27	a	DT	O	a	det	29	SENT_78	[p5l1386t3496r1421b3537],
28	confidence	NN	O	confidence	nn	29	SENT_78	[p5l1455t3479r1842b3537],
29	interval	NN	O	interval	prep_with	25	SENT_78	[p5l1877t3479r2148b3537],

1	(	NN	O	(	nn	3	SENT_79	[p6l12t19r138b91],
2	CI	NN	O	ci	nn	3	SENT_79	[p6l12t19r138b91],
3	)	NN	O	)	_	0	SENT_79	[p6l12t19r138b91],
4	of	IN	O	of	_	0	SENT_79	[p6l178t18r250b76],
5	95	CD	PERCENT	95	num	6	SENT_79	[p6l282t20r452b76],
6	%	NN	PERCENT	%	prep_of	3	SENT_79	[p6l282t20r452b76],
7	.	.	O	.	_	0	SENT_79	[p6l282t20r452b76],

1	RR	NN	O	rr	nsubjpass	3	SENT_80	[p6l492t21r586b75],
2	was	VBD	O	be	auxpass	3	SENT_80	[p6l618t35r746b76],
3	calculated	VBN	O	calculate	_	0	SENT_80	[p6l783t18r1139b76],
4	using	VBG	O	use	xcomp	3	SENT_80	[p6l1173t21r1365b94],
5	the	DT	O	the	det	8	SENT_80	[p6l1399t18r1511b76],
6	wild-type	JJ	O	wild-type	amod	8	SENT_80	[p6l1545t18r1877b94],
7	homozygosity	NN	O	homozygosity	nn	8	SENT_80	[p6l1913t19r2148b76, p6l8t117r297b190],
8	condition	NN	O	condition	dobj	4	SENT_80	[p6l360t114r706b172],
9	as	IN	O	as	_	0	SENT_80	[p6l771t131r836b172],
10	referent	NN	O	referent	prep_as	4	SENT_80	[p6l902t114r1194b172],
11	.	.	O	.	_	0	SENT_80	[p6l902t114r1194b172],

1	The	DT	O	the	det	2	SENT_81	[p6l1260t114r1393b172],
2	level	NN	O	level	nsubjpass	7	SENT_81	[p6l1459t114r1621b172],
3	of	IN	O	of	_	0	SENT_81	[p6l1686t114r1758b172],
4	statistical	JJ	O	statistical	amod	5	SENT_81	[p6l1820t114r2149b172],
5	significance	NN	O	significance	prep_of	2	SENT_81	[p6l10t208r425b284],
6	was	VBD	O	be	auxpass	7	SENT_81	[p6l460t225r588b266],
7	set	VBN	O	set	_	0	SENT_81	[p6l625t216r718b266],
8	at	IN	O	at	_	0	SENT_81	[p6l754t216r817b266],
9	P	NN	O	p	prep_at	7	SENT_81	[p6l849t211r956b266],
10	<	JJR	O	<	dep	11	SENT_81	[p6l849t211r956b266],
11	0.05	CD	NUMBER	0.05	advmod	7	SENT_81	[p6l971t210r1139b266],
12	.	.	O	.	_	0	SENT_81	[p6l971t210r1139b266],

1	The	DT	O	the	det	3	SENT_82	[p6l1176t209r1309b266],
2	statistical	JJ	O	statistical	amod	3	SENT_82	[p6l1346t209r1675b266],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_82	[p6l1711t209r1986b284],
4	was	VBD	O	be	auxpass	5	SENT_82	[p6l2020t225r2148b266],
5	performed	VBN	O	perform	_	0	SENT_82	[p6l8t304r376b380],
6	with	IN	O	with	_	0	SENT_82	[p6l403t304r565b362],
7	the	DT	O	the	det	10	SENT_82	[p6l593t304r705b362],
8	SPPS	NN	O	spp	nn	10	SENT_82	[p6l736t306r895b362],
9	11.0	CD	NUMBER	11.0	num	10	SENT_82	[p6l930t306r1075b362],
10	software	NN	O	software	prep_with	5	SENT_82	[p6l1105t304r1397b362],
11	(	CD	NUMBER	(	num	14	SENT_82	[p6l1430t304r1608b376],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	14	SENT_82	[p6l1430t304r1608b376],
13	Inc	NNP	ORGANIZATION	Inc	nn	14	SENT_82	[p6l1638t304r1793b376],
14	)	NNP	O	)	dep	10	SENT_82	[p6l1638t304r1793b376],
15	.	.	O	.	_	0	SENT_82	[p6l1638t304r1793b376],

1	Results	NNS	O	result	npadvmod	9	SENT_83	[p6l11t504r279b561],
2	Among	IN	O	among	_	0	SENT_83	[p6l7t600r268b675],
3	the	DT	O	the	det	5	SENT_83	[p6l291t599r403b657],
4	1050	CD	DATE	1050	num	5	SENT_83	[p6l434t600r600b657],
5	patients	NNS	O	patient	prep_among	9	SENT_83	[p6l623t602r905b675],
6	recruited	VBN	O	recruit	partmod	5	SENT_83	[p6l930t599r1263b669],
7	,	,	O	,	_	0	SENT_83	[p6l930t599r1263b669],
8	80	CD	NUMBER	80	nsubj	9	SENT_83	[p6l1293t600r1375b657],
9	refused	VBD	O	refuse	_	0	SENT_83	[p6l1400t599r1653b657],
10	to	TO	O	to	aux	11	SENT_83	[p6l1677t606r1746b657],
11	participate	VB	O	participate	xcomp	9	SENT_83	[p6l1770t602r2147b675],
12	in	IN	O	in	_	0	SENT_83	[p6l8t697r79b751],
13	the	DT	O	the	det	14	SENT_83	[p6l116t694r229b752],
14	study	NN	O	study	prep_in	11	SENT_83	[p6l269t694r471b770],
15	.	.	O	.	_	0	SENT_83	[p6l269t694r471b770],

1	Thus	RB	O	thus	advmod	4	SENT_84	[p6l511t694r702b764],
2	,	,	O	,	_	0	SENT_84	[p6l511t694r702b764],
3	we	PRP	O	we	nsubj	4	SENT_84	[p6l743t711r839b752],
4	enrolled	VBD	O	enrol	_	0	SENT_84	[p6l879t694r1170b752],
5	970	CD	NUMBER	970	num	7	SENT_84	[p6l1209t695r1335b752],
6	hypertensive	JJ	O	hypertensive	amod	7	SENT_84	[p6l1373t694r1827b770],
7	patients	NNS	O	patient	dobj	4	SENT_84	[p6l1865t697r2148b770],
8	whose	WP$	O	whose	dep	12	SENT_84	[p6l7t787r229b844],
9	clinical	JJ	O	clinical	amod	10	SENT_84	[p6l259t787r514b844],
10	characteristics	NNS	O	characteristic	nsubjpass	12	SENT_84	[p6l543t787r1043b844],
11	are	VBP	O	be	auxpass	12	SENT_84	[p6l1074t804r1175b844],
12	shown	VBN	O	show	dep	7	SENT_84	[p6l1206t787r1438b844],
13	in	IN	O	in	_	0	SENT_84	[p6l1466t790r1537b844],
14	Table	NNP	O	Table	prep_in	12	SENT_84	[p6l1563t787r1748b844],
15	1	CD	NUMBER	1	num	14	SENT_84	[p6l1784t789r1836b844],
16	.	.	O	.	_	0	SENT_84	[p6l1784t789r1836b844],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_85	[p6l1869t790r2148b844],
2	were	VBD	O	be	auxpass	3	SENT_85	[p6l7t900r170b941],
3	divided	VBN	O	divide	_	0	SENT_85	[p6l203t883r465b941],
4	into	IN	O	into	_	0	SENT_85	[p6l497t886r640b941],
5	two	CD	NUMBER	two	num	6	SENT_85	[p6l671t890r801b941],
6	groups	NNS	O	group	prep_into	3	SENT_85	[p6l833t900r1069b959],
7	according	VBG	O	accord	_	0	SENT_85	[p6l1102t883r1450b959],
8	to	TO	O	to	prepc_according_to	3	SENT_85	[p6l1479t890r1549b941],
9	their	PRP$	O	they	poss	13	SENT_85	[p6l1580t883r1748b941],
10	antihyper	JJ	O	antihyper	amod	13	SENT_85	[p6l1779t883r2148b959],
11	—	NN	O	—	nn	13	SENT_85	[p6l1779t883r2148b959],
12	tensive	NN	O	tensive	nn	13	SENT_85	[p6l8t981r256b1036],
13	treatment	NN	O	treatment	pobj	3	SENT_85	[p6l286t985r654b1036],
14	.	.	O	.	_	0	SENT_85	[p6l286t985r654b1036],

1	There	EX	O	there	expl	2	SENT_86	[p6l685t978r886b1036],
2	were	VBD	O	be	_	0	SENT_86	[p6l914t995r1078b1036],
3	statistically	RB	O	statistically	advmod	4	SENT_86	[p6l1110t978r1508b1054],
4	significant	JJ	O	significant	amod	5	SENT_86	[p6l1536t978r1907b1054],
5	differences	NNS	O	difference	nsubj	2	SENT_86	[p6l1937t978r2147b1036, p6l9t1089r199b1130],
6	between	IN	O	between	_	0	SENT_86	[p6l230t1072r528b1130],
7	the	DT	O	the	det	9	SENT_86	[p6l559t1073r672b1130],
8	study	NN	O	study	nn	9	SENT_86	[p6l707t1072r900b1148],
9	groups	NNS	O	group	prep_between	5	SENT_86	[p6l930t1089r1166b1148],
10	in	IN	O	in	_	0	SENT_86	[p6l1199t1075r1269b1129],
11	sex	NN	O	sex	nn	12	SENT_86	[p6l1303t1089r1412b1130],
12	distribution	NN	O	distribution	prep_in	9	SENT_86	[p6l1445t1072r1863b1130],
13	and	CC	O	and	_	0	SENT_86	[p6l1896t1072r2045b1143],
14	,	,	O	,	_	0	SENT_86	[p6l1896t1072r2045b1143],
15	as	IN	O	as	mark	16	SENT_86	[p6l2083t1089r2147b1130],
16	expected	VBN	O	expect	dep	2	SENT_86	[p6l9t1168r339b1244],
17	,	,	O	,	_	0	SENT_86	[p6l9t1168r339b1244],
18	in	IN	O	in	conj_and	2	SENT_86	[p6l398t1171r469b1225],
19	heart	NN	O	heart	pobj	18	SENT_86	[p6l523t1168r706b1226],
20	rate	NN	O	rate	nn	22	SENT_86	[p6l760t1175r890b1226],
21	(	CD	NUMBER	(	num	22	SENT_86	[p6l949t1168r1156b1240],
22	Table	NNP	O	Table	dep	19	SENT_86	[p6l949t1168r1156b1240],
23	1	CD	NUMBER	1	number	24	SENT_86	[p6l1217t1168r1296b1240],
24	)	CD	NUMBER	)	dep	22	SENT_86	[p6l1217t1168r1296b1240],
25	.	.	O	.	_	0	SENT_86	[p6l1217t1168r1296b1240],

1	On	IN	O	on	_	0	SENT_87	[p6l1357t1170r1464b1226],
2	the	DT	O	the	det	3	SENT_87	[p6l1518t1168r1631b1226],
3	contrary	NN	O	contrary	prep_on	10	SENT_87	[p6l1687t1175r1997b1244],
4	,	,	O	,	_	0	SENT_87	[p6l1687t1175r1997b1244],
5	no	DT	O	no	det	8	SENT_87	[p6l2057t1185r2148b1226],
6	statistically	RB	O	statistically	advmod	7	SENT_87	[p6l10t1263r409b1339],
7	significant	JJ	O	significant	amod	8	SENT_87	[p6l476t1263r847b1339],
8	difference	NN	O	difference	nsubjpass	10	SENT_87	[p6l916t1263r1265b1321],
9	was	VBD	O	be	auxpass	10	SENT_87	[p6l1333t1280r1461b1321],
10	detected	VBN	O	detect	_	0	SENT_87	[p6l1531t1263r1829b1321],
11	in	IN	O	in	_	0	SENT_87	[p6l1897t1266r1967b1320],
12	the	DT	O	the	det	13	SENT_87	[p6l2035t1263r2147b1321],
13	duration	NN	O	duration	prep_in	10	SENT_87	[p6l9t1358r315b1415],
14	of	IN	O	of	_	0	SENT_87	[p6l373t1357r444b1415],
15	the	DT	O	the	det	17	SENT_87	[p6l497t1358r609b1415],
16	antihypertensive	JJ	O	antihypertensive	amod	17	SENT_87	[p6l668t1358r1264b1433],
17	treatment	NN	O	treatment	prep_of	13	SENT_87	[p6l1322t1365r1672b1415],
18	nor	CC	O	nor	_	0	SENT_87	[p6l1729t1374r1851b1415],
19	in	IN	O	in	prep_in	10	SENT_87	[p6l1908t1361r1978b1415],
20	the	DT	O	the	det	21	SENT_87	[p6l2035t1358r2147b1415],
21	percentage	NN	O	percentage	pobj	19	SENT_87	[p6l8t1460r390b1529],
22	of	IN	O	of	_	0	SENT_87	[p6l433t1453r504b1511],
23	patients	NNS	O	patient	prep_of	10	SENT_87	[p6l540t1456r823b1529],
24	that	WDT	O	that	nsubj	25	SENT_87	[p6l864t1453r1007b1511],
25	received	VBD	O	receive	rcmod	23	SENT_87	[p6l1048t1453r1338b1511],
26	combination	NN	O	combination	nn	27	SENT_87	[p6l1380t1453r1837b1511],
27	therapy	NN	O	therapy	dobj	25	SENT_87	[p6l1878t1453r2151b1529],
28	including	VBG	O	include	_	0	SENT_87	[p6l8t1548r350b1624],
29	diuretics	NNS	O	diuretic	prep_including	27	SENT_87	[p6l375t1548r675b1606],
30	(	RB	O	(	dep	31	SENT_87	[p6l705t1548r912b1620],
31	Table	NNP	O	Table	dep	29	SENT_87	[p6l705t1548r912b1620],
32	1	CD	NUMBER	1	number	33	SENT_87	[p6l944t1548r1023b1620],
33	)	CD	NUMBER	)	num	31	SENT_87	[p6l944t1548r1023b1620],
34	.	.	O	.	_	0	SENT_87	[p6l944t1548r1023b1620],

1	The	DT	O	the	det	2	SENT_88	[p6l1050t1548r1183b1606],
2	frequencies	NNS	O	frequency	nsubj	28	SENT_88	[p6l1209t1548r1611b1624],
3	of	IN	O	of	_	0	SENT_88	[p6l1638t1548r1709b1606],
4	the	DT	O	the	det	5	SENT_88	[p6l1730t1548r1842b1606],
5	variants	NNS	O	variant	prep_of	2	SENT_88	[p6l1866t1551r2148b1606],
6	of	IN	O	of	_	0	SENT_88	[p6l9t1643r80b1701],
7	each	DT	O	each	prep_of	5	SENT_88	[p6l123t1643r283b1701],
8	considered	VBN	O	consider	partmod	7	SENT_88	[p6l330t1643r712b1701],
9	gene	NN	O	gene	nsubjpass	11	SENT_88	[p6l758t1660r921b1719],
10	are	VBP	O	be	auxpass	11	SENT_88	[p6l969t1660r1070b1701],
11	given	VBN	O	give	ccomp	8	SENT_88	[p6l1117t1646r1310b1719],
12	in	IN	O	in	_	0	SENT_88	[p6l1355t1646r1426b1700],
13	Table	NNP	O	Table	prep_in	11	SENT_88	[p6l1469t1643r1655b1701],
14	2	CD	NUMBER	2	num	13	SENT_88	[p6l1702t1644r1741b1700],
15	being	VBG	O	be	cop	17	SENT_88	[p6l1786t1643r1984b1719],
16	not	RB	O	not	neg	17	SENT_88	[p6l2028t1650r2149b1701],
17	different	JJ	O	different	xcomp	11	SENT_88	[p6l9t1737r313b1795],
18	from	IN	O	from	_	0	SENT_88	[p6l339t1737r509b1795],
19	those	DT	O	those	prep_from	17	SENT_88	[p6l536t1737r725b1795],
20	observed	VBN	O	observe	partmod	19	SENT_88	[p6l754t1737r1066b1795],
21	in	IN	O	in	_	0	SENT_88	[p6l1093t1740r1163b1794],
22	a	DT	O	a	det	23	SENT_88	[p6l1191t1754r1226b1795],
23	population	NN	O	population	prep_in	20	SENT_88	[p6l1251t1737r1645b1813],
24	of	IN	O	of	_	0	SENT_88	[p6l1672t1737r1743b1795],
25	normotensive	JJ	O	normotensive	amod	27	SENT_88	[p6l1766t1745r2147b1795, p6l10t1835r139b1890],
26	blood	NN	O	blood	nn	27	SENT_88	[p6l167t1832r372b1890],
27	donors	NNS	O	donor	prep_of	23	SENT_88	[p6l401t1832r644b1890],
28	(	VBP	O	(	_	0	SENT_88	[p6l678t1832r851b1904],
29	data	NNS	O	datum	dobj	28	SENT_88	[p6l678t1832r851b1904],
30	not	RB	O	not	neg	31	SENT_88	[p6l880t1839r1000b1890],
31	shown	VBN	O	show	rcmod	29	SENT_88	[p6l1032t1832r1309b1904],
32	)	NN	O	)	dobj	31	SENT_88	[p6l1032t1832r1309b1904],
33	.	.	O	.	_	0	SENT_88	[p6l1032t1832r1309b1904],

1	Impact	NN	O	impact	dep	7	SENT_89	[p6l12t2000r255b2074],
2	of	IN	O	of	_	0	SENT_89	[p6l284t1998r355b2056],
3	[	CD	NUMBER	[	prep_of	1	SENT_89	[p6l383t2001r416b2071],
4	3	CD	NUMBER	3	num	5	SENT_89	[p6l383t2001r416b2071],
5	AR	NN	ORGANIZATION	ar	dep	7	SENT_89	[p6l444t2000r540b2056],
6	Gene	NN	ORGANIZATION	gene	nn	7	SENT_89	[p6l570t2000r754b2056],
7	Polymorphisms	NNS	ORGANIZATION	polymorphism	dep	28	SENT_89	[p6l789t1998r1330b2074],
8	on	IN	O	on	_	0	SENT_89	[p6l1361t2015r1447b2056],
9	Metabolic	JJ	O	metabolic	amod	10	SENT_89	[p6l1483t1998r1834b2056],
10	Profile	NNP	O	Profile	prep_on	7	SENT_89	[p6l1867t1998r2091b2056],
11	In	IN	O	in	_	0	SENT_89	[p6l9t2095r82b2150],
12	the	DT	O	the	det	14	SENT_89	[p6l107t2093r220b2151],
13	overall	JJ	O	overall	amod	14	SENT_89	[p6l247t2093r485b2151],
14	population	NN	O	population	prep_in	28	SENT_89	[p6l510t2093r920b2169],
15	,	,	O	,	_	0	SENT_89	[p6l510t2093r920b2169],
16	dyslipidemia	NN	O	dyslipidemia	nsubj	28	SENT_89	[p6l952t2093r1422b2169],
17	,	,	O	,	_	0	SENT_89	[p6l952t2093r1422b2169],
18	that	WDT	O	that	nsubj	21	SENT_89	[p6l1453t2093r1596b2151],
19	is	VBZ	O	be	cop	21	SENT_89	[p6l1621t2096r1672b2151],
20	the	DT	O	the	det	21	SENT_89	[p6l1698t2093r1811b2151],
21	evidence	NN	O	evidence	rcmod	16	SENT_89	[p6l1838t2093r2148b2151],
22	of	IN	O	of	_	0	SENT_89	[p6l9t2187r81b2245],
23	elevated	JJ	O	elevated	amod	24	SENT_89	[p6l131t2188r422b2245],
24	triglycerides	NNS	O	triglyceride	prep_of	21	SENT_89	[p6l476t2188r906b2263],
25	and/or	VBP	O	and/or	rcmod	21	SENT_89	[p6l962t2187r1199b2253],
26	cholesterol	NN	O	cholesterol	dobj	25	SENT_89	[p6l1252t2188r1657b2258],
27	,	,	O	,	_	0	SENT_89	[p6l1252t2188r1657b2258],
28	occurred	VBD	O	occur	_	0	SENT_89	[p6l1717t2188r2024b2245],
29	in	IN	O	in	_	0	SENT_89	[p6l2078t2191r2148b2245],
30	37.3	CD	PERCENT	37.3	num	31	SENT_89	[p6l10t2285r245b2353],
31	%	NN	PERCENT	%	prep_in	28	SENT_89	[p6l10t2285r245b2353],
32	,	,	O	,	_	0	SENT_89	[p6l10t2285r245b2353],
33	and	CC	O	and	_	0	SENT_89	[p6l283t2283r414b2341],
34	diabetes	NN	O	diabetes	nsubjpass	36	SENT_89	[p6l447t2283r732b2341],
35	was	VBD	O	be	auxpass	36	SENT_89	[p6l763t2300r891b2341],
36	observed	VBN	O	observe	conj_and	28	SENT_89	[p6l925t2283r1237b2341],
37	in	IN	O	in	_	0	SENT_89	[p6l1269t2286r1339b2340],
38	4.0	CD	PERCENT	4.0	num	39	SENT_89	[p6l1372t2285r1547b2341],
39	%	NN	PERCENT	%	prep_in	36	SENT_89	[p6l1372t2285r1547b2341],
40	of	IN	O	of	_	0	SENT_89	[p6l1580t2283r1651b2341],
41	patients	NNS	O	patient	prep_of	39	SENT_89	[p6l1679t2286r1980b2359],
42	.	.	O	.	_	0	SENT_89	[p6l1679t2286r1980b2359],

1	The	DT	O	the	det	5	SENT_90	[p6l2015t2283r2147b2341],
2	[	CD	NUMBER	[	num	5	SENT_90	[p6l13t2380r182b2451],
3	32AR	NN	O	32ar	nn	5	SENT_90	[p6l13t2380r182b2451],
4	Glu27	NN	O	glu27	nn	5	SENT_90	[p6l206t2378r418b2436],
5	variant	NN	O	variant	nsubjpass	7	SENT_90	[p6l442t2381r694b2436],
6	was	VBD	O	be	auxpass	7	SENT_90	[p6l716t2395r844b2436],
7	associated	VBN	O	associate	dep	38	SENT_90	[p6l870t2378r1225b2436],
8	with	IN	O	with	_	0	SENT_90	[p6l1247t2378r1409b2436],
9	a	DT	O	a	det	11	SENT_90	[p6l1434t2395r1469b2436],
10	larger	JJR	O	larger	amod	11	SENT_90	[p6l1492t2378r1691b2454],
11	incidence	NN	O	incidence	prep_with	7	SENT_90	[p6l1714t2378r2055b2436],
12	of	IN	O	of	_	0	SENT_90	[p6l2081t2378r2152b2436],
13	dyslipidemia	NN	O	dyslipidemia	prep_of	11	SENT_90	[p6l9t2473r462b2549],
14	(	CD	NUMBER	(	number	15	SENT_90	[p6l502t2473r674b2545],
15	48.4	CD	NUMBER	48.4	dep	13	SENT_90	[p6l502t2473r674b2545],
16	vs	CC	O	vs	_	0	SENT_90	[p6l713t2490r776b2531],
17	37.3	CD	PERCENT	37.3	num	18	SENT_90	[p6l815t2474r1050b2543],
18	%	NN	PERCENT	%	prep_of	11	SENT_90	[p6l815t2474r1050b2543],
19	,	,	O	,	_	0	SENT_90	[p6l815t2474r1050b2543],
20	P	NN	O	p	appos	18	SENT_90	[p6l1088t2473r1384b2545],
21	<	JJR	O	<	amod	18	SENT_90	[p6l1088t2473r1384b2545],
22	0.05	CD	NUMBER	0.05	num	23	SENT_90	[p6l1088t2473r1384b2545],
23	)	NN	O	)	npadvmod	21	SENT_90	[p6l1088t2473r1384b2545],
24	due	JJ	O	due	_	0	SENT_90	[p6l1425t2473r1551b2531],
25	to	TO	O	to	_	0	SENT_90	[p6l1589t2480r1658b2531],
26	an	DT	O	a	det	28	SENT_90	[p6l1697t2490r1782b2531],
27	increased	VBN	O	increase	amod	28	SENT_90	[p6l1818t2473r2148b2531],
28	proportion	NN	O	proportion	prep_due_to	21	SENT_90	[p6l8t2572r395b2645],
29	of	IN	O	of	_	0	SENT_90	[p6l444t2569r515b2627],
30	patients	NNS	O	patient	prep_of	28	SENT_90	[p6l559t2572r841b2645],
31	with	IN	O	with	_	0	SENT_90	[p6l887t2569r1049b2627],
32	this	DT	O	this	det	33	SENT_90	[p6l1097t2569r1227b2627],
33	polymorphism	NN	O	polymorphism	prep_with	30	SENT_90	[p6l1275t2569r1801b2645],
34	showing	VBG	O	show	partmod	33	SENT_90	[p6l1851t2569r2149b2645],
35	elevated	JJ	O	elevated	amod	37	SENT_90	[p6l9t2664r300b2722],
36	serum	NN	O	serum	nn	37	SENT_90	[p6l361t2681r574b2722],
37	triglycerides	NNS	O	triglyceride	dobj	34	SENT_90	[p6l635t2664r1065b2740],
38	(	VBP	O	(	_	0	SENT_90	[p6l1130t2664r1467b2736],
39	Gln/Gln	NN	O	gln/gln	dobj	38	SENT_90	[p6l1130t2664r1467b2736],
40	:	:	O	:	_	0	SENT_90	[p6l1130t2664r1467b2736],
41	12.9	CD	PERCENT	12.9	num	42	SENT_90	[p6l1538t2665r1770b2733],
42	%	NN	PERCENT	%	dep	39	SENT_90	[p6l1538t2665r1770b2733],
43	;	:	O	;	_	0	SENT_90	[p6l1538t2665r1770b2733],
44	Gln/Glu	NNP	O	Gln/Glu	dep	39	SENT_90	[p6l1835t2664r2144b2729],
45	:	:	O	:	_	0	SENT_90	[p6l1835t2664r2144b2729],
46	18.6	CD	PERCENT	18.6	num	47	SENT_90	[p6l14t2758r246b2826],
47	%	NN	PERCENT	%	dep	39	SENT_90	[p6l14t2758r246b2826],
48	;	:	O	;	_	0	SENT_90	[p6l14t2758r246b2826],
49	Glu/Glu	NNP	O	Glu/Glu	dep	39	SENT_90	[p6l285t2757r590b2822],
50	:	:	O	:	_	0	SENT_90	[p6l285t2757r590b2822],
51	25.0	CD	PERCENT	25.0	num	52	SENT_90	[p6l629t2758r866b2826],
52	%	NN	PERCENT	%	dep	39	SENT_90	[p6l629t2758r866b2826],
53	;	:	O	;	_	0	SENT_90	[p6l629t2758r866b2826],
54	x2	NN	O	x2	dep	39	SENT_90	[p6l903t2750r989b2829],
55	:	:	O	:	_	0	SENT_90	[p6l903t2750r989b2829],
56	8.147	CD	NUMBER	8.147	dep	39	SENT_90	[p6l1028t2758r1239b2826],
57	;	:	O	;	_	0	SENT_90	[p6l1028t2758r1239b2826],
58	P	NN	O	p	dep	39	SENT_90	[p6l1273t2757r1590b2829],
59	<	JJR	O	<	dep	58	SENT_90	[p6l1273t2757r1590b2829],
60	0.02	CD	NUMBER	0.02	num	61	SENT_90	[p6l1273t2757r1590b2829],
61	)	NN	O	)	nsubj	38	SENT_90	[p6l1273t2757r1590b2829],
62	.	.	O	.	_	0	SENT_90	[p6l1273t2757r1590b2829],

1	The	DT	O	the	det	3	SENT_91	[p6l1626t2757r1759b2815],
2	regression	NN	O	regression	nn	3	SENT_91	[p6l1793t2760r2148b2833],
3	analysis	NN	O	analysis	nsubj	4	SENT_91	[p6l9t2852r284b2928],
4	showed	VBD	O	show	_	0	SENT_91	[p6l314t2852r581b2910],
5	that	IN	O	that	_	0	SENT_91	[p6l607t2853r750b2910],
6	the	DT	O	the	det	7	SENT_91	[p6l777t2853r890b2910],
7	condition	NN	O	condition	prep_that	4	SENT_91	[p6l918t2852r1265b2910],
8	of	IN	O	of	_	0	SENT_91	[p6l1293t2852r1365b2910],
9	hypertryglyceridemia	NN	O	hypertryglyceridemia	prep_of	7	SENT_91	[p6l1387t2852r2148b2928],

1	Table	NNP	O	Table	_	0	SENT_92	[p6l9t3024r101b3052],
2	1	CD	NUMBER	1	num	1	SENT_92	[p6l118t3025r129b3051],
3	Demographic	JJ	MISC	demographic	amod	6	SENT_92	[p6l174t3025r396b3060],
4	and	CC	O	and	_	0	SENT_92	[p6l410t3025r469b3052],
5	clinical	JJ	O	clinical	amod	6	SENT_92	[p6l484t3025r594b3052],
6	characteristics	NNS	O	characteristic	dep	1	SENT_92	[p6l609t3025r841b3052],
7	of	IN	O	of	_	0	SENT_92	[p6l855t3025r888b3052],
8	the	DT	O	the	det	10	SENT_92	[p6l900t3025r953b3052],
9	study	NN	O	study	nn	10	SENT_92	[p6l967t3025r1056b3060],
10	population	NN	O	population	prep_of	6	SENT_92	[p6l1070t3025r1247b3060],

1	Whole	JJ	O	whole	amod	3	SENT_93	[p6l1513t3154r1690b3207],
2	(	NN	O	(	nn	3	SENT_93	[p6l1456t3238r1517b3304],
3	n	NN	O	n	_	0	SENT_93	[p6l1456t3238r1517b3304],
4	=	JJ	O	=	dep	3	SENT_93	[p6l1532t3264r1579b3281],
5	970	CD	NUMBER	970	num	6	SENT_93	[p6l1601t3238r1735b3304],
6	)	NN	O	)	dep	3	SENT_93	[p6l1601t3238r1735b3304],

1	Age	NNP	O	Age	nn	3	SENT_94	[p7l6t56r124b122],
2	(	CD	NUMBER	(	num	3	SENT_94	[p7l153t53r352b122],
3	years	NNS	NUMBER	year	nsubj	6	SENT_94	[p7l153t53r352b122],
4	)	CD	NUMBER	)	num	6	SENT_94	[p7l153t53r352b122],
5	Gender	NN	O	gender	nn	6	SENT_94	[p7l10t135r236b188],
6	(	NN	O	(	_	0	SENT_94	[p7l262t135r423b201],
7	M/F	NN	O	m/f	nn	17	SENT_94	[p7l262t135r423b201],
8	,	,	O	,	_	0	SENT_94	[p7l262t135r423b201],
9	%	NN	O	%	dep	17	SENT_94	[p7l455t135r538b201],
10	)	CD	NUMBER	)	num	17	SENT_94	[p7l455t135r538b201],
11	BMI	NN	O	bmus	nn	17	SENT_94	[p7l12t221r124b270],
12	(	CD	NUMBER	(	num	17	SENT_94	[p7l155t212r393b288],
13	kg/m2	NN	O	kg/m2	nn	17	SENT_94	[p7l155t212r393b288],
14	)	CD	NUMBER	)	num	17	SENT_94	[p7l155t212r393b288],
15	Smoke	NN	O	smoke	nn	17	SENT_94	[p7l10t302r212b354],
16	(	CD	NUMBER	(	num	17	SENT_94	[p7l241t302r396b367],
17	N/Y	NN	O	n/y	nsubj	46	SENT_94	[p7l241t302r396b367],
18	,	,	O	,	_	0	SENT_94	[p7l241t302r396b367],
19	%	NN	O	%	npadvmod	46	SENT_94	[p7l428t302r511b367],
20	)	CD	NUMBER	)	num	19	SENT_94	[p7l428t302r511b367],
21	On	IN	O	on	_	0	SENT_94	[p7l10t387r98b437],
22	Treatment	NN	O	treatment	prep_on	46	SENT_94	[p7l126t387r445b437],
23	(	CD	NUMBER	(	num	24	SENT_94	[p7l471t385r671b454],
24	years	NNS	NUMBER	year	dep	37	SENT_94	[p7l471t385r671b454],
25	)	CD	NUMBER	)	num	28	SENT_94	[p7l471t385r671b454],
26	Systolic	JJ	O	systolic	amod	28	SENT_94	[p7l10t468r234b537],
27	BP	NN	O	bp	nn	28	SENT_94	[p7l264t470r334b519],
28	(	NN	O	(	dep	24	SENT_94	[p7l363t468r622b537],
29	mmHg	NN	O	mmhg	dep	37	SENT_94	[p7l363t468r622b537],
30	)	CD	NUMBER	)	num	29	SENT_94	[p7l363t468r622b537],
31	Diastolic	JJ	O	diastolic	amod	37	SENT_94	[p7l12t551r266b603],
32	BP	NN	O	bp	nn	37	SENT_94	[p7l296t553r365b602],
33	(	NN	O	(	nn	37	SENT_94	[p7l395t551r653b620],
34	mmHg	NN	O	mmhg	nn	37	SENT_94	[p7l395t551r653b620],
35	)	CD	NUMBER	)	num	37	SENT_94	[p7l395t551r653b620],
36	Heart	NNP	O	Heart	nn	37	SENT_94	[p7l12t636r174b686],
37	rate	NN	O	rate	dep	22	SENT_94	[p7l202t640r314b686],
38	(	CD	NUMBER	(	num	39	SENT_94	[p7l342t634r530b703],
39	bpm	NN	O	bpm	dep	37	SENT_94	[p7l342t634r530b703],
40	)	CD	NUMBER	)	num	45	SENT_94	[p7l342t634r530b703],
41	Statin	NNP	O	Statin	nn	45	SENT_94	[p7l10t717r178b768],
42	Fibrates	NNP	O	Fibrates	nn	45	SENT_94	[p7l12t798r241b850],
43	Hypoglycaemics	NNP	O	Hypoglycaemics	nn	45	SENT_94	[p7l12t880r506b949],
44	Diuretics	NNP	O	Diuretics	nn	45	SENT_94	[p7l12t964r273b1015],
45	oc-blockers	NNS	O	oc-blocker	nsubj	46	SENT_94	[p7l10t1045r317b1097],
46	oc	VBP	O	oc	rcmod	6	SENT_94	[p7l10t1128r383b1194],
47	/	:	O	/	punct	55	SENT_94	[p7l10t1128r383b1194],
48	[	CD	NUMBER	[	num	49	SENT_94	[p7l10t1128r383b1194],
49	3-blockers	NNS	O	3-blocker	dep	55	SENT_94	[p7l10t1128r383b1194],
50	ACE	NN	O	ace	nn	51	SENT_94	[p7l6t1211r131b1262],
51	inhibitors	NNS	O	inhibitor	dep	49	SENT_94	[p7l160t1210r441b1262],
52	AT1	NN	O	at1	nn	55	SENT_94	[p7l6t1294r112b1344],
53	antagonist	NN	O	antagonist	nn	55	SENT_94	[p7l153t1294r475b1362],
54	Ca	NN	O	ca	nn	55	SENT_94	[p7l10t1377r86b1428],
55	antagonists	NNS	O	antagonist	parataxis	6	SENT_94	[p7l115t1377r461b1445],

1	/	:	O	/	punct	2	SENT_95	[p7l383t1472r664b1539],
2	3-blocker	NN	O	3-blocker	_	0	SENT_95	[p7l383t1472r664b1539],
3	therapy	NN	O	therapy	dep	2	SENT_95	[p7l688t1472r917b1542],

1	(	NN	O	(	nn	2	SENT_96	[p7l504t1580r565b1648],
2	n	NN	O	n	_	0	SENT_96	[p7l504t1580r565b1648],
3	=	JJ	O	=	dep	2	SENT_96	[p7l581t1606r629b1624],
4	214	CD	NUMBER	214	num	5	SENT_96	[p7l647t1580r790b1648],
5	)	NN	O	)	dep	2	SENT_96	[p7l647t1580r790b1648],

1	51	CD	NUMBER	51	num	2	SENT_97	[p7l532t1762r596b1814],
2	i0	NN	O	i0	dep	20	SENT_97	[p7l624t1762r782b1822],
3	.7	CD	NUMBER	.7	number	4	SENT_97	[p7l624t1762r782b1822],
4	52.3	CD	NUMBER	52.3	dep	2	SENT_97	[p7l471t1846r811b1907],
5	/	:	O	/	punct	7	SENT_97	[p7l471t1846r811b1907],
6	47.7	CD	NUMBER	47.7	number	7	SENT_97	[p7l471t1846r811b1907],
7	*	CD	NUMBER	*	dep	4	SENT_97	[p7l471t1846r811b1907],
8	27.2	CD	NUMBER	27.2	num	10	SENT_97	[p7l471t1933r780b1994],
9	i0	NN	O	i0	nn	10	SENT_97	[p7l471t1933r780b1994],
10	.3	NN	NUMBER	.3	dep	7	SENT_97	[p7l471t1933r780b1994],
11	47.8	CD	NUMBER	47.8	dep	7	SENT_97	[p7l469t2017r779b2078],
12	/	:	O	/	punct	7	SENT_97	[p7l469t2017r779b2078],
13	52.2	CD	NUMBER	52.2	number	14	SENT_97	[p7l469t2017r779b2078],
14	6.29	CD	NUMBER	6.29	num	15	SENT_97	[p7l472t2104r822b2164],
15	i0	NN	O	i0	dep	4	SENT_97	[p7l472t2104r822b2164],
16	.48	CD	NUMBER	.48	num	17	SENT_97	[p7l472t2104r822b2164],
17	147i1	NN	O	147i1	dep	20	SENT_97	[p7l494t2189r781b2249],
18	.4	CD	NUMBER	.4	num	20	SENT_97	[p7l494t2189r781b2249],
19	91	CD	NUMBER	91	num	20	SENT_97	[p7l533t2274r596b2326],
20	i0	NN	O	i0	dep	24	SENT_97	[p7l624t2274r782b2334],
21	.7	CD	NUMBER	.7	num	22	SENT_97	[p7l624t2274r782b2334],
22	70i0	CD	NUMBER	70i0	dep	20	SENT_97	[p7l536t2359r813b2419],
23	.7	CD	NUMBER	.7	num	24	SENT_97	[p7l536t2359r813b2419],
24	*	NN	O	*	dep	26	SENT_97	[p7l536t2359r813b2419],
25	3.7	CD	PERCENT	3.7	num	26	SENT_97	[p7l568t2445r729b2497],
26	%	NN	PERCENT	%	_	0	SENT_97	[p7l568t2445r729b2497],

1	51	CD	NUMBER	51	num	2	SENT_98	[p7l1484t55r1546b105],
2	i0	NN	O	i0	dep	19	SENT_98	[p7l1574t55r1727b113],
3	.4	CD	NUMBER	.4	number	4	SENT_98	[p7l1574t55r1727b113],
4	60.5	CD	NUMBER	60.5	dep	2	SENT_98	[p7l1425t135r1723b194],
5	/	:	O	/	punct	7	SENT_98	[p7l1425t135r1723b194],
6	39.5	CD	NUMBER	39.5	number	7	SENT_98	[p7l1425t135r1723b194],
7	27.3	CD	NUMBER	27.3	dep	4	SENT_98	[p7l1424t220r1557b271],
8	iO	NN	O	io	dep	7	SENT_98	[p7l1574t220r1714b279],
9	.1	CD	NUMBER	.1	num	10	SENT_98	[p7l1574t220r1714b279],
10	44.0	CD	NUMBER	44.0	dep	7	SENT_98	[p7l1422t302r1725b361],
11	/	:	O	/	punct	7	SENT_98	[p7l1422t302r1725b361],
12	56.0	CD	NUMBER	56.0	num	14	SENT_98	[p7l1422t302r1725b361],
13	6.43	CD	NUMBER	6.43	num	14	SENT_98	[p7l1425t387r1557b437],
14	iO	NN	O	io	dep	4	SENT_98	[p7l1574t387r1766b445],
15	.23	CD	NUMBER	.23	num	16	SENT_98	[p7l1574t387r1766b445],
16	147i0	NN	O	147i0	dep	19	SENT_98	[p7l1447t470r1727b528],
17	.6	CD	NUMBER	.6	num	19	SENT_98	[p7l1447t470r1727b528],
18	91	CD	NUMBER	91	num	19	SENT_98	[p7l1485t553r1546b603],
19	iO	NN	O	io	dep	26	SENT_98	[p7l1574t553r1725b611],
20	.3	NN	PERCENT	.3	dep	19	SENT_98	[p7l1574t553r1725b611],
21	74i0	CD	PERCENT	74i0	num	20	SENT_98	[p7l1488t636r1727b694],
22	.4	CD	PERCENT	.4	number	23	SENT_98	[p7l1488t636r1727b694],
23	6.6	CD	PERCENT	6.6	num	24	SENT_98	[p7l1517t718r1676b768],
24	%	NN	PERCENT	%	dep	20	SENT_98	[p7l1517t718r1676b768],
25	0.3	CD	PERCENT	0.3	num	26	SENT_98	[p7l1516t800r1676b850],
26	%	NN	PERCENT	%	dep	36	SENT_98	[p7l1516t800r1676b850],
27	1.9	CD	PERCENT	1.9	num	28	SENT_98	[p7l1519t882r1676b933],
28	%	NN	PERCENT	%	dep	26	SENT_98	[p7l1519t882r1676b933],
29	24.9	CD	PERCENT	24.9	number	30	SENT_98	[p7l1496t964r1696b1015],
30	%	NN	PERCENT	%	amod	28	SENT_98	[p7l1496t964r1696b1015],
31	4.9	CD	PERCENT	4.9	number	32	SENT_98	[p7l1514t1046r1676b1097],
32	%	NN	PERCENT	%	amod	28	SENT_98	[p7l1514t1046r1676b1097],
33	3.5	CD	PERCENT	3.5	number	34	SENT_98	[p7l1519t1129r1676b1180],
34	%	NN	PERCENT	%	amod	28	SENT_98	[p7l1519t1129r1676b1180],
35	28.6	CD	PERCENT	28.6	num	36	SENT_98	[p7l1496t1211r1696b1262],
36	%	NN	PERCENT	%	_	0	SENT_98	[p7l1496t1211r1696b1262],
37	11	CD	PERCENT	11	num	38	SENT_98	[p7l1529t1294r1665b1345],
38	%	NN	PERCENT	%	dep	36	SENT_98	[p7l1529t1294r1665b1345],
39	24.2	CD	PERCENT	24.2	number	40	SENT_98	[p7l1496t1377r1696b1428],
40	%	NN	PERCENT	%	amod	38	SENT_98	[p7l1496t1377r1696b1428],

1	Other	JJ	O	other	amod	2	SENT_99	[p7l1686t1472r1859b1525],
2	therapies	NNS	O	therapy	_	0	SENT_99	[p7l1884t1472r2152b1542],

1	(	NN	O	(	nn	2	SENT_100	[p7l1773t1580r1898b1648],
2	n	NN	O	n	_	0	SENT_100	[p7l1773t1580r1898b1648],
3	=	JJ	O	=	dep	2	SENT_100	[p7l1773t1580r1898b1648],
4	756	CD	NUMBER	756	num	5	SENT_100	[p7l1921t1580r2059b1648],
5	)	NN	O	)	dep	2	SENT_100	[p7l1921t1580r2059b1648],

1	51	CD	NUMBER	51	num	2	SENT_101	[p7l1801t1762r1864b1814],
2	i0	NN	O	i0	dep	18	SENT_101	[p7l1893t1762r2050b1822],
3	.4	CD	NUMBER	.4	number	4	SENT_101	[p7l1893t1762r2050b1822],
4	62.6	CD	NUMBER	62.6	dep	2	SENT_101	[p7l1740t1846r2048b1907],
5	/	:	O	/	punct	7	SENT_101	[p7l1740t1846r2048b1907],
6	37.4	CD	NUMBER	37.4	number	7	SENT_101	[p7l1740t1846r2048b1907],
7	27.3	CD	NUMBER	27.3	dep	4	SENT_101	[p7l1739t1933r2050b1994],
8	i0	NN	O	i0	nn	9	SENT_101	[p7l1739t1933r2050b1994],
9	.2	NN	NUMBER	.2	dep	7	SENT_101	[p7l1739t1933r2050b1994],
10	43.1	CD	NUMBER	43.1	dep	7	SENT_101	[p7l1738t2017r2048b2078],
11	/	:	O	/	punct	7	SENT_101	[p7l1738t2017r2048b2078],
12	56.9	CD	NUMBER	56.9	number	13	SENT_101	[p7l1738t2017r2048b2078],
13	6.73	CD	NUMBER	6.73	num	14	SENT_101	[p7l1740t2104r2089b2164],
14	i0	NN	O	i0	dep	4	SENT_101	[p7l1740t2104r2089b2164],
15	.25	CD	NUMBER	.25	num	16	SENT_101	[p7l1740t2104r2089b2164],
16	146i	NNS	O	146us	dep	18	SENT_101	[p7l1763t2189r1938b2249],
17	0.7	CD	NUMBER	0.7	num	18	SENT_101	[p7l1954t2189r2051b2241],
18	92	CD	NUMBER	92	dep	31	SENT_101	[p7l1801t2274r1876b2326],
19	$	$	MONEY	$	dep	18	SENT_101	[p7l1893t2274r2050b2334],
20	0.4	CD	MONEY	0.4	num	19	SENT_101	[p7l1893t2274r2050b2334],
21	75	CD	MONEY	75	num	19	SENT_101	[p7l1805t2359r1875b2411],
22	$	$	PERCENT	$	amod	19	SENT_101	[p7l1893t2359r2050b2419],
23	0.4	CD	PERCENT	0.4	number	22	SENT_101	[p7l1893t2359r2050b2419],
24	7.5	CD	PERCENT	7.5	number	25	SENT_101	[p7l1837t2445r1998b2497],
25	%	NN	PERCENT	%	amod	19	SENT_101	[p7l1837t2445r1998b2497],
26	0.4	CD	PERCENT	0.4	number	27	SENT_101	[p7l1834t2531r1998b2583],
27	%	NN	PERCENT	%	amod	19	SENT_101	[p7l1834t2531r1998b2583],
28	0.8	CD	PERCENT	0.8	number	29	SENT_101	[p7l1834t2616r1998b2669],
29	%	NN	PERCENT	%	amod	19	SENT_101	[p7l1834t2616r1998b2669],
30	21.5	CD	PERCENT	21.5	num	31	SENT_101	[p7l1813t2702r2018b2755],
31	%	NN	PERCENT	%	_	0	SENT_101	[p7l1813t2702r2018b2755],

1	*	NN	O	*	nn	2	SENT_102	[p7l10t3236r121b3258],
2	P	NN	O	p	nsubj	15	SENT_102	[p7l10t3236r121b3258],
3	<	JJR	O	<	dep	2	SENT_102	[p7l10t3236r121b3258],
4	0.05	CD	NUMBER	0.05	dep	2	SENT_102	[p7l10t3236r121b3258],
5	vs	CC	O	vs	_	0	SENT_102	[p7l135t3242r158b3258],
6	other	JJ	O	other	amod	7	SENT_102	[p7l168t3236r236b3258],
7	therapies	NNS	O	therapy	dep	2	SENT_102	[p7l246t3236r368b3265],
8	,	,	O	,	_	0	SENT_102	[p7l246t3236r368b3265],
9	12	CD	NUMBER	12	num	10	SENT_102	[p7l381t3233r406b3264],
10	test	NN	O	test	appos	7	SENT_102	[p7l417t3238r469b3263],
11	;	:	O	;	_	0	SENT_102	[p7l417t3238r469b3263],
12	35	CD	PERCENT	35	number	13	SENT_102	[p7l484t3236r540b3258],
13	%	NN	PERCENT	%	amod	14	SENT_102	[p7l484t3236r540b3258],
14	patients	NNS	O	patient	dep	7	SENT_102	[p7l553t3236r652b3265],
15	were	VBD	O	be	ccomp	29	SENT_102	[p7l663t3242r724b3258],
16	in	IN	O	in	_	0	SENT_102	[p7l737t3236r757b3258],
17	monotherapy	NN	O	monotherapy	prep_in	15	SENT_102	[p7l770t3236r943b3265],
18	with	IN	O	with	_	0	SENT_102	[p7l953t3236r1008b3258],
19	[	NN	O	[	nn	20	SENT_102	[p7l1022t3236r1156b3264],
20	5-blockers	NNS	O	5-blocker	prep_with	17	SENT_102	[p7l1022t3236r1156b3264],
21	,	,	O	,	_	0	SENT_102	[p7l1022t3236r1156b3264],
22	47	CD	PERCENT	47	num	23	SENT_102	[p7l1169t3236r1227b3258],
23	%	NN	PERCENT	%	nsubj	29	SENT_102	[p7l1169t3236r1227b3258],
24	of	IN	O	of	_	0	SENT_102	[p7l1239t3236r1264b3258],
25	patients	NNS	O	patient	prep_of	23	SENT_102	[p7l1275t3236r1374b3265],
26	in	IN	O	in	_	0	SENT_102	[p7l1386t3236r1407b3258],
27	other	JJ	O	other	amod	28	SENT_102	[p7l1419t3236r1487b3258],
28	therapies	NNS	O	therapy	prep_in	25	SENT_102	[p7l1497t3236r1612b3265],
29	were	VBD	O	be	_	0	SENT_102	[p7l1623t3242r1684b3258],
30	in	IN	O	in	_	0	SENT_102	[p7l1697t3236r1717b3258],
31	monotherapy	NN	O	monotherapy	prep_in	29	SENT_102	[p7l1730t3236r1909b3265],
32	.	.	O	.	_	0	SENT_102	[p7l1730t3236r1909b3265],

1	The	DT	O	the	det	3	SENT_103	[p7l9t3365r56b3387],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_103	[p7l68t3365r318b3394],
3	journal	NN	O	journal	nsubj	10	SENT_103	[p7l329t3365r416b3392],
4	both	CC	O	both	prep	3	SENT_103	[p7l7t3548r174b3606],
5	alone	RB	O	alone	dep	8	SENT_103	[p7l214t3548r405b3606],
6	and	CC	O	and	_	0	SENT_103	[p7l447t3548r578b3606],
7	in	IN	O	in	conj_and	5	SENT_103	[p7l618t3551r688b3605],
8	combination	NN	O	combination	dep	4	SENT_103	[p7l728t3548r1185b3606],
9	was	VBD	O	be	cop	10	SENT_103	[p7l1223t3565r1351b3606],
10	dependent	JJ	O	dependent	_	0	SENT_103	[p7l1392t3548r1771b3624],
11	upon	IN	O	upon	_	0	SENT_103	[p7l1809t3565r1996b3624],
12	the	DT	O	the	det	13	SENT_103	[p7l2035t3548r2148b3606],
13	presence	NN	O	presence	prep_upon	10	SENT_103	[p7l8t3660r313b3719],
14	of	IN	O	of	_	0	SENT_103	[p7l367t3643r439b3701],
15	1	CD	NUMBER	1	number	16	SENT_103	[p7l493t3645r522b3700],
16	(	CD	NUMBER	(	prep_of	13	SENT_103	[p7l583t3643r787b3715],
17	Wald	NNP	PERSON	Wald	dep	16	SENT_103	[p7l583t3643r787b3715],
18	4.101	CD	NUMBER	4.101	num	17	SENT_103	[p7l840t3644r1051b3712],
19	;	:	O	;	_	0	SENT_103	[p7l840t3644r1051b3712],
20	P	NN	O	p	dep	16	SENT_103	[p7l1105t3644r1395b3713],
21	<	JJR	O	<	dep	20	SENT_103	[p7l1105t3644r1395b3713],
22	0.05	CD	NUMBER	0.05	dep	20	SENT_103	[p7l1105t3644r1395b3713],
23	,	,	O	,	_	0	SENT_103	[p7l1105t3644r1395b3713],
24	RR	NN	O	rr	appos	22	SENT_103	[p7l1453t3645r1564b3700],
25	:	:	O	:	_	0	SENT_103	[p7l1453t3645r1564b3700],
26	1.581	CD	NUMBER	1.581	dep	16	SENT_103	[p7l1626t3644r1831b3713],
27	,	,	O	,	_	0	SENT_103	[p7l1626t3644r1831b3713],
28	95	CD	PERCENT	95	number	29	SENT_103	[p7l1890t3644r2145b3701],
29	%	NN	PERCENT	%	amod	30	SENT_103	[p7l1890t3644r2145b3701],
30	CI	NN	O	ci	appos	26	SENT_103	[p7l1890t3644r2145b3701],
31	:	:	O	:	_	0	SENT_103	[p7l1890t3644r2145b3701],
32	1.015	CD	NUMBER	1.015	number	33	SENT_103	[p7l14t3737r483b3808],
33	—	CD	NUMBER	—	dep	16	SENT_103	[p7l14t3737r483b3808],
34	2.464	CD	NUMBER	2.464	num	35	SENT_103	[p7l14t3737r483b3808],
35	)	NN	O	)	dep	33	SENT_103	[p7l14t3737r483b3808],
36	,	,	O	,	_	0	SENT_103	[p7l14t3737r483b3808],
37	or	CC	O	or	_	0	SENT_103	[p7l516t3753r588b3794],
38	2	CD	NUMBER	2	number	39	SENT_103	[p7l615t3738r654b3793],
39	(	CD	NUMBER	(	conj_or	16	SENT_103	[p7l685t3736r907b3809],
40	Wald	NNP	PERSON	Wald	dep	39	SENT_103	[p7l685t3736r907b3809],
41	:	:	O	:	_	0	SENT_103	[p7l685t3736r907b3809],
42	6.906	CD	NUMBER	6.906	conj_or	16	SENT_103	[p7l941t3738r1150b3807],
43	,	,	O	,	_	0	SENT_103	[p7l941t3738r1150b3807],
44	P	NN	O	p	dep	45	SENT_103	[p7l1180t3738r1469b3807],
45	<	JJR	O	<	appos	42	SENT_103	[p7l1180t3738r1469b3807],
46	0.01	CD	NUMBER	0.01	dep	45	SENT_103	[p7l1180t3738r1469b3807],
47	,	,	O	,	_	0	SENT_103	[p7l1180t3738r1469b3807],
48	RR	NN	O	rr	conj_or	16	SENT_103	[p7l1503t3739r1614b3794],
49	:	:	O	:	_	0	SENT_103	[p7l1503t3739r1614b3794],
50	2.358	CD	NUMBER	2.358	conj_or	16	SENT_103	[p7l1647t3738r1857b3807],
51	,	,	O	,	_	0	SENT_103	[p7l1647t3738r1857b3807],
52	95	CD	PERCENT	95	number	53	SENT_103	[p7l1890t3738r2145b3794],
53	%	NN	PERCENT	%	amod	54	SENT_103	[p7l1890t3738r2145b3794],
54	CI	NN	O	ci	conj_or	16	SENT_103	[p7l1890t3738r2145b3794],
55	:	:	O	:	_	0	SENT_103	[p7l1890t3738r2145b3794],

1	1.244	CD	NUMBER	1.244	_	0	SENT_104	[p8l14t19r461b90],
2	—	CD	NUMBER	—	number	3	SENT_104	[p8l14t19r461b90],
3	2.358	CD	NUMBER	2.358	num	5	SENT_104	[p8l14t19r461b90],
4	)	NN	O	)	nn	5	SENT_104	[p8l14t19r461b90],
5	alleles	NNS	O	allele	dep	1	SENT_104	[p8l505t18r718b76],
6	of	IN	O	of	_	0	SENT_104	[p8l759t18r831b76],
7	the	DT	O	the	det	10	SENT_104	[p8l866t18r978b76],
8	[	CD	NUMBER	[	num	10	SENT_104	[p8l1022t18r1409b91],
9	32AR27Glu	NN	O	32ar27glu	nn	10	SENT_104	[p8l1022t18r1409b91],
10	variant	NN	O	variant	prep_of	5	SENT_104	[p8l1447t21r1716b76],
11	.	.	O	.	_	0	SENT_104	[p8l1447t21r1716b76],

1	The	DT	O	the	det	2	SENT_105	[p8l1757t18r1890b76],
2	occurrence	NN	O	occurrence	nsubjpass	7	SENT_105	[p8l1930t35r2147b76, p8l9t131r198b171],
3	of	IN	O	of	_	0	SENT_105	[p8l229t114r300b171],
4	low	JJ	O	low	amod	5	SENT_105	[p8l327t114r455b171],
5	HDL	NN	O	hdl	prep_of	2	SENT_105	[p8l484t116r646b170],
6	was	VBD	O	be	auxpass	7	SENT_105	[p8l672t131r800b171],
7	observed	VBN	O	observe	_	0	SENT_105	[p8l832t114r1145b171],
8	in	IN	O	in	_	0	SENT_105	[p8l1174t117r1245b170],
9	the	DT	O	the	det	11	SENT_105	[p8l1275t114r1388b171],
10	27.8	CD	PERCENT	27.8	num	11	SENT_105	[p8l1419t116r1638b171],
11	%	NN	PERCENT	%	prep_in	7	SENT_105	[p8l1419t116r1638b171],
12	of	IN	O	of	_	0	SENT_105	[p8l1669t114r1740b171],
13	the	DT	O	the	det	15	SENT_105	[p8l1766t114r1879b171],
14	overall	JJ	O	overall	amod	15	SENT_105	[p8l1910t114r2148b171],
15	population	NN	O	population	prep_of	11	SENT_105	[p8l8t209r419b284],
16	.	.	O	.	_	0	SENT_105	[p8l8t209r419b284],

1	Although	IN	O	although	mark	4	SENT_106	[p8l447t209r783b284],
2	not	RB	O	not	neg	4	SENT_106	[p8l808t216r929b266],
3	statistically	RB	O	statistically	advmod	4	SENT_106	[p8l955t209r1354b284],
4	significant	JJ	O	significant	advcl	13	SENT_106	[p8l1378t208r1766b284],
5	,	,	O	,	_	0	SENT_106	[p8l1378t208r1766b284],
6	the	DT	O	the	det	8	SENT_106	[p8l1795t209r1907b266],
7	Glu27	NN	O	glu27	nn	8	SENT_106	[p8l1935t209r2147b266],
8	variant	NN	O	variant	nsubj	13	SENT_106	[p8l6t307r258b362],
9	of	IN	O	of	_	0	SENT_106	[p8l281t304r352b362],
10	the	DT	O	the	det	12	SENT_106	[p8l371t304r483b362],
11	BZAR	NN	ORGANIZATION	bzar	nn	12	SENT_106	[p8l511t306r681b377],
12	gene	NN	O	gene	prep_of	8	SENT_106	[p8l702t321r865b380],
13	associated	VBN	O	associate	_	0	SENT_106	[p8l890t304r1246b362],
14	with	IN	O	with	_	0	SENT_106	[p8l1267t304r1428b362],
15	larger	JJR	O	larger	amod	16	SENT_106	[p8l1451t304r1649b380],
16	occurrence	NN	O	occurrence	prep_with	13	SENT_106	[p8l1672t321r2057b362],
17	of	IN	O	of	_	0	SENT_106	[p8l2081t304r2153b362],
18	low	JJ	O	low	advmod	19	SENT_106	[p8l9t398r137b456],
19	HDL	NN	O	hdl	prep_of	16	SENT_106	[p8l157t401r319b455],
20	(	CD	NUMBER	(	num	21	SENT_106	[p8l343t398r679b470],
21	Gln/Gln	NN	O	gln/gln	dep	19	SENT_106	[p8l343t398r679b470],
22	:	:	O	:	_	0	SENT_106	[p8l343t398r679b470],
23	26.4	CD	PERCENT	26.4	num	24	SENT_106	[p8l707t400r944b468],
24	%	NN	PERCENT	%	dep	19	SENT_106	[p8l707t400r944b468],
25	;	:	O	;	_	0	SENT_106	[p8l707t400r944b468],
26	Gln/Glu	NNP	O	Gln/Glu	dep	19	SENT_106	[p8l971t398r1280b463],
27	:	:	O	:	_	0	SENT_106	[p8l971t398r1280b463],
28	28.2	CD	PERCENT	28.2	num	29	SENT_106	[p8l1306t400r1543b468],
29	%	NN	PERCENT	%	dep	19	SENT_106	[p8l1306t400r1543b468],
30	;	:	O	;	_	0	SENT_106	[p8l1306t400r1543b468],
31	Glu/Glu	NN	PERCENT	glu/glu	dep	19	SENT_106	[p8l1571t398r1858b463],
32	33.9	CD	PERCENT	33.9	num	33	SENT_106	[p8l1881t398r2144b470],
33	%	NN	PERCENT	%	dep	31	SENT_106	[p8l1881t398r2144b470],
34	)	CD	NUMBER	)	dobj	13	SENT_106	[p8l1881t398r2144b470],
35	,	,	O	,	_	0	SENT_106	[p8l1881t398r2144b470],
36	although	IN	O	although	mark	39	SENT_106	[p8l9t494r331b569],
37	the	DT	O	the	det	38	SENT_106	[p8l373t494r486b551],
38	analysis	NN	O	analysis	nsubj	39	SENT_106	[p8l529t494r805b569],
39	fell	VBD	O	fall	dep	34	SENT_106	[p8l848t493r956b551],
40	short	RB	O	short	advmod	39	SENT_106	[p8l1000t494r1180b551],
41	of	IN	O	of	_	0	SENT_106	[p8l1223t493r1295b551],
42	statistical	JJ	O	statistical	amod	43	SENT_106	[p8l1334t494r1664b551],
43	significance	NN	O	significance	prep_of	39	SENT_106	[p8l1708t493r2144b569],
44	.	.	O	.	_	0	SENT_106	[p8l1708t493r2144b569],

1	This	DT	O	this	det	2	SENT_107	[p8l7t589r156b647],
2	variant	NN	O	variant	nsubj	9	SENT_107	[p8l177t592r428b647],
3	of	IN	O	of	_	0	SENT_107	[p8l450t589r522b647],
4	the	DT	O	the	det	6	SENT_107	[p8l540t589r652b647],
5	BZAR	NN	ORGANIZATION	bzar	nn	6	SENT_107	[p8l679t591r849b662],
6	gene	NN	O	gene	prep_of	2	SENT_107	[p8l870t606r1033b665],
7	does	VBZ	O	do	aux	9	SENT_107	[p8l1056t589r1212b647],
8	not	RB	O	not	neg	9	SENT_107	[p8l1235t596r1356b647],
9	seem	VB	O	seem	_	0	SENT_107	[p8l1379t606r1554b647],
10	to	TO	O	to	aux	11	SENT_107	[p8l1576t596r1645b647],
11	interfere	VB	O	interfere	xcomp	9	SENT_107	[p8l1668t589r1966b647],
12	with	IN	O	with	_	0	SENT_107	[p8l1987t589r2148b647],
13	glucose	NN	O	glucose	nn	14	SENT_107	[p8l9t683r268b759],
14	homeostasis	NN	O	homeostasis	prep_with	11	SENT_107	[p8l293t683r743b754],
15	,	,	O	,	_	0	SENT_107	[p8l293t683r743b754],
16	since	IN	O	since	mark	25	SENT_107	[p8l772t686r947b741],
17	the	DT	O	the	det	18	SENT_107	[p8l970t684r1083b741],
18	incidence	NN	O	incidence	nsubj	25	SENT_107	[p8l1107t683r1448b741],
19	of	IN	O	of	_	0	SENT_107	[p8l1473t683r1544b741],
20	diabetes	NN	O	diabetes	prep_of	18	SENT_107	[p8l1564t683r1849b741],
21	in	IN	O	in	_	0	SENT_107	[p8l1873t686r1943b740],
22	these	DT	O	these	det	23	SENT_107	[p8l1966t683r2148b741],
23	patients	NNS	O	patient	prep_in	20	SENT_107	[p8l8t782r290b855],
24	was	VBD	O	be	cop	25	SENT_107	[p8l324t796r452b837],
25	similar	JJ	O	similar	advcl	11	SENT_107	[p8l489t779r729b837],
26	to	TO	O	to	_	0	SENT_107	[p8l762t786r832b837],
27	that	DT	O	that	prep_to	25	SENT_107	[p8l868t779r1011b837],
28	of	IN	O	of	_	0	SENT_107	[p8l1046t779r1117b837],
29	the	DT	O	the	det	31	SENT_107	[p8l1148t779r1260b837],
30	general	JJ	O	general	amod	31	SENT_107	[p8l1297t779r1553b855],
31	population	NN	O	population	nn	41	SENT_107	[p8l1587t779r1980b855],
32	(	CD	NUMBER	(	number	33	SENT_107	[p8l2019t779r2145b851],
33	4.5	CD	NUMBER	4.5	amod	41	SENT_107	[p8l2019t779r2145b851],
34	and	CC	O	and	_	0	SENT_107	[p8l9t873r141b931],
35	4.1	CD	PERCENT	4.1	number	36	SENT_107	[p8l164t875r356b944],
36	%	NN	PERCENT	%	amod	41	SENT_107	[p8l164t875r356b944],
37	,	,	O	,	_	0	SENT_107	[p8l164t875r356b944],
38	respectively	RB	O	respectively	dep	36	SENT_107	[p8l384t873r812b949],
39	,	,	O	,	_	0	SENT_107	[p8l384t873r812b949],
40	NS	NN	O	n	nn	41	SENT_107	[p8l838t874r980b945],
41	)	NN	O	)	prep_of	27	SENT_107	[p8l838t874r980b945],
42	.	.	O	.	_	0	SENT_107	[p8l838t874r980b945],

1	Other	JJ	O	other	amod	2	SENT_108	[p8l1009t873r1214b931],
2	variants	NNS	O	variant	nsubj	17	SENT_108	[p8l1234t876r1516b931],
3	of	IN	O	of	_	0	SENT_108	[p8l1540t873r1611b931],
4	the	DT	O	the	det	6	SENT_108	[p8l1630t873r1742b931],
5	BZAR	NN	ORGANIZATION	bzar	nn	6	SENT_108	[p8l1771t875r1941b946],
6	gene	NN	O	gene	prep_of	2	SENT_108	[p8l1962t890r2144b949],
7	,	,	O	,	_	0	SENT_108	[p8l1962t890r2144b949],
8	namely	RB	O	namely	advmod	2	SENT_108	[p8l9t968r274b1044],
9	the	DT	O	the	det	10	SENT_108	[p8l298t968r410b1026],
10	Arg16	NN	O	arg16	dep	2	SENT_108	[p8l436t970r644b1044],
11	and	CC	O	and	_	0	SENT_108	[p8l673t968r804b1026],
12	the	DT	O	the	det	13	SENT_108	[p8l830t968r943b1026],
13	lle164	NN	O	lle164	dep	2	SENT_108	[p8l971t968r1205b1039],
14	,	,	O	,	_	0	SENT_108	[p8l971t968r1205b1039],
15	did	VBD	O	do	aux	17	SENT_108	[p8l1237t968r1350b1026],
16	not	RB	O	not	neg	17	SENT_108	[p8l1376t976r1497b1026],
17	interfere	VB	O	interfere	_	0	SENT_108	[p8l1523t968r1821b1026],
18	with	IN	O	with	mark	29	SENT_108	[p8l1847t968r2009b1026],
19	the	DT	O	the	det	25	SENT_108	[p8l2035t968r2148b1026],
20	lipid	NN	O	lipid	nn	25	SENT_108	[p8l9t1064r186b1140],
21	,	,	O	,	_	0	SENT_108	[p8l9t1064r186b1140],
22	HDL	NN	O	hdl	nn	25	SENT_108	[p8l216t1066r378b1121],
23	and	CC	O	and	_	0	SENT_108	[p8l401t1064r532b1122],
24	glucose	NN	O	glucose	conj_and	20	SENT_108	[p8l556t1064r816b1140],
25	profile	NN	O	profile	nsubj	29	SENT_108	[p8l840t1064r1069b1140],
26	of	IN	O	of	_	0	SENT_108	[p8l1095t1064r1167b1122],
27	hypertensive	JJ	O	hypertensive	amod	28	SENT_108	[p8l1186t1064r1641b1140],
28	patients	NNS	O	patient	prep_of	25	SENT_108	[p8l1665t1067r1947b1140],
29	(	VBP	O	(	advcl	17	SENT_108	[p8l1976t1064r2149b1136],
30	data	NNS	O	datum	dobj	29	SENT_108	[p8l1976t1064r2149b1136],
31	not	RB	O	not	neg	32	SENT_108	[p8l9t1165r129b1215],
32	shown	VBN	O	show	rcmod	30	SENT_108	[p8l160t1158r437b1230],
33	)	NN	O	)	dobj	32	SENT_108	[p8l160t1158r437b1230],
34	.	.	O	.	_	0	SENT_108	[p8l160t1158r437b1230],

1	The	DT	O	the	det	2	SENT_109	[p8l83t1254r216b1312],
2	impact	NN	O	impact	nsubj	17	SENT_109	[p8l253t1257r497b1330],
3	of	IN	O	of	_	0	SENT_109	[p8l533t1254r605b1312],
4	the	DT	O	the	det	8	SENT_109	[p8l636t1254r748b1312],
5	[	CD	NUMBER	[	num	6	SENT_109	[p8l790t1256r960b1327],
6	33AR	NN	O	33ar	npadvmod	7	SENT_109	[p8l790t1256r960b1327],
7	variant	JJ	O	variant	amod	8	SENT_109	[p8l992t1257r1243b1312],
8	Arg64	NN	O	arg64	prep_of	2	SENT_109	[p8l1277t1256r1485b1330],
9	on	IN	O	on	_	0	SENT_109	[p8l1522t1271r1614b1312],
10	the	DT	O	the	det	12	SENT_109	[p8l1650t1254r1762b1312],
11	metabolic	JJ	O	metabolic	amod	12	SENT_109	[p8l1798t1254r2149b1312],
12	profile	NN	O	profile	prep_on	8	SENT_109	[p8l8t1350r237b1426],
13	of	IN	O	of	_	0	SENT_109	[p8l270t1350r341b1408],
14	hypertensive	JJ	O	hypertensive	amod	15	SENT_109	[p8l368t1350r822b1426],
15	patients	NNS	O	patient	prep_of	12	SENT_109	[p8l853t1353r1135b1426],
16	also	RB	O	also	advmod	17	SENT_109	[p8l1168t1350r1301b1408],
17	appears	VBZ	O	appear	_	0	SENT_109	[p8l1334t1367r1598b1426],
18	to	TO	O	to	aux	20	SENT_109	[p8l1629t1357r1699b1408],
19	be	VB	O	be	cop	20	SENT_109	[p8l1728t1350r1808b1408],
20	relevant	JJ	O	relevant	xcomp	17	SENT_109	[p8l1840t1350r2144b1420],
21	,	,	O	,	_	0	SENT_109	[p8l1840t1350r2144b1420],
22	since	IN	O	since	mark	34	SENT_109	[p8l10t1448r185b1503],
23	the	DT	O	the	det	24	SENT_109	[p8l224t1445r337b1503],
24	incidence	NN	O	incidence	nsubj	34	SENT_109	[p8l377t1445r718b1503],
25	of	IN	O	of	_	0	SENT_109	[p8l759t1445r831b1503],
26	dyslipidemia	NN	O	dyslipidemia	prep_of	24	SENT_109	[p8l866t1445r1320b1521],
27	among	IN	O	among	_	0	SENT_109	[p8l1359t1462r1605b1521],
28	the	DT	O	the	det	29	SENT_109	[p8l1643t1445r1755b1503],
29	bearers	NNS	O	bearer	prep_among	26	SENT_109	[p8l1793t1445r2041b1503],
30	of	IN	O	of	_	0	SENT_109	[p8l2081t1445r2153b1503],
31	this	DT	O	this	det	32	SENT_109	[p8l8t1540r138b1598],
32	polymorphism	NN	O	polymorphism	prep_of	29	SENT_109	[p8l179t1540r705b1616],
33	was	VBD	O	be	cop	34	SENT_109	[p8l744t1557r872b1598],
34	55.1	CD	NUMBER	55.1	advcl	20	SENT_109	[p8l916t1542r1059b1598],
35	vs	CC	O	vs	_	0	SENT_109	[p8l1104t1557r1168b1598],
36	37.3	CD	PERCENT	37.3	num	37	SENT_109	[p8l1211t1542r1429b1598],
37	%	NN	PERCENT	%	conj_vs	34	SENT_109	[p8l1211t1542r1429b1598],
38	among	IN	O	among	_	0	SENT_109	[p8l1470t1557r1716b1616],
39	the	DT	O	the	det	41	SENT_109	[p8l1756t1540r1868b1598],
40	overall	JJ	O	overall	amod	41	SENT_109	[p8l1911t1540r2148b1598],
41	population	NN	O	population	prep_among	37	SENT_109	[p8l8t1634r401b1710],
42	(	CD	NUMBER	(	num	43	SENT_109	[p8l431t1635r558b1707],
43	P	NN	O	p	npadvmod	44	SENT_109	[p8l431t1635r558b1707],
44	<	JJR	O	<	dep	58	SENT_109	[p8l431t1635r558b1707],
45	0.05	CD	NUMBER	0.05	num	46	SENT_109	[p8l573t1635r768b1706],
46	)	NN	O	)	nsubj	58	SENT_109	[p8l573t1635r768b1706],
47	,	,	O	,	_	0	SENT_109	[p8l573t1635r768b1706],
48	again	RB	O	again	dep	46	SENT_109	[p8l800t1637r989b1710],
49	due	JJ	O	due	_	0	SENT_109	[p8l1016t1634r1142b1692],
50	to	TO	O	to	_	0	SENT_109	[p8l1169t1642r1239b1692],
51	the	DT	O	the	det	53	SENT_109	[p8l1265t1634r1378b1692],
52	increased	VBN	O	increase	amod	53	SENT_109	[p8l1406t1634r1736b1692],
53	occurrence	NN	O	occurrence	prep_due_to	46	SENT_109	[p8l1762t1651r2147b1692],
54	of	IN	O	of	_	0	SENT_109	[p8l9t1730r81b1788],
55	elevated	JJ	O	elevated	amod	57	SENT_109	[p8l121t1730r412b1788],
56	serum	NN	O	serum	nn	57	SENT_109	[p8l456t1747r669b1788],
57	triglycerides	NNS	O	triglyceride	prep_of	53	SENT_109	[p8l712t1730r1143b1806],
58	(	VBP	O	(	dep	34	SENT_109	[p8l1190t1730r1397b1802],
59	Table	NNP	O	Table	nsubj	61	SENT_109	[p8l1190t1730r1397b1802],
60	3	CD	NUMBER	3	num	61	SENT_109	[p8l1443t1730r1526b1802],
61	)	NN	O	)	xcomp	58	SENT_109	[p8l1443t1730r1526b1802],
62	.	.	O	.	_	0	SENT_109	[p8l1443t1730r1526b1802],

1	No	DT	O	no	det	2	SENT_110	[p8l1573t1732r1676b1788],
2	effects	NNS	O	effect	nsubjpass	4	SENT_110	[p8l1720t1730r1941b1788],
3	were	VBD	O	be	auxpass	4	SENT_110	[p8l1984t1747r2148b1788],
4	detected	VBN	O	detect	_	0	SENT_110	[p8l9t1824r307b1882],
5	of	IN	O	of	_	0	SENT_110	[p8l349t1824r421b1882],
6	this	DT	O	this	det	7	SENT_110	[p8l458t1824r587b1882],
7	polymorphism	NN	O	polymorphism	prep_of	4	SENT_110	[p8l629t1824r1155b1900],
8	on	IN	O	on	_	0	SENT_110	[p8l1198t1841r1289b1882],
9	the	DT	O	the	det	10	SENT_110	[p8l1330t1824r1442b1882],
10	occurrence	NN	O	occurrence	prep_on	7	SENT_110	[p8l1486t1841r1870b1882],
11	of	IN	O	of	_	0	SENT_110	[p8l1914t1824r1986b1882],
12	low	JJ	O	low	amod	15	SENT_110	[p8l2023t1824r2151b1882],
13	HDL	NN	O	hdl	nn	15	SENT_110	[p8l9t1922r171b1976],
14	(	CD	NUMBER	(	num	15	SENT_110	[p8l206t1919r515b1995],
15	Trp/Arg	NN	O	trp/arg	prep_of	10	SENT_110	[p8l206t1919r515b1995],
16	:	:	O	:	_	0	SENT_110	[p8l206t1919r515b1995],
17	25.0	CD	PERCENT	25.0	num	18	SENT_110	[p8l553t1920r817b1991],
18	%	NN	PERCENT	%	dep	10	SENT_110	[p8l553t1920r817b1991],
19	)	CD	NUMBER	)	dep	18	SENT_110	[p8l553t1920r817b1991],
20	.	.	O	.	_	0	SENT_110	[p8l553t1920r817b1991],

1	Regardless	RB	O	regardless	_	0	SENT_111	[p8l855t1919r1217b1995],
2	of	IN	O	of	_	0	SENT_111	[p8l1251t1919r1323b1977],
3	the	DT	O	the	det	5	SENT_111	[p8l1350t1919r1463b1977],
4	drug	NN	O	drug	nn	5	SENT_111	[p8l1498t1919r1659b1995],
5	regimen	NN	O	regimen	prep_regardless_of	17	SENT_111	[p8l1690t1922r1998b1995],
6	,	,	O	,	_	0	SENT_111	[p8l1690t1922r1998b1995],
7	the	DT	O	the	det	8	SENT_111	[p8l2035t1919r2148b1977],
8	incidence	NN	O	incidence	nsubj	17	SENT_111	[p8l9t2015r350b2073],
9	of	IN	O	of	_	0	SENT_111	[p8l383t2015r455b2073],
10	diabetes	NN	O	diabetes	prep_of	8	SENT_111	[p8l483t2015r768b2073],
11	among	IN	O	among	_	0	SENT_111	[p8l801t2032r1046b2091],
12	the	DT	O	the	det	13	SENT_111	[p8l1077t2015r1189b2073],
13	hypertensives	NNS	O	hypertensive	prep_among	10	SENT_111	[p8l1222t2015r1708b2091],
14	bearing	VBG	O	bear	partmod	13	SENT_111	[p8l1739t2015r2005b2091],
15	the	DT	O	the	det	16	SENT_111	[p8l2035t2015r2148b2073],
16	Arg64	NN	O	arg64	dobj	14	SENT_111	[p8l7t2111r215b2185],
17	doubled	VBD	O	double	_	0	SENT_111	[p8l250t2110r537b2167],
18	that	IN	O	that	complm	19	SENT_111	[p8l571t2110r714b2167],
19	recorded	VBN	O	record	ccomp	17	SENT_111	[p8l748t2110r1055b2167],
20	among	IN	O	among	_	0	SENT_111	[p8l1089t2126r1334b2185],
21	the	DT	O	the	det	23	SENT_111	[p8l1367t2110r1479b2167],
22	wild-type	JJ	O	wild-type	amod	23	SENT_111	[p8l1511t2110r1844b2185],
23	population	NN	O	population	prep_among	19	SENT_111	[p8l1878t2110r2148b2185, p8l8t2208r170b2275],
24	,	,	O	,	_	0	SENT_111	[p8l1878t2110r2148b2185, p8l8t2208r170b2275],
25	although	IN	O	although	mark	31	SENT_111	[p8l209t2205r530b2280],
26	the	DT	O	the	det	28	SENT_111	[p8l562t2205r675b2262],
27	statistical	JJ	O	statistical	amod	28	SENT_111	[p8l710t2205r1040b2262],
28	significance	NN	O	significance	nsubjpass	31	SENT_111	[p8l1074t2204r1491b2280],
29	was	VBD	O	be	auxpass	31	SENT_111	[p8l1523t2221r1651b2262],
30	not	RB	O	not	neg	31	SENT_111	[p8l1684t2212r1805b2262],
31	achieved	VBN	O	achieve	advcl	17	SENT_111	[p8l1838t2205r2149b2262],
32	(	NN	O	(	dobj	31	SENT_111	[p8l12t2300r140b2372],
33	9.8	CD	NUMBER	9.8	num	32	SENT_111	[p8l12t2300r140b2372],
34	vs	CC	O	vs	_	0	SENT_111	[p8l171t2317r235b2358],
35	4.0	CD	PERCENT	4.0	num	36	SENT_111	[p8l265t2302r457b2370],
36	%	NN	PERCENT	%	conj_vs	32	SENT_111	[p8l265t2302r457b2370],
37	,	,	O	,	_	0	SENT_111	[p8l265t2302r457b2370],
38	X22015	NN	O	x22015	nn	39	SENT_111	[p8l492t2293r842b2373],
39	)	NN	O	)	appos	36	SENT_111	[p8l492t2293r842b2373],
40	.	.	O	.	_	0	SENT_111	[p8l492t2293r842b2373],

1	Table	NNP	O	Table	nn	3	SENT_112	[p8l7t2571r196b2628],
2	2	CD	NUMBER	2	num	3	SENT_112	[p8l242t2573r280b2627],
3	Frequencies	NNS	O	frequency	_	0	SENT_112	[p8l361t2573r756b2645],
4	of	IN	O	of	_	0	SENT_112	[p8l801t2573r869b2628],
5	B2	NN	O	b2	prep_of	3	SENT_112	[p8l910t2576r973b2642],
6	and	CC	O	and	_	0	SENT_112	[p8l1016t2573r1137b2628],
7	[	NN	O	[	prep_of	3	SENT_112	[p8l1185t2576r1245b2642],
8	33	CD	NUMBER	33	num	11	SENT_112	[p8l1185t2576r1245b2642],
9	AR	NN	O	ar	nn	11	SENT_112	[p8l1288t2575r1379b2627],
10	gene	NN	O	gene	nn	11	SENT_112	[p8l1422t2589r1586b2645],
11	polymorphisms	NNS	O	polymorphism	dep	3	SENT_112	[p8l1633t2573r2148b2645],
12	among	IN	O	among	_	0	SENT_112	[p8l9t2681r241b2737],
13	hypertensive	JJ	O	hypertensive	amod	14	SENT_112	[p8l274t2665r702b2737],
14	patients	NNS	O	patient	prep_among	11	SENT_112	[p8l734t2666r1002b2737],

1	Wild	NNP	O	Wild	nn	2	SENT_113	[p8l410t2838r540b2893],
2	type	NN	O	type	dep	6	SENT_113	[p8l567t2845r692b2910],
3	(	CD	PERCENT	(	num	4	SENT_113	[p8l717t2839r828b2907],
4	%	NN	PERCENT	%	dep	2	SENT_113	[p8l717t2839r828b2907],
5	)	CD	NUMBER	)	dep	6	SENT_113	[p8l717t2839r828b2907],
6	Heterozygous	JJ	O	heterozygous	dep	12	SENT_113	[p8l951t2841r1358b2910],
7	(	CD	PERCENT	(	num	8	SENT_113	[p8l1385t2839r1496b2907],
8	%	NN	PERCENT	%	dep	6	SENT_113	[p8l1385t2839r1496b2907],
9	)	CD	NUMBER	)	npadvmod	10	SENT_113	[p8l1385t2839r1496b2907],
10	Homozygous	JJ	O	homozygous	amod	8	SENT_113	[p8l1619t2841r2009b2910],
11	(	CD	PERCENT	(	num	12	SENT_113	[p8l2036t2839r2147b2907],
12	%	NN	PERCENT	%	dep	13	SENT_113	[p8l2036t2839r2147b2907],
13	)	CD	NUMBER	)	_	0	SENT_113	[p8l2036t2839r2147b2907],

1	[	NN	O	[	nn	2	SENT_114	[p8l8t3023r242b3090],
2	32AR16	NN	O	32ar16	dep	13	SENT_114	[p8l8t3023r242b3090],
3	17.9	CD	NUMBER	17.9	number	4	SENT_114	[p8l466t3023r603b3076],
4	17.3	CD	NUMBER	17.3	num	6	SENT_114	[p8l642t3023r770b3076],
5	46.4	CD	NUMBER	46.4	number	6	SENT_114	[p8l1067t3023r1211b3076],
6	48.6	CD	NUMBER	48.6	dep	2	SENT_114	[p8l1239t3023r1380b3076],
7	35.7	CD	NUMBER	35.7	number	8	SENT_114	[p8l1729t3023r1869b3076],
8	34.7	CD	NUMBER	34.7	num	9	SENT_114	[p8l1901t3023r2029b3076],
9	[	NN	O	[	dep	6	SENT_114	[p8l8t3111r241b3178],
10	32AR27	NN	O	32ar27	dep	13	SENT_114	[p8l8t3111r241b3178],
11	59.0	CD	NUMBER	59.0	num	10	SENT_114	[p8l461t3111r602b3164],
12	56.3	CD	NUMBER	56.3	num	13	SENT_114	[p8l631t3111r770b3164],
13	32.1	CD	NUMBER	32.1	dep	20	SENT_114	[p8l1070t3111r1198b3164],
14	37.4	CD	NUMBER	37.4	number	15	SENT_114	[p8l1241t3111r1376b3164],
15	8.9	CD	NUMBER	8.9	dep	13	SENT_114	[p8l1767t3111r1868b3164],
16	6.4	CD	NUMBER	6.4	num	18	SENT_114	[p8l1901t3111r1994b3164],
17	[	NN	O	[	nn	18	SENT_114	[p8l8t3219r283b3286],
18	32AR164	NN	O	32ar164	dep	15	SENT_114	[p8l8t3219r283b3286],
19	97.6	CD	NUMBER	97.6	num	20	SENT_114	[p8l461t3219r603b3272],
20	97.6	CD	NUMBER	97.6	dep	31	SENT_114	[p8l636t3219r774b3272],
21	2.4	CD	NUMBER	2.4	number	22	SENT_114	[p8l1110t3219r1211b3272],
22	2.4	CD	NUMBER	2.4	num	26	SENT_114	[p8l1238t3219r1335b3272],
23	O	NN	O	o	nn	26	SENT_114	[p8l1831t3219r1869b3272],
24	o	NN	O	o	nn	26	SENT_114	[p8l1902t3219r1935b3272],
25	[	CD	NUMBER	[	num	26	SENT_114	[p8l8t3327r241b3394],
26	33AR64	NN	O	33ar64	dep	20	SENT_114	[p8l8t3327r241b3394],
27	92.2	CD	NUMBER	92.2	number	28	SENT_114	[p8l461t3327r603b3380],
28	92.4	CD	NUMBER	92.4	num	26	SENT_114	[p8l636t3327r770b3380],
29	7.8	CD	NUMBER	7.8	number	30	SENT_114	[p8l1113t3327r1210b3380],
30	7.5	CD	NUMBER	7.5	amod	26	SENT_114	[p8l1243t3328r1336b3380],
31	O	NN	O	o	_	0	SENT_114	[p8l1831t3327r1869b3380],
32	0.2	CD	NUMBER	0.2	num	31	SENT_114	[p8l1902t3327r1997b3380],

1	The	DT	O	the	det	4	SENT_115	[p9l7t36r103b81],
2	observed	VBN	O	observe	amod	4	SENT_115	[p9l132t36r364b81],
3	allele	NN	O	allele	nn	4	SENT_115	[p9l395t36r524b81],
4	frequencies	NNS	O	frequency	nsubjpass	6	SENT_115	[p9l551t36r849b95],
5	are	VBP	O	be	auxpass	6	SENT_115	[p9l878t49r955b81],
6	depicted	VBN	O	depict	_	0	SENT_115	[p9l984t36r1208b95],
7	in	IN	O	in	_	0	SENT_115	[p9l1241t37r1282b80],
8	bold	JJ	O	bold	prep_in	6	SENT_115	[p9l1315t36r1443b81],
9	.	.	O	.	_	0	SENT_115	[p9l1315t36r1443b81],

1	the	DT	O	the	nsubj	2	SENT_116	[p9l1474t36r1557b81],
2	expected	VBN	O	expect	_	0	SENT_116	[p9l1586t36r1822b95],
3	frequencies	NNS	O	frequency	dobj	2	SENT_116	[p9l1850t36r2148b95],
4	according	VBG	O	accord	_	0	SENT_116	[p9l9t111r264b169],
5	to	TO	O	to	prepc_according_to	2	SENT_116	[p9l286t116r337b155],
6	the	DT	O	the	det	7	SENT_116	[p9l357t111r439b155],
7	Hardy	NNP	PERSON	Hardy	pobj	2	SENT_116	[p9l463t111r898b169],
8	.	.	O	.	_	0	SENT_116	[p9l463t111r898b169],

1	—	NN	O	—	_	0	SENT_117	[p9l463t111r898b169],
2	.	.	O	.	_	0	SENT_117	[p9l463t111r898b169],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_118	[p9l463t111r898b169],
2	equilibrium	NN	O	equilibrium	nsubjpass	14	SENT_118	[p9l921t111r1231b169],
3	,	,	O	,	_	0	SENT_118	[p9l921t111r1231b169],
4	based	VBN	O	base	partmod	2	SENT_118	[p9l1257t111r1403b155],
5	on	IN	O	on	_	0	SENT_118	[p9l1426t124r1489b155],
6	the	DT	O	the	det	7	SENT_118	[p9l1511t111r1593b155],
7	frequency	NN	O	frequency	prep_on	4	SENT_118	[p9l1612t111r1872b169],
8	of	IN	O	of	_	0	SENT_118	[p9l1892t111r1942b155],
9	the	DT	O	the	det	12	SENT_118	[p9l1959t111r2042b155],
10	less	JJR	O	less	amod	12	SENT_118	[p9l2064t111r2149b155],
11	frequent	JJ	O	frequent	amod	12	SENT_118	[p9l6t185r230b244],
12	allele	NN	O	allele	prep_of	7	SENT_118	[p9l250t185r379b230],
13	are	VBP	O	be	auxpass	14	SENT_118	[p9l401t198r478b230],
14	indicated	VBN	O	indicate	_	0	SENT_118	[p9l502t185r737b230],
15	in	IN	O	in	_	0	SENT_118	[p9l762t186r804b229],
16	italics	NNS	O	italics	prep_in	14	SENT_118	[p9l829t185r983b230],
17	.	.	O	.	_	0	SENT_118	[p9l829t185r983b230],

1	All	DT	O	all	det	2	SENT_119	[p9l1006t185r1067b229],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_119	[p9l1089t185r1386b244],
3	are	VBP	O	be	auxpass	4	SENT_119	[p9l1409t198r1485b230],
4	indicated	VBN	O	indicate	_	0	SENT_119	[p9l1508t185r1743b230],
5	as	IN	O	as	_	0	SENT_119	[p9l1768t198r1817b230],
6	percentage	NN	O	percentage	prep_as	4	SENT_119	[p9l1841t190r2146b244],
7	.	.	O	.	_	0	SENT_119	[p9l1841t190r2146b244],

1	The	DT	O	the	det	2	SENT_120	[p9l7t260r103b305],
2	distribution	NN	O	distribution	nsubj	8	SENT_120	[p9l136t260r431b305],
3	of	IN	O	of	_	0	SENT_120	[p9l467t260r517b305],
4	the	DT	O	the	det	5	SENT_120	[p9l547t260r629b305],
5	alleles	NNS	O	allele	prep_of	2	SENT_120	[p9l663t260r816b305],
6	was	VBD	O	be	cop	8	SENT_120	[p9l847t273r944b305],
7	not	RB	O	not	neg	8	SENT_120	[p9l979t265r1065b305],
8	different	JJ	O	different	_	0	SENT_120	[p9l1097t260r1315b305],
9	than	IN	O	than	_	0	SENT_120	[p9l1346t260r1461b305],
10	that	DT	O	that	prep_than	8	SENT_120	[p9l1496t260r1600b305],
11	predicted	VBN	O	predict	partmod	10	SENT_120	[p9l1633t260r1876b318],
12	from	IN	O	from	_	0	SENT_120	[p9l1910t260r2031b304],
13	the	DT	O	the	det	14	SENT_120	[p9l2066t260r2148b305],
14	Hardy	NNP	PERSON	Hardy	prep_from	11	SENT_120	[p9l11t335r447b394],
15	.	.	O	.	_	0	SENT_120	[p9l11t335r447b394],

1	—	NN	O	—	_	0	SENT_121	[p9l11t335r447b394],
2	.	.	O	.	_	0	SENT_121	[p9l11t335r447b394],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_122	[p9l11t335r447b394],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_122	[p9l473t335r784b394],
3	.	.	O	.	_	0	SENT_122	[p9l473t335r784b394],

1	[	NN	O	[	nn	2	SENT_123	[p9l10t509r266b566],
2	3-blockade	NN	O	3-blockade	_	0	SENT_123	[p9l10t509r266b566],
3	and	CC	O	and	_	0	SENT_123	[p9l285t509r373b554],
4	dyslipidemia	NN	O	dyslipidemia	conj_and	2	SENT_123	[p9l392t509r697b568],
5	@	IN	O	@	dep	6	SENT_123	[p9l2026t497r2152b621],
6	G	NN	O	g	amod	7	SENT_123	[p9l9t582r39b622],
7	Iaccarino	NN	O	iaccarino	dep	2	SENT_123	[p9l61t581r242b622],
8	et	FW	O	et	nn	9	SENT_123	[p9l262t585r298b622],
9	al	FW	O	al	dep	7	SENT_123	[p9l315t580r351b622],

1	Occurrence	NN	O	occurrence	_	0	SENT_124	[p9l11t870r412b926],
2	of	IN	O	of	_	0	SENT_124	[p9l456t868r528b926],
3	Adverse	JJ	O	adverse	amod	5	SENT_124	[p9l564t868r847b926],
4	Metabolic	JJ	O	metabolic	amod	5	SENT_124	[p9l893t868r1245b926],
5	Outcome	NN	O	outcome	prep_of	1	SENT_124	[p9l1287t870r1611b926],
6	to	TO	O	to	dep	1	SENT_124	[p9l1654t875r1725b926],
7	[	CD	NUMBER	[	num	8	SENT_124	[p9l1769t868r2148b942],
8	3-Blockade	NN	O	3-blockade	pobj	6	SENT_124	[p9l1769t868r2148b942],
9	According	VBG	O	accord	_	0	SENT_124	[p9l8t961r367b1037],
10	to	TO	O	to	aux	11	SENT_124	[p9l398t968r470b1019],
11	|	VB	O	|	prepc_according	8	SENT_124	[p9l503t964r634b1035],
12	3AR	NN	O	3ar	nn	13	SENT_124	[p9l503t964r634b1035],
13	Genotype	NN	O	genotype	dobj	11	SENT_124	[p9l664t963r1010b1037],
14	To	TO	O	to	aux	15	SENT_124	[p9l8t1060r92b1115],
15	evaluate	VB	O	evaluate	xcomp	11	SENT_124	[p9l161t1057r452b1115],
16	the	DT	O	the	det	17	SENT_124	[p9l520t1057r633b1115],
17	impact	NN	O	impact	dobj	15	SENT_124	[p9l702t1060r946b1133],
18	of	IN	O	of	_	0	SENT_124	[p9l1013t1057r1085b1115],
19	treatment	NN	O	treatment	prep_of	17	SENT_124	[p9l1148t1064r1498b1115],
20	with	IN	O	with	_	0	SENT_124	[p9l1564t1057r1726b1115],
21	B-blockers	NNS	O	b-blocker	prep_with	15	SENT_124	[p9l1797t1057r2148b1130],
22	(	CD	NUMBER	(	num	23	SENT_124	[p9l13t1153r327b1225],
23	atenolol	NN	O	atenolol	dep	21	SENT_124	[p9l13t1153r327b1225],
24	or	CC	O	or	_	0	SENT_124	[p9l378t1169r449b1210],
25	metoprolol	NN	O	metoprolol	prep_with	15	SENT_124	[p9l497t1153r915b1228],
26	)	CD	NUMBER	)	num	25	SENT_124	[p9l497t1153r915b1228],
27	our	PRP$	O	we	poss	28	SENT_124	[p9l969t1169r1088b1210],
28	population	NN	O	population	dep	25	SENT_124	[p9l1135t1153r1528b1228],
29	of	IN	O	of	_	0	SENT_124	[p9l1578t1152r1649b1210],
30	hypertensive	JJ	O	hypertensive	prep_of	28	SENT_124	[p9l1694t1153r2149b1228],

1	Table	NNP	O	Table	nn	3	SENT_125	[p9l8t1378r197b1435],
2	4	CD	NUMBER	4	num	3	SENT_125	[p9l235t1381r277b1434],
3	Incidence	NN	O	incidence	_	0	SENT_125	[p9l357t1380r672b1435],
4	of	IN	O	of	_	0	SENT_125	[p9l712t1380r780b1435],
5	diabetes	NN	O	diabetes	prep_of	3	SENT_125	[p9l815t1380r1098b1435],
6	among	IN	O	among	_	0	SENT_125	[p9l1137t1396r1368b1452],
7	hypertensive	JJ	O	hypertensive	amod	8	SENT_125	[p9l1411t1380r1840b1452],
8	patients	NNS	O	patient	prep_among	3	SENT_125	[p9l1881t1380r2148b1452],
9	according	VBG	O	accord	_	0	SENT_125	[p9l10t1454r337b1526],
10	to	TO	O	to	prepc_according_to	3	SENT_125	[p9l368t1460r436b1509],
11	[	CD	NUMBER	[	num	12	SENT_125	[p9l466t1457r529b1523],
12	52	CD	NUMBER	52	pobj	3	SENT_125	[p9l466t1457r529b1523],
13	and	CC	O	and	_	0	SENT_125	[p9l557t1454r678b1509],
14	B3	NN	O	b3	nn	16	SENT_125	[p9l710t1457r771b1523],
15	AR	NNS	O	ar	nn	16	SENT_125	[p9l798t1456r889b1508],
16	genotype	NN	O	genotype	pobj	3	SENT_125	[p9l917t1460r1235b1526],

1	Wild	NNP	O	Wild	_	0	SENT_126	[p9l783t1627r913b1682],
2	type	NN	O	type	dep	1	SENT_126	[p9l940t1634r1065b1699],
3	Heterozygous	NNP	O	Heterozygous	nn	4	SENT_126	[p9l1194t1630r1601b1699],
4	Homozygous	NNP	O	Homozygous	dep	1	SENT_126	[p9l1730t1630r2119b1699],

1	BZAR	NN	O	bzar	nn	3	SENT_127	[p9l13t1899r162b1966],
2	G	NN	O	g	nn	3	SENT_127	[p9l190t1897r490b1952],
3	|	NNS	O	|	dep	14	SENT_127	[p9l190t1897r490b1952],
4	u27G	NN	O	u27g	nn	6	SENT_127	[p9l190t1897r490b1952],
5	|	NN	O	|	nn	6	SENT_127	[p9l190t1897r490b1952],
6	n	NN	O	n	dep	3	SENT_127	[p9l190t1897r490b1952],
7	with	IN	O	with	_	0	SENT_127	[p9l519t1897r655b1952],
8	5.0	CD	NUMBER	5.0	num	9	SENT_127	[p9l869t1899r967b1952],
9	6.8	CD	NUMBER	6.8	prep_with	6	SENT_127	[p9l1367t1899r1463b1952],
10	5.3	CD	NUMBER	5.3	num	11	SENT_127	[p9l1872t1899r1969b1952],
11	B-blockers	NNS	O	b-blocker	dep	14	SENT_127	[p9l13t1984r329b2053],
12	BZAR	NN	O	bzar	nn	14	SENT_127	[p9l13t2073r162b2140],
13	G	NN	O	g	nn	14	SENT_127	[p9l190t2071r490b2126],
14	|	NNS	O	|	dep	17	SENT_127	[p9l190t2071r490b2126],
15	u27G	NN	O	u27g	nn	16	SENT_127	[p9l190t2071r490b2126],
16	|	NN	O	|	dep	14	SENT_127	[p9l190t2071r490b2126],
17	n	NN	O	n	_	0	SENT_127	[p9l190t2071r490b2126],
18	3.7	CD	NUMBER	3.7	num	17	SENT_127	[p9l872t2073r966b2126],
19	3.6	CD	NUMBER	3.6	number	20	SENT_127	[p9l1369t2073r1464b2126],
20	6.5	CD	NUMBER	6.5	npadvmod	21	SENT_127	[p9l1873t2073r1968b2126],
21	without	IN	O	without	dep	17	SENT_127	[p9l8t2159r256b2214],
22	[	CD	NUMBER	[	num	23	SENT_127	[p9l286t2159r603b2228],
23	3-blockers	NNS	O	3-blocker	pobj	21	SENT_127	[p9l286t2159r603b2228],

1	B3AR	NN	O	b3ar	nn	2	SENT_128	[p9l13t2334r162b2402],
2	Arg64Trp	NN	O	arg64trp	dep	10	SENT_128	[p9l187t2334r487b2405],
3	with	IN	O	with	_	0	SENT_128	[p9l514t2333r650b2387],
4	3.4	CD	NUMBER	3.4	number	5	SENT_128	[p9l872t2334r966b2388],
5	16.7	CD	NUMBER	16.7	prep_with	2	SENT_128	[p9l1328t2334r1464b2387],
6	—	CD	NUMBER	—	num	7	SENT_128	[p9l1885t2367r1958b2371],
7	[	NN	O	[	dep	10	SENT_128	[p9l13t2419r329b2488],
8	3	CD	NUMBER	3	num	10	SENT_128	[p9l13t2419r329b2488],
9	—	NN	O	—	nn	10	SENT_128	[p9l13t2419r329b2488],
10	b	NN	O	b	dep	13	SENT_128	[p9l13t2419r329b2488],
11	|	NN	O	|	nn	12	SENT_128	[p9l13t2419r329b2488],
12	ockers	NNS	O	ocker	dep	10	SENT_128	[p9l13t2419r329b2488],
13	[	VBP	O	[	_	0	SENT_128	[p9l13t2507r162b2575],
14	33AR	NN	O	33ar	nn	15	SENT_128	[p9l13t2507r162b2575],
15	Arg64Trp	NN	O	arg64trp	dobj	13	SENT_128	[p9l187t2508r487b2578],
16	4.8	CD	NUMBER	4.8	number	17	SENT_128	[p9l867t2508r966b2561],
17	11.8	CD	NUMBER	11.8	num	18	SENT_128	[p9l1327t2508r1463b2561],
18	—	NN	O	—	npadvmod	13	SENT_128	[p9l1885t2540r1958b2545],
19	without	IN	O	without	_	0	SENT_128	[p9l8t2592r256b2647],
20	[	CD	NUMBER	[	num	21	SENT_128	[p9l286t2592r603b2661],
21	3-blockers	NNS	O	3-blocker	prep_without	13	SENT_128	[p9l286t2592r603b2661],

1	The	DT	O	the	det	2	SENT_129	[p9l7t2738r103b2782],
2	percentages	NNS	O	percentage	nsubjpass	8	SENT_129	[p9l133t2743r447b2796],
3	of	IN	O	of	_	0	SENT_129	[p9l475t2738r525b2782],
4	patients	NNS	O	patient	prep_of	2	SENT_129	[p9l552t2739r755b2796],
5	with	IN	O	with	_	0	SENT_129	[p9l781t2738r893b2782],
6	diabetes	NNS	O	diabetes	prep_with	4	SENT_129	[p9l923t2738r1138b2782],
7	are	VBP	O	be	auxpass	8	SENT_129	[p9l1166t2751r1243b2782],
8	indicated	VBN	O	indicate	_	0	SENT_129	[p9l1272t2738r1509b2782],
9	according	VBG	O	accord	_	0	SENT_129	[p9l1539t2738r1794b2796],
10	to	TO	O	to	prepc_according_to	8	SENT_129	[p9l1823t2743r1875b2782],
11	genotype	NN	O	genotype	pobj	8	SENT_129	[p9l1903t2743r2149b2796],
12	and	CC	O	and	_	0	SENT_129	[p9l10t2812r103b2857],
13	assumption	NN	O	assumption	pobj	8	SENT_129	[p9l146t2813r442b2871],
14	of	IN	O	of	_	0	SENT_129	[p9l486t2812r536b2857],
15	B-blocker	NN	O	b-blocker	prep_of	11	SENT_129	[p9l577t2812r829b2868],
16	.	.	O	.	_	0	SENT_129	[p9l577t2812r829b2868],

1	Frequencies	NNS	O	frequency	nsubjpass	3	SENT_130	[p9l876t2813r1180b2871],
2	are	VBP	O	be	auxpass	3	SENT_130	[p9l1221t2825r1297b2857],
3	indicated	VBN	O	indicate	_	0	SENT_130	[p9l1340t2812r1575b2857],
4	in	IN	O	in	_	0	SENT_130	[p9l1620t2813r1662b2856],
5	percentage	NN	O	percentage	prep_in	3	SENT_130	[p9l1706t2817r2011b2871],
6	.	.	O	.	_	0	SENT_130	[p9l1706t2817r2011b2871],

1	The	DT	O	the	det	2	SENT_131	[p9l2053t2812r2149b2857],
2	number	NN	O	number	nsubj	9	SENT_131	[p9l11t2887r216b2932],
3	of	IN	O	of	_	0	SENT_131	[p9l238t2887r289b2932],
4	patients	NNS	O	patient	prep_of	2	SENT_131	[p9l312t2888r514b2946],
5	taking	VBG	O	take	partmod	4	SENT_131	[p9l538t2887r696b2946],
6	[	CD	NUMBER	[	num	7	SENT_131	[p9l725t2887r965b2943],
7	3-blocker	NN	O	3-blocker	dobj	5	SENT_131	[p9l725t2887r965b2943],
8	was	VBD	O	be	cop	9	SENT_131	[p9l986t2900r1083b2932],
9	214	CD	NUMBER	214	_	0	SENT_131	[p9l1107t2888r1204b2931],
10	vs	CC	O	vs	cc	9	SENT_131	[p9l1232t2900r1278b2932],
11	756	CD	NUMBER	756	num	12	SENT_131	[p9l1303t2889r1398b2932],
12	patients	NNS	O	patient	npadvmod	13	SENT_131	[p9l1425t2888r1627b2946],
13	not	RB	O	not	advmod	9	SENT_131	[p9l1654t2892r1739b2932],
14	on	IN	O	on	_	0	SENT_131	[p9l1761t2900r1824b2932],
15	this	DT	O	this	det	16	SENT_131	[p9l1849t2887r1939b2932],
16	class	NN	O	class	prep_on	9	SENT_131	[p9l1963t2887r2078b2932],
17	of	IN	O	of	_	0	SENT_131	[p9l2102t2887r2152b2932],
18	drugs	NNS	O	drug	prep_of	16	SENT_131	[p9l10t2962r168b3021],
19	.	.	O	.	_	0	SENT_131	[p9l10t2962r168b3021],

1	I	PRP	O	I	_	0	SENT_132	[p9l445t3097r611b3157],
2	:	:	O	:	_	0	SENT_132	[p9l445t3097r611b3157],
3	High	JJ	O	high	amod	4	SENT_132	[p9l640t3104r772b3169],
4	Cholesterol	NN	O	cholesterol	dep	1	SENT_132	[p9l798t3103r1136b3155],

1	30	CD	NUMBER	30	_	0	SENT_133	[p10l209t47r282b97],
2	I	PRP	O	I	dep	1	SENT_133	[p10l445t21r611b80],
3	:	:	O	:	_	0	SENT_133	[p10l445t21r611b80],
4	High	JJ	O	high	amod	5	SENT_133	[p10l640t24r772b89],
5	Triglycerides	NNS	O	triglyceride	dep	2	SENT_133	[p10l796t24r1180b89],

1	S	NN	O	s	_	0	SENT_134	[p10l442t117r613b182],
2	Combined	VBN	O	combine	partmod	1	SENT_134	[p10l638t122r944b174],
3	Dyslipidemia	NNP	O	Dyslipidemia	dep	10	SENT_134	[p10l971t123r1352b187],
4	en	IN	O	en	_	0	SENT_134	[p10l114t448r154b482],
5	20	CD	NUMBER	20	num	6	SENT_134	[p10l209t433r282b482],
6	II-5	NN	O	ii-5	prep_en	3	SENT_134	[p10l105t486r153b508],
7	c	NN	O	c	dep	10	SENT_134	[p10l114t510r153b544],
8	.1	CD	NUMBER	.1	num	7	SENT_134	[p10l102t548r154b600],
9	’	CD	NUMBER	’	num	10	SENT_134	[p10l102t548r154b600],
10	III	NNP	O	III	dep	1	SENT_134	[p10l105t606r153b628],
11	’	CD	NUMBER	’	num	10	SENT_134	[p10l105t606r153b628],
12	as	IN	O	as	_	0	SENT_134	[p10l114t629r153b663],
13	n.	NN	O	n.	nn	15	SENT_134	[p10l103t667r153b705],
14	‘	CD	NUMBER	‘	num	15	SENT_134	[p10l102t728r153b750, p10l114t752r154b789],
15	Io	NNP	O	Io	prep_as	10	SENT_134	[p10l102t728r153b750, p10l114t752r154b789],
16	$	$	MONEY	$	amod	15	SENT_134	[p10l103t813r154b871],
17	10	CD	MONEY	10	number	16	SENT_134	[p10l213t818r282b868],

1	I	PRP	O	I	_	0	SENT_135	[p10l542t1118r635b1226],
2	l	NN	O	l	dep	1	SENT_135	[p10l999t448r1244b1226],
3	*	CD	NUMBER	*	num	4	SENT_135	[p10l999t448r1244b1226],
4	*	NN	O	*	dep	1	SENT_135	[p10l1785t885r1817b915],

1	Gln/Gln	NN	O	gln/gln	_	0	SENT_136	[p10l483t1279r708b1332],
2	Gln/Glu	NN	O	gln/glu	nn	3	SENT_136	[p10l1093t1279r1317b1331],
3	Glu/Glu	NN	O	glu/glu	dep	1	SENT_136	[p10l1702t1279r1926b1331],

1	[	NN	O	[	nn	3	SENT_137	[p10l910t1386r1078b1455],
2	32AR	NN	O	32ar	nn	3	SENT_137	[p10l910t1386r1078b1455],
3	Gene	NN	O	gene	_	0	SENT_137	[p10l1102t1387r1269b1440],
4	Variant	JJ	O	variant	dep	3	SENT_137	[p10l1291t1388r1520b1439],

1	*	NNP	O	*	_	0	SENT_138	[p10l776t1489r814b1539],
2	:	:	O	:	_	0	SENT_138	[p10l776t1489r814b1539],
3	p	NN	O	p	dep	4	SENT_138	[p10l842t1490r1056b1553],
4	<	JJR	O	<	dep	1	SENT_138	[p10l842t1490r1056b1553],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_138	[p10l842t1490r1056b1553],
6	vs	CC	O	vs	_	0	SENT_138	[p10l1078t1501r1144b1540],
7	Gln/Gln	NN	O	gln/gln	conj_vs	4	SENT_138	[p10l1168t1487r1410b1548],
8	;	:	O	;	_	0	SENT_138	[p10l1168t1487r1410b1548],
9	x2	NN	O	x2	nn	10	SENT_138	[p10l1435t1468r1498b1554],
10	test	NN	O	test	dep	7	SENT_138	[p10l1520t1492r1628b1540],

1	Figure	NNP	O	Figure	nn	3	SENT_139	[p10l13t1626r205b1694],
2	1	CD	NUMBER	1	num	3	SENT_139	[p10l237t1627r258b1677],
3	Effects	NNS	O	effect	_	0	SENT_139	[p10l339t1626r542b1677],
4	of	IN	O	of	_	0	SENT_139	[p10l570t1626r633b1677],
5	BZAR	NN	O	bzar	nn	7	SENT_139	[p10l659t1628r805b1691],
6	G	NN	O	g	nn	7	SENT_139	[p10l832t1626r1017b1677],
7	|	NNS	O	|	prep_of	3	SENT_139	[p10l832t1626r1017b1677],
8	u27	NN	O	u27	nn	9	SENT_139	[p10l832t1626r1017b1677],
9	polymorphism	NN	O	polymorphism	nsubj	17	SENT_139	[p10l1045t1626r1498b1694],
10	on	IN	O	on	_	0	SENT_139	[p10l1528t1641r1605b1677],
11	the	DT	O	the	det	12	SENT_139	[p10l1633t1626r1734b1677],
12	incidence	NN	O	incidence	prep_on	9	SENT_139	[p10l1764t1626r2060b1677],
13	of	IN	O	of	_	0	SENT_139	[p10l2089t1626r2152b1677],
14	elevated	JJ	O	elevated	amod	16	SENT_139	[p10l10t1711r275b1763],
15	serum	NN	O	serum	nn	16	SENT_139	[p10l321t1726r510b1763],
16	triglycerides	NNS	O	triglyceride	prep_of	12	SENT_139	[p10l554t1711r943b1779],
17	(	VBP	O	(	rcmod	3	SENT_139	[p10l989t1711r1067b1776],
18	>	JJR	O	>	dobj	17	SENT_139	[p10l989t1711r1067b1776],
19	150	CD	NUMBER	150	num	21	SENT_139	[p10l1086t1712r1195b1763],
20	mg/dl	NN	O	mg/dl	nn	21	SENT_139	[p10l1212t1711r1446b1779],
21	)	NN	O	)	dep	18	SENT_139	[p10l1212t1711r1446b1779],
22	,	,	O	,	_	0	SENT_139	[p10l1212t1711r1446b1779],
23	elevated	JJ	O	elevated	amod	24	SENT_139	[p10l1493t1711r1759b1763],
24	cholesterol	NN	O	cholesterol	conj_and	18	SENT_139	[p10l1804t1711r2147b1763],
25	(	CD	NUMBER	(	num	26	SENT_139	[p10l12t1797r212b1861],
26	>	JJR	O	>	dep	24	SENT_139	[p10l12t1797r212b1861],
27	200	CD	NUMBER	200	num	29	SENT_139	[p10l12t1797r212b1861],
28	mg/dl	NN	O	mg/dl	nn	29	SENT_139	[p10l228t1796r436b1864],
29	)	NN	O	)	dep	24	SENT_139	[p10l228t1796r436b1864],
30	and	CC	O	and	_	0	SENT_139	[p10l463t1796r574b1848],
31	combined	JJ	O	combined	amod	34	SENT_139	[p10l599t1796r901b1848],
32	dyslipidemia	NN	O	dyslipidemia	nn	34	SENT_139	[p10l927t1796r1308b1864],
33	(	NN	O	(	nn	34	SENT_139	[p10l1334t1796r1728b1864],
34	tryglicerides	NNS	O	trygliceride	dep	35	SENT_139	[p10l1334t1796r1728b1864],
35	>	JJR	O	>	conj_and	18	SENT_139	[p10l1762t1811r1806b1848],
36	150	CD	NUMBER	150	num	37	SENT_139	[p10l1843t1798r1949b1848],
37	mg/dl	NN	O	mg/dl	dep	35	SENT_139	[p10l1965t1796r2147b1864],
38	and	CC	O	and	_	0	SENT_139	[p10l10t1881r124b1932],
39	cho	NN	O	cho	dep	43	SENT_139	[p10l153t1881r684b1932],
40	|	CD	NUMBER	|	num	39	SENT_139	[p10l153t1881r684b1932],
41	estero	NN	O	estero	npadvmod	43	SENT_139	[p10l153t1881r684b1932],
42	|	CD	NUMBER	|	num	41	SENT_139	[p10l153t1881r684b1932],
43	>	JJR	O	>	rcmod	3	SENT_139	[p10l153t1881r684b1932],
44	200	CD	NUMBER	200	num	46	SENT_139	[p10l153t1881r684b1932],
45	mg/dl	NN	O	mg/dl	nn	46	SENT_139	[p10l701t1881r916b1949],
46	)	NN	O	)	dep	3	SENT_139	[p10l701t1881r916b1949],
47	in	IN	O	in	_	0	SENT_139	[p10l947t1881r1000b1932],
48	patients	NNS	O	patient	prep_in	46	SENT_139	[p10l1031t1881r1282b1949],
49	NOT	RB	O	not	neg	50	SENT_139	[p10l1312t1882r1454b1932],
50	taking	VBG	O	take	partmod	48	SENT_139	[p10l1478t1881r1673b1949],
51	[	CD	NUMBER	[	num	52	SENT_139	[p10l1703t1881r2034b1946],
52	3-blockers	NNS	O	3-blocker	dobj	50	SENT_139	[p10l1703t1881r2034b1946],
53	.	.	O	.	_	0	SENT_139	[p10l1703t1881r2034b1946],

1	Table	NNP	O	Table	nn	3	SENT_140	[p10l9t2073r101b2101],
2	3	CD	NUMBER	3	num	3	SENT_140	[p10l117t2074r133b2101],
3	Incidence	NN	O	incidence	_	0	SENT_140	[p10l174t2074r329b2101],
4	of	IN	O	of	_	0	SENT_140	[p10l343t2074r376b2101],
5	dyslipidemia	NN	O	dyslipidemia	prep_of	3	SENT_140	[p10l389t2074r595b2109],
6	among	IN	O	among	_	0	SENT_140	[p10l609t2082r722b2109],
7	hypertensive	JJ	O	hypertensive	amod	8	SENT_140	[p10l739t2074r948b2109],
8	patients	NNS	O	patient	prep_among	3	SENT_140	[p10l963t2074r1094b2109],
9	according	VBG	O	accord	_	0	SENT_140	[p10l1108t2074r1268b2109],
10	to	TO	O	to	prepc_according_to	3	SENT_140	[p10l1283t2077r1316b2101],
11	|	VB	O	|	pcomp	3	SENT_140	[p10l1331t2075r1406b2108],
12	33AR	NN	O	33ar	nn	13	SENT_140	[p10l1331t2075r1406b2108],
13	genotype	NN	O	genotype	dobj	11	SENT_140	[p10l1420t2077r1575b2109],

1	Arg/Arg	NN	O	arg/arg	nn	3	SENT_141	[p10l1292t2159r1407b2194],
2	(	CD	NUMBER	(	num	3	SENT_141	[p10l1420t2159r1482b2193],
3	n	NN	O	n	_	0	SENT_141	[p10l1420t2159r1482b2193],
4	=	JJ	O	=	amod	3	SENT_141	[p10l1420t2159r1482b2193],
5	894	CD	NUMBER	894	number	6	SENT_141	[p10l1492t2159r1561b2193],
6	)	CD	NUMBER	)	dep	4	SENT_141	[p10l1492t2159r1561b2193],
7	Trp/Arg	NN	O	trp/arg	nn	9	SENT_141	[p10l1895t2159r2005b2194],
8	(	NN	O	(	nn	9	SENT_141	[p10l2018t2159r2049b2193],
9	n	NN	O	n	dep	3	SENT_141	[p10l2018t2159r2049b2193],
10	=	JJ	O	=	amod	12	SENT_141	[p10l2057t2172r2080b2181],
11	76	CD	NUMBER	76	tmod	10	SENT_141	[p10l2091t2159r2139b2193],
12	)	NN	O	)	dep	9	SENT_141	[p10l2091t2159r2139b2193],

1	Overall	JJ	O	overall	advmod	4	SENT_142	[p10l10t2249r116b2275],
2	population	NN	O	population	nn	4	SENT_142	[p10l133t2249r298b2284],
3	(	CD	NUMBER	(	num	4	SENT_142	[p10l314t2249r463b2282],
4	n	NN	O	n	nsubjpass	85	SENT_142	[p10l314t2249r463b2282],
5	:970	CD	NUMBER	:970	num	6	SENT_142	[p10l314t2249r463b2282],
6	)	NN	O	)	dep	4	SENT_142	[p10l314t2249r463b2282],
7	,	,	O	,	_	0	SENT_142	[p10l314t2249r463b2282],
8	Chol/Tg/Cho	NNP	O	Chol/Tg/Cho	nn	9	SENT_142	[p10l480t2249r751b2284],
9	|	NN	O	|	appos	6	SENT_142	[p10l480t2249r751b2284],
10	+	CC	O	+	_	0	SENT_142	[p10l480t2249r751b2284],
11	Tg	NN	O	tg	conj_+	4	SENT_142	[p10l480t2249r751b2284],
12	(	CD	PERCENT	(	num	13	SENT_142	[p10l767t2249r821b2282],
13	%	NN	PERCENT	%	dep	11	SENT_142	[p10l767t2249r821b2282],
14	)	CD	NUMBER	)	number	15	SENT_142	[p10l767t2249r821b2282],
15	23.6	CD	NUMBER	23.6	num	13	SENT_142	[p10l1329t2249r1525b2279],
16	/	:	O	/	punct	17	SENT_142	[p10l1329t2249r1525b2279],
17	5.1	CD	NUMBER	5.1	dep	13	SENT_142	[p10l1329t2249r1525b2279],
18	/	:	O	/	punct	20	SENT_142	[p10l1329t2249r1525b2279],
19	8.6	CD	NUMBER	8.6	number	20	SENT_142	[p10l1329t2249r1525b2279],
20	27.6	CD	NUMBER	27.6	dep	13	SENT_142	[p10l1882t2249r2149b2279],
21	/	:	O	/	punct	20	SENT_142	[p10l1882t2249r2149b2279],
22	10.3	CD	NUMBER	10.3	number	23	SENT_142	[p10l1882t2249r2149b2279],
23	*	CD	NUMBER	*	num	13	SENT_142	[p10l1882t2249r2149b2279],
24	/	:	O	/	punct	29	SENT_142	[p10l1882t2249r2149b2279],
25	17.2	CD	NUMBER	17.2	number	26	SENT_142	[p10l1882t2249r2149b2279],
26	*	CD	NUMBER	*	num	27	SENT_142	[p10l1882t2249r2149b2279],
27	Patients	NNS	O	patient	npadvmod	28	SENT_142	[p10l11t2292r129b2318],
28	not	RB	O	not	dep	29	SENT_142	[p10l145t2294r195b2318],
29	taking	VBG	O	take	dep	4	SENT_142	[p10l207t2291r301b2326],
30	B	NN	O	b	nn	31	SENT_142	[p10l318t2292r334b2325],
31	blocker	NN	O	blocker	dobj	29	SENT_142	[p10l349t2291r461b2318],
32	(	CD	NUMBER	(	num	31	SENT_142	[p10l473t2291r503b2324],
33	n	NN	O	n	nn	38	SENT_142	[p10l473t2291r503b2324],
34	=	JJ	O	=	amod	38	SENT_142	[p10l513t2304r536b2313],
35	756	CD	NUMBER	756	number	36	SENT_142	[p10l547t2291r615b2324],
36	)	CD	NUMBER	)	dep	34	SENT_142	[p10l547t2291r615b2324],
37	Chol/Tg/Cho	NNP	O	Chol/Tg/Cho	nn	38	SENT_142	[p10l630t2291r902b2326],
38	|	NN	O	|	tmod	29	SENT_142	[p10l630t2291r902b2326],
39	+	CC	O	+	_	0	SENT_142	[p10l630t2291r902b2326],
40	Tg	NN	O	tg	tmod	29	SENT_142	[p10l630t2291r902b2326],
41	(	CD	PERCENT	(	num	42	SENT_142	[p10l917t2291r972b2324],
42	%	NN	PERCENT	%	dep	38	SENT_142	[p10l917t2291r972b2324],
43	)	CD	NUMBER	)	number	44	SENT_142	[p10l917t2291r972b2324],
44	23.5	CD	NUMBER	23.5	num	42	SENT_142	[p10l1329t2291r1525b2321],
45	/	:	O	/	punct	46	SENT_142	[p10l1329t2291r1525b2321],
46	5.1	CD	NUMBER	5.1	dep	42	SENT_142	[p10l1329t2291r1525b2321],
47	/	:	O	/	punct	49	SENT_142	[p10l1329t2291r1525b2321],
48	9.2	CD	NUMBER	9.2	number	49	SENT_142	[p10l1329t2291r1525b2321],
49	29.8	CD	NUMBER	29.8	dep	46	SENT_142	[p10l1907t2291r2124b2321],
50	/	:	O	/	punct	49	SENT_142	[p10l1907t2291r2124b2321],
51	5.9	CD	NUMBER	5.9	dep	46	SENT_142	[p10l1907t2291r2124b2321],
52	/	:	O	/	punct	46	SENT_142	[p10l1907t2291r2124b2321],
53	17.6	CD	NUMBER	17.6	num	54	SENT_142	[p10l1907t2291r2124b2321],
54	Patients	NNS	O	patient	dep	42	SENT_142	[p10l11t2334r129b2360],
55	taking	VBG	O	take	partmod	38	SENT_142	[p10l143t2333r237b2368],
56	[	JJ	O	[	amod	59	SENT_142	[p10l254t2333r396b2367],
57	5-blocker	NN	O	5-blocker	nn	59	SENT_142	[p10l254t2333r396b2367],
58	(	NN	O	(	nn	59	SENT_142	[p10l409t2333r824b2368],
59	n	NN	O	n	dobj	55	SENT_142	[p10l409t2333r824b2368],
60	=	JJ	O	=	dep	59	SENT_142	[p10l409t2333r824b2368],
61	214	CD	NUMBER	214	num	62	SENT_142	[p10l409t2333r824b2368],
62	)	CD	NUMBER	)	iobj	60	SENT_142	[p10l409t2333r824b2368],
63	Cho	NNP	O	Cho	dobj	60	SENT_142	[p10l409t2333r824b2368],
64	|	CD	NUMBER	|	num	63	SENT_142	[p10l409t2333r824b2368],
65	/	:	O	/	punct	67	SENT_142	[p10l409t2333r824b2368],
66	Tg/Cho	NN	O	tg/cho	nn	67	SENT_142	[p10l409t2333r824b2368],
67	|	NN	O	|	dep	63	SENT_142	[p10l409t2333r824b2368],
68	+	CC	O	+	_	0	SENT_142	[p10l409t2333r824b2368],
69	Tg	NN	O	tg	conj_+	67	SENT_142	[p10l409t2333r824b2368],
70	(	CD	PERCENT	(	num	71	SENT_142	[p10l840t2333r894b2366],
71	%	NN	PERCENT	%	dep	69	SENT_142	[p10l840t2333r894b2366],
72	)	CD	NUMBER	)	num	73	SENT_142	[p10l840t2333r894b2366],
73	23.2	CD	NUMBER	23.2	dep	67	SENT_142	[p10l1329t2333r1525b2363],
74	/	:	O	/	punct	67	SENT_142	[p10l1329t2333r1525b2363],
75	7.1	CD	NUMBER	7.1	amod	63	SENT_142	[p10l1329t2333r1525b2363],
76	/	:	O	/	punct	78	SENT_142	[p10l1329t2333r1525b2363],
77	5.4	CD	NUMBER	5.4	number	78	SENT_142	[p10l1329t2333r1525b2363],
78	25.0	CD	NUMBER	25.0	dep	59	SENT_142	[p10l1897t2333r2134b2363],
79	/	:	O	/	punct	78	SENT_142	[p10l1897t2333r2134b2363],
80	16.7	CD	NUMBER	16.7	dep	38	SENT_142	[p10l1897t2333r2134b2363],
81	/	:	O	/	punct	29	SENT_142	[p10l1897t2333r2134b2363],
82	16.7	CD	NUMBER	16.7	num	83	SENT_142	[p10l1897t2333r2134b2363],
83	Patients	NNS	O	patient	dep	4	SENT_142	[p10l11t2405r108b2427],
84	were	VBD	O	be	auxpass	85	SENT_142	[p10l120t2411r182b2427],
85	divided	VBN	O	divide	_	0	SENT_142	[p10l195t2405r287b2427],
86	according	VBG	O	accord	_	0	SENT_142	[p10l301t2405r425b2434],
87	to	TO	O	to	prepc_according_to	85	SENT_142	[p10l439t2408r464b2427],
88	the	DT	O	the	det	89	SENT_142	[p10l477t2405r517b2427],
89	presence	NN	O	presence	pobj	85	SENT_142	[p10l531t2411r642b2434],
90	of	IN	O	of	_	0	SENT_142	[p10l655t2405r680b2427],
91	the	DT	O	the	det	93	SENT_142	[p10l691t2405r731b2427],
92	Trp64	NN	O	trp64	nn	93	SENT_142	[p10l743t2406r819b2434],
93	allele	NN	O	allele	prep_of	89	SENT_142	[p10l832t2405r895b2427],
94	of	IN	O	of	_	0	SENT_142	[p10l908t2405r933b2427],
95	the	DT	O	the	det	97	SENT_142	[p10l944t2405r984b2427],
96	B3AR	NN	O	b3ar	nn	97	SENT_142	[p10l999t2406r1059b2433],
97	gene	NN	O	gene	prep_of	93	SENT_142	[p10l1071t2411r1140b2434],
98	.	.	O	.	_	0	SENT_142	[p10l1071t2411r1140b2434],

1	The	DT	O	the	det	2	SENT_143	[p10l1153t2405r1200b2427],
2	percentage	NN	O	percentage	_	0	SENT_143	[p10l1214t2408r1356b2434],
3	of	IN	O	of	_	0	SENT_143	[p10l1369t2405r1394b2427],
4	patients	NNS	O	patient	prep_of	2	SENT_143	[p10l1407t2405r1506b2434],
5	presenting	VBG	O	present	partmod	4	SENT_143	[p10l1519t2405r1652b2434],
6	isolated	VBN	O	isolate	amod	7	SENT_143	[p10l1667t2405r1762b2427],
7	hypercholesterolemia	NN	O	hypercholesterolemia	dobj	5	SENT_143	[p10l1777t2405r2048b2434],
8	(	CD	NUMBER	(	num	9	SENT_143	[p10l2062t2405r2148b2433],
9	Chol	NNP	ORGANIZATION	Chol	dep	2	SENT_143	[p10l2062t2405r2148b2433],
10	)	CD	NUMBER	)	num	9	SENT_143	[p10l2062t2405r2148b2433],
11	,	,	O	,	_	0	SENT_143	[p10l2062t2405r2148b2433],
12	isolated	VBN	O	isolate	partmod	9	SENT_143	[p10l10t2442r105b2464],
13	hypertriglyceridemia	NN	O	hypertriglyceridemia	dobj	12	SENT_143	[p10l116t2442r378b2471],
14	(	CD	NUMBER	(	num	13	SENT_143	[p10l388t2442r439b2471],
15	Tg	NN	O	tg	dep	13	SENT_143	[p10l388t2442r439b2471],
16	)	CD	NUMBER	)	num	15	SENT_143	[p10l388t2442r439b2471],
17	or	CC	O	or	_	0	SENT_143	[p10l449t2448r475b2464],
18	combined	VBN	O	combine	amod	22	SENT_143	[p10l483t2442r610b2464],
19	dyslipidemia	NN	O	dyslipidemia	nn	22	SENT_143	[p10l620t2442r778b2471],
20	(	CD	NUMBER	(	num	22	SENT_143	[p10l789t2442r921b2470],
21	Cho	NNP	O	Cho	nn	22	SENT_143	[p10l789t2442r921b2470],
22	|	NN	O	|	conj_or	13	SENT_143	[p10l789t2442r921b2470],
23	+	CC	O	+	_	0	SENT_143	[p10l789t2442r921b2470],
24	TG	NN	O	tg	nn	25	SENT_143	[p10l789t2442r921b2470],
25	)	NN	O	)	conj_+	9	SENT_143	[p10l789t2442r921b2470],
26	are	VBP	O	be	auxpass	27	SENT_143	[p10l931t2448r968b2464],
27	reported	VBN	O	report	rcmod	25	SENT_143	[p10l979t2442r1094b2471],
28	.	.	O	.	_	0	SENT_143	[p10l979t2442r1094b2471],

1	In	IN	O	in	_	0	SENT_144	[p10l1106t2443r1126b2464],
2	the	DT	O	the	det	4	SENT_144	[p10l1136t2442r1176b2464],
3	first	JJ	ORDINAL	first	amod	4	SENT_144	[p10l1184t2442r1231b2464],
4	line	NN	O	line	prep_in	9	SENT_144	[p10l1240t2442r1290b2469],
5	,	,	O	,	_	0	SENT_144	[p10l1240t2442r1290b2469],
6	the	DT	O	the	det	7	SENT_144	[p10l1300t2442r1340b2464],
7	population	NN	O	population	nsubjpass	9	SENT_144	[p10l1350t2442r1487b2471],
8	was	VBD	O	be	auxpass	9	SENT_144	[p10l1496t2448r1544b2464],
9	considered	VBN	O	consider	_	0	SENT_144	[p10l1553t2442r1690b2464],
10	as	IN	O	as	_	0	SENT_144	[p10l1700t2448r1724b2464],
11	a	DT	O	a	det	12	SENT_144	[p10l1733t2448r1745b2464],
12	whole	JJ	O	whole	prep_as	9	SENT_144	[p10l1754t2442r1838b2469],
13	,	,	O	,	_	0	SENT_144	[p10l1754t2442r1838b2469],
14	while	IN	O	while	mark	25	SENT_144	[p10l1848t2442r1915b2464],
15	in	IN	O	in	_	0	SENT_144	[p10l1925t2442r1945b2464],
16	the	DT	O	the	det	20	SENT_144	[p10l1955t2442r1995b2464],
17	second	JJ	ORDINAL	second	amod	20	SENT_144	[p10l2005t2442r2093b2464],
18	and	CC	ORDINAL	and	_	0	SENT_144	[p10l2103t2442r2149b2464],
19	third	JJ	ORDINAL	third	conj_and	17	SENT_144	[p10l9t2479r68b2501],
20	lines	NNS	O	line	prep_in	25	SENT_144	[p10l82t2479r143b2506],
21	,	,	O	,	_	0	SENT_144	[p10l82t2479r143b2506],
22	patients	NNS	O	patient	nsubjpass	25	SENT_144	[p10l157t2480r256b2508],
23	were	VBD	O	be	auxpass	25	SENT_144	[p10l266t2486r328b2501],
24	furthermore	RB	O	furthermore	advmod	25	SENT_144	[p10l338t2479r492b2501],
25	stratified	VBN	O	stratify	advcl	9	SENT_144	[p10l504t2479r611b2501],
26	according	VBG	O	accord	_	0	SENT_144	[p10l624t2479r749b2508],
27	to	TO	O	to	prepc_according_to	25	SENT_144	[p10l761t2482r786b2501],
28	B-blockers	NNS	O	b-blocker	pobj	25	SENT_144	[p10l799t2479r926b2507],
29	in	IN	O	in	_	0	SENT_144	[p10l939t2480r959b2501],
30	therapy	NN	O	therapy	prep_in	28	SENT_144	[p10l971t2479r1075b2508],
31	.	.	O	.	_	0	SENT_144	[p10l971t2479r1075b2508],

1	*	NN	O	*	nn	2	SENT_145	[p10l10t2517r60b2538],
2	P	NN	O	p	_	0	SENT_145	[p10l10t2517r60b2538],
3	<	JJR	O	<	dep	2	SENT_145	[p10l10t2517r60b2538],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_145	[p10l66t2517r121b2538],
5	vs	CC	O	vs	_	0	SENT_145	[p10l135t2522r158b2538],
6	respective	JJ	O	respective	amod	7	SENT_145	[p10l169t2516r294b2545],
7	values	NNS	O	value	conj_vs	3	SENT_145	[p10l305t2516r383b2538],
8	in	IN	O	in	_	0	SENT_145	[p10l395t2516r415b2538],
9	Arg/Arg	NN	O	arg/arg	prep_in	7	SENT_145	[p10l427t2516r535b2545],
10	.	.	O	.	_	0	SENT_145	[p10l427t2516r535b2545],

1	www.nature.com/tp]	NN	O	www.nature.com/tp]	_	0	SENT_146	[p10l1881t2645r2149b2674],

1	@	SYM	O	@	dep	2	SENT_147	[p10l8t2828r135b2952],
2	[	CD	NUMBER	[	dep	7	SENT_147	[p10l1461t2840r1718b2897],
3	3-blockade	NN	O	3-blockade	nn	7	SENT_147	[p10l1461t2840r1718b2897],
4	and	CC	O	and	_	0	SENT_147	[p10l1737t2840r1824b2885],
5	dyslipidemia	NN	O	dyslipidemia	nn	7	SENT_147	[p10l1844t2840r2148b2899],
6	G	NN	O	g	nn	7	SENT_147	[p10l1812t2913r1842b2953],
7	Iaccarino	NN	O	iaccarino	_	0	SENT_147	[p10l1864t2912r2044b2953],
8	et	FW	O	et	nn	9	SENT_147	[p10l2065t2916r2101b2953],
9	al	FW	O	al	dep	7	SENT_147	[p10l2117t2911r2153b2953],

1	40	CD	NUMBER	40	num	2	SENT_148	[p11l206t117r278b167],
2	ll	NN	O	ll	_	0	SENT_148	[p11l468t84r633b143],
3	High	JJ	O	high	amod	5	SENT_148	[p11l662t90r793b155],
4	Cholesterol	NN	O	cholesterol	nn	5	SENT_148	[p11l819t89r1158b141],
5	*	NN	O	*	dep	2	SENT_148	[p11l1940t118r1972b148],

1	Zl	NNP	O	Zl	nn	3	SENT_149	[p11l468t182r633b242],
2	High	NNP	O	High	nn	3	SENT_149	[p11l662t189r793b254],
3	Triglycerides	NNPS	O	Triglycerides	_	0	SENT_149	[p11l817t189r1201b254],
4	2	CD	NUMBER	2	num	6	SENT_149	[p11l466t279r636b343],
5	Combined	JJ	O	combined	amod	6	SENT_149	[p11l660t287r964b339],
6	Dyslipidemia	NN	O	dyslipidemia	dep	3	SENT_149	[p11l992t288r1373b352],

1	%	NN	O	%	_	0	SENT_150	[p11l96t878r146b936],
2	of	IN	O	of	_	0	SENT_150	[p11l95t794r146b856],
3	Patients	NNS	O	patient	prep_of	1	SENT_150	[p11l95t511r146b770],

1	Gln/Gln	NN	O	gln/gln	_	0	SENT_151	[p11l475t1344r700b1396],
2	Gln/Glu	NN	O	gln/glu	nn	3	SENT_151	[p11l1093t1344r1318b1396],
3	Glu/Glu	NN	O	glu/glu	dep	1	SENT_151	[p11l1702t1344r1927b1396],

1	[	NN	O	[	nn	3	SENT_152	[p11l902t1451r1071b1520],
2	32AR	NN	O	32ar	nn	3	SENT_152	[p11l902t1451r1071b1520],
3	Gene	NN	O	gene	_	0	SENT_152	[p11l1095t1453r1262b1505],
4	Variant	JJ	O	variant	dep	3	SENT_152	[p11l1284t1453r1513b1505],

1	*	NNP	O	*	_	0	SENT_153	[p11l757t1551r794b1601],
2	:	:	O	:	_	0	SENT_153	[p11l757t1551r794b1601],
3	p	NN	O	p	dep	4	SENT_153	[p11l823t1552r1027b1615],
4	<	JJR	O	<	dep	1	SENT_153	[p11l823t1552r1027b1615],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_153	[p11l823t1552r1027b1615],
6	vs	CC	O	vs	_	0	SENT_153	[p11l1049t1564r1115b1602],
7	Gln/Gln	NN	O	gln/gln	conj_vs	4	SENT_153	[p11l1139t1550r1381b1611],
8	;	:	O	;	_	0	SENT_153	[p11l1139t1550r1381b1611],
9	X2	NN	O	x2	nn	10	SENT_153	[p11l1406t1530r1470b1616],
10	test	NN	O	test	dep	7	SENT_153	[p11l1487t1554r1595b1602],

1	Figure	NN	O	figure	nsubj	46	SENT_154	[p11l12t1689r204b1756],
2	2	CD	NUMBER	2	num	3	SENT_154	[p11l232t1690r267b1739],
3	Effects	NNS	O	effect	nsubj	18	SENT_154	[p11l339t1688r542b1740],
4	of	IN	O	of	_	0	SENT_154	[p11l569t1688r633b1740],
5	[	CD	NUMBER	[	num	8	SENT_154	[p11l659t1691r804b1754],
6	52AR	NN	O	52ar	nn	8	SENT_154	[p11l659t1691r804b1754],
7	G	NN	O	g	nn	8	SENT_154	[p11l832t1688r1016b1740],
8	|	NNS	O	|	prep_of	3	SENT_154	[p11l832t1688r1016b1740],
9	u27	NN	O	u27	nn	10	SENT_154	[p11l832t1688r1016b1740],
10	polymorphism	NN	O	polymorphism	dep	8	SENT_154	[p11l1045t1688r1497b1756],
11	on	IN	O	on	_	0	SENT_154	[p11l1527t1703r1603b1740],
12	the	DT	O	the	det	13	SENT_154	[p11l1632t1688r1733b1740],
13	incidence	NN	O	incidence	prep_on	10	SENT_154	[p11l1763t1688r2060b1740],
14	of	IN	O	of	_	0	SENT_154	[p11l2088t1688r2152b1740],
15	elevated	JJ	O	elevated	amod	17	SENT_154	[p11l9t1774r274b1826],
16	serum	NN	O	serum	nn	17	SENT_154	[p11l319t1789r509b1826],
17	triglycerides	NNS	O	triglyceride	prep_of	13	SENT_154	[p11l553t1774r942b1842],
18	(	VBP	O	(	rcmod	1	SENT_154	[p11l988t1775r1067b1839],
19	>	JJR	O	>	dobj	18	SENT_154	[p11l988t1775r1067b1839],
20	150	CD	NUMBER	150	num	22	SENT_154	[p11l1085t1776r1194b1826],
21	mg/dl	NN	O	mg/dl	nn	22	SENT_154	[p11l1211t1774r1445b1842],
22	)	NN	O	)	dep	19	SENT_154	[p11l1211t1774r1445b1842],
23	,	,	O	,	_	0	SENT_154	[p11l1211t1774r1445b1842],
24	elevated	JJ	O	elevated	amod	25	SENT_154	[p11l1492t1774r1758b1826],
25	cholesterol	NN	O	cholesterol	conj_and	19	SENT_154	[p11l1803t1774r2147b1826],
26	(	CD	NUMBER	(	num	27	SENT_154	[p11l11t1859r217b1923],
27	>	JJR	O	>	dep	25	SENT_154	[p11l11t1859r217b1923],
28	200	CD	NUMBER	200	num	30	SENT_154	[p11l11t1859r217b1923],
29	mg/dl	NN	O	mg/dl	nn	30	SENT_154	[p11l234t1858r450b1926],
30	)	NN	O	)	dep	25	SENT_154	[p11l234t1858r450b1926],
31	and	CC	O	and	_	0	SENT_154	[p11l474t1858r588b1910],
32	combined	JJ	O	combined	amod	35	SENT_154	[p11l613t1858r924b1910],
33	dyslipidemia	NN	O	dyslipidemia	nn	35	SENT_154	[p11l948t1858r1345b1926],
34	(	NN	O	(	nn	35	SENT_154	[p11l1370t1858r1782b1926],
35	tryglicerides	NNS	O	trygliceride	conj_and	19	SENT_154	[p11l1370t1858r1782b1926],
36	>	JJR	O	>	dep	18	SENT_154	[p11l1814t1873r1857b1910],
37	150	CD	NUMBER	150	num	38	SENT_154	[p11l1893t1860r2002b1910],
38	mg	NN	O	mg	dep	36	SENT_154	[p11l2019t1858r2149b1926],
39	/	:	O	/	punct	36	SENT_154	[p11l2019t1858r2149b1926],
40	dl	NN	O	dl	dep	36	SENT_154	[p11l9t1943r63b1995],
41	and	CC	O	and	_	0	SENT_154	[p11l96t1943r210b1995],
42	cho	NN	O	cho	nn	44	SENT_154	[p11l242t1943r772b1995],
43	|	CD	NUMBER	|	num	44	SENT_154	[p11l242t1943r772b1995],
44	estero	NN	O	estero	conj_and	40	SENT_154	[p11l242t1943r772b1995],
45	|	CD	NUMBER	|	num	46	SENT_154	[p11l242t1943r772b1995],
46	>	JJR	O	>	_	0	SENT_154	[p11l242t1943r772b1995],
47	200	CD	NUMBER	200	num	49	SENT_154	[p11l242t1943r772b1995],
48	mg/dl	NN	O	mg/dl	nn	49	SENT_154	[p11l789t1943r1004b2011],
49	)	NN	O	)	dobj	46	SENT_154	[p11l789t1943r1004b2011],
50	in	IN	O	in	_	0	SENT_154	[p11l1038t1944r1091b1994],
51	patients	NNS	O	patient	prep_in	49	SENT_154	[p11l1124t1944r1376b2011],
52	with	IN	O	with	_	0	SENT_154	[p11l1404t1943r1541b1995],
53	B-blockers	NNS	O	b-blocker	prep_with	46	SENT_154	[p11l1573t1943r1887b2009],
54	in	IN	O	in	_	0	SENT_154	[p11l1918t1944r1971b1994],
55	their	PRP$	O	they	poss	57	SENT_154	[p11l2001t1943r2151b1995],
56	antihypertensive	JJ	O	antihypertensive	amod	57	SENT_154	[p11l9t2029r536b2096],
57	treatment	NN	O	treatment	prep_in	53	SENT_154	[p11l562t2034r898b2080],
58	.	.	O	.	_	0	SENT_154	[p11l562t2034r898b2080],

1	|	NN	O	|	_	0	SENT_155	[p11l626t2274r783b2331],
2	:	:	O	:	_	0	SENT_155	[p11l626t2274r783b2331],
3	|	CD	NUMBER	|	num	4	SENT_155	[p11l626t2274r783b2331],
4	Normolipidemia	NN	O	normolipidemia	dep	1	SENT_155	[p11l811t2283r1280b2347],

1	75	CD	NUMBER	75	_	0	SENT_156	[p11l303t2400r374b2449],
2	I	PRP	O	I	dep	1	SENT_156	[p11l624t2356r785b2417],
3	Dyslipidemia	FW	O	dyslipidemia	nn	4	SENT_156	[p11l812t2367r1192b2431],
4	*	FW	O	*	dep	1	SENT_156	[p11l1860t2347r1902b2386],

1	01	NN	NUMBER	01	nn	2	SENT_157	[p11l303t2765r336b2814],
2	O	NN	O	o	_	0	SENT_157	[p11l341t2764r375b2814],

1	%	NN	O	%	_	0	SENT_158	[p11l92t3210r142b3267],
2	of	IN	O	of	_	0	SENT_158	[p11l91t3125r142b3187],
3	[	CD	NUMBER	[	num	4	SENT_158	[p11l89t2745r157b3105],
4	32ARGlu27	NN	O	32arglu27	prep_of	1	SENT_158	[p11l89t2745r157b3105],
5	homozygous	JJ	O	homozygous	amod	6	SENT_158	[p11l179t2928r243b3343],
6	patients	NNS	O	patient	dep	1	SENT_158	[p11l178t2647r243b2903],

1	N	NN	O	n	_	0	SENT_159	[p11l302t3130r336b3178],
2	U	NNP	O	U	nn	3	SENT_159	[p11l341t3130r374b3179],
3	‘	NNP	O	‘	dep	1	SENT_159	[p11l341t3130r374b3179],
4	!	.	O	!	_	0	SENT_159	[p11l341t3130r374b3179],

1	Without	IN	O	without	_	0	SENT_160	[p11l532t3558r762b3609],
2	B-blocker	NN	O	b-blocker	pobj	1	SENT_160	[p11l786t3556r1063b3623],
3	With	IN	O	with	_	0	SENT_160	[p11l1503t3558r1635b3608],
4	B-blocker	NN	O	b-blocker	prep_with	2	SENT_160	[p11l1662t3556r1939b3623],

1	*	NNP	O	*	_	0	SENT_161	[p11l753t3685r790b3735],
2	:	:	O	:	_	0	SENT_161	[p11l753t3685r790b3735],
3	p	NN	O	p	dep	1	SENT_161	[p11l819t3686r1034b3749],
4	<	JJR	O	<	dep	3	SENT_161	[p11l819t3686r1034b3749],
5	0.05	CD	NUMBER	0.05	dep	3	SENT_161	[p11l819t3686r1034b3749],
6	vs	CC	O	vs	cc	5	SENT_161	[p11l1056t3698r1122b3736],
7	without	IN	O	without	_	0	SENT_161	[p11l1144t3685r1358b3736],
8	B-blocker	NN	O	b-blocker	prep_without	5	SENT_161	[p11l1382t3684r1672b3750],
9	;	:	O	;	_	0	SENT_161	[p11l1382t3684r1672b3750],
10	X2	NN	O	x2	dep	1	SENT_161	[p11l1697t3664r1751b3747],

1	Figure	NNP	O	Figure	nn	3	SENT_162	[p12l12t44r204b111],
2	3	CD	NUMBER	3	num	3	SENT_162	[p12l233t45r264b95],
3	Effects	NNS	O	effect	_	0	SENT_162	[p12l338t43r541b95],
4	of	IN	O	of	_	0	SENT_162	[p12l568t43r632b95],
5	B	NN	O	b	nn	6	SENT_162	[p12l657t46r686b109],
6	blockade	NN	O	blockade	prep_of	3	SENT_162	[p12l715t43r993b95],
7	on	IN	O	on	_	0	SENT_162	[p12l1021t58r1098b95],
8	the	DT	O	the	det	9	SENT_162	[p12l1126t43r1227b95],
9	incidence	NN	O	incidence	prep_on	6	SENT_162	[p12l1256t43r1553b95],
10	of	IN	O	of	_	0	SENT_162	[p12l1581t43r1645b95],
11	dyslipidemia	NN	O	dyslipidemia	prep_of	9	SENT_162	[p12l1668t43r2065b111],
12	in	IN	O	in	_	0	SENT_162	[p12l2094t44r2147b94],
13	hypertensive	JJ	O	hypertensive	amod	14	SENT_162	[p12l11t129r413b196],
14	patients	NNS	O	patient	prep_in	11	SENT_162	[p12l476t129r728b196],
15	bearing	VBG	O	bear	partmod	3	SENT_162	[p12l790t129r1027b196],
16	the	DT	O	the	det	20	SENT_162	[p12l1088t129r1190b180],
17	G	NN	O	g	nn	20	SENT_162	[p12l1251t129r1542b180],
18	|	NNS	O	|	nn	20	SENT_162	[p12l1251t129r1542b180],
19	u27G	NN	O	u27g	nn	20	SENT_162	[p12l1251t129r1542b180],
20	|	NN	O	|	nn	30	SENT_162	[p12l1251t129r1542b180],
21	u	NN	O	u	nn	22	SENT_162	[p12l1251t129r1542b180],
22	variant	NN	O	variant	dep	20	SENT_162	[p12l1602t129r1824b180],
23	of	IN	O	of	_	0	SENT_162	[p12l1882t129r1946b180],
24	[	CD	NUMBER	[	num	27	SENT_162	[p12l2004t131r2149b194],
25	SZAR	NN	ORGANIZATION	szar	nn	27	SENT_162	[p12l2004t131r2149b194],
26	(	NN	O	(	nn	27	SENT_162	[p12l11t214r269b279],
27	n	NN	O	n	prep_of	22	SENT_162	[p12l11t214r269b279],
28	=	JJ	O	=	amod	30	SENT_162	[p12l11t214r269b279],
29	87	CD	NUMBER	87	tmod	28	SENT_162	[p12l11t214r269b279],
30	)	NN	O	)	dobj	15	SENT_162	[p12l11t214r269b279],
31	.	.	O	.	_	0	SENT_162	[p12l11t214r269b279],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_163	[p12l311t214r560b265],
2	homozygous	JJ	O	homozygous	amod	1	SENT_163	[p12l599t214r1001b282],
3	for	IN	O	for	_	0	SENT_163	[p12l1036t214r1129b265],
4	this	DT	O	this	det	5	SENT_163	[p12l1162t214r1274b265],
5	variant	NN	O	variant	prep_for	2	SENT_163	[p12l1309t214r1531b265],
6	were	VBD	O	be	auxpass	7	SENT_163	[p12l1564t229r1718b265],
7	grouped	VBN	O	group	_	0	SENT_163	[p12l1755t214r2022b282],
8	for	IN	O	for	_	0	SENT_163	[p12l2059t214r2151b265],
9	the	DT	O	the	det	10	SENT_163	[p12l8t298r110b350],
10	presence	NN	O	presence	prep_for	7	SENT_163	[p12l155t313r434b366],
11	of	IN	O	of	_	0	SENT_163	[p12l478t298r541b350],
12	[	CD	NUMBER	[	num	13	SENT_163	[p12l583t298r896b364],
13	5-blockers	NNS	O	5-blocker	prep_of	10	SENT_163	[p12l583t298r896b364],
14	(	CD	PERCENT	(	number	15	SENT_163	[p12l943t299r1192b364],
15	28.8	CD	PERCENT	28.8	num	16	SENT_163	[p12l943t299r1192b364],
16	%	NN	PERCENT	%	dobj	39	SENT_163	[p12l943t299r1192b364],
17	)	CD	NUMBER	)	dep	31	SENT_163	[p12l943t299r1192b364],
18	in	IN	O	in	_	0	SENT_163	[p12l1239t299r1291b349],
19	their	PRP$	O	they	poss	20	SENT_163	[p12l1336t298r1486b350],
20	treatment	NN	O	treatment	prep_in	17	SENT_163	[p12l1526t304r1846b350],
21	and	CC	O	and	_	0	SENT_163	[p12l1888t298r2002b350],
22	the	DT	O	the	det	23	SENT_163	[p12l2046t298r2148b350],
23	incidence	NN	O	incidence	dep	31	SENT_163	[p12l10t384r306b435],
24	of	IN	O	of	_	0	SENT_163	[p12l331t384r395b435],
25	any	DT	O	any	det	27	SENT_163	[p12l416t399r527b451],
26	blood	NN	O	blood	nn	27	SENT_163	[p12l551t384r729b435],
27	lipid	NN	O	lipid	prep_of	23	SENT_163	[p12l756t384r888b451],
28	disorder	NN	O	disorder	dep	31	SENT_163	[p12l914t384r1177b435],
29	(	CD	NUMBER	(	num	28	SENT_163	[p12l1201t384r1415b449],
30	serum	NN	O	serum	nn	31	SENT_163	[p12l1201t384r1415b449],
31	triglycerides	NNS	O	triglyceride	dep	35	SENT_163	[p12l1440t384r1828b451],
32	>	JJR	O	>	dep	31	SENT_163	[p12l1863t385r2033b435],
33	150	CD	NUMBER	150	num	35	SENT_163	[p12l1863t385r2033b435],
34	mg	NN	O	mg	nn	35	SENT_163	[p12l2050t399r2146b451],
35	and/or	NN	O	and/or	dep	16	SENT_163	[p12l9t469r228b527],
36	cho	NN	O	cho	nn	38	SENT_163	[p12l252t469r782b520],
37	|	NN	O	|	nn	38	SENT_163	[p12l252t469r782b520],
38	esterol	NN	O	esterol	dep	35	SENT_163	[p12l252t469r782b520],
39	>	JJR	O	>	dep	13	SENT_163	[p12l252t469r782b520],
40	200	CD	NUMBER	200	num	42	SENT_163	[p12l252t469r782b520],
41	mg/dl	NN	O	mg/dl	nn	42	SENT_163	[p12l799t469r1015b537],
42	)	NN	O	)	nsubjpass	44	SENT_163	[p12l799t469r1015b537],
43	is	VBZ	O	be	auxpass	44	SENT_163	[p12l1045t469r1087b520],
44	reported	VBN	O	report	ccomp	39	SENT_163	[p12l1116t469r1389b537],
45	for	IN	O	for	_	0	SENT_163	[p12l1415t469r1508b520],
46	each	DT	O	each	det	47	SENT_163	[p12l1532t469r1675b520],
47	group	NN	O	group	prep_for	44	SENT_163	[p12l1703t484r1909b537],
48	.	.	O	.	_	0	SENT_163	[p12l1703t484r1909b537],

1	patients	NNS	O	patient	nsubjpass	3	SENT_164	[p12l8t717r290b790],
2	was	VBD	O	be	auxpass	3	SENT_164	[p12l342t731r470b772],
3	divided	VBN	O	divide	_	0	SENT_164	[p12l524t714r787b772],
4	into	IN	O	into	_	0	SENT_164	[p12l840t717r984b772],
5	two	CD	NUMBER	two	num	6	SENT_164	[p12l1038t721r1168b772],
6	groups	NNS	O	group	prep_into	3	SENT_164	[p12l1222t731r1458b790],
7	according	VBG	O	accord	_	0	SENT_164	[p12l1513t714r1860b790],
8	to	TO	O	to	prepc_according_to	3	SENT_164	[p12l1912t721r1981b772],
9	the	DT	O	the	det	10	SENT_164	[p12l2035t714r2148b772],
10	presence	NN	O	presence	pobj	3	SENT_164	[p12l8t826r313b885],
11	of	IN	O	of	_	0	SENT_164	[p12l342t809r414b867],
12	current	JJ	DATE	current	amod	13	SENT_164	[p12l437t816r694b867],
13	assumption	NN	O	assumption	prep_of	10	SENT_164	[p12l722t812r1132b885],
14	of	IN	O	of	_	0	SENT_164	[p12l1160t809r1232b867],
15	this	DT	O	this	det	16	SENT_164	[p12l1255t809r1384b867],
16	class	NN	O	class	prep_of	13	SENT_164	[p12l1413t809r1570b867],
17	of	IN	O	of	_	0	SENT_164	[p12l1599t809r1670b867],
18	drugs	NNS	O	drug	prep_of	16	SENT_164	[p12l1694t809r1903b885],
19	.	.	O	.	_	0	SENT_164	[p12l1694t809r1903b885],

1	In	IN	O	in	_	0	SENT_165	[p12l1935t811r2008b866],
2	the	DT	O	the	det	4	SENT_165	[p12l2035t809r2148b867],
3	overall	JJ	O	overall	amod	4	SENT_165	[p12l9t903r247b961],
4	population	NN	O	population	prep_in	11	SENT_165	[p12l308t903r719b979],
5	,	,	O	,	_	0	SENT_165	[p12l308t903r719b979],
6	treatment	NN	O	treatment	nsubjpass	11	SENT_165	[p12l786t911r1137b961],
7	with	IN	O	with	_	0	SENT_165	[p12l1197t903r1358b961],
8	B-blockers	NNS	MISC	b-blocker	prep_with	6	SENT_165	[p12l1425t903r1776b976],
9	was	VBD	O	be	auxpass	11	SENT_165	[p12l1837t920r1966b961],
10	not	RB	O	not	neg	11	SENT_165	[p12l2028t911r2149b961],
11	associated	VBN	O	associate	_	0	SENT_165	[p12l9t999r365b1057],
12	with	IN	O	with	_	0	SENT_165	[p12l395t999r557b1057],
13	a	DT	O	a	det	15	SENT_165	[p12l589t1016r624b1057],
14	higher	JJR	O	higher	amod	15	SENT_165	[p12l655t999r886b1075],
15	incidence	NN	O	incidence	prep_with	11	SENT_165	[p12l916t999r1258b1057],
16	of	IN	O	of	_	0	SENT_165	[p12l1291t999r1363b1057],
17	dyslipidemia	NN	O	dyslipidemia	prep_of	15	SENT_165	[p12l1391t999r1845b1075],
18	(	CD	NUMBER	(	num	19	SENT_165	[p12l1879t999r2052b1071],
19	37.4	CD	NUMBER	37.4	dobj	11	SENT_165	[p12l1879t999r2052b1071],
20	vs	CC	O	vs	_	0	SENT_165	[p12l2085t1016r2148b1057],
21	39.5	CD	NUMBER	39.5	conj_vs	19	SENT_165	[p12l10t1094r176b1163],
22	,	,	O	,	_	0	SENT_165	[p12l10t1094r176b1163],
23	NS	NN	O	n	nn	24	SENT_165	[p12l204t1093r346b1165],
24	)	NN	O	)	appos	21	SENT_165	[p12l204t1093r346b1165],
25	.	.	O	.	_	0	SENT_165	[p12l204t1093r346b1165],

1	No	DT	O	no	det	2	SENT_166	[p12l374t1095r477b1150],
2	difference	NN	O	difference	nsubjpass	18	SENT_166	[p12l503t1092r852b1150],
3	in	IN	O	in	_	0	SENT_166	[p12l878t1095r948b1149],
4	the	DT	O	the	det	5	SENT_166	[p12l973t1092r1085b1150],
5	occurrence	NN	O	occurrence	prep_in	2	SENT_166	[p12l1112t1109r1496b1150],
6	of	IN	O	of	_	0	SENT_166	[p12l1523t1092r1595b1150],
7	diabetes	NN	O	diabetes	prep_of	5	SENT_166	[p12l1616t1092r1901b1150],
8	(	CD	NUMBER	(	number	9	SENT_166	[p12l1930t1092r2058b1165],
9	3.9	CD	NUMBER	3.9	dep	5	SENT_166	[p12l1930t1092r2058b1165],
10	vs	CC	O	vs	cc	9	SENT_166	[p12l2085t1109r2148b1150],
11	4.7	CD	PERCENT	4.7	number	12	SENT_166	[p12l9t1190r202b1259],
12	%	NN	PERCENT	%	amod	9	SENT_166	[p12l9t1190r202b1259],
13	,	,	O	,	_	0	SENT_166	[p12l9t1190r202b1259],
14	NS	NN	O	n	nn	15	SENT_166	[p12l236t1189r356b1261],
15	)	NN	O	)	appos	5	SENT_166	[p12l236t1189r356b1261],
16	was	VBD	O	be	auxpass	18	SENT_166	[p12l389t1205r517b1246],
17	also	RB	O	also	advmod	18	SENT_166	[p12l550t1189r684b1246],
18	observed	VBN	O	observe	_	0	SENT_166	[p12l717t1189r1047b1246],
19	.	.	O	.	_	0	SENT_166	[p12l717t1189r1047b1246],

1	We	PRP	O	we	nsubj	3	SENT_167	[p12l1081t1191r1190b1246],
2	then	RB	O	then	advmod	3	SENT_167	[p12l1223t1189r1387b1246],
3	analyzed	VBD	O	analyze	_	0	SENT_167	[p12l1418t1189r1729b1264],
4	the	DT	O	the	det	5	SENT_167	[p12l1759t1189r1872b1246],
5	impact	NN	O	impact	dobj	3	SENT_167	[p12l1905t1192r2149b1264],
6	of	IN	O	of	_	0	SENT_167	[p12l9t1284r81b1342],
7	the	DT	O	the	det	9	SENT_167	[p12l99t1284r212b1342],
8	BZAR	NN	O	bzar	nn	9	SENT_167	[p12l241t1286r411b1357],
9	Glu27	NN	O	glu27	prep_of	5	SENT_167	[p12l434t1284r646b1342],
10	and	CC	O	and	_	0	SENT_167	[p12l673t1284r804b1342],
11	the	DT	O	the	det	14	SENT_167	[p12l827t1284r939b1342],
12	B3AR	NN	O	b3ar	nn	14	SENT_167	[p12l968t1286r1138b1357],
13	Arg64	NN	O	arg64	nn	14	SENT_167	[p12l1159t1286r1366b1360],
14	variants	NNS	O	variant	prep_of	5	SENT_167	[p12l1389t1287r1670b1342],
15	on	IN	O	on	_	0	SENT_167	[p12l1695t1301r1786b1342],
16	the	DT	O	the	det	17	SENT_167	[p12l1810t1284r1922b1342],
17	safety	NN	O	safety	prep_on	3	SENT_167	[p12l1948t1284r2151b1360],
18	of	IN	O	of	_	0	SENT_167	[p12l9t1378r81b1436],
19	B-blocker	NN	MISC	b-blocker	nn	20	SENT_167	[p12l105t1379r427b1451],
20	treatment	NN	O	treatment	prep_of	17	SENT_167	[p12l450t1386r818b1436],
21	.	.	O	.	_	0	SENT_167	[p12l450t1386r818b1436],

1	In	IN	O	in	mark	6	SENT_168	[p12l847t1381r920b1436],
2	agreement	NN	O	agreement	nsubj	6	SENT_168	[p12l945t1386r1317b1454],
3	with	IN	O	with	_	0	SENT_168	[p12l1339t1379r1500b1436],
4	the	DT	O	the	det	5	SENT_168	[p12l1525t1379r1638b1436],
5	data	NNS	O	datum	prep_with	2	SENT_168	[p12l1663t1379r1812b1436],
6	obtained	VBN	O	obtain	advcl	25	SENT_168	[p12l1836t1379r2149b1436],
7	in	IN	O	in	_	0	SENT_168	[p12l9t1477r79b1531],
8	the	DT	O	the	det	10	SENT_168	[p12l102t1474r214b1531],
9	whole	JJ	O	whole	amod	10	SENT_168	[p12l237t1474r453b1531],
10	population	NN	O	population	prep_in	6	SENT_168	[p12l476t1474r886b1549],
11	,	,	O	,	_	0	SENT_168	[p12l476t1474r886b1549],
12	among	IN	O	among	_	0	SENT_168	[p12l916t1490r1162b1549],
13	patients	NNS	O	patient	prep_among	6	SENT_168	[p12l1183t1477r1465b1549],
14	not	RB	O	not	neg	15	SENT_168	[p12l1489t1481r1610b1531],
15	treated	VBN	O	treat	partmod	13	SENT_168	[p12l1633t1474r1879b1531],
16	with	IN	O	with	_	0	SENT_168	[p12l1900t1474r2061b1531],
17	[	CD	NUMBER	[	num	18	SENT_168	[p12l2089t1475r2148b1546, p12l7t1569r315b1639],
18	3blockers	NNS	O	3blocker	prep_with	15	SENT_168	[p12l2089t1475r2148b1546, p12l7t1569r315b1639],
19	,	,	O	,	_	0	SENT_168	[p12l2089t1475r2148b1546, p12l7t1569r315b1639],
20	those	DT	O	those	nsubj	25	SENT_168	[p12l370t1569r559b1627],
21	harbouring	VBG	O	harbour	partmod	20	SENT_168	[p12l610t1569r1008b1645],
22	the	DT	O	the	det	24	SENT_168	[p12l1057t1569r1169b1627],
23	Glu27	NN	O	glu27	nn	24	SENT_168	[p12l1222t1569r1434b1627],
24	allele	NN	O	allele	dobj	21	SENT_168	[p12l1487t1569r1669b1627],
25	presented	VBD	O	present	_	0	SENT_168	[p12l1719t1569r2063b1645],
26	a	DT	O	a	dobj	25	SENT_168	[p12l2114t1586r2149b1627],

1	The	DT	O	the	det	3	SENT_169	[p12l7t1837r103b1882],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_169	[p12l129t1837r640b1896],
3	Journal	NNP	O	Journal	nsubj	5	SENT_169	[p12l663t1837r842b1893],
4	larger	JJR	O	larger	amod	5	SENT_169	[p12l9t2049r208b2125],
5	occurrence	NN	O	occurrence	_	0	SENT_169	[p12l238t2066r622b2107],
6	of	IN	O	of	_	0	SENT_169	[p12l655t2049r726b2107],
7	dyslipidemia	NN	O	dyslipidemia	prep_of	5	SENT_169	[p12l754t2049r1206b2125],
8	when	WRB	O	when	advmod	7	SENT_169	[p12l1235t2049r1432b2107],
9	compared	VBN	O	compare	_	0	SENT_169	[p12l1463t2049r1813b2125],
10	with	IN	O	with	_	0	SENT_169	[p12l1841t2049r2003b2107],
11	the	DT	O	the	det	13	SENT_169	[p12l2033t2049r2145b2107],
12	Gln/Gln	NN	O	gln/gln	nn	13	SENT_169	[p12l11t2144r304b2209],
13	group	NN	O	group	prep_compared_with	7	SENT_169	[p12l357t2161r562b2220],
14	due	JJ	O	due	_	0	SENT_169	[p12l616t2144r742b2202],
15	to	TO	O	to	_	0	SENT_169	[p12l796t2151r866b2202],
16	an	DT	O	a	det	17	SENT_169	[p12l920t2161r1005b2202],
17	increase	NN	O	increase	prep_due_to	7	SENT_169	[p12l1058t2147r1340b2202],
18	in	IN	O	in	_	0	SENT_169	[p12l1394t2147r1465b2201],
19	the	DT	O	the	det	20	SENT_169	[p12l1518t2144r1630b2202],
20	incidence	NN	O	incidence	prep_in	17	SENT_169	[p12l1684t2144r2024b2202],
21	of	IN	O	of	_	0	SENT_169	[p12l2079t2144r2151b2202],
22	elevated	JJ	O	elevated	amod	24	SENT_169	[p12l10t2238r300b2296],
23	serum	NN	O	serum	nn	24	SENT_169	[p12l354t2255r567b2296],
24	triglycerides	NNS	O	triglyceride	prep_of	20	SENT_169	[p12l619t2238r1049b2314],
25	and	CC	O	and	_	0	SENT_169	[p12l1103t2238r1234b2296],
26	combined	VBN	O	combine	conj_and	7	SENT_169	[p12l1287t2238r1641b2296],
27	dyslipidemia	NN	O	dyslipidemia	nn	29	SENT_169	[p12l1694t2238r2147b2314],
28	(	CD	NUMBER	(	num	29	SENT_169	[p12l13t2334r251b2409],
29	Figure	NN	O	figure	tmod	26	SENT_169	[p12l13t2334r251b2409],
30	1	CD	NUMBER	1	num	31	SENT_169	[p12l314t2334r393b2406],
31	)	NN	O	)	dep	29	SENT_169	[p12l314t2334r393b2406],
32	.	.	O	.	_	0	SENT_169	[p12l314t2334r393b2406],

1	Treatment	NN	O	treatment	dep	7	SENT_170	[p12l451t2336r818b2391],
2	with	IN	O	with	_	0	SENT_170	[p12l871t2333r1032b2391],
3	B-blockers	NNS	O	b-blocker	prep_with	1	SENT_170	[p12l1092t2333r1443b2406],
4	in	IN	O	in	_	0	SENT_170	[p12l1500t2336r1570b2390],
5	these	DT	O	these	det	6	SENT_170	[p12l1626t2333r1807b2391],
6	patients	NNS	O	patient	prep_in	1	SENT_170	[p12l1863t2336r2146b2409],
7	associates	VBZ	O	associate	_	0	SENT_170	[p12l10t2432r349b2487],
8	with	IN	O	with	_	0	SENT_170	[p12l397t2429r559b2487],
9	a	DT	O	a	det	12	SENT_170	[p12l608t2446r643b2487],
10	further	JJ	O	further	amod	12	SENT_170	[p12l691t2429r938b2487],
11	significant	JJ	O	significant	amod	12	SENT_170	[p12l987t2429r1357b2505],
12	increase	NN	O	increase	prep_with	7	SENT_170	[p12l1407t2432r1689b2487],
13	of	IN	O	of	_	0	SENT_170	[p12l1740t2429r1811b2487],
14	elevated	JJ	O	elevated	amod	16	SENT_170	[p12l1856t2429r2147b2487],
15	serum	NN	O	serum	nn	16	SENT_170	[p12l11t2540r223b2581],
16	triglycerids	NNS	O	triglycerid	prep_of	12	SENT_170	[p12l267t2523r658b2599],
17	and	CC	O	and	_	0	SENT_170	[p12l703t2523r834b2581],
18	combined	VBN	O	combine	amod	19	SENT_170	[p12l877t2523r1231b2581],
19	dyslipidemia	NN	O	dyslipidemia	prep_of	12	SENT_170	[p12l1275t2523r1728b2599],
20	(	CD	NUMBER	(	num	23	SENT_170	[p12l1774t2524r2013b2599],
21	Figure	NN	O	figure	nn	23	SENT_170	[p12l1774t2524r2013b2599],
22	2	CD	NUMBER	2	num	23	SENT_170	[p12l2058t2524r2142b2596],
23	)	NN	O	)	nsubj	7	SENT_170	[p12l2058t2524r2142b2596],
24	.	.	O	.	_	0	SENT_170	[p12l2058t2524r2142b2596],

1	Multinomial	JJ	MISC	multinomial	amod	3	SENT_171	[p12l8t2619r456b2677],
2	regression	NN	O	regression	nn	3	SENT_171	[p12l481t2622r835b2695],
3	analysis	NN	O	analysis	nsubj	4	SENT_171	[p12l860t2619r1135b2695],
4	showed	VBD	O	show	_	0	SENT_171	[p12l1162t2619r1428b2677],
5	that	IN	O	that	complm	13	SENT_171	[p12l1451t2619r1594b2677],
6	the	DT	O	the	det	7	SENT_171	[p12l1618t2619r1730b2677],
7	interaction	NN	O	interaction	nsubj	13	SENT_171	[p12l1755t2622r2146b2677],
8	of	IN	O	of	_	0	SENT_171	[p12l10t2714r81b2772],
9	[	CD	NUMBER	[	num	10	SENT_171	[p12l112t2714r487b2787],
10	3-blockade	NN	O	3-blockade	prep_of	7	SENT_171	[p12l112t2714r487b2787],
11	and	CC	O	and	_	0	SENT_171	[p12l519t2714r650b2772],
12	genotype	NN	O	genotype	conj_and	10	SENT_171	[p12l680t2721r1006b2790],
13	occurs	VBZ	O	occur	ccomp	4	SENT_171	[p12l1038t2731r1261b2772],
14	within	IN	O	within	_	0	SENT_171	[p12l1289t2714r1525b2772],
15	the	DT	O	the	det	17	SENT_171	[p12l1555t2714r1668b2772],
16	BZARZ7	NNP	O	BZARZ7	nn	17	SENT_171	[p12l1704t2716r1957b2787],
17	Glu	NNP	O	Glu	prep_within	13	SENT_171	[p12l1991t2714r2146b2779],
18	/	:	O	/	punct	20	SENT_171	[p12l1991t2714r2146b2779],
19	Glu	NNP	O	Glu	nn	20	SENT_171	[p12l11t2809r137b2866],
20	condition	NN	O	condition	dep	17	SENT_171	[p12l184t2809r548b2866],
21	.	.	O	.	_	0	SENT_171	[p12l184t2809r548b2866],

1	Indeed	RB	O	indeed	advmod	11	SENT_172	[p12l601t2809r860b2879],
2	,	,	O	,	_	0	SENT_172	[p12l601t2809r860b2879],
3	in	IN	O	in	_	0	SENT_172	[p12l911t2812r981b2866],
4	this	DT	O	this	det	5	SENT_172	[p12l1028t2809r1157b2866],
5	group	NN	O	group	prep_in	11	SENT_172	[p12l1205t2825r1410b2884],
6	of	IN	O	of	_	0	SENT_172	[p12l1457t2808r1529b2866],
7	patients	NNS	O	patient	prep_of	5	SENT_172	[p12l1571t2812r1871b2884],
8	,	,	O	,	_	0	SENT_172	[p12l1571t2812r1871b2884],
9	the	DT	O	the	det	10	SENT_172	[p12l1923t2809r2035b2866],
10	Bblockade	NNP	MISC	Bblockade	nsubj	11	SENT_172	[p12l2087t2810r2146b2881, p12l7t2904r321b2962],
11	results	VBZ	O	result	_	0	SENT_172	[p12l364t2904r588b2962],
12	in	IN	O	in	_	0	SENT_172	[p12l630t2907r700b2961],
13	a	DT	O	a	det	18	SENT_172	[p12l743t2921r777b2962],
14	highly	RB	O	highly	advmod	15	SENT_172	[p12l818t2904r1048b2980],
15	statistical	JJ	O	statistical	amod	18	SENT_172	[p12l1089t2904r1418b2962],
16	significant	JJ	O	significant	amod	18	SENT_172	[p12l1461t2904r1832b2980],
17	4.0-fold	JJ	O	4.0-fold	amod	18	SENT_172	[p12l1874t2904r2146b2962],
18	increase	NN	O	increase	prep_in	11	SENT_172	[p12l9t3001r292b3056],
19	in	IN	O	in	_	0	SENT_172	[p12l315t3001r386b3055],
20	the	DT	O	the	det	21	SENT_172	[p12l407t2998r520b3056],
21	risk	NN	O	risk	prep_in	18	SENT_172	[p12l543t2999r668b3056],
22	to	TO	O	to	aux	23	SENT_172	[p12l688t3006r757b3056],
23	develop	VB	O	develop	infmod	21	SENT_172	[p12l781t2998r1056b3074],
24	hypertriglyceridemia	NN	O	hypertriglyceridemia	nn	25	SENT_172	[p12l1079t2998r1820b3074],
25	(	NN	O	(	dobj	23	SENT_172	[p12l1846t2999r2022b3070],
26	95	CD	PERCENT	95	number	27	SENT_172	[p12l1846t2999r2022b3070],
27	%	NN	PERCENT	%	amod	28	SENT_172	[p12l1846t2999r2022b3070],
28	CI	NN	O	ci	dep	25	SENT_172	[p12l2046t3000r2142b3056],
29	:	:	O	:	_	0	SENT_172	[p12l2046t3000r2142b3056],
30	1.597	CD	NUMBER	1.597	number	31	SENT_172	[p12l15t3094r527b3166],
31	—	CD	NUMBER	—	dep	25	SENT_172	[p12l15t3094r527b3166],
32	10.460	CD	NUMBER	10.460	num	33	SENT_172	[p12l15t3094r527b3166],
33	)	NN	O	)	dep	31	SENT_172	[p12l15t3094r527b3166],
34	.	.	O	.	_	0	SENT_172	[p12l15t3094r527b3166],

1	Accordingly	RB	O	accordingly	advmod	10	SENT_173	[p12l560t3094r1000b3170],
2	,	,	O	,	_	0	SENT_173	[p12l560t3094r1000b3170],
3	within	IN	O	within	_	0	SENT_173	[p12l1032t3094r1267b3152],
4	theGlu/Glu	NNP	O	theGlu/Glu	nn	5	SENT_173	[p12l1297t3094r1702b3159],
5	population	NN	O	population	prep_within	10	SENT_173	[p12l1732t3094r2142b3170],
6	,	,	O	,	_	0	SENT_173	[p12l1732t3094r2142b3170],
7	[	CD	NUMBER	[	num	9	SENT_173	[p12l14t3188r364b3261],
8	3-blockers	NNS	O	3-blocker	nn	9	SENT_173	[p12l14t3188r364b3261],
9	treatment	NN	O	treatment	nsubj	10	SENT_173	[p12l400t3196r750b3246],
10	associates	VBZ	O	associate	_	0	SENT_173	[p12l786t3191r1125b3246],
11	with	IN	O	with	_	0	SENT_173	[p12l1158t3188r1320b3246],
12	a	DT	O	a	det	14	SENT_173	[p12l1356t3205r1390b3246],
13	larger	JJR	O	larger	amod	14	SENT_173	[p12l1425t3188r1624b3264],
14	occurrence	NN	O	occurrence	prep_with	10	SENT_173	[p12l1658t3205r2043b3246],
15	of	IN	O	of	_	0	SENT_173	[p12l2079t3188r2151b3246],
16	total	JJ	O	total	amod	17	SENT_173	[p12l9t3284r171b3341],
17	dyslipidemia	NN	O	dyslipidemia	prep_of	14	SENT_173	[p12l197t3283r650b3359],
18	(	CD	NUMBER	(	num	17	SENT_173	[p12l679t3284r917b3359],
19	Figure	NNP	O	Figure	nn	21	SENT_173	[p12l679t3284r917b3359],
20	3	CD	NUMBER	3	num	21	SENT_173	[p12l946t3284r1029b3355],
21	)	NN	O	)	dep	17	SENT_173	[p12l946t3284r1029b3355],
22	.	.	O	.	_	0	SENT_173	[p12l946t3284r1029b3355],

1	On	IN	O	on	_	0	SENT_174	[p12l1061t3285r1168b3341],
2	the	DT	O	the	det	3	SENT_174	[p12l1193t3283r1306b3341],
3	contrary	NN	O	contrary	prep_on	14	SENT_174	[p12l1333t3291r1643b3359],
4	,	,	O	,	_	0	SENT_174	[p12l1333t3291r1643b3359],
5	B	NN	O	b	nn	6	SENT_174	[p12l1678t3285r1711b3356],
6	blockade	NN	O	blockade	nsubj	14	SENT_174	[p12l1735t3283r2049b3341],
7	in	IN	O	in	_	0	SENT_174	[p12l2076t3286r2146b3340],
8	patients	NNS	O	patient	prep_in	6	SENT_174	[p12l9t3382r291b3455],
9	harbouring	VBG	O	harbour	partmod	8	SENT_174	[p12l321t3379r718b3455],
10	this	DT	O	this	det	11	SENT_174	[p12l747t3379r876b3437],
11	polymorphism	NN	O	polymorphism	dobj	9	SENT_174	[p12l905t3379r1430b3455],
12	did	VBD	O	do	aux	14	SENT_174	[p12l1461t3379r1573b3437],
13	not	RB	O	not	neg	14	SENT_174	[p12l1602t3386r1722b3437],
14	change	VB	O	change	_	0	SENT_174	[p12l1752t3379r2003b3455],
15	the	DT	O	the	det	16	SENT_174	[p12l2033t3379r2145b3437],
16	occurrence	NN	O	occurrence	dobj	14	SENT_174	[p12l10t3489r394b3530],
17	of	IN	O	of	_	0	SENT_174	[p12l426t3472r497b3530],
18	diabetes	NN	O	diabetes	nn	20	SENT_174	[p12l523t3473r807b3530],
19	(	CD	NUMBER	(	num	20	SENT_174	[p12l841t3473r1048b3545],
20	Table	NNP	O	Table	prep_of	16	SENT_174	[p12l841t3473r1048b3545],
21	4	CD	NUMBER	4	number	22	SENT_174	[p12l1078t3473r1141b3545],
22	)	CD	NUMBER	)	dep	20	SENT_174	[p12l1078t3473r1141b3545],
23	or	CC	O	or	_	0	SENT_174	[p12l1175t3489r1246b3530],
24	low	JJ	O	low	amod	25	SENT_174	[p12l1275t3473r1402b3530],
25	HDL	NN	O	hdl	conj_or	20	SENT_174	[p12l1430t3475r1592b3530],
26	(	CD	NUMBER	(	npadvmod	27	SENT_174	[p12l1624t3473r1768b3545],
27	not	RB	O	not	neg	28	SENT_174	[p12l1624t3473r1768b3545],
28	shown	VBN	O	show	partmod	25	SENT_174	[p12l1799t3473r2075b3545],
29	)	NN	O	)	dobj	28	SENT_174	[p12l1799t3473r2075b3545],
30	.	.	O	.	_	0	SENT_174	[p12l1799t3473r2075b3545],

1	The	DT	O	the	det	2	SENT_175	[p13l84t19r216b77],
2	impact	NN	O	impact	nsubj	17	SENT_175	[p13l241t22r485b95],
3	of	IN	O	of	_	0	SENT_175	[p13l509t19r581b77],
4	B-blockade	NN	O	b-blockade	prep_of	2	SENT_175	[p13l604t19r980b92],
5	in	IN	O	in	_	0	SENT_175	[p13l1005t22r1075b76],
6	the	DT	O	the	det	7	SENT_175	[p13l1099t19r1211b77],
7	incidence	NN	O	incidence	prep_in	4	SENT_175	[p13l1236t19r1577b77],
8	of	IN	O	of	_	0	SENT_175	[p13l1602t19r1673b77],
9	dyslipidemia	NN	O	dyslipidemia	prep_of	7	SENT_175	[p13l1694t19r2147b95],
10	among	IN	O	among	_	0	SENT_175	[p13l10t131r255b190],
11	patients	NNS	O	patient	prep_among	9	SENT_175	[p13l277t117r559b190],
12	carrying	VBG	O	carry	partmod	11	SENT_175	[p13l584t117r875b190],
13	the	DT	O	the	det	16	SENT_175	[p13l898t114r1010b172],
14	B3AR	NN	O	b3ar	nn	16	SENT_175	[p13l1040t116r1209b187],
15	ARG64	NN	O	arg64	nn	16	SENT_175	[p13l1230t116r1476b172],
16	variant	NN	O	variant	dobj	12	SENT_175	[p13l1499t117r1750b172],
17	resulted	VBD	O	result	_	0	SENT_175	[p13l1773t114r2053b172],
18	in	IN	O	in	_	0	SENT_175	[p13l2076t117r2146b171],
19	a	DT	O	a	det	21	SENT_175	[p13l10t226r45b267],
20	larger	JJR	O	larger	amod	21	SENT_175	[p13l81t209r280b285],
21	incidence	NN	O	incidence	prep_in	17	SENT_175	[p13l316t209r656b267],
22	of	IN	O	of	_	0	SENT_175	[p13l695t209r766b267],
23	patients	NNS	O	patient	prep_of	21	SENT_175	[p13l799t212r1081b285],
24	with	IN	O	with	_	0	SENT_175	[p13l1116t209r1278b267],
25	isolated	VBN	O	isolate	amod	28	SENT_175	[p13l1315t209r1587b267],
26	hypertriglycer	NN	O	hypertriglycer	nn	28	SENT_175	[p13l1624t209r2145b285],
27	—	NN	O	—	nn	28	SENT_175	[p13l1624t209r2145b285],
28	idemia	NN	O	idemia	prep_with	17	SENT_175	[p13l9t304r266b374],
29	,	,	O	,	_	0	SENT_175	[p13l9t304r266b374],
30	which	WDT	O	which	nsubj	33	SENT_175	[p13l337t304r558b362],
31	was	VBD	O	be	cop	33	SENT_175	[p13l624t321r751b362],
32	about	IN	O	about	dep	33	SENT_175	[p13l821t304r1021b362],
33	three-fold	JJ	O	three-fold	rcmod	28	SENT_175	[p13l1089t304r1438b362],
34	larger	JJR	O	larger	dep	33	SENT_175	[p13l1505t304r1704b380],
35	than	IN	O	than	_	0	SENT_175	[p13l1771t304r1936b362],
36	that	DT	O	that	prep_than	33	SENT_175	[p13l2003t304r2146b362],
37	recorded	VBN	O	record	partmod	36	SENT_175	[p13l9t398r316b456],
38	among	IN	O	among	_	0	SENT_175	[p13l350t415r595b474],
39	patients	NNS	O	patient	prep_among	37	SENT_175	[p13l626t401r908b474],
40	with	IN	O	with	_	0	SENT_175	[p13l941t398r1102b456],
41	the	DT	O	the	det	43	SENT_175	[p13l1135t399r1247b456],
42	same	JJ	O	same	amod	43	SENT_175	[p13l1284t415r1458b456],
43	allele	NN	O	allele	prep_with	37	SENT_175	[p13l1494t398r1675b456],
44	treated	VBN	O	treat	partmod	43	SENT_175	[p13l1709t398r1954b456],
45	with	IN	O	with	_	0	SENT_175	[p13l1985t398r2146b456],
46	other	JJ	O	other	amod	48	SENT_175	[p13l10t494r198b552],
47	antihypertensive	JJ	O	antihypertensive	amod	48	SENT_175	[p13l248t494r843b570],
48	drugs	NNS	O	drug	prep_with	44	SENT_175	[p13l895t494r1103b570],
49	,	,	O	,	_	0	SENT_175	[p13l895t494r1103b570],
50	although	IN	O	although	mark	58	SENT_175	[p13l1159t494r1497b570],
51	,	,	O	,	_	0	SENT_175	[p13l1159t494r1497b570],
52	again	RB	O	again	advmod	58	SENT_175	[p13l1553t497r1759b570],
53	,	,	O	,	_	0	SENT_175	[p13l1553t497r1759b570],
54	statistical	JJ	O	statistical	amod	55	SENT_175	[p13l1817t494r2146b552],
55	significance	NN	O	significance	nsubjpass	58	SENT_175	[p13l11t588r427b664],
56	was	VBD	O	be	auxpass	58	SENT_175	[p13l486t605r614b646],
57	not	RB	O	not	neg	58	SENT_175	[p13l675t596r796b646],
58	achieved	VBN	O	achieve	advcl	33	SENT_175	[p13l856t588r1167b646],
59	on	IN	O	on	_	0	SENT_175	[p13l1227t605r1318b646],
60	account	NN	O	account	_	0	SENT_175	[p13l1379t596r1660b646],
61	of	IN	O	of	_	0	SENT_175	[p13l1720t588r1791b646],
62	the	DT	O	the	det	64	SENT_175	[p13l1847t588r1960b646],
63	low	JJ	O	low	amod	64	SENT_175	[p13l2021t588r2148b646],
64	incidence	NN	O	incidence	prep_on_account_of	58	SENT_175	[p13l9t683r350b741],
65	of	IN	O	of	_	0	SENT_175	[p13l393t683r464b741],
66	this	DT	O	this	det	67	SENT_175	[p13l500t683r629b741],
67	polymorphism	NN	O	polymorphism	prep_of	64	SENT_175	[p13l671t683r1196b759],
68	in	IN	O	in	_	0	SENT_175	[p13l1237t686r1308b740],
69	the	DT	O	the	det	70	SENT_175	[p13l1348t683r1461b741],
70	population	NN	O	population	prep_in	67	SENT_175	[p13l1502t684r1894b759],
71	(	CD	NUMBER	(	num	74	SENT_175	[p13l1939t683r2145b755],
72	Table	NNP	O	Table	nn	74	SENT_175	[p13l1939t683r2145b755],
73	3	CD	NUMBER	3	num	74	SENT_175	[p13l11t778r94b850],
74	)	NN	O	)	xcomp	58	SENT_175	[p13l11t778r94b850],
75	.	.	O	.	_	0	SENT_175	[p13l11t778r94b850],

1	There	EX	O	there	expl	2	SENT_176	[p13l121t778r321b836],
2	was	VBD	O	be	_	0	SENT_176	[p13l344t795r472b836],
3	no	DT	O	no	det	4	SENT_176	[p13l497t795r588b836],
4	difference	NN	O	difference	nsubj	2	SENT_176	[p13l614t778r963b836],
5	in	IN	O	in	_	0	SENT_176	[p13l988t781r1058b835],
6	the	DT	O	the	det	7	SENT_176	[p13l1082t778r1195b836],
7	incidence	NN	O	incidence	prep_in	4	SENT_176	[p13l1220t778r1561b836],
8	of	IN	O	of	_	0	SENT_176	[p13l1587t778r1658b836],
9	diabetes	NN	O	diabetes	prep_of	7	SENT_176	[p13l1679t778r1964b836],
10	after	IN	O	after	mark	25	SENT_176	[p13l1989t778r2147b836],
11	[	CD	NUMBER	[	number	12	SENT_176	[p13l14t875r47b946],
12	3	CD	NUMBER	3	num	13	SENT_176	[p13l14t875r47b946],
13	blockade	NN	O	blockade	nsubj	25	SENT_176	[p13l94t874r408b931],
14	in	IN	O	in	_	0	SENT_176	[p13l458t877r528b931],
15	the	DT	O	the	det	17	SENT_176	[p13l577t874r689b931],
16	B3ARG64	NN	O	b3arg64	nn	17	SENT_176	[p13l743t875r1058b946],
17	patients	NNS	O	patient	prep_in	13	SENT_176	[p13l1108t877r1390b949],
18	compared	VBN	O	compare	_	0	SENT_176	[p13l1440t874r1790b949],
19	to	TO	O	to	prepc_compared_to	17	SENT_176	[p13l1838t881r1907b931],
20	those	DT	O	those	pobj	17	SENT_176	[p13l1956t874r2145b931],
21	treated	VBN	O	treat	partmod	20	SENT_176	[p13l9t969r254b1026],
22	with	IN	O	with	_	0	SENT_176	[p13l281t969r443b1026],
23	other	JJ	O	other	amod	24	SENT_176	[p13l473t969r661b1026],
24	antihypertensives	NNS	O	antihypertensive	prep_with	21	SENT_176	[p13l690t969r1316b1044],
25	(	VBP	O	(	advcl	2	SENT_176	[p13l1350t969r1557b1041],
26	Table	NNP	O	Table	nsubj	28	SENT_176	[p13l1350t969r1557b1041],
27	4	CD	NUMBER	4	num	28	SENT_176	[p13l1587t969r1672b1041],
28	)	CD	NUMBER	)	xcomp	25	SENT_176	[p13l1587t969r1672b1041],
29	.	.	O	.	_	0	SENT_176	[p13l1587t969r1672b1041],

1	Discussion	NN	O	discussion	_	0	SENT_177	[p13l12t1198r404b1255],

1	The	DT	O	the	det	3	SENT_178	[p13l8t1293r140b1350],
2	major	JJ	O	major	amod	3	SENT_178	[p13l178t1295r385b1368],
3	finding	NN	O	finding	nsubj	9	SENT_178	[p13l421t1292r681b1368],
4	of	IN	O	of	_	0	SENT_178	[p13l718t1292r789b1350],
5	our	PRP$	O	we	poss	6	SENT_178	[p13l823t1309r941b1350],
6	study	NN	O	study	prep_of	3	SENT_178	[p13l979t1293r1171b1368],
7	is	VBZ	O	be	cop	9	SENT_178	[p13l1205t1295r1256b1350],
8	the	DT	O	the	det	9	SENT_178	[p13l1294t1292r1406b1350],
9	observation	NN	O	observation	_	0	SENT_178	[p13l1445t1292r1859b1350],
10	that	IN	O	that	nsubj	13	SENT_178	[p13l1896t1292r2039b1350],
11	in	IN	O	in	_	0	SENT_178	[p13l2076t1295r2146b1349],
12	patients	NNS	O	patient	prep_in	13	SENT_178	[p13l9t1391r291b1464],
13	carrying	VBG	O	carry	rcmod	9	SENT_178	[p13l323t1391r614b1464],
14	the	DT	O	the	det	16	SENT_178	[p13l643t1388r756b1446],
15	BZAR	NNP	O	BZAR	nn	16	SENT_178	[p13l793t1389r962b1461],
16	Glu	NNP	O	Glu	nsubj	25	SENT_178	[p13l993t1388r1119b1446],
17	27	CD	NUMBER	27	num	16	SENT_178	[p13l1151t1389r1232b1445],
18	variant	JJ	O	variant	dep	25	SENT_178	[p13l1263t1391r1514b1446],
19	in	IN	O	in	_	0	SENT_178	[p13l1545t1391r1615b1445],
20	homozygosity	NN	O	homozygosity	prep_in	18	SENT_178	[p13l1646t1388r2149b1464],
21	the	DT	O	the	det	22	SENT_178	[p13l9t1481r122b1539],
22	treatment	NN	O	treatment	nsubj	25	SENT_178	[p13l185t1489r535b1539],
23	with	IN	O	with	_	0	SENT_178	[p13l595t1481r756b1539],
24	B-blockers	NNS	MISC	b-blocker	prep_with	22	SENT_178	[p13l823t1481r1174b1554],
25	induced	VBD	O	induce	xcomp	13	SENT_178	[p13l1237t1481r1523b1539],
26	an	DT	O	a	det	27	SENT_178	[p13l1586t1498r1670b1539],
27	increase	NN	O	increase	dobj	25	SENT_178	[p13l1732t1484r2015b1539],
28	of	IN	O	of	_	0	SENT_178	[p13l2079t1481r2151b1539],
29	incidence	NN	O	incidence	prep_of	27	SENT_178	[p13l9t1577r350b1635],
30	of	IN	O	of	_	0	SENT_178	[p13l382t1577r453b1635],
31	dyslipidemia	NN	O	dyslipidemia	prep_of	29	SENT_178	[p13l480t1577r950b1653],
32	.	.	O	.	_	0	SENT_178	[p13l480t1577r950b1653],

1	In	IN	O	in	_	0	SENT_179	[p13l985t1580r1058b1634],
2	fact	NN	O	fact	prep_in	11	SENT_179	[p13l1088t1577r1233b1648],
3	,	,	O	,	_	0	SENT_179	[p13l1088t1577r1233b1648],
4	in	IN	O	in	_	0	SENT_179	[p13l1268t1580r1338b1634],
5	Gln/Gln	NN	O	gln/gln	nn	8	SENT_179	[p13l1370t1577r1663b1643],
6	and	CC	O	and	_	0	SENT_179	[p13l1694t1577r1825b1635],
7	Gln/Glu	NN	O	gln/glu	conj_and	5	SENT_179	[p13l1856t1577r2146b1643],
8	groups	NNS	O	group	prep_in	11	SENT_179	[p13l9t1690r245b1749],
9	B-blocker	JJ	MISC	b-blocker	amod	10	SENT_179	[p13l284t1673r606b1746],
10	treatment	NN	O	treatment	nsubj	11	SENT_179	[p13l639t1680r990b1731],
11	failed	VBD	O	fail	_	0	SENT_179	[p13l1023t1673r1218b1731],
12	to	TO	O	to	aux	13	SENT_179	[p13l1251t1680r1321b1731],
13	induce	VB	O	induce	xcomp	11	SENT_179	[p13l1356t1673r1594b1731],
14	any	DT	O	any	det	15	SENT_179	[p13l1631t1690r1760b1749],
15	change	NN	O	change	dobj	13	SENT_179	[p13l1793t1673r2043b1749],
16	of	IN	O	of	_	0	SENT_179	[p13l2079t1673r2150b1731],
17	lipid	NN	O	lipid	nn	18	SENT_179	[p13l9t1768r170b1843],
18	profile	NN	O	profile	prep_of	15	SENT_179	[p13l200t1767r448b1843],
19	.	.	O	.	_	0	SENT_179	[p13l200t1767r448b1843],

1	This	DT	O	this	det	2	SENT_180	[p13l483t1768r632b1825],
2	result	NN	O	result	nsubj	5	SENT_180	[p13l664t1768r859b1825],
3	is	VBZ	O	be	cop	5	SENT_180	[p13l891t1771r941b1825],
4	particularly	RB	O	particularly	advmod	5	SENT_180	[p13l973t1768r1382b1843],
5	noteworthy	JJ	O	noteworthy	_	0	SENT_180	[p13l1411t1768r1838b1843],
6	,	,	O	,	_	0	SENT_180	[p13l1411t1768r1838b1843],
7	because	IN	O	because	mark	9	SENT_180	[p13l1872t1768r2145b1825],
8	it	PRP	O	it	nsubj	9	SENT_180	[p13l9t1866r58b1920],
9	allows	VBZ	O	allow	advcl	5	SENT_180	[p13l91t1863r309b1920],
10	to	TO	O	to	aux	11	SENT_180	[p13l343t1870r412b1920],
11	identify	VB	O	identify	xcomp	9	SENT_180	[p13l446t1862r724b1938],
12	a	DT	O	a	det	13	SENT_180	[p13l755t1879r789b1920],
13	subpopulation	NN	O	subpopulation	dobj	11	SENT_180	[p13l824t1863r1336b1938],
14	where	WRB	O	where	advmod	24	SENT_180	[p13l1367t1863r1580b1920],
15	the	DT	O	the	det	16	SENT_180	[p13l1614t1863r1726b1920],
16	occurrence	NN	O	occurrence	nsubj	24	SENT_180	[p13l1761t1879r2145b1920],
17	of	IN	O	of	_	0	SENT_180	[p13l10t1958r81b2016],
18	dyslipidemia	NN	O	dyslipidemia	prep_of	16	SENT_180	[p13l128t1958r581b2034],
19	after	IN	O	after	_	0	SENT_180	[p13l632t1958r790b2016],
20	B	NN	O	b	nn	21	SENT_180	[p13l844t1960r878b2031],
21	blockade	NN	O	blockade	prep_after	18	SENT_180	[p13l926t1958r1240b2016],
22	is	VBZ	O	be	cop	24	SENT_180	[p13l1292t1961r1343b2016],
23	very	RB	O	very	advmod	24	SENT_180	[p13l1392t1975r1545b2034],
24	likely	JJ	O	likely	advcl	11	SENT_180	[p13l1593t1958r1796b2034],
25	,	,	O	,	_	0	SENT_180	[p13l1593t1958r1796b2034],
26	with	IN	O	with	_	0	SENT_180	[p13l1850t1958r2011b2016],
27	an	DT	O	a	det	28	SENT_180	[p13l2062t1975r2146b2016],
28	incidence	NN	O	incidence	prep_with	24	SENT_180	[p13l9t2052r350b2109],
29	that	WDT	O	that	nsubj	30	SENT_180	[p13l402t2052r545b2109],
30	is	VBZ	O	be	rcmod	28	SENT_180	[p13l596t2055r647b2109],
31	above	IN	O	above	_	0	SENT_180	[p13l699t2052r903b2109],
32	60	CD	PERCENT	60	num	33	SENT_180	[p13l957t2053r1126b2109],
33	%	NN	PERCENT	%	prep_above	30	SENT_180	[p13l957t2053r1126b2109],
34	.	.	O	.	_	0	SENT_180	[p13l957t2053r1126b2109],

1	The	DT	O	the	det	2	SENT_181	[p13l1180t2052r1312b2109],
2	identification	NN	O	identification	nsubj	6	SENT_181	[p13l1365t2052r1846b2109],
3	of	IN	O	of	_	0	SENT_181	[p13l1898t2052r1969b2109],
4	this	DT	O	this	det	5	SENT_181	[p13l2017t2052r2146b2109],
5	subpopulation	NN	O	subpopulation	prep_of	2	SENT_181	[p13l11t2147r524b2223],
6	makes	VBZ	O	make	_	0	SENT_181	[p13l553t2147r772b2205],
7	safer	JJR	O	safer	acomp	6	SENT_181	[p13l803t2147r963b2205],
8	the	DT	O	the	det	10	SENT_181	[p13l991t2147r1103b2205],
9	long-term	JJ	O	long-term	amod	10	SENT_181	[p13l1134t2147r1485b2223],
10	treatment	NN	O	treatment	dep	7	SENT_181	[p13l1514t2154r1865b2205],
11	with	IN	O	with	_	0	SENT_181	[p13l1892t2147r2053b2205],
12	[	NN	O	[	nn	13	SENT_181	[p13l2087t2149r2146b2220, p13l7t2241r297b2299],
13	3blockers	NNS	O	3blocker	prep_with	10	SENT_181	[p13l2087t2149r2146b2220, p13l7t2241r297b2299],
14	in	IN	O	in	_	0	SENT_181	[p13l338t2244r408b2298],
15	patients	NNS	O	patient	prep_in	13	SENT_181	[p13l448t2244r730b2317],
16	who	WP	O	who	nsubj	19	SENT_181	[p13l769t2241r923b2299],
17	do	VBP	O	do	aux	19	SENT_181	[p13l964t2242r1051b2299],
18	not	RB	O	not	neg	19	SENT_181	[p13l1092t2249r1213b2299],
19	carry	VB	O	carry	dep	6	SENT_181	[p13l1253t2258r1430b2317],
20	the	DT	O	the	det	21	SENT_181	[p13l1468t2241r1580b2299],
21	polymorphism	NN	O	polymorphism	dobj	19	SENT_181	[p13l1621t2241r2146b2317],
22	and	CC	O	and	_	0	SENT_181	[p13l10t2337r141b2395],
23	who	WP	O	who	nsubj	24	SENT_181	[p13l168t2337r321b2395],
24	represent	VBP	O	represent	dep	6	SENT_181	[p13l352t2344r677b2413],
25	the	DT	O	the	det	26	SENT_181	[p13l707t2337r819b2395],
26	majority	NN	O	majority	dobj	24	SENT_181	[p13l849t2340r1153b2413],
27	of	IN	O	of	_	0	SENT_181	[p13l1180t2337r1252b2395],
28	hypertensive	JJ	O	hypertensive	amod	29	SENT_181	[p13l1277t2337r1731b2413],
29	patients	NNS	O	patient	prep_of	26	SENT_181	[p13l1761t2340r2061b2413],
30	.	.	O	.	_	0	SENT_181	[p13l1761t2340r2061b2413],

1	In	IN	O	in	_	0	SENT_182	[p13l87t2434r159b2488],
2	the	DT	O	the	det	4	SENT_182	[p13l186t2431r299b2489],
3	overall	JJ	O	overall	amod	4	SENT_182	[p13l328t2431r565b2489],
4	population	NN	O	population	prep_in	7	SENT_182	[p13l593t2431r1003b2507],
5	,	,	O	,	_	0	SENT_182	[p13l593t2431r1003b2507],
6	we	PRP	O	we	nsubj	7	SENT_182	[p13l1033t2448r1129b2489],
7	found	VBD	O	find	_	0	SENT_182	[p13l1158t2431r1369b2489],
8	that	IN	O	that	complm	15	SENT_182	[p13l1396t2431r1539b2489],
9	the	DT	O	the	det	13	SENT_182	[p13l1566t2432r1678b2489],
10	BZAR	NNP	O	BZAR	nn	13	SENT_182	[p13l1712t2433r1882b2504],
11	Glu	NNP	O	Glu	nn	13	SENT_182	[p13l1909t2431r2035b2489],
12	27	CD	NUMBER	27	num	13	SENT_182	[p13l2064t2433r2145b2488],
13	variant	NN	O	variant	nsubjpass	15	SENT_182	[p13l7t2530r258b2584],
14	is	VBZ	O	be	auxpass	15	SENT_182	[p13l281t2530r331b2584],
15	associated	VBN	O	associate	ccomp	7	SENT_182	[p13l355t2527r711b2584],
16	with	IN	O	with	_	0	SENT_182	[p13l731t2527r892b2584],
17	a	DT	O	a	det	19	SENT_182	[p13l916t2543r951b2584],
18	larger	JJR	O	larger	amod	19	SENT_182	[p13l973t2527r1172b2602],
19	occurrence	NN	O	occurrence	prep_with	15	SENT_182	[p13l1194t2543r1579b2584],
20	of	IN	O	of	_	0	SENT_182	[p13l1603t2526r1675b2584],
21	dyslipidemia	NN	O	dyslipidemia	prep_of	19	SENT_182	[p13l1694t2527r2147b2602],
22	due	JJ	O	due	_	0	SENT_182	[p13l10t2622r136b2680],
23	to	TO	O	to	_	0	SENT_182	[p13l179t2629r248b2680],
24	increased	VBN	O	increase	amod	26	SENT_182	[p13l291t2622r622b2680],
25	serum	NN	O	serum	nn	26	SENT_182	[p13l666t2639r878b2680],
26	triglycerides	NNS	O	triglyceride	prep_due_to	21	SENT_182	[p13l921t2622r1368b2698],
27	,	,	O	,	_	0	SENT_182	[p13l921t2622r1368b2698],
28	independently	RB	O	independently	advmod	15	SENT_182	[p13l1416t2622r1937b2698],
29	from	IN	O	from	_	0	SENT_182	[p13l1977t2622r2146b2680],
30	treatment	NN	O	treatment	prep_from	15	SENT_182	[p13l9t2723r377b2773],
31	.	.	O	.	_	0	SENT_182	[p13l9t2723r377b2773],

1	These	DT	O	these	det	2	SENT_183	[p13l411t2716r613b2773],
2	data	NNS	O	datum	nsubj	19	SENT_183	[p13l648t2716r796b2773],
3	are	VBP	O	be	cop	19	SENT_183	[p13l829t2732r930b2773],
4	in	IN	O	in	_	0	SENT_183	[p13l964t2719r1034b2772],
5	line	NN	O	line	prep_in	19	SENT_183	[p13l1066t2716r1197b2773],
6	with	IN	O	with	_	0	SENT_183	[p13l1229t2716r1391b2773],
7	those	DT	O	those	prep_with	5	SENT_183	[p13l1423t2716r1612b2773],
8	of	IN	O	of	_	0	SENT_183	[p13l1645t2715r1717b2773],
9	Iwamoto	NNP	PERSON	Iwamoto	prep_of	7	SENT_183	[p13l1746t2718r2059b2773],
10	et	FW	O	et	nn	12	SENT_183	[p13l2092t2721r2153b2773],
11	al.	FW	O	al.	nn	12	SENT_183	[p13l10t2802r156b2867],
12	”	NN	O	”	dep	9	SENT_183	[p13l10t2802r156b2867],
13	and	CC	O	and	_	0	SENT_183	[p13l207t2809r339b2866],
14	of	IN	O	of	_	0	SENT_183	[p13l388t2808r459b2866],
15	Ehrenborg	NNP	LOCATION	Ehrenborg	prep_of	19	SENT_183	[p13l505t2809r875b2884],
16	et	FW	O	et	nn	17	SENT_183	[p13l923t2814r984b2866],
17	al.	FW	O	al.	dep	19	SENT_183	[p13l1027t2802r1175b2867],
18	1	CD	NUMBER	1	num	19	SENT_183	[p13l1027t2802r1175b2867],
19	°	NN	O	°	conj_and	19	SENT_183	[p13l1027t2802r1175b2867],
20	who	WP	O	who	nsubj	21	SENT_183	[p13l1223t2809r1375b2866],
21	described	VBD	O	describe	rcmod	19	SENT_183	[p13l1426t2809r1757b2866],
22	the	DT	O	the	det	24	SENT_183	[p13l1807t2809r1919b2866],
23	same	JJ	O	same	amod	24	SENT_183	[p13l1971t2826r2145b2866],
24	association	NN	O	association	dobj	21	SENT_183	[p13l10t2908r400b2963],
25	between	IN	O	between	_	0	SENT_183	[p13l441t2905r738b2963],
26	the	DT	O	the	det	28	SENT_183	[p13l782t2905r894b2963],
27	BZAR	NNP	O	BZAR	nn	28	SENT_183	[p13l942t2907r1112b2978],
28	Glu	NNP	O	Glu	prep_between	24	SENT_183	[p13l1155t2905r1281b2963],
29	27	CD	NUMBER	27	number	30	SENT_183	[p13l1326t2907r1407b2962],
30	variant	JJ	O	variant	amod	28	SENT_183	[p13l1450t2908r1701b2963],
31	and	CC	O	and	_	0	SENT_183	[p13l1744t2905r1875b2963],
32	hypertriglyceridemia	NN	O	hypertriglyceridemia	dobj	21	SENT_183	[p13l1918t2905r2145b2981, p13l9t3000r544b3076],
33	in	IN	O	in	_	0	SENT_183	[p13l578t3003r648b3057],
34	unselected	JJ	O	unselected	amod	35	SENT_183	[p13l680t3000r1057b3058],
35	populations	NNS	O	population	prep_in	32	SENT_183	[p13l1090t3000r1532b3076],
36	.	.	O	.	_	0	SENT_183	[p13l1090t3000r1532b3076],

1	The	DT	O	the	det	2	SENT_184	[p13l1568t3000r1700b3058],
2	mechanism	NN	O	mechanism	nsubj	19	SENT_184	[p13l1735t3000r2146b3058],
3	by	IN	O	by	_	0	SENT_184	[p13l7t3095r95b3171],
4	which	WDT	O	which	agent	10	SENT_184	[p13l119t3095r339b3153],
5	the	DT	O	the	det	8	SENT_184	[p13l368t3095r480b3153],
6	BZAR	NN	O	bzar	nn	8	SENT_184	[p13l514t3097r684b3168],
7	Glu27	NN	O	glu27	nn	8	SENT_184	[p13l712t3095r924b3153],
8	variant	NN	O	variant	nsubjpass	10	SENT_184	[p13l953t3098r1204b3153],
9	is	VBZ	O	be	auxpass	10	SENT_184	[p13l1232t3098r1282b3153],
10	associated	VBN	O	associate	rcmod	2	SENT_184	[p13l1313t3095r1668b3153],
11	with	IN	O	with	_	0	SENT_184	[p13l1695t3095r1856b3153],
12	a	DT	O	a	det	14	SENT_184	[p13l1886t3112r1920b3153],
13	larger	JJR	O	larger	amod	14	SENT_184	[p13l1949t3095r2147b3171],
14	incidence	NN	O	incidence	prep_with	10	SENT_184	[p13l9t3189r350b3247],
15	of	IN	O	of	_	0	SENT_184	[p13l386t3189r457b3247],
16	dyslipidemia	NN	O	dyslipidemia	prep_of	14	SENT_184	[p13l488t3189r940b3265],
17	is	VBZ	O	be	cop	19	SENT_184	[p13l974t3192r1024b3247],
18	presently	RB	O	presently	advmod	19	SENT_184	[p13l1059t3190r1386b3265],
19	unknown	JJ	O	unknown	_	0	SENT_184	[p13l1416t3189r1777b3247],
20	.	.	O	.	_	0	SENT_184	[p13l1416t3189r1777b3247],

1	However	RB	O	however	advmod	14	SENT_185	[p13l1817t3192r2141b3260],
2	,	,	O	,	_	0	SENT_185	[p13l1817t3192r2141b3260],
3	the	DT	O	the	det	5	SENT_185	[p13l9t3285r122b3343],
4	key	JJ	O	key	amod	5	SENT_185	[p13l179t3285r300b3361],
5	role	NN	O	role	nsubjpass	14	SENT_185	[p13l354t3285r485b3343],
6	of	IN	O	of	_	0	SENT_185	[p13l543t3285r615b3343],
7	BZAR	NN	ORGANIZATION	bzar	prep_of	5	SENT_185	[p13l671t3287r840b3358],
8	in	IN	O	in	_	0	SENT_185	[p13l894t3288r965b3342],
9	the	DT	O	the	det	10	SENT_185	[p13l1021t3285r1133b3343],
10	regulation	NN	O	regulation	prep_in	7	SENT_185	[p13l1190t3285r1554b3361],
11	of	IN	O	of	_	0	SENT_185	[p13l1610t3285r1682b3343],
12	lypolysis	NN	O	lypolysis	prep_of	10	SENT_185	[p13l1733t3285r2038b3361],
13	is	VBZ	O	be	auxpass	14	SENT_185	[p13l2095t3288r2146b3343],
14	acquired	VBN	O	acquire	_	0	SENT_185	[p13l10t3379r331b3455],
15	.	.	O	.	_	0	SENT_185	[p13l10t3379r331b3455],

1	Indeed	RB	O	indeed	advmod	6	SENT_186	[p13l367t3379r626b3450],
2	,	,	O	,	_	0	SENT_186	[p13l367t3379r626b3450],
3	it	PRP	O	it	nsubjpass	6	SENT_186	[p13l662t3382r711b3437],
4	has	VBZ	O	have	aux	6	SENT_186	[p13l742t3379r858b3437],
5	been	VBN	O	be	auxpass	6	SENT_186	[p13l888t3380r1057b3437],
6	demonstrated	VBN	O	demonstrate	_	0	SENT_186	[p13l1089t3379r1579b3437],
7	that	IN	O	that	complm	17	SENT_186	[p13l1609t3380r1753b3437],
8	in	IN	O	in	_	0	SENT_186	[p13l1784t3382r1854b3436],
9	skeletal	JJ	O	skeletal	amod	10	SENT_186	[p13l1887t3379r2146b3437],
10	muscle	NN	O	muscle	prep_in	17	SENT_186	[p13l9t3475r273b3545],
11	,	,	O	,	_	0	SENT_186	[p13l9t3475r273b3545],
12	BZAR	NN	O	bzar	nn	13	SENT_186	[p13l316t3476r485b3547],
13	subtype	NN	O	subtype	nsubj	17	SENT_186	[p13l519t3475r790b3550],
14	is	VBZ	O	be	cop	17	SENT_186	[p13l825t3478r875b3532],
15	the	DT	O	the	det	17	SENT_186	[p13l909t3475r1022b3532],
16	only	JJ	O	only	amod	17	SENT_186	[p13l1057t3475r1217b3550],
17	receptor	NN	O	receptor	ccomp	6	SENT_186	[p13l1248t3482r1538b3550],
18	involved	VBN	O	involve	partmod	17	SENT_186	[p13l1571t3475r1879b3532],
19	in	IN	O	in	_	0	SENT_186	[p13l1913t3478r1983b3532],
20	this	DT	O	this	det	21	SENT_186	[p13l2017t3475r2146b3532],
21	function	NN	O	function	prep_in	18	SENT_186	[p13l9t3561r401b3638],
22	,	,	O	,	_	0	SENT_186	[p13l9t3561r401b3638],
23	”	CD	NUMBER	”	appos	21	SENT_186	[p13l9t3561r401b3638],
24	whereas	IN	O	whereas	mark	34	SENT_186	[p13l435t3568r719b3626],
25	in	IN	O	in	_	0	SENT_186	[p13l755t3571r826b3625],
26	adipose	NN	O	adipose	nn	27	SENT_186	[p13l861t3568r1125b3644],
27	tissue	NN	O	tissue	prep_in	34	SENT_186	[p13l1161t3571r1356b3626],
28	[	CD	NUMBER	[	num	29	SENT_186	[p13l1397t3570r1461b3641],
29	31	CD	NUMBER	31	nsubjpass	34	SENT_186	[p13l1397t3570r1461b3641],
30	and	CC	O	and	_	0	SENT_186	[p13l1500t3568r1631b3626],
31	B3AR	NN	O	b3ar	nsubjpass	34	SENT_186	[p13l1670t3570r1840b3641],
32	are	VBP	O	be	auxpass	34	SENT_186	[p13l1874t3585r1975b3626],
33	also	RB	O	also	advmod	34	SENT_186	[p13l2012t3568r2146b3626],
34	involved	VBN	O	involve	advcl	18	SENT_186	[p13l9t3654r404b3719],
35	.	.	O	.	_	0	SENT_186	[p13l9t3654r404b3719],

1	”	NN	O	”	nsubj	9	SENT_187	[p13l9t3654r404b3719],
2	The	DT	O	the	det	3	SENT_187	[p13l451t3662r584b3719],
3	Glu27	NN	O	glu27	dep	1	SENT_187	[p13l634t3662r846b3719],
4	is	VBZ	O	be	cop	9	SENT_187	[p13l895t3665r946b3719],
5	a	DT	O	a	det	9	SENT_187	[p13l995t3679r1030b3719],
6	gain-of	JJ	O	gain-of	amod	9	SENT_187	[p13l1077t3661r1659b3737],
7	—	NN	O	—	nn	9	SENT_187	[p13l1077t3661r1659b3737],
8	function	NN	O	function	nn	9	SENT_187	[p13l1077t3661r1659b3737],
9	variant	NN	O	variant	_	0	SENT_187	[p13l1705t3665r1956b3719],
10	that	WDT	O	that	nsubj	11	SENT_187	[p13l2003t3662r2147b3719],
11	causes	VBZ	O	cause	rcmod	9	SENT_187	[p13l10t3774r228b3815],
12	an	DT	O	a	det	13	SENT_187	[p13l260t3774r344b3815],
13	increase	NN	O	increase	dobj	11	SENT_187	[p13l374t3761r656b3815],
14	in	IN	O	in	_	0	SENT_187	[p13l688t3761r758b3815],
15	the	DT	O	the	det	17	SENT_187	[p13l787t3758r899b3815],
16	BZAR	NN	ORGANIZATION	bzar	nn	17	SENT_187	[p13l935t3759r1104b3830],
17	signaling	NN	O	signaling	prep_in	13	SENT_187	[p13l1134t3758r1471b3833],
18	,	,	O	,	_	0	SENT_187	[p13l1134t3758r1471b3833],
19	and	CC	O	and	_	0	SENT_187	[p13l1506t3758r1637b3815],
20	therefore	RB	O	therefore	advmod	23	SENT_187	[p13l1667t3757r1986b3815],
21	it	PRP	O	it	nsubj	23	SENT_187	[p13l2017t3761r2066b3815],
22	is	VBZ	O	be	cop	23	SENT_187	[p13l2096t3761r2146b3815],
23	possible	JJ	O	possible	conj_and	9	SENT_187	[p14l9t27r289b103],
24	to	TO	O	to	aux	25	SENT_187	[p14l336t34r405b85],
25	speculate	VB	O	speculate	xcomp	23	SENT_187	[p14l454t27r777b103],
26	that	IN	O	that	complm	33	SENT_187	[p14l825t27r968b85],
27	the	DT	O	the	det	29	SENT_187	[p14l1013t27r1126b85],
28	resulting	VBG	O	result	amod	29	SENT_187	[p14l1173t27r1484b103],
29	physiology	NN	O	physiology	nsubj	33	SENT_187	[p14l1529t27r1920b103],
30	is	VBZ	O	be	cop	33	SENT_187	[p14l1963t30r2014b85],
31	an	DT	O	a	det	33	SENT_187	[p14l2062t44r2146b85],
32	increased	VBN	O	increase	amod	33	SENT_187	[p14l9t122r339b180],
33	lypolysis	NN	O	lypolysis	ccomp	25	SENT_187	[p14l363t122r687b198],
34	,	,	O	,	_	0	SENT_187	[p14l363t122r687b198],
35	leading	VBG	O	lead	appos	33	SENT_187	[p14l716t122r977b198],
36	to	TO	O	to	_	0	SENT_187	[p14l1000t129r1070b180],
37	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_to	35	SENT_187	[p14l1095t122r1854b198],
38	.	.	O	.	_	0	SENT_187	[p14l1095t122r1854b198],

1	Regarding	VBG	O	regard	_	0	SENT_188	[p14l1884t122r2148b198, p14l9t220r122b293],
2	the	DT	O	the	det	3	SENT_188	[p14l153t217r265b275],
3	reasons	NNS	O	reason	prep_regarding	30	SENT_188	[p14l299t234r559b275],
4	why	WRB	O	why	advmod	11	SENT_188	[p14l591t217r744b293],
5	[	NN	O	[	nn	8	SENT_188	[p14l779t217r1101b289],
6	3	CD	NUMBER	3	num	8	SENT_188	[p14l779t217r1101b289],
7	—	NN	O	—	nn	8	SENT_188	[p14l779t217r1101b289],
8	blocker	NN	O	blocker	nsubjpass	11	SENT_188	[p14l779t217r1101b289],
9	treatment	NN	O	treatment	dep	8	SENT_188	[p14l1133t224r1483b275],
10	is	VBZ	O	be	auxpass	11	SENT_188	[p14l1516t220r1566b275],
11	associated	VBN	O	associate	rcmod	3	SENT_188	[p14l1600t217r1956b275],
12	with	IN	O	with	_	0	SENT_188	[p14l1987t217r2148b275],
13	an	DT	O	a	det	15	SENT_188	[p14l9t328r94b369],
14	increased	VBN	O	increase	amod	15	SENT_188	[p14l123t311r454b369],
15	incidence	NN	O	incidence	prep_with	11	SENT_188	[p14l483t312r824b369],
16	of	IN	O	of	_	0	SENT_188	[p14l855t311r927b369],
17	dyslipidemia	NN	O	dyslipidemia	prep_of	15	SENT_188	[p14l953t311r1406b387],
18	in	IN	O	in	_	0	SENT_188	[p14l1435t314r1505b368],
19	patients	NNS	O	patient	prep_in	17	SENT_188	[p14l1534t314r1816b387],
20	with	IN	O	with	_	0	SENT_188	[p14l1844t311r2006b369],
21	the	DT	O	the	det	23	SENT_188	[p14l2035t311r2148b369],
22	BZAR	NNP	O	BZAR	nn	23	SENT_188	[p14l13t408r183b479],
23	Glu	NNP	O	Glu	prep_with	19	SENT_188	[p14l216t406r342b464],
24	27	CD	NUMBER	27	number	25	SENT_188	[p14l376t408r457b463],
25	variant	JJ	O	variant	amod	23	SENT_188	[p14l490t409r758b477],
26	,	,	O	,	_	0	SENT_188	[p14l490t409r758b477],
27	it	PRP	O	it	nsubjpass	30	SENT_188	[p14l797t409r846b464],
28	can	MD	O	can	aux	30	SENT_188	[p14l879t423r1001b464],
29	be	VB	O	be	auxpass	30	SENT_188	[p14l1033t406r1113b464],
30	hypothesized	VBN	O	hypothesize	ccomp	50	SENT_188	[p14l1147t406r1621b482],
31	that	IN	O	that	complm	36	SENT_188	[p14l1653t406r1797b464],
32	the	DT	O	the	det	35	SENT_188	[p14l1829t406r1942b464],
33	[	CD	NUMBER	[	num	35	SENT_188	[p14l1980t408r2150b479],
34	31AR	NN	O	31ar	nn	35	SENT_188	[p14l1980t408r2150b479],
35	blockade	NN	O	blockade	nsubj	36	SENT_188	[p14l7t502r321b560],
36	induced	VBN	O	induce	ccomp	30	SENT_188	[p14l370t502r656b560],
37	by	IN	O	by	_	0	SENT_188	[p14l701t502r789b578],
38	atenolol	NN	O	atenolol	prep_by	36	SENT_188	[p14l835t502r1125b560],
39	or	CC	O	or	_	0	SENT_188	[p14l1174t519r1245b560],
40	metoprolol	NN	O	metoprolol	prep_by	36	SENT_188	[p14l1293t502r1705b578],
41	,	,	O	,	_	0	SENT_188	[p14l1293t502r1705b578],
42	two	CD	NUMBER	two	num	46	SENT_188	[p14l1758t509r1889b560],
43	rather	RB	O	rather	advmod	44	SENT_188	[p14l1937t502r2149b560],
44	selective	JJ	O	selective	amod	46	SENT_188	[p14l10t595r306b652],
45	B1	NN	O	b1	nn	46	SENT_188	[p14l360t596r423b667],
46	antagonists	NNS	O	antagonist	dep	36	SENT_188	[p14l476t587r969b670],
47	,	,	O	,	_	0	SENT_188	[p14l476t587r969b670],
48	”	NN	O	”	nsubj	50	SENT_188	[p14l476t587r969b670],
49	may	MD	O	may	aux	50	SENT_188	[p14l1017t612r1169b670],
50	result	VB	O	result	_	0	SENT_188	[p14l1216t595r1411b652],
51	in	IN	O	in	_	0	SENT_188	[p14l1459t598r1529b652],
52	the	DT	O	the	det	54	SENT_188	[p14l1578t595r1691b652],
53	preferential	JJ	O	preferential	amod	54	SENT_188	[p14l1740t594r2148b670],
54	activation	NN	O	activation	prep_in	50	SENT_188	[p14l9t694r364b749],
55	of	IN	O	of	_	0	SENT_188	[p14l395t691r467b749],
56	BZARS	NNS	O	bzar	prep_of	54	SENT_188	[p14l499t693r716b764],
57	.	.	O	.	_	0	SENT_188	[p14l499t693r716b764],

1	The	DT	O	the	det	2	SENT_189	[p14l750t691r883b749],
2	consequence	NN	O	consequence	nsubj	9	SENT_189	[p14l917t708r1371b767],
3	of	IN	O	of	_	0	SENT_189	[p14l1405t691r1476b749],
4	this	DT	O	this	det	5	SENT_189	[p14l1503t691r1633b749],
5	phenomenon	NN	O	phenomenon	prep_of	2	SENT_189	[p14l1665t691r2149b767],
6	would	MD	O	would	aux	9	SENT_189	[p14l7t786r228b844],
7	be	VB	O	be	cop	9	SENT_189	[p14l273t786r354b844],
8	even	RB	O	even	advmod	9	SENT_189	[p14l402t803r567b844],
9	larger	JJR	O	larger	_	0	SENT_189	[p14l614t786r813b862],
10	in	IN	O	in	_	0	SENT_189	[p14l859t789r930b843],
11	patients	NNS	O	patient	prep_in	9	SENT_189	[p14l976t789r1258b862],
12	with	IN	O	with	_	0	SENT_189	[p14l1305t786r1466b844],
13	the	DT	O	the	det	16	SENT_189	[p14l1513t786r1626b844],
14	BZAR	NN	ORGANIZATION	bzar	nn	16	SENT_189	[p14l1678t788r1848b859],
15	genetic	JJ	O	genetic	amod	16	SENT_189	[p14l1894t789r2149b862],
16	variant	NN	O	variant	prep_with	11	SENT_189	[p14l6t884r258b938],
17	resulting	VBG	O	result	partmod	16	SENT_189	[p14l287t881r599b956],
18	in	IN	O	in	_	0	SENT_189	[p14l626t884r697b938],
19	dyslipidemia	NN	O	dyslipidemia	prep_in	17	SENT_189	[p14l727t881r1198b956],
20	.	.	O	.	_	0	SENT_189	[p14l727t881r1198b956],

1	The	DT	O	the	det	5	SENT_190	[p14l83t975r215b1033],
2	[	CD	NUMBER	[	num	5	SENT_190	[p14l261t977r430b1048],
3	33AR	NN	O	33ar	nn	5	SENT_190	[p14l261t977r430b1048],
4	ARG64	NN	O	arg64	nn	5	SENT_190	[p14l468t977r711b1033],
5	variant	NN	O	variant	nsubj	6	SENT_190	[p14l752t978r999b1033],
6	associated	VBN	O	associate	_	0	SENT_190	[p14l1042t975r1391b1033],
7	with	IN	O	with	_	0	SENT_190	[p14l1431t975r1590b1033],
8	an	DT	O	a	det	9	SENT_190	[p14l1632t992r1717b1033],
9	increase	NN	O	increase	prep_with	6	SENT_190	[p14l1758t978r2037b1033],
10	in	IN	O	in	_	0	SENT_190	[p14l2079t978r2149b1032],
11	dyslipidemia	NN	O	dyslipidemia	prep_in	9	SENT_190	[p14l9t1070r471b1146],
12	,	,	O	,	_	0	SENT_190	[p14l9t1070r471b1146],
13	which	WDT	O	which	nsubjpass	16	SENT_190	[p14l499t1070r716b1128],
14	was	VBD	O	be	auxpass	16	SENT_190	[p14l739t1087r866b1128],
15	not	RB	O	not	neg	16	SENT_190	[p14l891t1078r1011b1128],
16	affected	VBN	O	affect	rcmod	11	SENT_190	[p14l1036t1070r1308b1128],
17	in	IN	O	in	_	0	SENT_190	[p14l1332t1073r1402b1127],
18	a	DT	O	a	det	20	SENT_190	[p14l1427t1087r1462b1128],
19	significant	JJ	O	significant	amod	20	SENT_190	[p14l1489t1070r1853b1146],
20	manner	NN	O	manner	prep_in	16	SENT_190	[p14l1877t1087r2150b1128],
21	by	IN	O	by	_	0	SENT_190	[p14l6t1166r93b1242],
22	the	DT	O	the	det	23	SENT_190	[p14l116t1166r228b1224],
23	treatment	NN	O	treatment	agent	16	SENT_190	[p14l254t1173r599b1224],
24	with	IN	O	with	_	0	SENT_190	[p14l622t1166r782b1224],
25	B1	NN	O	b1	nn	27	SENT_190	[p14l812t1166r1207b1238],
26	—	CD	NUMBER	—	num	27	SENT_190	[p14l812t1166r1207b1238],
27	blockers	NNS	O	blocker	prep_with	23	SENT_190	[p14l812t1166r1207b1238],
28	.	.	O	.	_	0	SENT_190	[p14l812t1166r1207b1238],

1	This	DT	O	this	det	2	SENT_191	[p14l1235t1166r1383b1224],
2	result	NN	O	result	nsubjpass	4	SENT_191	[p14l1409t1166r1600b1224],
3	is	VBZ	O	be	auxpass	4	SENT_191	[p14l1625t1169r1676b1224],
4	corroborated	VBN	O	corroborate	_	0	SENT_191	[p14l1702t1166r2150b1224],
5	by	IN	O	by	_	0	SENT_191	[p14l7t1261r93b1336],
6	a	DT	O	a	det	8	SENT_191	[p14l114t1277r149b1318],
7	previous	JJ	O	previous	amod	8	SENT_191	[p14l171t1263r466b1336],
8	observation	NN	O	observation	agent	4	SENT_191	[p14l490t1260r899b1318],
9	conducted	VBN	O	conduct	partmod	8	SENT_191	[p14l921t1260r1288b1318],
10	in	IN	O	in	_	0	SENT_191	[p14l1310t1263r1381b1317],
11	an	DT	O	a	det	13	SENT_191	[p14l1404t1277r1488b1318],
12	Indian	JJ	MISC	indian	amod	13	SENT_191	[p14l1512t1260r1740b1318],
13	population	NN	O	population	prep_in	9	SENT_191	[p14l1762t1260r2149b1336],
14	of	IN	O	of	_	0	SENT_191	[p14l9t1355r81b1413],
15	young	JJ	O	young	amod	16	SENT_191	[p14l103t1372r327b1431],
16	patients	NNS	O	patient	prep_of	13	SENT_191	[p14l355t1358r632b1431],
17	affected	VBN	O	affect	partmod	16	SENT_191	[p14l663t1355r935b1413],
18	by	IN	O	by	_	0	SENT_191	[p14l962t1355r1050b1431],
19	coronary	JJ	O	coronary	amod	21	SENT_191	[p14l1077t1372r1389b1431],
20	artery	NN	O	artery	nn	21	SENT_191	[p14l1418t1363r1620b1431],
21	disease	NN	O	disease	agent	17	SENT_191	[p14l1648t1356r1904b1426],
22	,	,	O	,	_	0	SENT_191	[p14l1648t1356r1904b1426],
23	where	WRB	O	where	advmod	29	SENT_191	[p14l1937t1356r2148b1413],
24	the	DT	O	the	det	28	SENT_191	[p14l8t1451r120b1509],
25	[	NN	O	[	nn	28	SENT_191	[p14l155t1453r323b1524],
26	33AR	NN	O	33ar	nn	28	SENT_191	[p14l155t1453r323b1524],
27	Trp64	NN	O	trp64	nn	28	SENT_191	[p14l349t1453r550b1527],
28	polymorphism	NN	O	polymorphism	nsubj	29	SENT_191	[p14l581t1451r1099b1527],
29	associates	VBZ	O	associate	rcmod	21	SENT_191	[p14l1129t1454r1463b1509],
30	with	IN	O	with	_	0	SENT_191	[p14l1491t1451r1652b1509],
31	higher	JJR	O	higher	amod	33	SENT_191	[p14l1681t1451r1909b1527],
32	serum	NN	O	serum	nn	33	SENT_191	[p14l1939t1468r2148b1509],
33	triglycerides	NNS	O	triglyceride	prep_with	29	SENT_191	[p14l8t1536r513b1619],
34	.	.	O	.	_	0	SENT_191	[p14l8t1536r513b1619],

1	”	NN	O	”	nsubj	4	SENT_192	[p14l8t1536r513b1619],
2	These	DT	O	these	det	3	SENT_192	[p14l537t1544r736b1601],
3	observations	NNS	O	observation	dep	1	SENT_192	[p14l761t1544r1198b1601],
4	suggest	VBP	O	suggest	_	0	SENT_192	[p14l1224t1551r1473b1619],
5	the	DT	O	the	det	6	SENT_192	[p14l1496t1544r1607b1601],
6	possibility	NN	O	possibility	dobj	4	SENT_192	[p14l1630t1544r1987b1619],
7	that	IN	O	that	complm	13	SENT_192	[p14l2008t1544r2149b1601],
8	[	NN	O	[	nsubj	13	SENT_192	[p14l13t1642r79b1713],
9	32	CD	NUMBER	32	num	8	SENT_192	[p14l13t1642r79b1713],
10	and	CC	O	and	_	0	SENT_192	[p14l127t1640r256b1698],
11	[	CD	NUMBER	[	num	12	SENT_192	[p14l307t1642r476b1713],
12	33AR	NN	O	33ar	conj_and	8	SENT_192	[p14l307t1642r476b1713],
13	interfere	VBP	O	interfere	ccomp	4	SENT_192	[p14l520t1640r813b1698],
14	with	IN	O	with	_	0	SENT_192	[p14l858t1640r1017b1698],
15	metabolism	NN	O	metabolism	prep_with	13	SENT_192	[p14l1064t1640r1473b1698],
16	through	IN	O	through	_	0	SENT_192	[p14l1520t1640r1805b1716],
17	different	JJ	O	different	amod	18	SENT_192	[p14l1852t1640r2150b1698],
18	mechanisms	NNS	O	mechanism	prep_through	13	SENT_192	[p14l9t1735r461b1793],
19	.	.	O	.	_	0	SENT_192	[p14l9t1735r461b1793],

1	Such	PDT	O	such	predet	3	SENT_193	[p14l516t1735r683b1793],
2	a	DT	O	a	det	3	SENT_193	[p14l732t1752r767b1793],
3	hypothesis	NN	O	hypothesis	nsubj	5	SENT_193	[p14l816t1735r1192b1811],
4	can	MD	O	can	aux	5	SENT_193	[p14l1243t1752r1364b1793],
5	find	VB	O	find	_	0	SENT_193	[p14l1413t1735r1555b1793],
6	support	NN	O	support	dobj	5	SENT_193	[p14l1605t1742r1869b1811],
7	in	IN	O	in	_	0	SENT_193	[p14l1918t1738r1987b1792],
8	the	DT	O	the	det	11	SENT_193	[p14l2037t1735r2148b1793],
9	different	JJ	O	different	amod	11	SENT_193	[p14l9t1830r307b1888],
10	tissue	NN	O	tissue	nn	11	SENT_193	[p14l334t1833r526b1888],
11	localizations	NNS	O	localization	prep_in	5	SENT_193	[p14l555t1830r990b1888],
12	of	IN	O	of	_	0	SENT_193	[p14l1019t1830r1091b1888],
13	the	DT	O	the	det	16	SENT_193	[p14l1114t1830r1225b1888],
14	two	CD	NUMBER	two	num	16	SENT_193	[p14l1254t1837r1382b1888],
15	BAR	NN	O	bar	nn	16	SENT_193	[p14l1416t1831r1552b1902],
16	subtypes	NNS	O	subtype	prep_of	11	SENT_193	[p14l1579t1830r1896b1906],
17	,	,	O	,	_	0	SENT_193	[p14l1579t1830r1896b1906],
18	with	IN	O	with	_	0	SENT_193	[p14l1926t1830r2085b1888],
19	a	DT	O	a	det	21	SENT_193	[p14l2114t1847r2149b1888],
20	larger	JJR	O	larger	amod	21	SENT_193	[p14l9t1925r204b2001],
21	component	NN	O	component	prep_with	5	SENT_193	[p14l244t1932r649b2001],
22	of	IN	O	of	_	0	SENT_193	[p14l689t1925r760b1983],
23	B3AR	NN	O	b3ar	prep_of	21	SENT_193	[p14l801t1927r970b1998],
24	at	IN	O	at	_	0	SENT_193	[p14l1009t1932r1072b1983],
25	the	DT	O	the	det	27	SENT_193	[p14l1112t1925r1223b1983],
26	fat	JJ	O	fat	amod	27	SENT_193	[p14l1265t1925r1355b1983],
27	cells	NNS	O	cell	prep_at	23	SENT_193	[p14l1395t1925r1560b1995],
28	,	,	O	,	_	0	SENT_193	[p14l1395t1925r1560b1995],
29	while	IN	O	while	mark	33	SENT_193	[p14l1603t1925r1794b1983],
30	BZAR	NN	ORGANIZATION	bzar	nsubj	33	SENT_193	[p14l1840t1927r2009b1998],
31	are	VBP	O	be	cop	33	SENT_193	[p14l2048t1942r2148b1983],
32	more	RBR	O	more	advmod	33	SENT_193	[p14l9t2035r188b2075],
33	localized	JJ	O	localized	advcl	5	SENT_193	[p14l217t2018r522b2075],
34	in	IN	O	in	_	0	SENT_193	[p14l549t2021r620b2075],
35	skeletal	JJ	O	skeletal	amod	36	SENT_193	[p14l649t2018r904b2075],
36	muscle	NN	O	muscle	prep_in	33	SENT_193	[p14l933t2018r1193b2075],
37	.	.	O	.	_	0	SENT_193	[p14l933t2018r1193b2075],

1	Limitation	NN	O	limitation	nsubj	15	SENT_194	[p14l13t2194r368b2251],
2	of	IN	O	of	_	0	SENT_194	[p14l401t2193r472b2251],
3	the	DT	O	the	det	6	SENT_194	[p14l499t2193r613b2251],
4	Study	NNP	O	Study	nn	6	SENT_194	[p14l645t2193r846b2269],
5	A	NNP	O	A	nn	6	SENT_194	[p14l7t2288r58b2343],
6	caveat	NN	O	caveat	prep_of	1	SENT_194	[p14l80t2294r300b2344],
7	that	IN	O	that	complm	10	SENT_194	[p14l322t2287r465b2344],
8	the	DT	O	the	det	9	SENT_194	[p14l487t2287r599b2344],
9	reader	NN	O	reader	nsubj	10	SENT_194	[p14l623t2287r840b2344],
10	has	VBZ	O	have	dep	6	SENT_194	[p14l861t2287r977b2344],
11	to	TO	O	to	aux	12	SENT_194	[p14l1000t2294r1069b2344],
12	bear	VB	O	bear	xcomp	10	SENT_194	[p14l1090t2287r1241b2344],
13	in	IN	O	in	_	0	SENT_194	[p14l1262t2290r1332b2343],
14	mind	NN	O	mind	prep_in	12	SENT_194	[p14l1354t2287r1543b2344],
15	is	VBZ	O	be	_	0	SENT_194	[p14l1565t2290r1615b2344],
16	that	IN	O	that	complm	20	SENT_194	[p14l1638t2287r1781b2344],
17	this	DT	O	this	nsubj	20	SENT_194	[p14l1803t2287r1932b2344],
18	is	VBZ	O	be	cop	20	SENT_194	[p14l1955t2290r2006b2344],
19	not	RB	O	not	neg	20	SENT_194	[p14l2028t2294r2149b2344],
20	a	DT	O	a	ccomp	15	SENT_194	[p14l9t2399r44b2440],
21	randomized	VBN	O	randomize	partmod	20	SENT_194	[p14l79t2382r520b2452],
22	,	,	O	,	_	0	SENT_194	[p14l79t2382r520b2452],
23	but	CC	O	but	_	0	SENT_194	[p14l558t2382r677b2440],
24	rather	RB	O	rather	_	0	SENT_194	[p14l713t2382r925b2440],
25	a	DT	O	a	det	29	SENT_194	[p14l960t2399r995b2440],
26	post	NN	O	post	amod	29	SENT_194	[p14l1022t2388r1167b2458],
27	hoc	FW	O	hoc	dep	26	SENT_194	[p14l1197t2382r1310b2440],
28	observational	JJ	O	observational	amod	29	SENT_194	[p14l1343t2382r1820b2440],
29	study	NN	O	study	conj_negcc	20	SENT_194	[p14l1858t2382r2060b2458],
30	.	.	O	.	_	0	SENT_194	[p14l1858t2382r2060b2458],

1	A	DT	O	a	det	2	SENT_195	[p14l2098t2384r2149b2439],
2	series	NN	O	series	nsubj	6	SENT_195	[p14l10t2479r196b2534],
3	of	IN	O	of	_	0	SENT_195	[p14l254t2476r325b2534],
4	ﬂaws	NNS	O	ﬂaws	prep_of	2	SENT_195	[p14l378t2476r554b2534],
5	could	MD	O	could	aux	6	SENT_195	[p14l612t2476r808b2534],
6	derive	VB	O	derive	_	0	SENT_195	[p14l865t2476r1078b2534],
7	from	IN	O	from	_	0	SENT_195	[p14l1135t2476r1305b2534],
8	this	DT	O	this	det	9	SENT_195	[p14l1361t2476r1491b2534],
9	design	NN	O	design	prep_from	6	SENT_195	[p14l1549t2476r1793b2552],
10	,	,	O	,	_	0	SENT_195	[p14l1549t2476r1793b2552],
11	like	IN	O	like	_	0	SENT_195	[p14l1854t2476r1978b2534],
12	the	DT	O	the	det	13	SENT_195	[p14l2035t2476r2148b2534],
13	assignment	NN	O	assignment	prep_like	9	SENT_195	[p14l9t2575r412b2648],
14	of	IN	O	of	_	0	SENT_195	[p14l443t2572r514b2630],
15	patients	NNS	O	patient	prep_of	13	SENT_195	[p14l541t2575r823b2648],
16	to	TO	O	to	_	0	SENT_195	[p14l855t2579r924b2630],
17	treatment	NN	O	treatment	prep_to	15	SENT_195	[p14l956t2579r1307b2630],
18	upon	IN	O	upon	_	0	SENT_195	[p14l1336t2589r1523b2648],
19	the	DT	O	the	det	20	SENT_195	[p14l1554t2572r1666b2630],
20	discretion	NN	O	discretion	prep_upon	6	SENT_195	[p14l1699t2572r2050b2630],
21	of	IN	O	of	_	0	SENT_195	[p14l2081t2572r2153b2630],
22	their	PRP$	O	they	poss	23	SENT_195	[p14l8t2667r176b2725],
23	physician	NN	O	physician	prep_of	20	SENT_195	[p14l212t2667r571b2743],
24	.	.	O	.	_	0	SENT_195	[p14l212t2667r571b2743],

1	This	DT	O	this	nsubjpass	3	SENT_196	[p14l612t2667r761b2725],
2	is	VBZ	O	be	auxpass	3	SENT_196	[p14l800t2670r851b2725],
3	demonstrated	VBN	O	demonstrate	_	0	SENT_196	[p14l890t2667r1380b2725],
4	by	IN	O	by	_	0	SENT_196	[p14l1415t2667r1503b2743],
5	the	DT	O	the	det	6	SENT_196	[p14l1538t2667r1651b2725],
6	difference	NN	O	difference	agent	3	SENT_196	[p14l1691t2667r2039b2725],
7	in	IN	O	in	_	0	SENT_196	[p14l2078t2670r2149b2724],
8	sex	NN	O	sex	prep_in	6	SENT_196	[p14l10t2778r119b2819],
9	and	CC	O	and	_	0	SENT_196	[p14l144t2762r276b2819],
10	age	NN	O	age	prep_in	6	SENT_196	[p14l302t2778r415b2837],
11	between	IN	O	between	_	0	SENT_196	[p14l439t2762r737b2819],
12	patients	NNS	O	patient	prep_between	8	SENT_196	[p14l762t2765r1044b2837],
13	on	IN	O	on	_	0	SENT_196	[p14l1071t2778r1162b2819],
14	B	NN	O	b	nn	15	SENT_196	[p14l1193t2763r1226b2834],
15	blockade	NN	O	blockade	prep_on	12	SENT_196	[p14l1250t2762r1564b2819],
16	and	CC	O	and	_	0	SENT_196	[p14l1592t2762r1724b2819],
17	patients	NNS	O	patient	prep_on	12	SENT_196	[p14l1748t2765r2030b2837],
18	on	IN	O	on	_	0	SENT_196	[p14l2057t2778r2148b2819],
19	other	JJ	O	other	amod	20	SENT_196	[p14l9t2857r198b2915],
20	regimens	NNS	O	regimen	prep_on	3	SENT_196	[p14l224t2860r564b2933],
21	.	.	O	.	_	0	SENT_196	[p14l224t2860r564b2933],

1	On	IN	O	on	_	0	SENT_197	[p14l597t2859r704b2915],
2	the	DT	O	the	det	4	SENT_197	[p14l731t2857r844b2915],
3	other	JJ	O	other	amod	4	SENT_197	[p14l873t2857r1062b2915],
4	hand	NN	O	hand	prep_on	8	SENT_197	[p14l1088t2857r1287b2928],
5	,	,	O	,	_	0	SENT_197	[p14l1088t2857r1287b2928],
6	our	PRP$	O	we	poss	7	SENT_197	[p14l1321t2874r1439b2915],
7	results	NNS	O	result	nsubj	8	SENT_197	[p14l1465t2857r1690b2915],
8	are	VBP	O	be	_	0	SENT_197	[p14l1719t2874r1821b2915],
9	closer	RBR	O	closer	advmod	8	SENT_197	[p14l1850t2857r2052b2915],
10	to	TO	O	to	_	0	SENT_197	[p14l2078t2864r2148b2915],
11	the	DT	O	the	det	13	SENT_197	[p14l8t2952r121b3010],
12	daily	JJ	SET	daily	amod	13	SENT_197	[p14l170t2952r343b3028],
13	practice	NN	O	practice	prep_to	9	SENT_197	[p14l387t2955r663b3028],
14	where	WRB	O	where	advmod	17	SENT_197	[p14l710t2952r923b3010],
15	the	DT	O	the	det	16	SENT_197	[p14l971t2952r1084b3010],
16	physician	NN	O	physician	nsubj	17	SENT_197	[p14l1131t2952r1473b3028],
17	chooses	VBZ	O	choose	dep	9	SENT_197	[p14l1520t2952r1794b3010],
18	what	WP	O	what	dep	20	SENT_197	[p14l1840t2952r2017b3010],
19	he	PRP	O	he	nsubj	20	SENT_197	[p14l2064t2952r2148b3010],
20	believes	VBZ	O	believe	ccomp	17	SENT_197	[p14l7t3047r285b3105],
21	is	VBZ	O	be	cop	24	SENT_197	[p14l329t3050r380b3105],
22	the	DT	O	the	det	24	SENT_197	[p14l423t3047r536b3105],
23	right	JJ	O	right	amod	24	SENT_197	[p14l581t3047r751b3123],
24	treatment	NN	O	treatment	ccomp	20	SENT_197	[p14l794t3054r1145b3105],
25	based	VBN	O	base	_	0	SENT_197	[p14l1186t3047r1384b3105],
26	on	IN	O	on	prepc_based_on	24	SENT_197	[p14l1428t3064r1519b3105],
27	the	DT	O	the	det	33	SENT_197	[p14l1562t3047r1675b3105],
28	anamnestic	JJ	O	anamnestic	amod	33	SENT_197	[p14l1720t3050r2144b3117],
29	,	,	O	,	_	0	SENT_197	[p14l1720t3050r2144b3117],
30	physical	JJ	O	physical	amod	33	SENT_197	[p14l8t3142r299b3218],
31	and	CC	O	and	_	0	SENT_197	[p14l326t3142r457b3200],
32	instrumental	JJ	O	instrumental	amod	33	SENT_197	[p14l482t3142r941b3200],
33	examination	NN	O	examination	pobj	24	SENT_197	[p14l968t3145r1437b3200],
34	.	.	O	.	_	0	SENT_197	[p14l968t3145r1437b3200],

1	Also	RB	O	also	advmod	8	SENT_198	[p14l1466t3142r1634b3212],
2	,	,	O	,	_	0	SENT_198	[p14l1466t3142r1634b3212],
3	a	DT	O	a	nsubj	8	SENT_198	[p14l1665t3159r1699b3200],
4	randomized	VBN	O	randomize	partmod	3	SENT_198	[p14l1725t3142r2149b3200],
5	study	NN	O	study	dobj	4	SENT_198	[p14l10t3237r203b3313],
6	would	MD	O	would	aux	8	SENT_198	[p14l224t3237r446b3295],
7	have	VB	O	have	aux	8	SENT_198	[p14l472t3237r637b3295],
8	required	VBN	O	require	_	0	SENT_198	[p14l664t3237r959b3313],
9	a	DT	O	a	det	11	SENT_198	[p14l986t3254r1021b3295],
10	larger	JJR	O	larger	amod	11	SENT_198	[p14l1047t3237r1246b3313],
11	effort	NN	O	effort	dobj	8	SENT_198	[p14l1271t3237r1462b3295],
12	to	TO	O	to	aux	13	SENT_198	[p14l1488t3244r1557b3295],
13	follow	VB	O	follow	xcomp	8	SENT_198	[p14l1584t3237r1808b3295],
14	the	DT	O	the	det	16	SENT_198	[p14l1832t3237r1944b3295],
15	same	JJ	O	same	amod	16	SENT_198	[p14l1973t3254r2147b3295],
16	number	NN	O	number	dobj	13	SENT_198	[p14l9t3332r288b3390],
17	of	IN	O	of	_	0	SENT_198	[p14l315t3332r386b3390],
18	patients	NNS	O	patient	prep_of	16	SENT_198	[p14l409t3335r691b3408],
19	for	IN	O	for	_	0	SENT_198	[p14l719t3332r817b3390],
20	such	PDT	O	such	predet	23	SENT_198	[p14l845t3332r1005b3390],
21	a	DT	O	a	det	23	SENT_198	[p14l1034t3349r1068b3390],
22	large	JJ	O	large	amod	23	SENT_198	[p14l1095t3332r1262b3408],
23	number	NN	O	number	prep_for	13	SENT_198	[p14l1291t3332r1570b3390],
24	of	IN	O	of	_	0	SENT_198	[p14l1597t3332r1668b3390],
25	years	NNS	DURATION	year	prep_of	23	SENT_198	[p14l1689t3349r1867b3408],
26	needed	VBN	O	need	partmod	25	SENT_198	[p14l1895t3332r2149b3390],
27	to	TO	O	to	aux	28	SENT_198	[p14l8t3434r78b3484],
28	detect	VB	O	detect	xcomp	26	SENT_198	[p14l116t3426r329b3484],
29	this	DT	O	this	det	31	SENT_198	[p14l365t3426r495b3484],
30	side	JJ	O	side	amod	31	SENT_198	[p14l534t3426r667b3484],
31	effect	NN	O	effect	dobj	28	SENT_198	[p14l705t3426r914b3484],
32	.	.	O	.	_	0	SENT_198	[p14l705t3426r914b3484],

1	Other	JJ	O	other	amod	2	SENT_199	[p14l956t3427r1161b3484],
2	drugs	NNS	O	drug	nsubj	4	SENT_199	[p14l1197t3426r1387b3502],
3	are	VBP	O	be	cop	4	SENT_199	[p14l1425t3443r1526b3484],
4	able	JJ	O	able	_	0	SENT_199	[p14l1565t3426r1705b3484],
5	to	TO	O	to	aux	6	SENT_199	[p14l1743t3434r1813b3484],
6	interfere	VB	O	interfere	xcomp	4	SENT_199	[p14l1849t3426r2147b3484],
7	with	IN	O	with	_	0	SENT_199	[p14l7t3522r168b3580],
8	the	DT	O	the	det	10	SENT_199	[p14l235t3522r348b3580],
9	lipid	NN	O	lipid	nn	10	SENT_199	[p14l416t3522r577b3598],
10	profile	NN	O	profile	prep_with	6	SENT_199	[p14l643t3522r872b3598],
11	in	IN	O	in	_	0	SENT_199	[p14l941t3525r1012b3579],
12	hypertensives	NNS	O	hypertensive	prep_in	10	SENT_199	[p14l1079t3522r1565b3598],
13	(	CD	NUMBER	(	dep	12	SENT_199	[p14l1636t3522r1717b3594],
14	ie	FW	O	ie	nn	16	SENT_199	[p14l1636t3522r1717b3594],
15	thiazides	FW	O	thiazides	nn	16	SENT_199	[p14l1785t3522r2143b3594],
16	)	FW	O	)	dobj	6	SENT_199	[p14l1785t3522r2143b3594],
17	,	,	O	,	_	0	SENT_199	[p14l1785t3522r2143b3594],
18	although	IN	O	although	mark	25	SENT_199	[p14l9t3617r331b3693],
19	the	DT	O	the	det	20	SENT_199	[p14l373t3617r486b3675],
20	mechanisms	NNS	O	mechanism	nsubjpass	25	SENT_199	[p14l529t3617r971b3675],
21	underlying	VBG	O	underlie	partmod	20	SENT_199	[p14l1013t3617r1405b3693],
22	are	VBP	O	be	auxpass	25	SENT_199	[p14l1448t3634r1548b3675],
23	not	RB	O	not	neg	25	SENT_199	[p14l1592t3624r1713b3675],
24	completely	RB	O	completely	advmod	25	SENT_199	[p14l1756t3617r2151b3693],
25	known	VBN	O	know	advcl	4	SENT_199	[p14l9t3712r272b3769],
26	.	.	O	.	_	0	SENT_199	[p14l9t3712r272b3769],

1	To	TO	O	to	aux	2	SENT_200	[p14l338t3714r423b3769],
2	rule	VB	O	rule	purpcl	12	SENT_200	[p14l489t3712r622b3769],
3	out	RP	O	out	prt	2	SENT_200	[p14l688t3719r806b3769],
4	the	DT	O	the	det	6	SENT_200	[p14l869t3712r982b3769],
5	confounding	JJ	O	confounding	amod	6	SENT_200	[p14l1048t3711r1509b3787],
6	effect	NN	O	effect	dobj	2	SENT_200	[p14l1573t3711r1764b3769],
7	of	IN	O	of	_	0	SENT_200	[p14l1829t3711r1900b3769],
8	other	JJ	O	other	amod	9	SENT_200	[p14l1961t3712r2150b3769],
9	treatments	NNS	O	treatment	prep_of	6	SENT_200	[p15l8t24r407b87],
10	,	,	O	,	_	0	SENT_200	[p15l8t24r407b87],
11	we	PRP	O	we	nsubj	12	SENT_200	[p15l453t34r549b75],
12	repeated	VBD	O	repeat	_	0	SENT_200	[p15l593t17r895b93],
13	the	DT	O	the	det	14	SENT_200	[p15l937t17r1049b75],
14	analyses	NNS	O	analysis	dobj	12	SENT_200	[p15l1094t17r1384b93],
15	of	IN	O	of	_	0	SENT_200	[p15l1429t17r1500b75],
16	the	DT	O	the	det	17	SENT_200	[p15l1539t17r1651b75],
17	incidence	NN	O	incidence	prep_of	14	SENT_200	[p15l1696t17r2036b75],
18	of	IN	O	of	_	0	SENT_200	[p15l2081t17r2153b75],
19	dyslipidemia	NN	O	dyslipidemia	prep_of	17	SENT_200	[p15l9t112r462b188],
20	according	VBG	O	accord	_	0	SENT_200	[p15l503t112r850b188],
21	to	TO	O	to	prepc_according_to	12	SENT_200	[p15l889t119r958b170],
22	the	DT	O	the	det	23	SENT_200	[p15l999t112r1111b170],
23	use	NN	O	use	pobj	12	SENT_200	[p15l1150t129r1263b170],
24	of	IN	O	of	_	0	SENT_200	[p15l1304t112r1376b170],
25	B-blockers	NNS	O	b-blocker	prep_of	23	SENT_200	[p15l1416t112r1767b185],
26	as	IN	O	as	_	0	SENT_200	[p15l1808t129r1873b170],
27	monotherapy	NN	O	monotherapy	prep_as	25	SENT_200	[p15l1913t129r2148b170, p15l9t207r291b283],
28	,	,	O	,	_	0	SENT_200	[p15l1913t129r2148b170, p15l9t207r291b283],
29	and	CC	O	and	_	0	SENT_200	[p15l319t207r450b265],
30	found	VBD	O	find	conj_and	12	SENT_200	[p15l472t207r684b265],
31	results	NNS	O	result	nsubj	32	SENT_200	[p15l706t207r931b265],
32	similar	JJ	O	similar	xcomp	30	SENT_200	[p15l956t207r1195b265],
33	to	TO	O	to	_	0	SENT_200	[p15l1216t214r1286b265],
34	those	DT	O	those	prep_to	32	SENT_200	[p15l1309t207r1498b265],
35	observed	VBN	O	observe	partmod	34	SENT_200	[p15l1522t207r1834b265],
36	in	IN	O	in	_	0	SENT_200	[p15l1857t210r1927b264],
37	the	DT	O	the	det	39	SENT_200	[p15l1949t207r2061b265],
38	[	CD	NUMBER	[	num	39	SENT_200	[p15l2089t208r2148b279, p15l7t302r296b360],
39	3blockers	NNS	O	3blocker	prep_in	35	SENT_200	[p15l2089t208r2148b279, p15l7t302r296b360],
40	population	NN	O	population	nsubj	47	SENT_200	[p15l326t302r719b378],
41	as	IN	O	as	_	0	SENT_200	[p15l749t319r814b360],
42	a	DT	O	a	det	45	SENT_200	[p15l845t319r880b360],
43	whole	JJ	O	whole	amod	45	SENT_200	[p15l907t302r1122b360],
44	(	NN	O	(	nn	45	SENT_200	[p15l1156t302r1329b374],
45	data	NNS	O	datum	prep_as	40	SENT_200	[p15l1156t302r1329b374],
46	not	RB	O	not	neg	47	SENT_200	[p15l1359t309r1479b360],
47	shown	VBN	O	show	rcmod	39	SENT_200	[p15l1510t302r1787b374],
48	)	NN	O	)	dobj	47	SENT_200	[p15l1510t302r1787b374],
49	.	.	O	.	_	0	SENT_200	[p15l1510t302r1787b374],

1	In	IN	O	in	_	0	SENT_201	[p15l86t399r159b453],
2	conclusion	NN	O	conclusion	prep_in	11	SENT_201	[p15l207t397r612b467],
3	,	,	O	,	_	0	SENT_201	[p15l207t397r612b467],
4	the	DT	O	the	det	5	SENT_201	[p15l664t396r776b454],
5	results	NNS	O	result	nsubj	11	SENT_201	[p15l825t396r1049b454],
6	of	IN	O	of	_	0	SENT_201	[p15l1098t396r1170b454],
7	the	DT	O	the	det	9	SENT_201	[p15l1213t396r1325b454],
8	present	JJ	DATE	present	amod	9	SENT_201	[p15l1373t404r1632b472],
9	study	NN	O	study	prep_of	5	SENT_201	[p15l1681t396r1873b472],
10	clearly	RB	O	clearly	advmod	11	SENT_201	[p15l1919t396r2151b472],
11	demonstrate	VBP	O	demonstrate	_	0	SENT_201	[p15l9t492r452b550],
12	that	IN	O	that	complm	26	SENT_201	[p15l490t492r633b550],
13	hypertensive	JJ	O	hypertensive	amod	14	SENT_201	[p15l670t492r1124b568],
14	patients	NNS	O	patient	nsubj	26	SENT_201	[p15l1162t495r1444b568],
15	bearing	VBG	O	bear	dep	14	SENT_201	[p15l1480t492r1747b568],
16	the	DT	O	the	det	18	SENT_201	[p15l1782t492r1895b550],
17	Glu27	NN	O	glu27	nn	18	SENT_201	[p15l1935t492r2147b550],
18	variant	NN	O	variant	dobj	15	SENT_201	[p15l6t589r258b644],
19	of	IN	O	of	_	0	SENT_201	[p15l300t586r371b644],
20	BZAR	NN	ORGANIZATION	bzar	nn	21	SENT_201	[p15l413t588r583b659],
21	gene	NN	O	gene	prep_of	18	SENT_201	[p15l623t603r786b662],
22	and	CC	O	and	_	0	SENT_201	[p15l830t586r961b644],
23	treated	VBN	O	treat	dep	14	SENT_201	[p15l1002t586r1247b644],
24	with	IN	O	with	_	0	SENT_201	[p15l1287t586r1448b644],
25	B-blockers	NNS	MISC	b-blocker	prep_with	23	SENT_201	[p15l1495t586r1846b659],
26	show	VBP	O	show	ccomp	11	SENT_201	[p15l1890t586r2074b644],
27	a	DT	O	a	det	29	SENT_201	[p15l2114t603r2149b644],
28	higher	JJR	O	higher	amod	29	SENT_201	[p15l9t682r240b758],
29	incidence	NN	O	incidence	dobj	26	SENT_201	[p15l290t682r631b740],
30	of	IN	O	of	_	0	SENT_201	[p15l684t682r756b740],
31	dyslipidemia	NN	O	dyslipidemia	prep_of	29	SENT_201	[p15l804t682r1275b758],
32	.	.	O	.	_	0	SENT_201	[p15l804t682r1275b758],

1	The	DT	O	the	det	2	SENT_202	[p15l1329t682r1461b740],
2	relevance	NN	O	relevance	nsubj	6	SENT_202	[p15l1514t682r1846b740],
3	of	IN	O	of	_	0	SENT_202	[p15l1900t682r1971b740],
4	this	DT	O	this	det	5	SENT_202	[p15l2018t682r2148b740],
5	finding	NN	O	finding	prep_of	2	SENT_202	[p15l9t777r268b853],
6	includes	VBZ	O	include	_	0	SENT_202	[p15l289t777r583b835],
7	the	DT	O	the	det	8	SENT_202	[p15l606t777r719b835],
8	possibility	NN	O	possibility	dobj	6	SENT_202	[p15l742t777r1106b853],
9	to	TO	O	to	aux	10	SENT_202	[p15l1127t784r1196b835],
10	predict	VB	O	predict	infmod	8	SENT_202	[p15l1218t777r1466b853],
11	those	DT	O	those	det	12	SENT_202	[p15l1488t777r1677b835],
12	patients	NNS	O	patient	dobj	10	SENT_202	[p15l1700t780r1982b853],
13	that	WDT	O	that	nsubj	16	SENT_202	[p15l2005t777r2149b835],
14	are	VBP	O	be	cop	16	SENT_202	[p15l9t888r111b929],
15	highly	RB	O	highly	advmod	16	SENT_202	[p15l134t872r365b947],
16	likely	JJ	O	likely	rcmod	12	SENT_202	[p15l386t872r579b947],
17	to	TO	O	to	aux	18	SENT_202	[p15l599t879r669b929],
18	develop	VB	O	develop	dep	16	SENT_202	[p15l693t872r969b947],
19	this	DT	O	this	det	21	SENT_202	[p15l992t872r1122b929],
20	side	JJ	O	side	amod	21	SENT_202	[p15l1147t872r1280b929],
21	effect	NN	O	effect	dobj	18	SENT_202	[p15l1305t871r1496b929],
22	and	CC	O	and	_	0	SENT_202	[p15l1520t872r1651b929],
23	consequently	RB	O	consequently	advmod	18	SENT_202	[p15l1674t872r2151b947],
24	to	TO	O	to	aux	25	SENT_202	[p15l8t974r78b1025],
25	extend	VB	O	extend	conj_and	18	SENT_202	[p15l122t967r363b1025],
26	to	TO	O	to	_	0	SENT_202	[p15l405t974r474b1025],
27	the	DT	O	the	det	28	SENT_202	[p15l517t967r629b1025],
28	majority	NN	O	majority	prep_to	25	SENT_202	[p15l672t970r976b1043],
29	of	IN	O	of	_	0	SENT_202	[p15l1016t967r1088b1025],
30	the	DT	O	the	det	31	SENT_202	[p15l1125t967r1238b1025],
31	patients	NNS	O	patient	prep_of	28	SENT_202	[p15l1280t970r1563b1043],
32	the	DT	O	the	det	33	SENT_202	[p15l1606t967r1718b1025],
33	benefits	NNS	O	benefit	dobj	25	SENT_202	[p15l1759t967r2038b1025],
34	of	IN	O	of	_	0	SENT_202	[p15l2081t967r2153b1025],
35	chronic	JJ	O	chronic	amod	36	SENT_202	[p15l9t1061r279b1119],
36	B-blockade	NN	O	b-blockade	prep_of	33	SENT_202	[p15l313t1061r707b1134],
37	.	.	O	.	_	0	SENT_202	[p15l313t1061r707b1134],

1	ACKNOWLEDGEMENTS	NNS	O	acknowledgement	nsubjpass	5	SENT_203	[p15l7t1251r873b1306],
2	This	DT	O	this	det	3	SENT_203	[p15l7t1340r140b1392],
3	work	NN	O	work	dep	1	SENT_203	[p15l173t1340r331b1392],
4	was	VBD	O	be	auxpass	5	SENT_203	[p15l361t1355r475b1392],
5	supported	VBN	O	support	_	0	SENT_203	[p15l511t1340r825b1408],
6	by	IN	O	by	_	0	SENT_203	[p15l857t1340r935b1408],
7	a	DT	O	a	det	8	SENT_203	[p15l968t1355r998b1392],
8	grant	NN	O	grant	agent	5	SENT_203	[p15l1033t1347r1198b1408],
9	from	IN	O	from	_	0	SENT_203	[p15l1231t1340r1382b1392],
10	the	DT	O	the	det	20	SENT_203	[p15l1416t1340r1516b1392],
11	Italian	JJ	ORGANIZATION	italian	amod	20	SENT_203	[p15l1552t1340r1754b1392],
12	Ministry	NNP	ORGANIZATION	Ministry	dep	20	SENT_203	[p15l1787t1342r2056b1408],
13	of	IN	ORGANIZATION	of	_	0	SENT_203	[p15l2089t1340r2153b1392],
14	Instruction	NNP	ORGANIZATION	Instruction	nn	15	SENT_203	[p15l9t1427r359b1477],
15	University	NNP	ORGANIZATION	University	prep_of	12	SENT_203	[p15l385t1427r713b1493],
16	and	CC	ORGANIZATION	and	_	0	SENT_203	[p15l736t1425r853b1476],
17	Research	NNP	ORGANIZATION	Research	prep_of	12	SENT_203	[p15l879t1425r1152b1477],
18	(	CD	NUMBER	(	num	17	SENT_203	[p15l1181t1425r1424b1489],
19	MIUR	NN	O	miur	nn	20	SENT_203	[p15l1181t1425r1424b1489],
20	)	NN	O	)	prep_from	8	SENT_203	[p15l1181t1425r1424b1489],
21	.	.	O	.	_	0	SENT_203	[p15l1181t1425r1424b1489],

1	DUALITY	NNP	O	DUALITY	nsubj	5	SENT_204	[p15l11t1631r343b1686],
2	OF	IN	O	of	_	0	SENT_204	[p15l374t1630r468b1686],
3	INTEREST	NN	O	interest	nn	4	SENT_204	[p15l500t1630r853b1686],
4	None	NN	O	none	prep_of	1	SENT_204	[p15l7t1726r198b1780],
5	declared	VBD	O	declare	_	0	SENT_204	[p15l229t1723r541b1780],
6	.	.	O	.	_	0	SENT_204	[p15l229t1723r541b1780],

1	[	NN	O	[	nn	2	SENT_205	[p15l10t1946r266b2003],
2	5-blockade	NN	O	5-blockade	_	0	SENT_205	[p15l10t1946r266b2003],
3	and	CC	O	and	_	0	SENT_205	[p15l284t1946r372b1991],
4	dyslipidemia	NN	O	dyslipidemia	nn	5	SENT_205	[p15l392t1946r696b2005],
5	mg	NN	O	mg	conj_and	2	SENT_205	[p15l2023t1934r2149b2058],
6	C	NN	O	c	nn	7	SENT_205	[p15l9t2019r39b2059],
7	laccarino	NN	O	laccarino	dep	2	SENT_205	[p15l61t2018r242b2059],
8	et	FW	O	et	nn	9	SENT_205	[p15l262t2022r298b2059],
9	al	FW	O	al	dep	2	SENT_205	[p15l315t2017r351b2059],

1	REFERENCES	NNS	O	reference	_	0	SENT_206	[p15l12t2305r465b2360],
2	1	CD	NUMBER	1	num	4	SENT_206	[p15l45t2389r61b2435],
3	Frishman	NNP	ORGANIZATION	Frishman	nn	4	SENT_206	[p15l144t2388r391b2436],
4	WH	NNP	ORGANIZATION	WH	dep	1	SENT_206	[p15l423t2390r541b2436],
5	.	.	O	.	_	0	SENT_206	[p15l423t2390r541b2436],

1	Beta-adrenergic	JJ	O	beta-adrenergic	amod	2	SENT_207	[p15l579t2388r1016b2451],
2	receptor	NN	O	receptor	_	0	SENT_207	[p15l1050t2394r1282b2451],
3	blockers	NNS	O	blocker	dep	2	SENT_207	[p15l1314t2388r1553b2436],
4	.	.	O	.	_	0	SENT_207	[p15l1314t2388r1553b2436],

1	Adverse	JJ	O	adverse	amod	2	SENT_208	[p15l1586t2388r1804b2436],
2	effects	NNS	O	effect	_	0	SENT_208	[p15l1836t2388r2011b2436],
3	and	CC	O	and	_	0	SENT_208	[p15l2043t2388r2144b2436],
4	drug	NN	O	drug	nn	5	SENT_208	[p15l142t2463r269b2525],
5	interactions	NNS	O	interaction	conj_and	2	SENT_208	[p15l299t2464r635b2510],
6	.	.	O	.	_	0	SENT_208	[p15l299t2464r635b2510],

1	Hypertension	NN	O	hypertension	_	0	SENT_209	[p15l667t2464r1011b2525],
2	1988	CD	DATE	1988	num	1	SENT_209	[p15l1038t2464r1192b2520],
3	;	:	O	;	_	0	SENT_209	[p15l1038t2464r1192b2520],
4	11	CD	NUMBER	11	num	6	SENT_209	[p15l1225t2464r1306b2510],
5	:	:	O	:	_	0	SENT_209	[p15l1225t2464r1306b2510],
6	|	CD	NUMBER	|	dep	1	SENT_209	[p15l1337t2464r1520b2510],
7	|	CD	NUMBER	|	number	8	SENT_209	[p15l1337t2464r1520b2510],
8	21	CD	NUMBER	21	num	10	SENT_209	[p15l1337t2464r1520b2510],
9	—	CD	NUMBER	—	number	10	SENT_209	[p15l1337t2464r1520b2510],
10	9	CD	NUMBER	9	dep	6	SENT_209	[p15l1337t2464r1520b2510],
11	.	.	O	.	_	0	SENT_209	[p15l1337t2464r1520b2510],

1	2	CD	NUMBER	2	num	3	SENT_210	[p15l42t2539r72b2585],
2	Green	NNP	ORGANIZATION	Green	nn	3	SENT_210	[p15l142t2539r306b2585],
3	SA	NNP	ORGANIZATION	SA	_	0	SENT_210	[p15l337t2539r419b2595],
4	,	,	O	,	_	0	SENT_210	[p15l337t2539r419b2595],
5	Turki	NNP	PERSON	Turki	nn	6	SENT_210	[p15l447t2537r582b2585],
6	J	NNP	PERSON	J	appos	3	SENT_210	[p15l610t2540r639b2596],
7	,	,	O	,	_	0	SENT_210	[p15l610t2540r639b2596],
8	Innis	NNP	PERSON	Innis	nn	9	SENT_210	[p15l672t2539r796b2585],
9	M	NNP	O	M	appos	3	SENT_210	[p15l826t2540r892b2595],
10	,	,	O	,	_	0	SENT_210	[p15l826t2540r892b2595],
11	Liggett	NNP	ORGANIZATION	Liggett	nn	12	SENT_210	[p15l926t2539r1119b2600],
12	SB	NN	O	sb	appos	3	SENT_210	[p15l1145t2539r1224b2585],
13	.	.	O	.	_	0	SENT_210	[p15l1145t2539r1224b2585],

1	Amino-terminal	JJ	O	amino-terminal	amod	2	SENT_211	[p15l1252t2537r1687b2585],
2	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_211	[p15l1719t2537r2145b2600],
3	of	IN	O	of	_	0	SENT_211	[p15l142t2612r195b2660],
4	the	DT	O	the	det	6	SENT_211	[p15l237t2612r325b2660],
5	human	JJ	O	human	amod	6	SENT_211	[p15l372t2612r564b2660],
6	beta	NN	O	beta	prep_of	2	SENT_211	[p15l614t2612r730b2660],
7	2	CD	NUMBER	2	number	8	SENT_211	[p15l776t2612r1130b2675],
8	—	CD	NUMBER	—	dep	6	SENT_211	[p15l776t2612r1130b2675],
9	adrenergic	JJ	O	adrenergic	amod	10	SENT_211	[p15l776t2612r1130b2675],
10	receptor	NN	O	receptor	dep	8	SENT_211	[p15l1177t2618r1408b2675],
11	impart	VB	O	impart	_	0	SENT_211	[p15l1453t2614r1635b2675],
12	distinct	JJ	O	distinct	amod	15	SENT_211	[p15l1678t2612r1881b2660],
13	agonistpromoted	JJ	O	agonistpromoted	amod	15	SENT_211	[p15l1924t2614r2145b2675, p15l144t2688r418b2751],
14	regulatory	JJ	O	regulatory	amod	15	SENT_211	[p15l447t2688r731b2751],
15	properties	NNS	O	property	dobj	11	SENT_211	[p15l757t2689r1049b2751],
16	.	.	O	.	_	0	SENT_211	[p15l757t2689r1049b2751],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_212	[p15l1080t2688r1416b2750],
2	1994	CD	DATE	1994	num	1	SENT_212	[p15l1438t2689r1592b2746],
3	;	:	O	;	_	0	SENT_212	[p15l1438t2689r1592b2746],
4	33	CD	NUMBER	33	num	6	SENT_212	[p15l1623t2689r1706b2736],
5	:	:	O	:	_	0	SENT_212	[p15l1623t2689r1706b2736],
6	9414-9419	CD	DURATION	9414-9419	dep	1	SENT_212	[p15l1735t2689r2069b2736],
7	.	.	O	.	_	0	SENT_212	[p15l1735t2689r2069b2736],

1	3	CD	NUMBER	3	num	3	SENT_213	[p15l45t2764r72b2811],
2	Green	NN	ORGANIZATION	green	nn	3	SENT_213	[p15l142t2764r306b2811],
3	SA	NNP	ORGANIZATION	SA	_	0	SENT_213	[p15l329t2764r411b2821],
4	,	,	O	,	_	0	SENT_213	[p15l329t2764r411b2821],
5	Turki	NNP	PERSON	Turki	nn	6	SENT_213	[p15l432t2763r567b2811],
6	]	NNP	O	]	appos	3	SENT_213	[p15l587t2765r616b2822],
7	,	,	O	,	_	0	SENT_213	[p15l587t2765r616b2822],
8	Hall	NNP	O	Hall	nn	9	SENT_213	[p15l642t2763r740b2811],
9	IP	NNP	O	IP	appos	3	SENT_213	[p15l765t2765r824b2821],
10	,	,	O	,	_	0	SENT_213	[p15l765t2765r824b2821],
11	Liggett	NNP	ORGANIZATION	Liggett	nn	12	SENT_213	[p15l849t2764r1042b2825],
12	SB	NN	O	sb	appos	3	SENT_213	[p15l1060t2764r1140b2811],
13	.	.	O	.	_	0	SENT_213	[p15l1060t2764r1140b2811],

1	Implications	NNS	O	implication	_	0	SENT_214	[p15l1165t2763r1498b2826],
2	of	IN	O	of	_	0	SENT_214	[p15l1518t2763r1572b2811],
3	genetic	JJ	O	genetic	amod	4	SENT_214	[p15l1588t2764r1792b2825],
4	variability	NN	O	variability	prep_of	1	SENT_214	[p15l1809t2763r2077b2826],
5	of	IN	O	of	_	0	SENT_214	[p15l2095t2763r2149b2811],
6	human	JJ	O	human	amod	7	SENT_214	[p15l144t2837r335b2885],
7	beta	NN	O	beta	prep_of	4	SENT_214	[p15l366t2837r483b2885],
8	2	CD	NUMBER	2	number	9	SENT_214	[p15l512t2837r865b2900],
9	—	CD	NUMBER	—	dep	1	SENT_214	[p15l512t2837r865b2900],
10	adrenergic	JJ	O	adrenergic	amod	12	SENT_214	[p15l512t2837r865b2900],
11	receptor	NN	O	receptor	nn	12	SENT_214	[p15l894t2843r1126b2900],
12	structure	NN	O	structure	dep	9	SENT_214	[p15l1150t2843r1410b2885],
13	.	.	O	.	_	0	SENT_214	[p15l1150t2843r1410b2885],

1	Pulm	NNP	O	Pulm	nn	2	SENT_215	[p15l1443t2837r1573b2885],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_215	[p15l1601t2837r1886b2885],
3	1995	CD	DATE	1995	num	2	SENT_215	[p15l1911t2839r2065b2895],
4	;	:	O	;	_	0	SENT_215	[p15l1911t2839r2065b2895],
5	8	CD	NUMBER	8	num	7	SENT_215	[p15l2094t2839r2143b2885],
6	:	:	O	:	_	0	SENT_215	[p15l2094t2839r2143b2885],
7	1-10	CD	NUMBER	1-10	dep	2	SENT_215	[p15l144t2915r295b2962],
8	.	.	O	.	_	0	SENT_215	[p15l144t2915r295b2962],

1	4	LS	NUMBER	4	dep	9	SENT_216	[p15l40t2991r73b3036],
2	Dishy	NNP	O	Dishy	nn	9	SENT_216	[p15l144t2989r295b3051],
3	V	NNP	O	V	nn	9	SENT_216	[p15l315t2990r366b3046],
4	,	,	O	,	_	0	SENT_216	[p15l315t2990r366b3046],
5	Sofowara	NNP	O	Sofowara	appos	9	SENT_216	[p15l394t2989r648b3036],
6	CG	NNP	O	CG	nn	9	SENT_216	[p15l673t2990r778b3046],
7	,	,	O	,	_	0	SENT_216	[p15l673t2990r778b3046],
8	Xie	NNP	O	Xie	appos	9	SENT_216	[p15l805t2990r890b3036],
9	HG	NNP	O	HG	_	0	SENT_216	[p15l917t2990r1017b3046],
10	,	,	O	,	_	0	SENT_216	[p15l917t2990r1017b3046],
11	Kim	NNP	PERSON	Kim	prep	9	SENT_216	[p15l1047t2990r1147b3036],
12	RB	NN	O	rb	dep	11	SENT_216	[p15l1177t2991r1256b3046],
13	,	,	O	,	_	0	SENT_216	[p15l1177t2991r1256b3046],
14	Byrne	NNP	PERSON	Byrne	nn	15	SENT_216	[p15l1286t2991r1439b3051],
15	DW	NNP	O	DW	appos	9	SENT_216	[p15l1466t2990r1580b3046],
16	,	,	O	,	_	0	SENT_216	[p15l1466t2990r1580b3046],
17	Stein	NNP	PERSON	Stein	nn	18	SENT_216	[p15l1609t2990r1741b3036],
18	CM	NN	O	cm	appos	15	SENT_216	[p15l1768t2990r1863b3036],
19	et	FW	O	et	nn	20	SENT_216	[p15l1891t2994r1940b3036],
20	al.	FW	O	al.	dep	18	SENT_216	[p15l1961t2989r2018b3036],
21	.	.	O	.	_	0	SENT_216	[p15l1961t2989r2018b3036],

1	The	DT	O	the	det	2	SENT_217	[p15l2043t2989r2146b3036],
2	effect	NN	O	effect	_	0	SENT_217	[p15l142t3064r294b3112],
3	of	IN	O	of	_	0	SENT_217	[p15l318t3064r372b3112],
4	common	JJ	O	common	amod	5	SENT_217	[p15l395t3078r643b3112],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_217	[p15l673t3064r1100b3127],
6	of	IN	O	of	_	0	SENT_217	[p15l1126t3064r1180b3112],
7	the	DT	O	the	det	9	SENT_217	[p15l1202t3064r1290b3112],
8	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	9	SENT_217	[p15l1318t3064r1793b3126],
9	receptor	NN	O	receptor	prep_of	2	SENT_217	[p15l1822t3069r2054b3127],
10	on	IN	O	on	_	0	SENT_217	[p15l2077t3078r2144b3112],
11	agonist-mediated	JJ	O	agonist-mediated	amod	13	SENT_217	[p15l142t3138r628b3201],
12	vascular	JJ	O	vascular	amod	13	SENT_217	[p15l667t3138r891b3186],
13	desensitization	NN	O	desensitization	prep_on	9	SENT_217	[p15l927t3138r1350b3186],
14	.	.	O	.	_	0	SENT_217	[p15l927t3138r1350b3186],

1	N	NN	O	n	dep	2	SENT_218	[p15l1394t3141r1438b3186],
2	Engl	NNP	LOCATION	Engl	dep	4	SENT_218	[p15l1475t3138r1587b3201],
3	/	:	O	/	punct	4	SENT_218	[p15l1616t3141r1637b3197],
4	Med	VBD	O	med	_	0	SENT_218	[p15l1673t3138r1791b3186],
5	2001	CD	DATE	2001	dobj	4	SENT_218	[p15l1824t3140r1981b3196],
6	;	:	O	;	_	0	SENT_218	[p15l1824t3140r1981b3196],
7	345	CD	NUMBER	345	num	9	SENT_218	[p15l2023t3140r2143b3186],
8	:	:	O	:	_	0	SENT_218	[p15l2023t3140r2143b3186],
9	1030-1035	CD	DATE	1030-1035	dep	5	SENT_218	[p15l145t3216r477b3263],
10	.	.	O	.	_	0	SENT_218	[p15l145t3216r477b3263],

1	Strosberg	NNP	PERSON	Strosberg	_	0	SENT_219	[p16l143t20r404b82],
2	AD	NN	O	ad	dep	1	SENT_219	[p16l459t22r559b68],
3	.	.	O	.	_	0	SENT_219	[p16l459t22r559b68],

1	Structure	NN	O	structure	_	0	SENT_220	[p16l619t21r885b78],
2	,	,	O	,	_	0	SENT_220	[p16l619t21r885b78],
3	function	NN	O	function	conj_and	1	SENT_220	[p16l942t20r1189b78],
4	,	,	O	,	_	0	SENT_220	[p16l942t20r1189b78],
5	and	CC	O	and	_	0	SENT_220	[p16l1248t20r1349b68],
6	regulation	NN	O	regulation	conj_and	1	SENT_220	[p16l1409t20r1686b82],
7	of	IN	O	of	_	0	SENT_220	[p16l1744t20r1798b68],
8	adrenergic	JJ	O	adrenergic	amod	9	SENT_220	[p16l1851t20r2147b82],
9	receptors	NNS	O	receptor	prep_of	1	SENT_220	[p16l144t100r413b157],
10	.	.	O	.	_	0	SENT_220	[p16l144t100r413b157],

1	Protein	NN	O	protein	_	0	SENT_221	[p16l445t96r627b142],
2	Sci	NNP	O	Sci	dep	1	SENT_221	[p16l653t96r726b142],
3	1993	CD	DATE	1993	num	2	SENT_221	[p16l750t96r904b152],
4	;	:	O	;	_	0	SENT_221	[p16l750t96r904b152],
5	2	CD	NUMBER	2	num	7	SENT_221	[p16l933t96r980b142],
6	:	:	O	:	_	0	SENT_221	[p16l933t96r980b142],
7	1198-1209	CD	DATE	1198-1209	dep	1	SENT_221	[p16l1012t96r1344b142],
8	.	.	O	.	_	0	SENT_221	[p16l1012t96r1344b142],

1	Revelli	NNP	PERSON	Revelli	nn	2	SENT_222	[p16l144t170r313b218],
2	JP	NNP	O	JP	_	0	SENT_222	[p16l350t172r413b229],
3	,	,	O	,	_	0	SENT_222	[p16l350t172r413b229],
4	Preitner	NNP	O	Preitner	nn	5	SENT_222	[p16l456t171r669b218],
5	F	NN	O	f	appos	2	SENT_222	[p16l706t172r744b228],
6	,	,	O	,	_	0	SENT_222	[p16l706t172r744b228],
7	Samec	NNP	PERSON	Samec	nn	8	SENT_222	[p16l785t171r965b218],
8	S	NNP	O	S	appos	2	SENT_222	[p16l1002t171r1045b228],
9	,	,	O	,	_	0	SENT_222	[p16l1002t171r1045b228],
10	Muniesa	NNP	PERSON	Muniesa	nn	11	SENT_222	[p16l1087t171r1316b218],
11	P	NN	PERSON	p	appos	2	SENT_222	[p16l1356t172r1399b228],
12	,	,	O	,	_	0	SENT_222	[p16l1356t172r1399b228],
13	Kuehne	NNP	PERSON	Kuehne	nn	14	SENT_222	[p16l1441t170r1647b218],
14	F	NN	O	f	appos	2	SENT_222	[p16l1687t172r1725b228],
15	,	,	O	,	_	0	SENT_222	[p16l1687t172r1725b228],
16	Boss	NNP	O	Boss	nn	17	SENT_222	[p16l1768t172r1883b218],
17	o	NN	O	o	appos	2	SENT_222	[p16l1919t172r1965b218],
18	et	FW	O	et	nn	19	SENT_222	[p16l2003t176r2052b218],
19	al.	FW	O	al.	dep	17	SENT_222	[p16l2085t170r2143b218],
20	.	.	O	.	_	0	SENT_222	[p16l2085t170r2143b218],

1	Targeted	VBN	O	target	_	0	SENT_223	[p16l139t245r387b307],
2	gene	NN	O	gene	nn	3	SENT_223	[p16l430t259r566b307],
3	disruption	NN	O	disruption	dobj	1	SENT_223	[p16l607t245r885b307],
4	reveals	VBZ	O	reveal	dep	1	SENT_223	[p16l931t245r1114b292],
5	a	DT	O	a	det	7	SENT_223	[p16l1155t259r1182b292],
6	leptin-independent	JJ	O	leptin-independent	amod	7	SENT_223	[p16l1226t245r1763b307],
7	role	NN	O	role	nsubj	1	SENT_223	[p16l1804t245r1904b292],
8	for	IN	O	for	_	0	SENT_223	[p16l1942t245r2020b292],
9	the	DT	O	the	det	11	SENT_223	[p16l2058t245r2146b292],
10	mouse	NN	O	mouse	nn	11	SENT_223	[p16l144t334r325b368],
11	beta3-adrenoceptor	NN	O	beta3-adrenoceptor	prep_for	7	SENT_223	[p16l347t320r905b383],
12	in	IN	O	in	_	0	SENT_223	[p16l923t321r968b367],
13	the	DT	O	the	det	14	SENT_223	[p16l989t320r1077b368],
14	regulation	NN	O	regulation	prep_in	11	SENT_223	[p16l1100t320r1377b382],
15	of	IN	O	of	_	0	SENT_223	[p16l1400t320r1454b368],
16	body	NN	O	body	nn	17	SENT_223	[p16l1473t320r1612b383],
17	composition	NN	O	composition	prep_of	14	SENT_223	[p16l1630t321r1991b383],
18	.	.	O	.	_	0	SENT_223	[p16l1630t321r1991b383],

1	/	:	O	/	punct	3	SENT_224	[p16l2010t322r2031b379],
2	Clin	NNP	O	Clin	nn	3	SENT_224	[p16l2051t320r2148b368],
3	Invest	NNP	O	Invest	_	0	SENT_224	[p16l144t397r298b442],
4	1997	CD	DATE	1997	dep	3	SENT_224	[p16l323t396r477b452],
5	;	:	O	;	_	0	SENT_224	[p16l323t396r477b452],
6	100	CD	NUMBER	100	dep	3	SENT_224	[p16l509t396r626b442],
7	:	:	O	:	_	0	SENT_224	[p16l509t396r626b442],
8	1098-1106	CD	DATE	1098-1106	dep	6	SENT_224	[p16l659t396r990b442],
9	.	.	O	.	_	0	SENT_224	[p16l659t396r990b442],

1	Susulic	NNP	O	Susulic	nn	2	SENT_225	[p16l143t470r330b518],
2	VS	NNP	O	VS	_	0	SENT_225	[p16l353t471r437b528],
3	,	,	O	,	_	0	SENT_225	[p16l353t471r437b528],
4	Frederich	NNP	PERSON	Frederich	nn	5	SENT_225	[p16l470t470r721b518],
5	RC	NNP	PERSON	RC	appos	2	SENT_225	[p16l753t471r839b528],
6	,	,	O	,	_	0	SENT_225	[p16l753t471r839b528],
7	Lawitts	NNP	PERSON	Lawitts	nn	8	SENT_225	[p16l872t471r1061b518],
8	J	NNP	PERSON	J	appos	2	SENT_225	[p16l1086t472r1115b529],
9	,	,	O	,	_	0	SENT_225	[p16l1086t472r1115b529],
10	Tozzo	NNP	O	Tozzo	nn	11	SENT_225	[p16l1143t472r1306b518],
11	E	NNP	O	E	appos	8	SENT_225	[p16l1335t472r1375b528],
12	,	,	O	,	_	0	SENT_225	[p16l1335t472r1375b528],
13	Kahn	NNP	PERSON	Kahn	nn	14	SENT_225	[p16l1408t470r1542b518],
14	BB	NNP	O	BB	appos	2	SENT_225	[p16l1574t472r1655b528],
15	,	,	O	,	_	0	SENT_225	[p16l1574t472r1655b528],
16	Harper	NNP	PERSON	Harper	dep	17	SENT_225	[p16l1687t472r1875b533],
17	ME	NNP	O	ME	dep	14	SENT_225	[p16l1901t472r1985b517],
18	et	FW	O	et	dep	17	SENT_225	[p16l2013t476r2062b518],
19	o	NN	O	o	dep	18	SENT_225	[p16l2085t470r2142b518],
20	/	:	O	/	punct	17	SENT_225	[p16l2085t470r2142b518],
21	.	.	O	.	_	0	SENT_225	[p16l2085t470r2142b518],

1	Targeted	VBN	O	target	_	0	SENT_226	[p16l139t545r387b607],
2	disruption	NN	O	disruption	dobj	1	SENT_226	[p16l411t545r690b607],
3	of	IN	O	of	_	0	SENT_226	[p16l715t545r768b592],
4	the	DT	O	the	det	8	SENT_226	[p16l787t545r875b592],
5	beta	NN	O	beta	nn	8	SENT_226	[p16l899t545r1016b592],
6	3-adrenergic	JJ	O	3-adrenergic	amod	8	SENT_226	[p16l1042t545r1393b607],
7	receptor	NN	O	receptor	nn	8	SENT_226	[p16l1417t550r1649b607],
8	gene	NN	O	gene	prep_of	2	SENT_226	[p16l1669t559r1820b607],
9	.	.	O	.	_	0	SENT_226	[p16l1669t559r1820b607],

1	/	:	O	/	punct	3	SENT_227	[p16l1841t547r1862b604],
2	Biol	NNP	ORGANIZATION	Biol	nn	3	SENT_227	[p16l1883t545r1977b592],
3	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_227	[p16l1998t545r2148b592],
4	1995	CD	DATE	1995	dep	3	SENT_227	[p16l145t621r299b677],
5	;	:	O	;	_	0	SENT_227	[p16l145t621r299b677],
6	270	CD	NUMBER	270	dep	3	SENT_227	[p16l328t621r448b667],
7	:	:	O	:	_	0	SENT_227	[p16l328t621r448b667],
8	29483-29492	CD	NUMBER	29483-29492	dep	6	SENT_227	[p16l477t621r885b667],
9	.	.	O	.	_	0	SENT_227	[p16l477t621r885b667],

1	Shima	NNP	PERSON	Shima	nn	2	SENT_228	[p16l143t695r311b743],
2	Y	NN	PERSON	y	_	0	SENT_228	[p16l335t697r383b753],
3	,	,	O	,	_	0	SENT_228	[p16l335t697r383b753],
4	Tsukada	NN	PERSON	tsukada	nn	5	SENT_228	[p16l410t695r635b743],
5	T	NN	PERSON	t	appos	2	SENT_228	[p16l660t697r708b753],
6	,	,	O	,	_	0	SENT_228	[p16l660t697r708b753],
7	Nakanishi	NNP	ORGANIZATION	Nakanishi	nn	8	SENT_228	[p16l741t695r1005b743],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_228	[p16l1035t697r1081b753],
9	,	,	O	,	_	0	SENT_228	[p16l1035t697r1081b753],
10	Ohta	NNP	PERSON	Ohta	nn	12	SENT_228	[p16l1111t695r1247b743],
11	H.	NNP	PERSON	H.	nn	12	SENT_228	[p16l1276t697r1330b743],
12	Association	NNP	PERSON	Association	appos	2	SENT_228	[p16l1356t696r1665b743],
13	of	IN	O	of	_	0	SENT_228	[p16l1694t695r1748b743],
14	the	DT	O	the	det	16	SENT_228	[p16l1769t695r1857b743],
15	Trp64Arg	NN	O	trp64arg	nn	16	SENT_228	[p16l1881t697r2144b758],
16	mutation	NN	O	mutation	prep_of	12	SENT_228	[p16l144t771r394b818],
17	of	IN	O	of	_	0	SENT_228	[p16l432t770r486b818],
18	the	DT	O	the	det	20	SENT_228	[p16l518t770r606b818],
19	beta3-adrenergic	JJ	O	beta3-adrenergic	amod	20	SENT_228	[p16l644t770r1121b833],
20	receptor	NN	O	receptor	prep_of	16	SENT_228	[p16l1158t775r1390b833],
21	with	IN	O	with	_	0	SENT_228	[p16l1422t770r1541b818],
22	fatty	JJ	O	fatty	amod	23	SENT_228	[p16l1577t770r1703b833],
23	liver	NN	O	liver	prep_with	20	SENT_228	[p16l1740t770r1852b818],
24	and	CC	O	and	_	0	SENT_228	[p16l1886t770r1986b818],
25	mild	JJ	O	mild	amod	27	SENT_228	[p16l2027t770r2144b818],
26	glucose	NN	O	glucose	nn	27	SENT_228	[p16l142t845r351b907],
27	intolerance	NN	O	intolerance	prep_with	20	SENT_228	[p16l389t845r695b893],
28	in	IN	O	in	_	0	SENT_228	[p16l733t846r777b892],
29	Japanese	JJ	MISC	japanese	amod	30	SENT_228	[p16l814t847r1056b908],
30	subjects	NNS	O	subject	prep_in	23	SENT_228	[p16l1092t845r1328b908],
31	.	.	O	.	_	0	SENT_228	[p16l1092t845r1328b908],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_229	[p16l1370t845r1468b893],
2	Chim	NNP	PERSON	Chim	nn	3	SENT_229	[p16l1506t845r1641b893],
3	Acta	NNP	PERSON	Acta	_	0	SENT_229	[p16l1673t847r1793b893],
4	1998	CD	DATE	1998	num	3	SENT_229	[p16l1829t846r1983b903],
5	;	:	O	;	_	0	SENT_229	[p16l1829t846r1983b903],
6	274	CD	NUMBER	274	num	8	SENT_229	[p16l2023t846r2143b893],
7	:	:	O	:	_	0	SENT_229	[p16l2023t846r2143b893],
8	167-176	CD	NUMBER	167-176	dep	3	SENT_229	[p16l145t923r404b969],
9	.	.	O	.	_	0	SENT_229	[p16l145t923r404b969],

1	Widen	VB	O	widen	_	0	SENT_230	[p16l139t996r317b1044],
2	E	NN	O	e	dep	1	SENT_230	[p16l344t998r384b1054],
3	,	,	O	,	_	0	SENT_230	[p16l344t998r384b1054],
4	Lehto	NNP	PERSON	Lehto	dep	5	SENT_230	[p16l412t996r563b1044],
5	M	NNP	O	M	dep	2	SENT_230	[p16l588t998r655b1054],
6	,	,	O	,	_	0	SENT_230	[p16l588t998r655b1054],
7	Kanninen	NNP	PERSON	Kanninen	nn	8	SENT_230	[p16l683t997r940b1044],
8	T	NN	PERSON	t	dep	14	SENT_230	[p16l962t998r1010b1054],
9	,	,	O	,	_	0	SENT_230	[p16l962t998r1010b1054],
10	Walston	NNP	PERSON	Walston	nn	11	SENT_230	[p16l1032t996r1255b1044],
11	J	NNP	PERSON	J	appos	8	SENT_230	[p16l1277t998r1307b1055],
12	,	,	O	,	_	0	SENT_230	[p16l1277t998r1307b1055],
13	Shuldiner	NNP	PERSON	Shuldiner	dep	14	SENT_230	[p16l1333t996r1597b1044],
14	AR	NNS	O	ar	dep	5	SENT_230	[p16l1614t998r1701b1054],
15	,	,	O	,	_	0	SENT_230	[p16l1614t998r1701b1054],
16	Groop	NNP	PERSON	Groop	nn	17	SENT_230	[p16l1727t997r1902b1059],
17	LC	NNP	O	LC	appos	14	SENT_230	[p16l1927t997r1994b1044],
18	et	FW	O	et	dep	17	SENT_230	[p16l2017t1002r2066b1044],
19	o	NN	O	o	dep	17	SENT_230	[p16l2085t996r2143b1044],
20	/	:	O	/	punct	2	SENT_230	[p16l2085t996r2143b1044],
21	.	.	O	.	_	0	SENT_230	[p16l2085t996r2143b1044],

1	Association	NNP	O	Association	_	0	SENT_231	[p16l139t1072r448b1118],
2	of	IN	O	of	_	0	SENT_231	[p16l477t1071r531b1118],
3	a	DT	O	a	det	4	SENT_231	[p16l554t1085r581b1118],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_231	[p16l610t1071r1011b1133],
5	in	IN	O	in	_	0	SENT_231	[p16l1041t1072r1085b1118],
6	the	DT	O	the	det	9	SENT_231	[p16l1113t1071r1201b1118],
7	beta	NN	O	beta	nn	9	SENT_231	[p16l1230t1071r1346b1118],
8	3-adrenergic-receptor	JJ	O	3-adrenergic-receptor	amod	9	SENT_231	[p16l1377t1071r1987b1133],
9	gene	NN	O	gene	prep_in	4	SENT_231	[p16l2010t1085r2146b1133],
10	with	IN	O	with	_	0	SENT_231	[p16l140t1145r259b1193],
11	features	NNS	O	feature	prep_with	9	SENT_231	[p16l286t1145r505b1193],
12	of	IN	O	of	_	0	SENT_231	[p16l532t1145r585b1193],
13	the	DT	O	the	det	16	SENT_231	[p16l608t1145r696b1193],
14	insulin	NN	O	insulin	nn	16	SENT_231	[p16l724t1145r898b1193],
15	resistance	NN	O	resistance	nn	16	SENT_231	[p16l929t1147r1195b1193],
16	syndrome	NN	O	syndrome	prep_of	11	SENT_231	[p16l1222t1145r1497b1208],
17	in	IN	O	in	_	0	SENT_231	[p16l1526t1147r1571b1193],
18	Finns	NNP	MISC	Finns	prep_in	1	SENT_231	[p16l1602t1147r1755b1193],
19	.	.	O	.	_	0	SENT_231	[p16l1602t1147r1755b1193],

1	N	NN	O	n	nn	3	SENT_232	[p16l1787t1148r1832b1193],
2	Englj	NNP	O	Englj	nn	3	SENT_232	[p16l1857t1145r2008b1208],
3	Med	NNP	O	Med	_	0	SENT_232	[p16l2033t1145r2152b1193],
4	1995	CD	DATE	1995	num	3	SENT_232	[p16l145t1222r299b1278],
5	;	:	O	;	_	0	SENT_232	[p16l145t1222r299b1278],
6	333	CD	NUMBER	333	num	8	SENT_232	[p16l329t1222r448b1268],
7	:	:	O	:	_	0	SENT_232	[p16l329t1222r448b1268],
8	348-351	CD	NUMBER	348-351	dep	3	SENT_232	[p16l480t1222r740b1268],
9	.	.	O	.	_	0	SENT_232	[p16l480t1222r740b1268],

1	Ehrenborg	NN	O	ehrenborg	nn	2	SENT_233	[p16l149t1296r435b1359],
2	E	NN	O	e	_	0	SENT_233	[p16l464t1298r504b1354],
3	,	,	O	,	_	0	SENT_233	[p16l464t1298r504b1354],
4	Skogsberg	NNP	PERSON	Skogsberg	nn	5	SENT_233	[p16l532t1296r818b1359],
5	J	NNP	PERSON	J	appos	2	SENT_233	[p16l842t1298r872b1355],
6	,	,	O	,	_	0	SENT_233	[p16l842t1298r872b1355],
7	Ruotolo	NNP	PERSON	Ruotolo	nn	8	SENT_233	[p16l901t1296r1112b1344],
8	G	NNP	O	G	appos	2	SENT_233	[p16l1138t1297r1195b1354],
9	,	,	O	,	_	0	SENT_233	[p16l1138t1297r1195b1354],
10	Large	JJ	O	large	amod	11	SENT_233	[p16l1225t1298r1372b1359],
11	V	NN	O	v	appos	2	SENT_233	[p16l1394t1298r1445b1354],
12	,	,	O	,	_	0	SENT_233	[p16l1394t1298r1445b1354],
13	Eriksson	NN	PERSON	eriksson	nn	14	SENT_233	[p16l1475t1296r1688b1344],
14	P	NN	O	p	appos	2	SENT_233	[p16l1717t1298r1759b1354],
15	,	,	O	,	_	0	SENT_233	[p16l1717t1298r1759b1354],
16	Arner	NNP	PERSON	Arner	nn	17	SENT_233	[p16l1785t1298r1938b1344],
17	P	NN	O	p	appos	2	SENT_233	[p16l1962t1298r1989b1343],
18	et	FW	O	et	nn	19	SENT_233	[p16l2015t1302r2064b1344],
19	al.	FW	O	al.	dep	17	SENT_233	[p16l2085t1296r2143b1344],
20	.	.	O	.	_	0	SENT_233	[p16l2085t1296r2143b1344],

1	The	DT	O	the	det	3	SENT_234	[p16l144t1371r247b1419],
2	Q/E27	NN	O	q/e27	nn	3	SENT_234	[p16l269t1371r443b1428],
3	polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_234	[p16l467t1371r868b1434],
4	in	IN	O	in	_	0	SENT_234	[p16l893t1372r938b1418],
5	the	DT	O	the	det	7	SENT_234	[p16l961t1371r1049b1419],
6	beta2-adrenoceptor	NN	O	beta2-adrenoceptor	nn	7	SENT_234	[p16l1072t1371r1630b1434],
7	gene	NN	O	gene	prep_in	3	SENT_234	[p16l1648t1385r1784b1433],
8	is	VBZ	O	be	auxpass	9	SENT_234	[p16l1808t1372r1842b1419],
9	associated	VBN	O	associate	_	0	SENT_234	[p16l1862t1371r2144b1419],
10	with	IN	O	with	_	0	SENT_234	[p16l144t1445r264b1493],
11	increased	VBN	O	increase	amod	13	SENT_234	[p16l297t1445r554b1493],
12	body	NN	O	body	nn	13	SENT_234	[p16l587t1445r726b1508],
13	weight	NN	O	weight	prep_with	9	SENT_234	[p16l753t1445r947b1508],
14	and	CC	O	and	_	0	SENT_234	[p16l974t1445r1075b1493],
15	dyslipoproteinaemia	NN	O	dyslipoproteinaemia	conj_and	13	SENT_234	[p16l1107t1445r1672b1508],
16	involving	VBG	O	involve	partmod	15	SENT_234	[p16l1704t1445r1953b1508],
17	triglyceride-rich	JJ	O	triglyceride-rich	amod	18	SENT_234	[p16l1984t1445r2145b1508, p16l146t1521r436b1569],
18	lipoproteins	NNS	O	lipoprotein	dobj	16	SENT_234	[p16l466t1521r809b1584],
19	.	.	O	.	_	0	SENT_234	[p16l466t1521r809b1584],

1	/	:	O	/	punct	3	SENT_235	[p16l833t1523r854b1580],
2	Intern	NNP	O	Intern	nn	3	SENT_235	[p16l879t1523r1033b1569],
3	Med	NNP	O	Med	_	0	SENT_235	[p16l1059t1521r1177b1569],
4	2000	CD	DATE	2000	dep	3	SENT_235	[p16l1198t1522r1355b1579],
5	;	:	O	;	_	0	SENT_235	[p16l1198t1522r1355b1579],
6	247	CD	NUMBER	247	dep	3	SENT_235	[p16l1384t1522r1504b1569],
7	:	:	O	:	_	0	SENT_235	[p16l1384t1522r1504b1569],
8	651-656	CD	NUMBER	651-656	dep	6	SENT_235	[p16l1534t1522r1795b1569],
9	.	.	O	.	_	0	SENT_235	[p16l1534t1522r1795b1569],

1	Malczewska-Malec	NNP	O	Malczewska-Malec	nn	2	SENT_236	[p16l149t1596r668b1643],
2	M	NNP	O	M	_	0	SENT_236	[p16l698t1598r765b1654],
3	,	,	O	,	_	0	SENT_236	[p16l698t1598r765b1654],
4	Wybranska	NNP	O	Wybranska	nn	5	SENT_236	[p16l795t1596r1098b1658],
5	I	NNP	O	I	appos	2	SENT_236	[p16l1130t1598r1155b1654],
6	,	,	O	,	_	0	SENT_236	[p16l1130t1598r1155b1654],
7	Leszczynska-Golabek	NNP	O	Leszczynska-Golabek	nn	8	SENT_236	[p16l1190t1596r1768b1658],
8	I	NNP	O	I	appos	2	SENT_236	[p16l1798t1598r1823b1653],
9	,	,	O	,	_	0	SENT_236	[p16l1798t1598r1823b1653],
10	Niedbal	NNP	O	Niedbal	nn	11	SENT_236	[p16l1857t1596r2068b1643],
11	S	NNP	O	S	appos	2	SENT_236	[p16l2100t1597r2143b1653],
12	,	,	O	,	_	0	SENT_236	[p16l2100t1597r2143b1653],
13	Kwasniak	NNP	O	Kwasniak	nn	14	SENT_236	[p16l149t1671r402b1719],
14	M	NNP	O	M	appos	2	SENT_236	[p16l454t1673r521b1729],
15	,	,	O	,	_	0	SENT_236	[p16l454t1673r521b1729],
16	Hartwich	NNP	PERSON	Hartwich	nn	17	SENT_236	[p16l577t1671r821b1719],
17	J	NNP	O	J	appos	2	SENT_236	[p16l872t1673r884b1730],
18	et	FW	O	et	nn	19	SENT_236	[p16l938t1677r986b1719],
19	al.	FW	O	al.	dep	17	SENT_236	[p16l1034t1671r1091b1719],
20	.	.	O	.	_	0	SENT_236	[p16l1034t1671r1091b1719],

1	An	DT	O	a	det	2	SENT_237	[p16l1142t1673r1215b1718],
2	analysis	NN	O	analysis	_	0	SENT_237	[p16l1267t1671r1475b1734],
3	of	IN	O	of	_	0	SENT_237	[p16l1524t1671r1578b1719],
4	the	DT	O	the	det	5	SENT_237	[p16l1624t1671r1712b1719],
5	link	NN	O	link	prep_of	2	SENT_237	[p16l1764t1671r1858b1719],
6	between	IN	O	between	_	0	SENT_237	[p16l1908t1671r2144b1719],
7	polymorphisms	NNS	O	polymorphism	prep_between	5	SENT_237	[p16l148t1745r576b1808],
8	of	IN	O	of	_	0	SENT_237	[p16l604t1745r657b1793],
9	the	DT	O	the	det	10	SENT_237	[p16l681t1745r770b1793],
10	beta2	NN	O	beta2	prep_of	7	SENT_237	[p16l800t1745r953b1793],
11	and	CC	O	and	_	0	SENT_237	[p16l982t1745r1083b1793],
12	beta3	NN	O	beta3	nn	15	SENT_237	[p16l1115t1745r1267b1793],
13	adrenergic	JJ	O	adrenergic	amod	15	SENT_237	[p16l1297t1745r1592b1808],
14	receptor	NN	O	receptor	nn	15	SENT_237	[p16l1623t1751r1854b1808],
15	gene	NN	O	gene	conj_and	10	SENT_237	[p16l1880t1759r2015b1808],
16	and	CC	O	and	_	0	SENT_237	[p16l2043t1745r2144b1793],
17	metabolic	JJ	O	metabolic	amod	18	SENT_237	[p16l148t1821r421b1869],
18	parameters	NNS	O	parameter	conj_and	10	SENT_237	[p16l455t1827r763b1884],
19	among	IN	O	among	_	0	SENT_237	[p16l795t1835r989b1884],
20	Polish	JJ	MISC	polish	amod	21	SENT_237	[p16l1026t1821r1181b1869],
21	Caucasians	NNS	MISC	caucasian	prep_among	2	SENT_237	[p16l1215t1822r1519b1869],
22	with	IN	O	with	_	0	SENT_237	[p16l1549t1821r1668b1869],
23	familial	JJ	O	familial	amod	24	SENT_237	[p16l1700t1821r1897b1869],
24	obesity	NN	O	obesity	prep_with	2	SENT_237	[p16l1931t1821r2143b1884],
25	.	.	O	.	_	0	SENT_237	[p16l1931t1821r2143b1884],

1	Med	NNP	O	Med	nn	3	SENT_238	[p16l148t1896r267b1943],
2	Sci	NNP	O	Sci	nn	3	SENT_238	[p16l289t1897r362b1943],
3	Monit	NNP	O	Monit	_	0	SENT_238	[p16l384t1897r542b1943],
4	2003	CD	DATE	2003	num	3	SENT_238	[p16l564t1897r721b1953],
5	;	:	O	;	_	0	SENT_238	[p16l564t1897r721b1953],
6	9	CD	NUMBER	9	dep	3	SENT_238	[p16l749t1897r797b1943],
7	:	:	O	:	_	0	SENT_238	[p16l749t1897r797b1943],
8	CR225-CR234	NN	O	cr225-cr234	dep	6	SENT_238	[p16l827t1897r1246b1943],
9	.	.	O	.	_	0	SENT_238	[p16l827t1897r1246b1943],

1	Ryden	NNP	PERSON	Ryden	nn	2	SENT_239	[p16l149t1970r314b2033],
2	M	NNP	O	M	_	0	SENT_239	[p16l342t1973r410b2028],
3	,	,	O	,	_	0	SENT_239	[p16l342t1973r410b2028],
4	Hoffstedt	NNP	PERSON	Hoffstedt	nn	5	SENT_239	[p16l439t1970r691b2018],
5	J	NNP	PERSON	J	appos	2	SENT_239	[p16l711t1973r741b2029],
6	,	,	O	,	_	0	SENT_239	[p16l711t1973r741b2029],
7	Eriksson	NNP	PERSON	Eriksson	nn	8	SENT_239	[p16l769t1970r982b2018],
8	P	NN	O	p	appos	2	SENT_239	[p16l1011t1973r1053b2028],
9	,	,	O	,	_	0	SENT_239	[p16l1011t1973r1053b2028],
10	Bringman	NNP	O	Bringman	nn	11	SENT_239	[p16l1083t1972r1348b2033],
11	S	NNP	O	S	appos	2	SENT_239	[p16l1375t1972r1417b2028],
12	,	,	O	,	_	0	SENT_239	[p16l1375t1972r1417b2028],
13	Arner	NNP	PERSON	Arner	nn	18	SENT_239	[p16l1441t1973r1595b2018],
14	P.	NNP	O	P.	nn	18	SENT_239	[p16l1618t1973r1661b2018],
15	The	NNP	O	The	nn	18	SENT_239	[p16l1685t1970r1787b2018],
16	Arg	NN	O	arg	nn	18	SENT_239	[p16l1808t1973r1903b2033],
17	389	CD	NUMBER	389	num	18	SENT_239	[p16l1931t1972r2032b2018],
18	Gly	NN	O	gly	appos	2	SENT_239	[p16l2057t1970r2148b2033],
19	beta1-adrenergic	JJ	O	beta1-adrenergic	amod	22	SENT_239	[p16l148t2046r624b2109],
20	receptor	NN	O	receptor	nn	22	SENT_239	[p16l668t2052r900b2109],
21	gene	NN	O	gene	nn	22	SENT_239	[p16l939t2060r1075b2109],
22	polymorphism	NN	O	polymorphism	dep	18	SENT_239	[p16l1119t2046r1520b2109],
23	and	CC	O	and	_	0	SENT_239	[p16l1564t2046r1665b2094],
24	human	JJ	O	human	amod	27	SENT_239	[p16l1711t2046r1902b2094],
25	fat	JJ	O	fat	amod	27	SENT_239	[p16l1944t2046r2017b2094],
26	cell	NN	O	cell	nn	27	SENT_239	[p16l2057t2046r2144b2094],
27	lipolysis	NN	O	lipolysis	appos	2	SENT_239	[p16l148t2121r374b2183],
28	.	.	O	.	_	0	SENT_239	[p16l148t2121r374b2183],

1	Int	NN	O	int	_	0	SENT_240	[p16l405t2123r476b2168],
2	I	CD	NUMBER	i	num	1	SENT_240	[p16l494t2123r515b2180],
3	Obes	NNP	O	Obes	nn	6	SENT_240	[p16l540t2121r671b2168],
4	Relat	NNP	O	Relat	nn	6	SENT_240	[p16l696t2121r828b2168],
5	Metab	NNP	O	Metab	nn	6	SENT_240	[p16l851t2121r1023b2168],
6	Disord	NNP	O	Disord	dep	1	SENT_240	[p16l1049t2121r1220b2168],
7	2001	CD	DATE	2001	num	6	SENT_240	[p16l1241t2122r1370b2168],
8	;	:	O	;	_	0	SENT_240	[p16l1384t2137r1398b2178],
9	25	CD	NUMBER	25	num	11	SENT_240	[p16l1427t2122r1511b2168],
10	:	:	O	:	_	0	SENT_240	[p16l1427t2122r1511b2168],
11	1599-1603	CD	DATE	1599-1603	dep	1	SENT_240	[p16l1542t2122r1875b2168],
12	.	.	O	.	_	0	SENT_240	[p16l1542t2122r1875b2168],

1	World	NNP	ORGANIZATION	World	nn	4	SENT_241	[p16l144t2196r310b2244],
2	Health	NNP	ORGANIZATION	Health	nn	4	SENT_241	[p16l374t2196r549b2244],
3	Organization-International	NNP	ORGANIZATION	Organization-International	nn	4	SENT_241	[p16l611t2196r1348b2258],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_241	[p16l1411t2197r1608b2259],
5	of	IN	O	of	_	0	SENT_241	[p16l1666t2196r1719b2244],
6	Hypertension	NN	O	hypertension	nn	7	SENT_241	[p16l1778t2197r2144b2259],
7	Guidelines	NNS	O	guideline	prep_of	4	SENT_241	[p16l147t2270r436b2318],
8	for	IN	O	for	_	0	SENT_241	[p16l462t2270r540b2318],
9	the	DT	O	the	det	10	SENT_241	[p16l564t2270r652b2318],
10	Management	NN	O	management	prep_for	4	SENT_241	[p16l683t2273r1057b2333],
11	of	IN	O	of	_	0	SENT_241	[p16l1083t2270r1137b2318],
12	Hypertension	NN	O	hypertension	prep_of	10	SENT_241	[p16l1165t2272r1548b2333],
13	.	.	O	.	_	0	SENT_241	[p16l1165t2272r1548b2333],

1	Guidelines	NNS	O	guideline	_	0	SENT_242	[p16l1580t2270r1870b2318],
2	Subcommittee	NNP	O	Subcommittee	dep	1	SENT_242	[p16l1899t2270r2146b2318, p16l148t2347r339b2394],
3	.	.	O	.	_	0	SENT_242	[p16l1899t2270r2146b2318, p16l148t2347r339b2394],

1	/	:	O	/	punct	2	SENT_243	[p16l364t2348r385b2405],
2	Hypertens	NNS	O	hyperten	_	0	SENT_243	[p16l408t2348r672b2409],
3	1999	CD	DATE	1999	dep	2	SENT_243	[p16l698t2347r852b2404],
4	;	:	O	;	_	0	SENT_243	[p16l698t2347r852b2404],
5	17	CD	NUMBER	17	dep	2	SENT_243	[p16l884t2347r965b2394],
6	:	:	O	:	_	0	SENT_243	[p16l884t2347r965b2394],
7	151-183	CD	NUMBER	151-183	dep	5	SENT_243	[p16l996t2347r1255b2394],
8	.	.	O	.	_	0	SENT_243	[p16l996t2347r1255b2394],

1	Iaccarino	NNP	O	Iaccarino	nn	2	SENT_244	[p16l149t2422r394b2468],
2	G	NNP	O	G	_	0	SENT_244	[p16l415t2422r472b2478],
3	,	,	O	,	_	0	SENT_244	[p16l415t2422r472b2478],
4	Lanni	NNP	PERSON	Lanni	nn	5	SENT_244	[p16l498t2422r642b2468],
5	F	NN	O	f	appos	2	SENT_244	[p16l666t2423r704b2478],
6	,	,	O	,	_	0	SENT_244	[p16l666t2423r704b2478],
7	Cipolletta	NN	O	cipolletta	nn	8	SENT_244	[p16l728t2421r994b2483],
8	E	NN	O	e	appos	2	SENT_244	[p16l1018t2423r1058b2479],
9	,	,	O	,	_	0	SENT_244	[p16l1018t2423r1058b2479],
10	Trimarco	NNP	ORGANIZATION	Trimarco	nn	11	SENT_244	[p16l1079t2422r1327b2468],
11	V	NNP	ORGANIZATION	V	appos	2	SENT_244	[p16l1345t2422r1396b2478],
12	,	,	O	,	_	0	SENT_244	[p16l1345t2422r1396b2478],
13	Izzo	NNP	PERSON	Izzo	nn	14	SENT_244	[p16l1422t2423r1525b2468],
14	R	NNP	O	R	appos	2	SENT_244	[p16l1548t2423r1591b2479],
15	,	,	O	,	_	0	SENT_244	[p16l1548t2423r1591b2479],
16	lovino	NN	O	lovino	nn	17	SENT_244	[p16l1618t2422r1784b2468],
17	CL	NN	O	cl	appos	2	SENT_244	[p16l1804t2422r1879b2468],
18	et	FW	O	et	nn	19	SENT_244	[p16l1899t2426r1948b2468],
19	al.	FW	O	al.	dep	17	SENT_244	[p16l1965t2421r2022b2468],
20	.	.	O	.	_	0	SENT_244	[p16l1965t2421r2022b2468],

1	The	DT	O	the	det	3	SENT_245	[p16l2043t2421r2146b2468],
2	Glu27	NN	O	glu27	nn	3	SENT_245	[p16l147t2495r313b2543],
3	allele	NN	O	allele	nsubj	9	SENT_245	[p16l354t2495r492b2543],
4	of	IN	O	of	_	0	SENT_245	[p16l533t2495r586b2543],
5	the	DT	O	the	det	8	SENT_245	[p16l622t2495r710b2543],
6	beta2	NN	O	beta2	nn	8	SENT_245	[p16l752t2495r905b2543],
7	adrenergic	JJ	O	adrenergic	amod	8	SENT_245	[p16l947t2495r1242b2558],
8	receptor	NN	O	receptor	prep_of	3	SENT_245	[p16l1284t2501r1516b2558],
9	increases	VBZ	O	increase	_	0	SENT_245	[p16l1555t2497r1801b2543],
10	the	DT	O	the	det	11	SENT_245	[p16l1839t2495r1927b2543],
11	risk	NN	O	risk	dobj	9	SENT_245	[p16l1970t2495r2057b2543],
12	of	IN	O	of	_	0	SENT_245	[p16l2095t2495r2149b2543],
13	cardiac	JJ	O	cardiac	amod	14	SENT_245	[p16l146t2571r342b2619],
14	hypertrophy	NN	O	hypertrophy	prep_of	11	SENT_245	[p16l365t2571r709b2634],
15	in	IN	O	in	_	0	SENT_245	[p16l730t2572r774b2618],
16	hypertension	NN	O	hypertension	prep_in	14	SENT_245	[p16l800t2571r1175b2634],
17	.	.	O	.	_	0	SENT_245	[p16l800t2571r1175b2634],

1	/	:	O	/	punct	2	SENT_246	[p16l1196t2573r1216b2630],
2	Hypertens	NNS	O	hyperten	_	0	SENT_246	[p16l1237t2573r1499b2634],
3	2004	CD	DATE	2004	dep	2	SENT_246	[p16l1518t2572r1675b2629],
4	;	:	O	;	_	0	SENT_246	[p16l1518t2572r1675b2629],
5	22	CD	NUMBER	22	dep	2	SENT_246	[p16l1700t2572r1784b2619],
6	:	:	O	:	_	0	SENT_246	[p16l1700t2572r1784b2619],
7	2117-2122	CD	DATE	2117-2122	dep	5	SENT_246	[p16l1808t2572r2143b2619],
8	.	.	O	.	_	0	SENT_246	[p16l1808t2572r2143b2619],

1	Report	NNP	O	Report	_	0	SENT_247	[p16l149t2648r330b2708],
2	of	IN	O	of	_	0	SENT_247	[p16l357t2646r411b2693],
3	the	DT	O	the	det	5	SENT_247	[p16l436t2646r524b2693],
4	expert	NN	O	expert	nn	5	SENT_247	[p16l553t2651r731b2708],
5	committee	NN	O	committee	prep_of	1	SENT_247	[p16l759t2647r1059b2693],
6	on	IN	O	on	_	0	SENT_247	[p16l1089t2660r1156b2693],
7	the	DT	O	the	det	8	SENT_247	[p16l1187t2646r1274b2693],
8	diagnosis	NN	O	diagnosis	prep_on	1	SENT_247	[p16l1304t2646r1560b2708],
9	and	CC	O	and	_	0	SENT_247	[p16l1590t2646r1690b2693],
10	classification	NN	O	classification	prep_on	1	SENT_247	[p16l1721t2646r2064b2693],
11	of	IN	O	of	_	0	SENT_247	[p16l2095t2646r2149b2693],
12	diabetes	NN	O	diabetes	nn	13	SENT_247	[p16l146t2721r377b2769],
13	mellitus	NN	O	mellitus	prep_of	8	SENT_247	[p16l404t2721r631b2769],
14	.	.	O	.	_	0	SENT_247	[p16l404t2721r631b2769],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_248	[p16l663t2721r892b2769],
2	Care	NNP	O	Care	dep	7	SENT_248	[p16l919t2722r1039b2769],
3	2003	CD	DATE	2003	num	5	SENT_248	[p16l1061t2722r1218b2778],
4	;	:	O	;	_	0	SENT_248	[p16l1061t2722r1218b2778],
5	26	CD	NUMBER	26	dep	2	SENT_248	[p16l1247t2721r1496b2784],
6	(	CD	NUMBER	(	dep	7	SENT_248	[p16l1247t2721r1496b2784],
7	Supp	NNP	O	Supp	dep	12	SENT_248	[p16l1247t2721r1496b2784],
8	|	CD	NUMBER	|	num	7	SENT_248	[p16l1247t2721r1496b2784],
9	1	CD	NUMBER	1	num	10	SENT_248	[p16l1527t2721r1594b2780],
10	)	NN	O	)	dep	7	SENT_248	[p16l1527t2721r1594b2780],
11	:	:	O	:	_	0	SENT_248	[p16l1527t2721r1594b2780],
12	S5	NN	O	s5	_	0	SENT_248	[p16l1625t2722r1842b2769],
13	.	.	O	.	_	0	SENT_248	[p16l1625t2722r1842b2769],

1	—	NN	O	—	_	0	SENT_249	[p16l1625t2722r1842b2769],
2	.	.	O	.	_	0	SENT_249	[p16l1625t2722r1842b2769],

1	S20	NN	O	s20	_	0	SENT_250	[p16l1625t2722r1842b2769],
2	.	.	O	.	_	0	SENT_250	[p16l1625t2722r1842b2769],

1	Third	NNP	ORDINAL	Third	nn	2	SENT_251	[p16l144t2795r287b2843],
2	Report	NNP	O	Report	dep	13	SENT_251	[p16l326t2798r507b2858],
3	of	IN	O	of	_	0	SENT_251	[p16l540t2795r593b2843],
4	the	DT	O	the	det	8	SENT_251	[p16l624t2795r712b2843],
5	National	NNP	ORGANIZATION	National	nn	8	SENT_251	[p16l749t2795r979b2843],
6	Cholesterol	NNP	ORGANIZATION	Cholesterol	nn	8	SENT_251	[p16l1016t2795r1327b2843],
7	Education	NNP	ORGANIZATION	Education	nn	8	SENT_251	[p16l1367t2795r1637b2843],
8	Program	NNP	ORGANIZATION	Program	prep_of	2	SENT_251	[p16l1676t2798r1908b2858],
9	(	CD	NUMBER	(	num	10	SENT_251	[p16l1946t2796r2145b2855],
10	NCEP	NN	O	ncep	dep	13	SENT_251	[p16l1946t2796r2145b2855],
11	)	CD	NUMBER	)	num	13	SENT_251	[p16l1946t2796r2145b2855],
12	Expert	NNP	O	Expert	nn	13	SENT_251	[p16l149t2873r323b2934],
13	Panel	NNP	O	Panel	dep	28	SENT_251	[p16l356t2871r497b2919],
14	on	IN	O	on	_	0	SENT_251	[p16l532t2885r599b2919],
15	Detection	NN	O	detection	prep_on	13	SENT_251	[p16l635t2872r919b2929],
16	,	,	O	,	_	0	SENT_251	[p16l635t2872r919b2929],
17	Evaluation	NN	O	evaluation	prep_on	13	SENT_251	[p16l957t2871r1254b2929],
18	,	,	O	,	_	0	SENT_251	[p16l957t2871r1254b2929],
19	and	CC	O	and	_	0	SENT_251	[p16l1289t2871r1390b2919],
20	Treatment	NN	ORGANIZATION	treatment	prep_on	13	SENT_251	[p16l1421t2873r1714b2919],
21	of	IN	ORGANIZATION	of	_	0	SENT_251	[p16l1743t2871r1796b2919],
22	High	JJ	ORGANIZATION	high	amod	24	SENT_251	[p16l1828t2871r1954b2934],
23	Blood	NN	ORGANIZATION	blood	nn	24	SENT_251	[p16l1991t2871r2144b2919],
24	Cholesterol	NN	ORGANIZATION	cholesterol	prep_of	15	SENT_251	[p16l147t2946r457b2993],
25	in	IN	O	in	_	0	SENT_251	[p16l483t2947r527b2993],
26	Adults	NNS	O	adult	prep_in	24	SENT_251	[p16l548t2946r722b2993],
27	(	CD	NUMBER	(	num	28	SENT_251	[p16l744t2946r936b3005],
28	Adults	NNS	O	adult	dep	29	SENT_251	[p16l744t2946r936b3005],
29	Treatment	NN	O	treatment	_	0	SENT_251	[p16l955t2948r1247b2993],
30	Panel	NNP	O	Panel	nn	34	SENT_251	[p16l1270t2946r1412b2993],
31	Ill	NNP	O	Ill	nn	34	SENT_251	[p16l1438t2946r1502b3005],
32	)	NNP	O	)	nn	34	SENT_251	[p16l1438t2946r1502b3005],
33	Final	NNP	O	Final	nn	34	SENT_251	[p16l1527t2946r1648b2993],
34	Report	NNP	O	Report	dep	29	SENT_251	[p16l1674t2948r1868b3008],
35	.	.	O	.	_	0	SENT_251	[p16l1674t2948r1868b3008],

1	Rationale	NN	O	rationale	_	0	SENT_252	[p16l1895t2946r2145b2993],
2	for	IN	O	for	_	0	SENT_252	[p16l144t3021r222b3069],
3	Intervention	NN	O	intervention	prep_for	1	SENT_252	[p16l247t3022r598b3069],
4	.	.	O	.	_	0	SENT_252	[p16l247t3022r598b3069],

1	Circulation	NN	O	circulation	_	0	SENT_253	[p16l631t3021r914b3069],
2	2002	CD	DATE	2002	num	1	SENT_253	[p16l938t3023r1095b3079],
3	;	:	O	;	_	0	SENT_253	[p16l938t3023r1095b3079],
4	106	CD	NUMBER	106	num	6	SENT_253	[p16l1128t3023r1245b3069],
5	:	:	O	:	_	0	SENT_253	[p16l1128t3023r1245b3069],
6	3163-3223	CD	DURATION	3163-3223	dep	1	SENT_253	[p16l1277t3023r1610b3069],
7	.	.	O	.	_	0	SENT_253	[p16l1277t3023r1610b3069],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_254	[p16l149t3098r392b3144],
2	N	NNP	O	N	_	0	SENT_254	[p16l420t3098r478b3154],
3	,	,	O	,	_	0	SENT_254	[p16l420t3098r478b3154],
4	Ogawa	NNP	PERSON	Ogawa	nn	5	SENT_254	[p16l506t3097r702b3159],
5	Y	NN	PERSON	y	appos	2	SENT_254	[p16l725t3098r773b3154],
6	,	,	O	,	_	0	SENT_254	[p16l725t3098r773b3154],
7	Kajihara	NNP	PERSON	Kajihara	nn	8	SENT_254	[p16l803t3096r1018b3159],
8	S	NNP	O	S	appos	2	SENT_254	[p16l1045t3097r1088b3154],
9	,	,	O	,	_	0	SENT_254	[p16l1045t3097r1088b3154],
10	Hisatomi	NNP	O	Hisatomi	nn	11	SENT_254	[p16l1118t3097r1357b3144],
11	A	NNP	O	A	appos	2	SENT_254	[p16l1381t3098r1434b3154],
12	,	,	O	,	_	0	SENT_254	[p16l1381t3098r1434b3154],
13	Yasutake	NNP	ORGANIZATION	Yasutake	nn	14	SENT_254	[p16l1459t3096r1701b3144],
14	T	NN	ORGANIZATION	t	appos	2	SENT_254	[p16l1724t3098r1772b3154],
15	,	,	O	,	_	0	SENT_254	[p16l1724t3098r1772b3154],
16	Yoshimura	NNP	PERSON	Yoshimura	nn	17	SENT_254	[p16l1797t3096r2090b3144],
17	T	NN	O	t	appos	2	SENT_254	[p16l2113t3098r2149b3143],
18	et	FW	O	et	nn	19	SENT_254	[p16l148t3177r197b3219],
19	al.	FW	O	al.	dep	17	SENT_254	[p16l230t3171r288b3219],
20	.	.	O	.	_	0	SENT_254	[p16l230t3171r288b3219],

1	G	NN	O	g	nn	2	SENT_255	[p16l328t3171r592b3219],
2	|	NNS	O	|	nsubjpass	10	SENT_255	[p16l328t3171r592b3219],
3	n27G	NN	O	n27g	nn	8	SENT_255	[p16l328t3171r592b3219],
4	|	NN	O	|	nn	8	SENT_255	[p16l328t3171r592b3219],
5	u	NN	O	u	nn	8	SENT_255	[p16l328t3171r592b3219],
6	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	8	SENT_255	[p16l633t3171r1109b3234],
7	receptor	NN	O	receptor	nn	8	SENT_255	[p16l1147t3177r1379b3234],
8	variant	NN	O	variant	dep	2	SENT_255	[p16l1410t3172r1601b3219],
9	is	VBZ	O	be	auxpass	10	SENT_255	[p16l1636t3172r1671b3219],
10	associated	VBN	O	associate	_	0	SENT_255	[p16l1707t3171r1988b3219],
11	with	IN	O	with	_	0	SENT_255	[p16l2024t3171r2144b3219],
12	hypertriglyceridemia	NN	O	hypertriglyceridemia	prep_with	10	SENT_255	[p16l148t3246r721b3308],
13	and	CC	O	and	_	0	SENT_255	[p16l746t3246r846b3293],
14	the	DT	O	the	det	15	SENT_255	[p16l871t3246r959b3293],
15	development	NN	O	development	conj_and	12	SENT_255	[p16l983t3246r1353b3308],
16	of	IN	O	of	_	0	SENT_255	[p16l1374t3246r1428b3293],
17	fatty	JJ	O	fatty	amod	18	SENT_255	[p16l1447t3246r1572b3308],
18	liver	NN	O	liver	prep_of	15	SENT_255	[p16l1596t3246r1721b3293],
19	.	.	O	.	_	0	SENT_255	[p16l1596t3246r1721b3293],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_256	[p16l1752t3246r1849b3293],
2	Chim	NNP	PERSON	Chim	nn	3	SENT_256	[p16l1874t3246r2009b3293],
3	Acta	NNP	PERSON	Acta	_	0	SENT_256	[p16l2029t3248r2149b3293],
4	2001	CD	DATE	2001	num	3	SENT_256	[p16l147t3322r304b3378],
5	;	:	O	;	_	0	SENT_256	[p16l147t3322r304b3378],
6	314	CD	NUMBER	314	num	8	SENT_256	[p16l333t3322r453b3368],
7	:	:	O	:	_	0	SENT_256	[p16l333t3322r453b3368],
8	85-91	CD	NUMBER	85-91	dep	3	SENT_256	[p16l483t3322r671b3368],
9	.	.	O	.	_	0	SENT_256	[p16l483t3322r671b3368],

1	Hagstrom-Toft	JJ	O	hagstrom-toft	amod	2	SENT_257	[p16l149t3396r555b3459],
2	E	NN	O	e	dep	16	SENT_257	[p16l593t3398r633b3454],
3	,	,	O	,	_	0	SENT_257	[p16l593t3398r633b3454],
4	Enoksson	NN	O	enoksson	nn	5	SENT_257	[p16l678t3396r927b3444],
5	S	NN	O	s	appos	2	SENT_257	[p16l969t3398r1012b3454],
6	,	,	O	,	_	0	SENT_257	[p16l969t3398r1012b3454],
7	Moberg	NNP	PERSON	Moberg	nn	8	SENT_257	[p16l1056t3396r1273b3459],
8	E	NNP	O	E	appos	2	SENT_257	[p16l1316t3398r1355b3454],
9	,	,	O	,	_	0	SENT_257	[p16l1316t3398r1355b3454],
10	Bolinder	NNP	PERSON	Bolinder	nn	11	SENT_257	[p16l1400t3396r1628b3444],
11	J	NNP	PERSON	J	appos	2	SENT_257	[p16l1662t3398r1692b3455],
12	,	,	O	,	_	0	SENT_257	[p16l1662t3398r1692b3455],
13	Amer	NNP	PERSON	Amer	nn	15	SENT_257	[p16l1731t3398r1884b3444],
14	P.	NNP	PERSON	P.	nn	15	SENT_257	[p16l1923t3398r1966b3444],
15	Betaadrenergic	NNP	PERSON	Betaadrenergic	appos	2	SENT_257	[p16l2009t3398r2145b3444, p16l146t3471r442b3533],
16	regulation	NN	O	regulation	_	0	SENT_257	[p16l481t3471r759b3533],
17	of	IN	O	of	_	0	SENT_257	[p16l799t3471r853b3518],
18	lipolysis	NN	O	lipolysis	nn	21	SENT_257	[p16l890t3471r1100b3533],
19	and	CC	O	and	_	0	SENT_257	[p16l1137t3471r1237b3518],
20	blood	NN	O	blood	conj_and	18	SENT_257	[p16l1279t3471r1435b3518],
21	flow	NN	O	flow	prep_of	16	SENT_257	[p16l1471t3471r1591b3518],
22	in	IN	O	in	_	0	SENT_257	[p16l1629t3472r1673b3518],
23	human	JJ	O	human	amod	25	SENT_257	[p16l1715t3471r1906b3518],
24	skeletal	JJ	O	skeletal	amod	25	SENT_257	[p16l1945t3471r2143b3518],
25	muscle	NN	O	muscle	prep_in	21	SENT_257	[p16l148t3546r338b3594],
26	in	FW	O	in	prep	25	SENT_257	[p16l366t3547r412b3593],
27	vivo	FW	O	vivo	pobj	26	SENT_257	[p16l439t3547r553b3594],
28	.	.	O	.	_	0	SENT_257	[p16l439t3547r553b3594],

1	Am	VBP	O	be	_	0	SENT_258	[p16l580t3548r668b3593],
2	/	:	O	/	punct	3	SENT_258	[p16l688t3548r708b3605],
3	Physiol	NNP	O	Physiol	nsubj	8	SENT_258	[p16l733t3546r916b3609],
4	1998	CD	DATE	1998	num	3	SENT_258	[p16l939t3548r1094b3604],
5	;	:	O	;	_	0	SENT_258	[p16l939t3548r1094b3604],
6	275	CD	NUMBER	275	dep	3	SENT_258	[p16l1122t3548r1243b3594],
7	:	:	O	:	_	0	SENT_258	[p16l1122t3548r1243b3594],
8	E909	NN	O	e909	ccomp	1	SENT_258	[p16l1275t3548r1597b3594],
9	.	.	O	.	_	0	SENT_258	[p16l1275t3548r1597b3594],

1	—	NN	O	—	_	0	SENT_259	[p16l1275t3548r1597b3594],
2	.	.	O	.	_	0	SENT_259	[p16l1275t3548r1597b3594],

1	E916	NN	O	e916	_	0	SENT_260	[p16l1275t3548r1597b3594],
2	.	.	O	.	_	0	SENT_260	[p16l1275t3548r1597b3594],

1	Holm	NNP	PERSON	Holm	nn	2	SENT_261	[p16l149t3621r294b3669],
2	C	NNP	O	C	_	0	SENT_261	[p16l335t3622r390b3679],
3	,	,	O	,	_	0	SENT_261	[p16l335t3622r390b3679],
4	Belfrage	NNP	PERSON	Belfrage	nn	5	SENT_261	[p16l435t3621r655b3684],
5	P	NN	PERSON	p	appos	2	SENT_261	[p16l697t3623r739b3679],
6	,	,	O	,	_	0	SENT_261	[p16l697t3623r739b3679],
7	Fredrikson	NNP	PERSON	Fredrikson	nn	10	SENT_261	[p16l784t3621r1063b3669],
8	G.	NNP	O	G.	nn	10	SENT_261	[p16l1105t3622r1163b3669],
9	Immunological	NNP	O	Immunological	nn	10	SENT_261	[p16l1207t3621r1622b3684],
10	evidence	NN	O	evidence	appos	2	SENT_261	[p16l1663t3621r1909b3669],
11	for	IN	O	for	_	0	SENT_261	[p16l1945t3621r2023b3669],
12	the	DT	O	the	det	13	SENT_261	[p16l2058t3621r2146b3669],
13	presence	NN	O	presence	prep_for	10	SENT_261	[p16l148t3710r391b3759],
14	of	IN	O	of	_	0	SENT_261	[p16l421t3696r475b3744],
15	hormone	NN	O	hormone	nn	16	SENT_261	[p16l503t3696r1012b3744],
16	—	NN	O	—	prep_of	13	SENT_261	[p16l503t3696r1012b3744],
17	sensitive	JJ	O	sensitive	amod	18	SENT_261	[p16l503t3696r1012b3744],
18	lipase	NN	O	lipase	dep	2	SENT_261	[p16l1043t3696r1194b3759],
19	in	IN	O	in	_	0	SENT_261	[p16l1225t3697r1269b3743],
20	rat	NN	O	rat	nn	21	SENT_261	[p16l1303t3701r1374b3744],
21	tissues	NNS	O	tissue	prep_in	18	SENT_261	[p16l1400t3697r1577b3744],
22	other	JJ	O	other	dep	2	SENT_261	[p16l1606t3696r1754b3744],
23	than	IN	O	than	_	0	SENT_261	[p16l1780t3696r1902b3744],
24	adipose	JJ	O	adipose	amod	25	SENT_261	[p16l1934t3696r2146b3759],
25	tissue	NN	O	tissue	prep_than	22	SENT_261	[p16l145t3772r313b3818],
26	.	.	O	.	_	0	SENT_261	[p16l145t3772r313b3818],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_262	[p16l344t3771r564b3818],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_262	[p16l591t3771r791b3833],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_262	[p16l816t3773r901b3818],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_262	[p16l928t3772r1168b3818],
5	1987	CD	DATE	1987	num	4	SENT_262	[p16l1195t3772r1349b3828],
6	;	:	O	;	_	0	SENT_262	[p16l1195t3772r1349b3828],
7	148	CD	NUMBER	148	num	9	SENT_262	[p16l1382t3772r1499b3818],
8	:	:	O	:	_	0	SENT_262	[p16l1382t3772r1499b3818],
9	99-105	CD	NUMBER	99-105	dep	4	SENT_262	[p16l1528t3772r1753b3818],
10	.	.	O	.	_	0	SENT_262	[p16l1528t3772r1753b3818],

1	20	CD	NUMBER	20	num	8	SENT_263	[p17l10t20r78b66],
2	Abraham	NNP	ORGANIZATION	Abraham	nn	8	SENT_263	[p17l144t18r396b66],
3	WT	NNP	ORGANIZATION	WT	nn	8	SENT_263	[p17l431t20r539b76],
4	,	,	O	,	_	0	SENT_263	[p17l431t20r539b76],
5	Iyengar	NNP	PERSON	Iyengar	appos	8	SENT_263	[p17l580t21r785b81],
6	S.	NNP	O	S.	nn	8	SENT_263	[p17l819t20r862b66],
7	Practical	NNP	O	Practical	nn	8	SENT_263	[p17l902t18r1126b66],
8	considerations	NNS	O	consideration	_	0	SENT_263	[p17l1163t18r1563b66],
9	for	IN	O	for	_	0	SENT_263	[p17l1595t18r1673b66],
10	switching	VBG	O	switch	prepc_for	8	SENT_263	[p17l1704t18r1968b81],
11	betablockers	NNS	O	betablocker	dobj	10	SENT_263	[p17l2007t18r2145b66, p17l148t94r372b142],

1	in	IN	O	in	_	0	SENT_264	[p17l397t95r442b141],
2	heart	NN	O	heart	nn	4	SENT_264	[p17l470t94r611b142],
3	failure	NN	O	failure	nn	4	SENT_264	[p17l630t94r800b142],
4	patients	NNS	O	patient	pobj	1	SENT_264	[p17l827t95r1058b157],
5	.	.	O	.	_	0	SENT_264	[p17l827t95r1058b157],

1	Rev	NN	MISC	rev	nn	3	SENT_265	[p17l1088t96r1181b142],
2	Cardiovasc	NNP	MISC	Cardiovasc	nn	3	SENT_265	[p17l1202t94r1491b142],
3	Med	NNP	O	Med	_	0	SENT_265	[p17l1512t94r1631b142],
4	2004	CD	DATE	2004	num	3	SENT_265	[p17l1650t95r1806b152],
5	;	:	O	;	_	0	SENT_265	[p17l1650t95r1806b152],
6	5	CD	NUMBER	5	number	7	SENT_265	[p17l1833t94r2046b157],
7	(	CD	NUMBER	(	num	11	SENT_265	[p17l1833t94r2046b157],
8	Supp	NNP	O	Supp	nn	11	SENT_265	[p17l1833t94r2046b157],
9	|	CD	NUMBER	|	num	11	SENT_265	[p17l1833t94r2046b157],
10	1	CD	NUMBER	1	amod	11	SENT_265	[p17l2076t94r2143b154],
11	)	NN	O	)	dep	3	SENT_265	[p17l2076t94r2143b154],
12	:	:	O	:	_	0	SENT_265	[p17l2076t94r2143b154],
13	$	$	MONEY	$	dep	11	SENT_265	[p17l147t171r401b217],
14	36	CD	MONEY	36	num	13	SENT_265	[p17l147t171r401b217],
15	-	:	O	-	_	0	SENT_265	[p17l147t171r401b217],
16	$	$	MONEY	$	dep	13	SENT_265	[p17l147t171r401b217],
17	44	CD	MONEY	44	num	16	SENT_265	[p17l147t171r401b217],
18	.	.	O	.	_	0	SENT_265	[p17l147t171r401b217],

1	Manraj	NNP	O	Manraj	nn	2	SENT_266	[p17l149t246r338b308],
2	M	NNP	O	M	_	0	SENT_266	[p17l371t247r439b303],
3	,	,	O	,	_	0	SENT_266	[p17l371t247r439b303],
4	Francke	NNP	PERSON	Francke	nn	5	SENT_266	[p17l475t245r683b293],
5	S	NNP	PERSON	S	conj_and	2	SENT_266	[p17l714t247r756b303],
6	,	,	O	,	_	0	SENT_266	[p17l714t247r756b303],
7	Hebe	NNP	O	Hebe	nn	8	SENT_266	[p17l793t245r933b293],
8	A	NNP	O	A	conj_and	2	SENT_266	[p17l961t247r1013b303],
9	,	,	O	,	_	0	SENT_266	[p17l961t247r1013b303],
10	Ramjuttun	NNP	LOCATION	Ramjuttun	nn	11	SENT_266	[p17l1049t246r1333b308],
11	US	NNP	LOCATION	US	conj_and	2	SENT_266	[p17l1367t247r1453b303],
12	,	,	O	,	_	0	SENT_266	[p17l1367t247r1453b303],
13	Froguel	NNP	ORGANIZATION	Froguel	nn	15	SENT_266	[p17l1489t245r1690b308],
14	P.	NNP	ORGANIZATION	P.	nn	15	SENT_266	[p17l1725t247r1768b293],
15	Genetic	NNP	ORGANIZATION	Genetic	conj_and	2	SENT_266	[p17l1801t246r2015b293],
16	and	CC	O	and	_	0	SENT_266	[p17l2043t245r2144b293],
17	environmental	JJ	O	environmental	amod	18	SENT_266	[p17l146t320r547b368],
18	nature	NN	O	nature	conj_and	2	SENT_266	[p17l598t326r774b368],
19	of	IN	O	of	_	0	SENT_266	[p17l819t320r873b368],
20	the	DT	O	the	det	23	SENT_266	[p17l915t320r1003b368],
21	insulin	NN	O	insulin	nn	23	SENT_266	[p17l1051t320r1224b368],
22	resistance	NN	O	resistance	nn	23	SENT_266	[p17l1274t322r1540b368],
23	syndrome	NN	O	syndrome	prep_of	18	SENT_266	[p17l1586t320r1861b383],
24	in	IN	O	in	_	0	SENT_266	[p17l1909t322r1953b368],
25	IndoMauritian	JJ	MISC	indomauritian	amod	26	SENT_266	[p17l2004t320r2145b368, p17l149t396r410b443],
26	subjects	NNS	O	subject	prep_in	23	SENT_266	[p17l435t395r655b458],
27	with	IN	O	with	_	0	SENT_266	[p17l677t395r796b443],
28	premature	JJ	O	premature	amod	31	SENT_266	[p17l823t400r1110b458],
29	coronary	JJ	O	coronary	amod	31	SENT_266	[p17l1134t409r1379b458],
30	heart	NN	O	heart	nn	31	SENT_266	[p17l1403t395r1544b443],
31	disease	NN	O	disease	prep_with	26	SENT_266	[p17l1565t395r1776b443],
32	:	:	O	:	_	0	SENT_266	[p17l1565t395r1776b443],
33	contribution	NN	O	contribution	dep	2	SENT_266	[p17l1802t395r2143b443],
34	of	IN	O	of	_	0	SENT_266	[p17l146t470r200b517],
35	beta3-adrenoreceptor	NN	O	beta3-adrenoreceptor	nn	37	SENT_266	[p17l239t470r852b532],
36	gene	NN	O	gene	nn	37	SENT_266	[p17l889t484r1024b532],
37	polymorphism	NN	O	polymorphism	prep_of	33	SENT_266	[p17l1067t470r1467b532],
38	and	CC	O	and	_	0	SENT_266	[p17l1509t470r1610b517],
39	beta	NN	O	beta	nn	40	SENT_266	[p17l1653t470r1770b517],
40	blockers	NNS	O	blocker	conj_and	37	SENT_266	[p17l1813t470r2037b517],
41	on	IN	O	on	_	0	SENT_266	[p17l2077t484r2144b517],
42	triglyceride	NN	O	triglyceride	nn	45	SENT_266	[p17l145t545r456b608],
43	and	CC	O	and	_	0	SENT_266	[p17l483t545r583b593],
44	HDL	NN	O	hdl	nn	45	SENT_266	[p17l614t547r732b592],
45	concentrations	NNS	O	concentration	prep_on	33	SENT_266	[p17l755t546r1181b593],
46	.	.	O	.	_	0	SENT_266	[p17l755t546r1181b593],

1	Diabetologia	NNP	O	Diabetologia	_	0	SENT_267	[p17l1213t545r1553b608],
2	2001	CD	DATE	2001	num	1	SENT_267	[p17l1576t547r1733b603],
3	;	:	O	;	_	0	SENT_267	[p17l1576t547r1733b603],
4	44	CD	NUMBER	44	num	6	SENT_267	[p17l1761t547r1846b593],
5	:	:	O	:	_	0	SENT_267	[p17l1761t547r1846b593],
6	115-122	CD	NUMBER	115-122	dep	1	SENT_267	[p17l1879t547r2137b593],
7	.	.	O	.	_	0	SENT_267	[p17l1879t547r2137b593],

1	www.nature.com/tpj	NN	O	www.nature.com/tpj	_	0	SENT_268	[p17l1595t800r2145b859],

